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 Pref ace 
 The chapters in this book, which review the presentations at the 6th International 
Symposium for Interface Oral Health Science held January 18–19, 2016, at Tohoku 
University, Sendai, Japan, is being issued as a special publication. I am honored and 
pleased to deliver  Interface Oral Health Science 2016 to our publisher. 
 Interface Oral Health Science is a new concept in dentistry, established by the 
Tohoku University Graduate School of Dentistry in 2002, based on the knowledge 
that normal oral function is maintained through harmony between three biological 
and biomechanical systems: (1) structure of the mouth, including teeth, the mucous 
membrane, bones, and muscles; (2) microorganisms in the mouth (parasites); and 
(3) biomaterials. Tooth decay, periodontal disease, and other oral disorders can be 
recognized as “interface disorders”, which are caused by the collapse of the inter-
face between systems. This concept is shared not only by dentistry and dental medi-
cine but also by a variety of disciplines, including medicine, material science, 
engineering, and others. 
 Since 2002, the Tohoku University Graduate School of Dentistry has regarded 
Interface Oral Health Science as the main theme of dental research in the twenty- 
fi rst century. We are committed to advancing dental studies by implementing 
Interface Oral Health Science while promoting interdisciplinary research across a 
wide range of related fi elds. Based on this concept, we have successfully organized 
international symposiums for Interface Oral Health Science fi ve times, in 2005, 
2007, 2009, 2011, and 2014, which included inspiring special lectures, symposium 
sessions, poster presentations, and other discussions. These presentations were pub-
lished in a series of English monographs titled  Interface Oral Health Science . 
 These achievements were praised, and in 2007 the “Highly-functional Interface 
Science: Innovation of Biomaterials with Highly-functional Interface to Host and 
Parasite” was adopted as a program for research and education funding for an Inter- 
University Research Project 2007–2011, Ministry of Education, Culture, Sports, 
Science and Technology (MEXT), Japan. Subsequently, we have been developing a 
broader and more advanced concept: “Biosis–Abiosis Intelligent Interface”, which 
also was adopted as the program for a Research Promotion Project 2012–2015, 
MEXT, Japan. It aims to create a highly functional and autonomic intelligent 
vi
 interface by combining the highly functional interface science established by the 
Tohoku University Graduate School of Dentistry and the Institute for Materials 
Research, Tohoku University. The accompanying technology for evaluation and 
control at the interface was provided by the Graduate School of Biomedical 
Engineering, Tohoku University. We fi rmly believe that the Biosis–Abiosis 
Intelligent Interface project can contribute to solving various problems not only in 
dentistry and medicine but also in other disciplines. 
 Therefore, the 6th International Symposium for Interface Oral Health Science 
was held in conjunction with the Innovative Research for Biosis–Abiosis Intelligent 
Interface Symposium, organized by the Tohoku University Graduate School of 
Dentistry with the aid of a Research Promotion Project Grant, MEXT, Japan. The 
symposium consisted of one special lecture, four focus sessions, and a poster ses-
sion with 61 poster presentations. We hosted 22 distinguished invited keynote 
speakers for the focus sessions. 
 I hope that our project, including the symposium and the book, will accelerate 
the progress of dental science and point the way for dental research for future gen-
eration. Finally, I would like to thank all members of our school and the participants 
in the symposium for your contributions. Our thanks go especially to the authors of 
the excellent review chapters in this book. 




 The editors wish to acknowledge the following members of Tohoku University 
Graduate School of Dentistry; Institute for Materials Research, Tohoku University; 
and Tohoku University Graduate School of Biomedical Engineering, all of whom 
have contributed their valued expertise and time to hold the symposium and to edit 
manuscripts submitted to  Interface Oral Health Science 2016 . These colleagues 
have provided essential assistance, without which it wouldn’t have been possible to 
publish this monograph in a timely manner.
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Chapter 1
Low-Modulus Ti Alloys Suitable for Rods 
in Spinal Fixation Devices
Mitsuo Niinomi
Abstract Low-Young’s modulus Ti alloys are expected to be suitable for use in the 
rods of spinal fixation devices. However, in addition to a low Young’s modulus, the 
rods must also exhibit a high Young’s modulus at the deformed region to reduce 
springback when surgeons bend the rod inside the narrow bodies of patients. Ti–Mo 
and Ti–Cr alloys are potential candidates to satisfy these two conflicting demands. 
In these alloys, known as Young’s modulus changeable or Young’s modulus self- 
adjustable Ti alloys, the ω-phase with high Young’s modulus is induced by defor-
mation. Among these alloys, Ti–12Cr is judged to be the most suitable for use in the 
rods of spinal fixation devices. This alloy exhibits a high uniaxial fatigue strength, 
and its compressive fatigue strength is significantly improved by cavitation 
peening.
Keywords Low Young’s modulus • Young’s modulus self-adjustability • Ti–Cr 
alloy • Ti–Mo alloy • Spinal fixation device • Compressive fatigue strength • 
Cavitation peening
1.1  Introduction
To inhibit stress shielding, which is caused by the mismatch in Young’s modulus 
between an implant and bone and leads to bone absorption and poor bone remodel-
ing, low-Young’s modulus titanium (Ti) alloys have been or are being developed for 
implant devices such as artificial hip joints, bone plates, and spinal fixation devices.
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A novel β-type Ti alloy composed of nontoxic and allergy-free elements 
(Ti–29Nb–13Ta–4.6Zr mass%, hereafter abbreviated as TNTZ) is a low-Young’s 
modulus Ti alloy developed by Niinomi et al. based on the d-electron design method 
[1]. This alloy exhibits excellent corrosion resistance and biocompatibility, with a 
low Young’s modulus (~60 GPa), and has thus been investigated for use in many 
practical applications, including the production of implant rods for spinal fixtures 
[2]. In spinal fixation rods, the low Young’s modulus and excellent biocompatibility 
of TNTZ is beneficial for patients; however, this alloy possesses only relatively 
moderate mechanical properties (ultimate tensile strength = ~510 MPa) [1], which 
are inadequate for practical application. However, according to surgeons specializ-
ing in spinal diseases, the implant rod should exhibit a small degree of springback 
to offer greater handling ability for surgeons, who are required to bend the rod to 
conform to the curvature of the spine within the limited space inside a patient’s body 
[3]. The amount of springback is determined by both the strength and Young’s mod-
ulus. Given the same strength, a rod with the higher Young’s modulus will exhibit 
less springback, that is, a high Young’s modulus is preferable to suppress springback 
from the viewpoint of surgeons. There is therefore a conflicting requirement con-
cerning the Young’s modulus from the viewpoint of patients and surgeons, which 
cannot be fully satisfied by TNTZ.
Recently, many researchers [4–7] have focused on the development of new 
β-type Ti alloys to solve this problem, such as Ti–Mo and Ti–Cr alloys. These alloys 
possess a novel property called “changeable Young’s modulus” or “Young’s modu-
lus self-adjustability,” in which the deformed region of the material exhibits a high 
Young’s modulus, whereas the Young’s modulus of the undeformed region remains 
low.
Therefore, changeable-Young’s modulus Ti alloys suitable for the rods of spinal 
fixation devices are introduced with a focus on Ti–Mo and Ti–Cr alloys.
1.2  Mechanism of Increasing Young’s Modulus in Deformed 
Region
The springback of the deformed rods of spinal fixation device can be reduced by 
increasing the Young’s modulus in the deformed region. This reduction can be 
achieved if a secondary phase with a high Young’s modulus is induced by deforma-
tion. In Ti alloys, metastable phases such as αʹ martensite with hcp structure, α″ 
martensite with orthorhombic structure, and ω-phase with hexagonal or trigonal 
structure can form between the stable α- and β-phases based on the amount of 
β-stabilizing element, as depicted in the schematic phase diagram of Ti alloys in 
Fig. 1.1. Therefore, various phases such as αʹ-, α″-, and ω-phases can be induced by 
deformation. ω-phase precipitation is known to increase the Young’s modulus of the 
alloys, whereas αʹ- and α″-phase precipitations result in a decrease. Therefore, if the 
β-phase stability is controlled for the ω-phase to be induced by deformation, the 
M. Niinomi
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Young’s modulus of the alloys is partially increased in the deformed region, leading 
to a decrease in springback of the alloy and thereby maintaining the deformed shape 
of the rod.
1.3  Possible Alloy System
The addition of molybdenum (Mo) results in β-stabilizing properties in Ti alloys 
[8], and, thus, it is an effective β stabilizer for designing β-type alloys. In addition, 
Hanada et al. reported that a ω-phase forms during the cold working of as-quenched 
Ti–Mo alloys within the composition range of 11–18 mass% Mo [9–11]. Thus, it is 
possible to realize a changeable Young’s modulus in metastable Ti–Mo alloys via 
deformation-induced ω-phase transformation. Moreover, Mo is less toxic than Al 
and V [1]. Many studies have demonstrated the excellent mechanical compatibility 
and good cytocompatibility of Ti alloys containing Mo, such as Ti–Mo, Ti–Mo–Ta, 
and Ti–Mo–Zr–Fe [12–17]. Karthega et al. [18] reported that Ti–15Mo exhibits cor-
rosion resistance similar to that of TNTZ in Hank’s solution. Both Zhou et al. and 
Oliveira et al. [19] reported that Ti–Mo alloys exhibit excellent corrosion 
resistance.
Hanada et al. reported that the ω-phase forms during the cold working of as- 
quenched Ti–Cr alloys within the composition range of 8–11.5 mass% Cr [20]. 

































Fig. 1.1 Relationship between schematic phase diagram of titanium alloys and β stability
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Ti–V, Ti–Fe, and Ti–Mo metastable β-type alloys [10, 11, 21–23]. Furthermore, Cr 
is known to control the anodic activity of the alloy and increase the tendency of Ti 
to passivate [24], and the passive films of Ti alloys, in turn, allow them to maintain 
corrosion resistance [25–27].
Thus, Mo and Cr are suitable alloying elements to develop Ti-based biomaterials 
with Young’s modulus adjustability.
However, as depicted in the schematic illustration of the relationship between tem-
perature and alloying element content in Fig. 1.2 [23, 28], with each appearing phase, 
deformation-induced ω-phase precipitation occurs, and the lowest Young’s modulus 
before deformation is highly expected in the relatively high β stability region.
To optimize the chemical compositions of Ti–Mo and Ti–Cr alloys exhibiting the 
greatest increase in Young’s modulus after deformation (the best Young’s modulus 
adjustability), the Mo equivalent, Moeq, was considered, and 1 mass%Cr is equiva-
lent to 1.25 mass%Mo. Then, the Ti–Mo and Ti–Cr alloys, whose nominal chemical 
compositions are listed in Table 1.1 [29], were examined. The Young’s moduli, 
microstructures, and deformation behaviors of both alloy systems were examined 
before and after deformation; deformation was simulated by cold rolling with a 
reduction of 10 %.















Fig. 1.2 Schematic 
variation of Young’s 
modulus in Ti–M (M: β 
stabilizer) binary alloys as 
a function of alloying 
element content. ST and 
CR indicates solution 
treatment and cold rolling, 
respectively
Table 1.1 Nominal chemical compositions of Ti–Mo and T–Cr systems alloys examined to 
optimize their chemical compositions exhibiting the greatest increase in Young’s modulus after 
deformation (the best Young’s modulus adjustability)
Ti–Cr system Ti–10Cr Ti–11Cr Ti–12Cr Ti–13Cr
Ti–Mo system Ti–13Mo Ti–15Mo Ti–16Mo Ti–17Mo
M. Niinomi
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1.4  Ti–Mo Alloys
1.4.1  Microstructures Before and After Deformation
The X-ray diffraction (XRD) profiles of the Ti–(13–18)Mo alloys subjected to solu-
tion treatment and cold rolling with a reduction of 10 % (hereafter called as cold 
rolling (CR)) are shown in Fig. 1.3 [29, 30]. Only peaks corresponding to the 
β-phase are detected in each solution-treated (ST) specimen. No peaks correspond-
ing to the ω-phase are detected by XRD. In addition, after cold rolling, only single 
β-phases are detected in each CR specimen. However, the enlarged XRD profiles of 
Ti–13Mo alloy subjected to solution treatment (ST) and CR in Fig. 1.4 [29] contain 
ω- and α″-phase peaks, respectively. For Ti–13Mo alloy, it is apparent that 
deformation- induced α″-phase transformation occurs.
Figure 1.5 [29, 30] shows selected area electron diffraction patterns of the Ti–
(13–18)Mo alloys subjected to ST. The existence of a small amount of athermal 
ω-phase is recognized in the Ti–(13–16)Mo alloys subjected to ST. As the intensi-
ties of the ω reflections decrease with increasing Mo content, the amount of the 
athermal ω-phase in the ST specimens decreases. It is well known that the amount 
of the athermal ω-phase in β-type alloys depends on the stability of the β-phase. 
Specifically, the stability of the β-phase increases with increasing Mo content. Thus, 
the formation of the athermal ω-phase during water quenching (WQ) is suppressed 
in high-β-stable alloys. The amount of the athermal ω-phase in Ti–16Mo–ST is thus 
less than that in Ti–13Mo–ST, and the athermal ω-phase in Ti–17Mo–ST and 
Ti–18Mo–ST disappears.























































Fig. 1.3 XRD profiles of Ti–(13–18)Mo alloys subjected to solution treatment (ST) and cold roll-
ing (CR)
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Figure 1.6 [29, 30] shows selected area electron diffraction patterns of the Ti–
(13–18)Mo alloys subjected to CR. After cold rolling, the ω spots in all the alloys 
become sharp. This result confirms that deformation-induced ω-phase transforma-
tion occurs during CR. After CR, the ω reflections in Ti–13Mo–Cr, Ti–15Mo–CR, 
and Ti–16Mo–CR are much sharper than in Ti–13Mo, Ti–15Mo–ST, and Ti–16Mo–
ST, indicating that the amount of ω-phase increases because of CR. Moreover, sharp 
extra spots corresponding to the ω-phase are observed in Ti–17Mo–CR and 
Ti–18Mo–CR, suggesting that a considerable amount of ω-phase is formed in these 
two alloys. These findings confirm that deformation-induced ω-phase transforma-
Ti-13Mo ST
Ti-17Mo ST



















Ti-13Mo STAthermal ω phase + β phase
ω

















Fig. 1.4 XRD profiles of 
Ti–13Mo alloy subjected 
to solution treatment (ST) 
and cold rolling (CR)
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tion occurs in all the Ti–(13–18)Mo alloys during CR. With increasing Mo content, 
the intensities of the ω reflections decrease, indicating that deformation-induced 
ω-phase transformation is dependent on the stability of the β-phase. Specifically, as 
the Mo content increases, the stability of the β-phase increases and deformation- 
induced ω-phase transformation becomes difficult during CR. Thus, the amount of 
deformation-induced ω-phase decreases with increasing Mo content.
1.4.2  Young’s Modulus Change by Deformation
Figure 1.7 [29, 30] shows the Young’s moduli of the Ti–(13–18)Mo alloys subjected 
to solution treatment and CR. Except Ti–13Mo alloy, all the alloys subjected to ST 
exhibit low Young’s moduli of <80 GPa, which is much lower than those of SUS 
316 L stainless steel (SUS 316 L), commercially pure titanium (CP Ti), and 
Ti–6Al–4 V extra low interstitial (ELI) alloy (Ti64 ELI). For the Ti–(15–18)Mo 
alloys, the Young’s moduli of the alloys subjected to CR are higher than those sub-
jected to ST. For the ST specimens, with increasing Mo content, the Young’s modu-
lus first decreases slightly from 79 GPa for Ti–15Mo–ST to 73 GPa for Ti–17Mo–ST, 
after which the value slightly increases to 75 GPa for Ti–18Mo–ST. According to 
the TEM observation and XRD analysis results, the amount of athermal ω-phase in 
the alloys decreases with increasing Mo content. There is no athermal ω-phase in 
Ti–17Mo–ST or Ti–18Mo–ST. The ω-phase is known to have a significant effect on 
the mechanical properties of Ti alloys and is likely to increase the Young’s modulus. 
In this case, the athermal ω-phase is the main factor contributing to the change in the 
Ti-13Mo CR Ti-15Mo CR Ti-16Mo CR
Ti-17Mo CR Ti-18Mo CR
β
ω
Fig. 1.6 Selected area electron diffraction patterns of Ti–(13–18)Cr alloys subjected to cold roll-
ing (CR)
1 Low-Modulus Ti Alloys Suitable for Rods in Spinal Fixation Devices
10
Young’s modulus. Therefore, the Young’s modulus of the alloys first decreases, and 
Ti–17Mo–ST exhibits the lowest Young’s modulus among the designed alloys. 
With a further increase in the Mo content, the athermal ω-phase in the alloy disap-
pears. Thus, the solid solution strengthening with Mo becomes the primary cause of 
the changes in the Young’s modulus. The Young’s modulus increases as the bcc 
lattice contracts with increasing Mo content. Therefore, the Young’s modulus of 
Ti–18Mo–ST is slightly higher than that of Ti–17Mo–ST. The microstructural anal-
ysis indicates that deformation-induced ω-phase transformation occurs in all the 
alloys. Therefore, the increase in the Young’s moduli of these four alloys following 
CR is attributed to the deformation-induced ω-phase transformation that occurred 
during CR. The lack of change in the Young’s modulus of Ti–13Mo alloy is consid-
ered to result from the combined effect of deformation- induced ω-phase transfor-
mation and deformation-induced α″-phase transformation.
1.4.3  Deformation-Induced Products and Phase Constitutions
The deformation-induced products in Ti–(13–18)Mo alloys resulting from CR are 
summarized in Table 1.2 [29]. Except for Ti–13Mo alloy, the ω-phase as well as 
{332}β<113>β and {112}β<111>β twins are formed by CR. For Ti–13Mo alloy, the 
ω- and α″-phase as well as {332}β<113>β and {112}β<111>β twins are formed by 
CR.
The constituent phases of the Ti–(13–18)Mo alloys subjected to ST and CR are 
summarized in Table 1.3 [29]. The constituent phases of the Ti–(13–16)Mo alloys 
subjected to ST are the β- and athermal ω-phases, whereas that of the Ti–17Mo and 
Ti–18Mo alloys subjected to ST is ω-phase.
The constituent phases of the Ti–13Mo alloy subjected to CR are β-, athermal ω-, 























Fig. 1.7 Young’s moduli 
of Ti–(13–18)Mo alloys 
subjected to solution 




phases of the Ti–15Mo and Ti–16Mo alloys subjected to CR are the β-, athermal ω-, 
and deformation-induced ω-phases. Further, the constituent phases of the Ti–16Mo 
and Ti–17Mo alloys subjected to CR are β- and deformation-induced ω-phases.
1.4.4  Springback
Ti–17Mo alloy exhibited the greatest increase in Young’s modulus after CR, as 
stated above. The ratios of springback per unit load as a function of applied strain 
for Ti–17Mo alloy, Ti64 ELI, which is the most widely used Ti alloy for biomedical 
applications, and TNTZ, and strains for the calculation of the springback ratio are 
shown in Fig. 1.8 [29, 30]. The springback per unit load ratio of Ti–17Mo alloy is 
smaller than that of TNTZ and close to that of Ti64 ELI and reaches to a stable value 
for an applied strain greater than 2 %. The springback of a rod composed of Ti–17Mo 
alloy is expected to be significantly suppressed.






Mechanical twinning ({332}β<113>β 
and {112}β<111>β)
Ti–13Mo ☆ ☆ ☆
Ti–15Mo ☆ × ☆
Ti–16Mo ☆ × ☆
Ti–17Mo ☆ × ☆
Ti–18Mo ☆ × ☆
Table 1.3 Summary of phase constitutions of Ti–(13–18)Mo alloys subjected to solution treatment 
(ST) and cold rolling (CR)
Alloy
Subjected to solution 
treatment Subjected to solution treatment and cold rolling
Ti–13Mo β + athermal ω β + athermal ω + deformation-induced ω + deformation- 
induced α″
Ti–15Mo β + athermal ω β + athermal ω + deformation-induced ω
Ti–16Mo β + athermal ω β + athermal ω + deformation-induced ω
Ti–17Mo β β + deformation-induced ω
Ti–18Mo β β + deformation-induced ω
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1.5  Ti–Cr Alloys
1.5.1  Microstructures Before and After Deformation
Figure 1.9 [31] shows the XRD profiles of the Ti–xCr (x = 10, 11, 12, 13, and 14 
mass%) alloys subjected to ST and CR. Only the peaks corresponding to the bcc 
β-phase were detected in every specimen under both ST and CR conditions. No 
peaks corresponding to the ω-phase were detected by XRD.
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Fig. 1.8 Ratio of springback per unit load as a function of applied strain for Ti–17Mo alloy, 
Ti–6Al–4V ELI alloy (Ti64 ELI), and Ti–29Nb–13Ta–4.6Zr alloy (TNTZ) and strains for calcula-
tion of the springback ratio
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Figure 1.10 [31] shows the selected area electron diffraction patterns of the Ti–
xCr (x = 10, 11, 12, 13, and 14 mass%) alloys subjected to ST. The electron diffrac-
tion patterns of the [110]β zone of the Ti–10Cr–ST reveal weak extra spots in 
addition to spots derived from the β-phase, suggesting that a small amount of the 
athermal ω-phase is formed in Ti–10Cr–ST during WQ. For Ti–11Cr–ST, the 
 intensities of the ω reflections decrease, which is reflected by the change in the cir-
cular diffuse streaks. As observed in Fig. 1.5b–e, as the Cr content continues to 
increase, the circular diffuse streaks are weakened. It is well known that the inten-
sity of the ω reflection is related to the amount of the ω-phase. The amount of the 
athermal ω-phase in the designed alloys is observed to be dependent on the stability 
of the β-phase. Specifically, as the Cr content increased, the β-phase became more 
stable, leading to suppression of the formation of the athermal ω-phase during water 
quenching. Therefore, the amount of the athermal ω-phase in Ti–11Cr–ST is lower 
than that in Ti–10Cr–ST, and the athermal ω-phase disappears almost completely in 
Ti–12Cr–ST, Ti–13Cr–ST, and Ti–14Cr–ST.
Figure 1.11 [31] shows selected area electron diffraction patterns of the Ti–
(1–14)Cr alloys subjected to CR. After CR, the ω reflections in Ti–10Cr–CR are 
much sharper than in Ti–10Cr–ST, indicating that the amount of the ω-phase 
increases in response to CR. Furthermore, the intensities of the ω reflections increase 
in Ti–11Cr–CR and Ti–12Cr–CR compared with those in Ti–11Cr–ST and Ti–12Cr–
ST. These findings confirm that the deformation-induced ω-phase transformation 
occurs in the Ti–10Cr, Ti–11Cr, and Ti–12Cr alloys during CR. The amount of the 
ω-phase in Ti–10Cr–CR, Ti–11Cr–CR, and Ti–12Cr–CR is too small to be detected 
by XRD analysis, but the deformation-induced ω-phase is evident upon TEM obser-
vation. Specifically, as the Cr content increases, the intensities of the ω reflections 
Ti-10Cr ST Ti-11Cr ST Ti-12Cr ST
Ti-13Cr ST Ti-14Cr ST
β
ω
Fig. 1.10 Selected area electron diffraction patterns of Ti–(10–14)Cr alloys subjected to solution 
treatment (ST)
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decrease. In addition, only diffuse streaks are observed in Ti–13Cr–CR and 
Ti–14Cr–CR, suggesting that the amount of the ω-phase does not change during 
cold rolling. These findings indicate that the deformation-induced ω-phase transfor-
mation does not occur in Ti–13Cr and Ti–14Cr alloys during CR. Thus, the defor-
mation-induced ω-phase transformation is dependent on the β-phase stability. In 
lower-stability alloys, such as Ti–10Cr, Ti–11Cr, and Ti–12Cr, the deformation-
induced ω-phase transformation may occur; however, with increasing Cr content, 
the β-phase can become more stable, thereby suppressing the deformation- induced 
ω-phase transformation. The combined EBSD analysis and TEM observation results 
indicate that the deformation-induced ω-phase transformation is accompanied by 
{332}β mechanical twinning.
1.5.2  Young’s Modulus Change by Deformation
Figure 1.12 [31] shows the Young’s moduli of the designed alloys subjected to ST 
and CR. In the ST specimens, as the Cr content increases, the Young’s modulus 
decreases from 82 GPa for Ti–10Cr–ST to 68 GPa for Ti–12Cr–ST and then 
increases to 79 GPa for Ti–14Cr–ST. The changes in the Young’s modulus can be 
attributed to two primary factors: the athermal ω-phase and solution strength of Cr. 
When the Cr content is less than 12 mass%, the amount of the athermal ω-phase in 
the designed alloys decreases drastically as the Cr content increases. In this case, the 
athermal ω-phase is the main factor responsible for the change in the Young’s modu-
lus; therefore, the Young’s modulus initially decreases with increasing Cr content. 
However, when the Cr content increases beyond 12 mass%, the athermal ω-phase is 










becomes the primary cause of the changes in the Young’s modulus. As a result, the 
Young’s modulus increases as the Cr content increases from 12 to 14 mass%. After 
CR, Young’s moduli of Ti–10Cr, Ti–11Cr, and Ti–12Cr alloys increase remarkably 
compared with those after ST, whereas the changes in the moduli of Ti–13Cr and 
Ti–14Cr are negligible. Microstructural analysis indicates that the deformation- 
induced ω-phase transformation occurs in Ti–10Cr–CR, Ti–11Cr–CR, and Ti–12Cr–
CR and that the ω-phase in β-type Ti alloys is likely to be the source of the increase 
in the Young’s modulus. Therefore, the increase in the Young’s moduli observed for 
these three alloys can be attributed to the deformation-induced ω-phase transforma-
tion that occurs during cold rolling. The degree of the increase in the Young’s modu-
lus is dependent on the amount of the deformation-induced ω-phase; thus, the 
Young’s moduli of Ti–10Cr–CR, Ti–11Cr–CR, and Ti–12Cr–CR decrease as the Cr 
content increases. In this study, Ti–12Cr exhibits a low Young’s modulus of 68 GPa 
after ST and a high Young’s modulus of 85 GPa after CR.
1.5.3  Deformation-Induced Products and Phase Constitutions
The deformation-induced products formed by CR in the Ti–(10–14)Cr alloys are 
summarized in Table 1.4 [29]. For the Ti–(11–12)Cr alloys, the deformation-induced 
ω-phase and {332}β<113>β mechanical twins are formed by CR. However, for 
Ti–13 and Ti–14 alloys, no deformation-induced products are formed by CR.
The constituent phases of the Ti–(10–14)Cr alloys subjected to ST and CR are 
summarized in Table 1.5 [29]. The constituent phases of the Ti–10 and Ti–11Cr 
alloys subjected to ST are β- and athermal ω-phases. The constituent phases that of 
the Ti–(12–14) alloys subjected to ST is the single β-phase.
The constituent phases of the Ti–10Cr and Ti–11Cr alloys subjected to CR are 
β-, athermal ω-, and deformation-induced ω-phases. The constituent phases of the 
Ti–12Cr alloy subjected to CR are β- and deformation-induced ω-phases. The con-



















Cr content / (%)
Fig. 1.12 Young’s moduli 
of Ti–(10–14)Cr alloys 
subjected to solution 
treatment (ST) and cold 
rolling (CR)
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1.5.4  Springback
Ti–12Cr alloy exhibited the greatest increase in Young’s modulus after CR as stated 
above. The ratios of springback per unit load as a function of applied strain for 
Ti–12Cr alloy, Ti64 ELI, and TNTZ, and strains for the calculation of the spring-
back ratio are shown in Fig. 1.13 [32]. The springback per unit load ratio of Ti–12Cr 
alloy is less than that of TNTZ and close to that of Ti64 ELI and reaches to a stable 
value for an applied strain beyond 2 %. The springback of a rod composed of 
Ti–13Cr alloy is expected to be significantly suppressed.
1.6  Young’s Modulus Under Solution Treatment Conditions 
and Increment Ratio of Young’s Modulus by Cold 
Rolling
To select of the optimal alloy for spinal fixation rods, the relationships between the 
Young’s modulus under ST conditions and increment ratio, IR, of the Young’s mod-
ulus by CR of Ti–Mo and Ti–Cr alloys are plotted in Fig. 1.14 [29]. IR of the 
Young’s modulus by CR was calculated by the following equation:
 IR = −( )×E E Es c s/ %100  (1.1)
where Es is the Young’s modulus under ST conditions and Ec is the Young’s modu-
lus after CR.
Table 1.5 Summary of phase constitutions of Ti–(1–14)Cr alloys subjected to solution treatment 
(ST) and cold rolling (CR)
Alloy Subjected to solution treatment
Subjected to solution treatment and cold 
rolling
Ti–10Cr β + athermal ω β + athermal ω + deformation-induced ω
Ti–11Cr β + athermal ω β + athermal ω + deformation-induced ω
Ti–12Cr β β + deformation-induced ω
Ti–13Cr β β
Ti–14Cr β β








Ti–10Cr ☆ × ☆
Ti–11Cr ☆ × ☆
Ti–12Cr ☆ × ☆
Ti–13Cr × × ×
Ti–14Cr × × ×
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Ti–12Cr alloy exhibits the lowest Young’s modulus and highest IR under ST 
conditions and is thus the most suitable for fixation device rods.
1.7  Toward Practical Applications
In the application of Ti alloys with changeable Young’s modulus for spinal fixation 
device rods, their fatigue strengths are highly important. The uniaxial fatigue 
strength of Ti–12Cr alloy, a Ti alloy with changeable Young’s modulus, was exam-


































Fig. 1.13 Ratio of 
springback per unit load as 
a function of applied strain 
for Ti–12Cr alloy, 
Ti–6Al–4V ELI alloy 
(Ti64 ELI), and Ti–29Nb–
13Ta–4.6Zr alloy (TNTZ) 
and strains for calculation 






































Young's modulus, Es (GPa)
Fig. 1.14 Distribution of 
Ti–Cr and Ti–Mo alloys in 
a plot of Young’s modulus 
under solution-treated (ST) 
conditions against 
increment ratio of Young’s 
modulus by cold rolling 
(CR)
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conditions. The results are shown in Fig. 1.15 [33] and demonstrate excellent uni-
axial fatigue strength of this alloy. The fatigue limits of Ti–12Cr alloy and Ti64 ELI 
are shown for comparison. The fatigue ratio, which is the ratio of the fatigue limit 
to tensile strength, of Ti–12Cr alloy is approximately 0.9, whereas that of Ti64 ELI 
is approximately 0.6.
However, to employ the alloy in practical rod applications, its endurance must be 
evaluated in a laboratory according to ASTM F1717, which describes a testing 
method for evaluating the compressive fatigue strength of spinal fixation rods using 
a simulated spinal fixation model, as shown in Fig. 1.16 [34]. The spinal fixation 
device comprises a screw and plug made of Ti64 ELI and a rod made of Ti–12Cr 
alloy. A Ti64 ELI rod was also used for comparison. Bone was simulated using 
ultrahigh molecular weight polyethylene (UHMWPE). The compressive fatigue 
































PaFig. 1.15 Fatigue limit of 




Fig. 1.17 [35]. In the ASTM F1717 compressive fatigue test, the rod typically fails 
at the contact area between the rod and plug. Therefore, fretting that occurs between 
the rod and plug is thought to reduce the compressive fatigue strength of the rod. An 
effective solution to such a problem is to improve the mechanical properties and 
tribological characteristics of the rod. The introduction of a hardened layer via com-
pressive residual stress on the surface of the rod effectively prevents fretting fatigue. 
Peening techniques can introduce these hardened layers through plastic deforma-
tion, i.e., work hardening delivered by a large impact on the material’s surface. 
Among the major peening techniques, cavitation peening, which is schematically 
illustrated in Fig. 1.18 [36], appears to be a highly promising method for improving 
the compressive fatigue strength of rods used in spinal fixation devices because it 
induces less surface damage than other peening techniques. Therefore, cavitation 
peening was performed on Ti–12Cr alloy rods to improve their compression fatigue 
strength as evaluated by ASTM F1717; the technique significantly increases the 
compressive fatigue strength of the rods, as demonstrated in Fig. 1.17.
1.8  Summary
Ti–17Mo and Ti–12Cr alloys with changeable Young’s modulus are suitable for 
spinal fixation device rods, but Ti–12Cr alloy is more suitable because of its higher 
IR of the Young’s modulus by deformation and lower Young’s modulus. The fatigue 




























NFig. 1.17 Compressive 
fatigue limit of Ti–6Al–4V 
ELI alloy (Ti64 ELI) and 
Ti–12Cr alloy subjected to 
solution treatment (ST) 
and cavitation peening 
(CP) after solution 
treatment evaluated 








Fig. 1.18 Schematic 
drawings of development 
and crashing of cavitation
1 Low-Modulus Ti Alloys Suitable for Rods in Spinal Fixation Devices
20
alloy is highly expected to be used for spinal fixation device rods because its com-
pression fatigue strength, which is evaluated according to the ASTM 17171 stan-
dard, is significantly improved by cavitation peening.
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 Chapter 2 
 Ceramic Coating of Ti and Its Alloys Using 
Dry Processes for Biomedical Applications 
 Takatoshi  Ueda ,  Natsumi  Kondo ,  Shota  Sado ,  Ozkan  Gokcekaya , 
 Kyosuke  Ueda ,  Kouetsu  Ogasawara , and  Takayuki  Narushima 
 Abstract  In this chapter, bioceramic coatings on Ti and its alloys are examined. 
Surface modifi cation processes of metallic biomaterials are reviewed, and the for-
mation and evaluation of amorphous calcium phosphate (ACP) and anatase-rich 
TiO 2 coatings are described. Dry processes such as radio-frequency (RF) magnetron 
sputtering and thermal oxidation are employed for coating. Ag-containing ACP 
coating fi lms exhibited antibacterial activity through the continuous release of Ag 
ions, caused by the resorbability of ACP. Anatase-rich TiO 2 layers fabricated by a 
two-step thermal oxidation process showed photodegradation of organic com-
pounds under both UV- and visible-light irradiation. The introduction of Au into 
TiO 2 layers from Ti-Au alloy substrates by thermal oxidation contributed to the 
expression of visible-light response. 
 Keywords  Calcium phosphate •  Silver •  Antibacterial activity •  Anatase • 
 Photocatalytic activity 
2.1  Introduction 
 Ti and its alloys (along with stainless steels and Co-Cr alloys) are recognized as 
primary metallic biomaterials because of their excellent balance of strength and 
ductility, along with their high corrosion resistance when forming passivation fi lms, 
low allergenic nature, and bone compatibility (osseointegration) [ 1 ,  2 ]. However, 
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biofunctions of metallic biomaterials are insuffi cient compared to those of ceramic 
and polymer biomaterials. Some ceramics have chemical compositions close to that 
of hard tissue and exhibit bioactivity and bioresorbability, while polymers can 
polymerize to form functional groups and segments for biomedical applications. 
Therefore, surface modifi cation is necessary to improve the biofunctionality of Ti 
and its alloys [ 3 ,  4 ]. Metallic biomaterial microstructures can generally be con-
trolled to exhibit desired mechanical properties seen in the bulk material, an advan-
tage they hold over ceramic and polymer biomaterials. Surface modifi cation can in 
turn impart biofunctionality without impacting the bulk properties. 
 The different processes used for surface modifi cation of metallic biomaterials are 
summarized in Fig.  2.1 [ 5 ]. These techniques are classifi ed into two groups of wet 
and dry processes. Wet processes use aqueous solution for steps such as immersion 
and electrifying, while dry processes are based on the reactions of the surface with 
gases, ions, and plasma. Surface modifi cation can control the morphology, compo-
sition, and/or phase of a given material. Controlling the surface morphology allows 
for high mechanical bonding between metallic biomaterials and hard tissues 
(mechanical anchoring) and for control of biological reactions of cells and proteins 
on the modifi ed surface. Acid etching, blasting, laser treatment, additive manufac-
turing (AM), and porous treatments using beads, Ti plasma spraying, and fi ber mesh 
coating are various examples of these processes.
 Controlling the composition/phase of a surface can be conducted through physi-
cal, chemical, and biological processes. Since the primary application of metallic 
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 Fig. 2.1  Surface modifi cation processes of metallic biomaterials 
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patibility can be utilized as agents for surface composition/phase control. Processes 
such as thermal spraying, vapor deposition, electrochemical treatment, and immer-
sion in simulated body fl uid (SBF) have been used to coat apatite, which is an 
 analogue for the inorganic components of hard tissues. In addition, TiO 2 , calcium 
phosphate, sodium titanate, and CaTiO 3 coatings formed by anodic oxidation, gas 
treatment, NaOH treatment and heating, ion implantation, and chemical conversion 
can improve bone compatibility of implant substrates under biological conditions. 
Anodic oxidation changes both the chemical composition and roughness of a sur-
face. Hybrid coatings of ceramics and polymers are candidates for further improve-
ments in the biofunctionality of metallic biomaterials. To this end, hybrids such as 
calcium phosphate+collagen and calcium phosphate+bone morphogenetic protein 
have been seen in recent study [ 6 – 8 ]. 
 In this chapter, the formation and evaluation of ceramic coatings of Ti and its 
alloys are described with a focus on their antibacterial potential. Radio-frequency 
(RF) magnetron sputtering and thermal oxidation are the main processes dis-
cussed here for controlling composition/phase of surfaces, which are classifi ed as 
dry processes. Surgical site infection (SSI) related to implants occurs at rates of 
2–30 % depending on the surgical site and the procedure, and SSI is even more 
frequent after revision surgery [ 9 ,  10 ]. Several approaches are known to lower the 
risk of SSI, such as the use of antibiotics. However, prolonged use of antibiotics 
at higher doses can lead to systematic drug resistance and local toxicity [ 11 ]. The 
use of ceramic coatings with antibacterial activity is a powerful method to miti-
gate SSI. 
2.2  Antibacterial Properties of Ag-Containing Amorphous 
Calcium Phosphate Coating Films 
 Ag, Cu, and Zn ions are known antibacterial agents. Ag ions are effective against 
many types of bacteria, are less likely to cause bacterial resistance, and express 
antibacterial activity at lower concentrations than Cu and Zn ions [ 12 – 14 ]. Here, 
amorphous calcium phosphate (ACP) coating fi lms on Ti and its alloys are fabri-
cated by RF magnetron sputtering and evaluated in vivo and in vitro [ 15 – 17 ]. 
Coating of implants with Ag-containing ACP is one possible technique for prevent-
ing infection; ACP possesses bioresorbability under biological conditions, which 
causes the continuous release of Ag ions from such Ag-containing fi lms, creating 
antibacterial activity for a desired duration. The addition of Ag to HAp (hydroxy-
apatite, Ca 10 (PO 4 ) 6 (OH) 2 ) has been studied previously [ 18 – 21 ], but HAp is less 
resorbable than ACP. Both antibacterial activity and improved bone forming are 
expected from implants coated with Ag-containing ACP. 
 Ag-containing β-TCP (β-type tricalcium phosphate, Ca 3 P 2 O 8 ) sintered body was 
fabricated by hot-pressing Ag and β-TCP raw powders as targets in RF magnetron 
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sputtering. The Ag content in Ag-containing β-TCP targets was 0, 15, and 30 mass% 
as listed in Table  2.1 . Plates (10 × 10 × 1 mm) of mirror-polished commercially pure 
(CP) Ti (grade 2) and blasted Ti-6mass%-Al-4mass%V (Ti-6Al-4V) alloy were 
used as substrates. The thickness of the coating fi lms for analysis and evaluation of 
antibacterial properties was fi xed at 0.5 μm, as controlled by adjusting the deposi-
tion time.
 Figure  2.2 shows X-ray diffraction (XRD) patterns of the coating fi lms formed 
on mirror-polished CP Ti substrates using a 15mass%-Ag-containing TCP 
(15AgTCP) target. A broad peak is present at a 2θ value of 25–35°, which is a char-
acteristic of ACP coating fi lms [ 15 ]. Cross-sectional scanning electron microscopy 
(SEM) images of coating fi lms on mirror-polished CP Ti substrates are present in 
Fig.  2.3 . The coating fi lms are dense and uniform, with good adhesion to the sub-
strates. The deposition rates were 0.02–0.1 nm⋅s −1 , depending on the target compo-
sition and RF power.
 The Ag contents of the coating fi lms formed using 15AgTCP and 30AgTCP 
targets were 2 and 15 mass%, respectively, lower than those of the targets. Lower 
Ag contents compared to target compositions have been previously reported in 
Ag-containing HAp coating fi lms [ 22 ]. These discrepancies may be linked to differ-
ences in the ionization rates between elements during sputtering. 
 E. coli and  S. aureus , Gram-negative and Gram-positive bacteria, respectively, 
were used for antibacterial testing. Ag-containing ACP coating fi lms on blasted 
Ti-6Al-4V substrates were shaking cultured at 200 rpm in 1/500 nutrient broth (NB) 
solution with an initial bacterial concentration of 1 × 10 7 CFU (colony-forming 
unit)·mL −1 for  E. coli and 1 × 10 5 CFU·mL −1 for  S. aureus . Solution temperature was 
maintained at 310 K and incubation was carried out for 10.8 and 86.4 ks. Afterward, 
the numbers of viable bacteria colonies were counted using a smear-plate culture 
method. 
 Figure  2.4 shows the relationship between the incubation time and the number of 
viable bacteria for coating fi lms formed on blasted Ti-6Al-4V substrates using a 
15AgTCP target. After incubation for 10.8 ks, the number of viable  E. coli was less 
than 1, which was plotted as 100 CFU. The number of viable  S. aureus decreased 
after incubation for 10.8 ks and became less than 1 after incubation for 86.4 ks.
 The amounts of Ca, P-related, and Ag ions after immersion of Ag-containing 
ACP coating fi lms in the 1/500 NB solution with shaking at 200 rpm are depicted in 
Fig.  2.5 . Ag ions elute from the Ag-containing ACP coating fi lms and exhibit anti-
bacterial activity. The Ag ion concentration was almost constant over all measured 
immersion times, caused by the formation of AgCl between the eluted Ag + and Cl − 
present in the 1/500 NB solution.
 Table 2.1  Notation and 




 Ag  β-TCP 
 0AgTCP  0  100 
 15AgTCP  15  85 
 30AgTCP  30  70 
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2.3  Photocatalytic Activity of TiO 2 Layers Formed 
by Two- Step Thermal Oxidation 
2.3.1  UV (Ultraviolet) Response 
 TiO 2 layers have been used as surface coatings of Ti implants [ 23 ], as TiO 2 exhibits 
photocatalytic activity under UV-light irradiation, such as photoinduced superhy-
drophilicity and photodegradation of organic compounds [ 24 ]. The photoinduced 
superhydrophilicity of TiO 2 layers on Ti improves bone compatibility [ 25 ,  26 ], and 
photodegradation contributes to the antibacterial activity of Ti implants by killing 
















 Fig. 2.2  XRD patterns of 
coating fi lms fabricated on 
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 Fig. 2.3  Cross-sectional SEM image of coating fi lms fabricated on mirror-polished CP Ti sub-
strates using ( a ) 0AgTCP, ( b ) 15AgTCP, and ( c ) 30AgTCP targets 
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nearby bacteria through radical formation [ 27 ,  28 ]. Rutile is a thermodynamically 
stable phase of TiO 2 with a band gap of 3.0 eV, while anatase is a metastable phase 
of TiO 2 having a band gap of 3.2 eV. The lifetimes of these electronic excitations are 
an order of magnitude larger for anatase as compared to rutile [ 29 ], and as such the 
higher photocatalytic activity is expected in anatase. 
 The present authors presented a two-step thermal oxidation process for the fab-
rication of anatase-rich TiO 2 layer on Ti and its alloys [ 30 – 32 ], consisting of initial 
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 Fig. 2.4  Number of viable ( a )  E. coli and ( b )  S. aureus after incubation with Ag-containing ACP 
coating fi lms fabricated on blasted Ti-6Al-4V substrates using a 15AgTCP target 
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treatment under CO-containing atmosphere and subsequent treatment in air, and 
evaluated the photocatalytic activity of anatase-containing TiO 2 layers on CP Ti and 
Ti-25mass%Mo and Ti-25mass%Nb alloys [ 32 ]. The anatase fraction in the TiO 2 
layer can be controlled during this process by controlling the temperature of the 
second step. By using TiO 2 layers with various anatase fractions, the degradation 
rate of methylene blue (MB) under UV-light irradiation was measured. Illumination 
was performed using a UV lamp with a central wavelength of 351 nm. The UV-light 
intensity was 1.0 mW⋅cm −2 at the surface of the specimen. The effects of anatase 
fraction on the MB degradation rates are summarized in Fig.  2.6 [ 32 ], where the 
maximum rate was obtained at an anatase fraction of approximately 0.8 for both CP 
Ti and its alloys. Su et al. [ 33 ] measured the MB degradation rates of TiO 2 fi lms on 
CP Ti formed by anodic oxidation, where the grain sizes, surface areas, and crystal-
linity of the TiO 2 fi lms were fi xed, but the anatase fraction was varied. They reported 
a maximum decomposition rate at an anatase fraction of approximately 0.6 and 
indicated that electrons that are photoexcited in rutile can migrate to the conduction 
band of anatase to leave electron holes in the rutile; as a result, recombination is 
effectively suppressed in anatase-rich TiO 2 layers. In our case, the second step tem-
perature was altered to control the resulting anatase fraction, but the thickness and 
surface roughness were not controlled. Nevertheless, a similar dependence of 
decomposition rate upon the anatase fraction was obtained compared to Su et al.; 

























 Fig. 2.6  Effects of the 
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layers on the rate constant 
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2.3.2  Visible-Light Response 
 The visible-light-responsive photocatalytic activity of implants is useful for anti-
bacterial activity during operation and in the reactivation of implants. Because SSI 
is caused by endogenous fl ora in the patient’s skin, mucous membranes, or hollow 
viscera, SSI cannot simply be prevented by sterilization before operation [ 34 ]. In 
order to express the photocatalytic activity of TiO 2 , UV-light irradiation is generally 
required, which is harmful to the human body. Therefore, visible-light response is 
more desirable for preventing infection during operation. Reactivation of implants 
is required during usage for some periods in a human body. While UV-light irradia-
tion is known to reactivate Ti implant surfaces [ 35 ], reactivation using visible-light 
irradiation is more favorable for the human body. 
 Au solutes in TiO 2 [ 36 ] and the addition of metallic Au nanoparticles to TiO 2 [ 36 , 
 37 ] can lead to visible-light response. Therefore, two-step thermal oxidation was 
applied to a Ti-Au alloy in order to fabricate Au-containing TiO 2 layers with visible- 
light- responsive photocatalytic activity. Ti-4.2at%Au alloy was employed as a sub-
strate material. The fi rst step treatment was conducted under an Ar-1%CO 
atmosphere at 1073 K for 3.6 ks, and the subsequent second step treatment was 
conducted in air at 673 K for 10.8 ks. An anatase-rich TiO 2 layer was obtained on 
the Ti-4.2at%Au alloy substrate after this process. Figure  2.7 depicts the cross- 
sectional microstructure of the anatase-rich TiO 2 layer as observed via transmission 
electron microscopy (TEM). Au nanoparticles can be seen here as small black par-
ticles approximately 5 nm in diameter.
 The photocatalytic activity of the Au-containing TiO 2 layer was evaluated by 
self-cleaning tests (JIS R 1753: 2013) based on the decomposition of a layer of 
steric acid on the Au-containing TiO 2 layer under visible-light irradiation, where the 
steric acid layer was prepared by dip coating. Substrates with this steric acid layer 
were irradiated with visible light with an intensity of 10 mW·cm −2 at the surface of 
the steric acid layer, for as long as 86.4 ks. The light source was a Xe lamp with a 
UV fi lter to produce light of λ >400 nm. Changes in the water contact angles under 
visible-light irradiation were measured to determine the extent of steric acid photo-
degradation, and the TiO 2 layer expressed visible-light-responsive photocatalytic 
activity. 
 Figure  2.8 shows the changes in water contact angles on as-polished and two- step 
(i.e., after two-step thermal oxidation) CP Ti and Ti-4.2at%Au substrates under vis-
ible-light irradiation [ 38 ]. The water contact angles on the as-polished specimens 
remained almost constant, indicating no visible-light response. On the other hand, 
the two-step specimens showed decreased water contact angles. For the two-step 
Ti-4.2at%Au alloy, the water contact angle decreased from 80 to 10°. Silva et al. [ 37 ] 
reported that electrons in Au nanoparticles (1.87–6.40 nm in diameter) attached on 
TiO 2 particles were excited by surface plasmon resonance and migrated to TiO 2 par-
ticles, producing H 2 by the photoreduction of H 2 O. The Au particle size recom-
mended in their study is close to that of our study (Fig.  2.7 ). One possible mechanism 
of visible-light response in the Au-containing TiO 2 layer formed by two-step thermal 
oxidation involves the decrease in band gap due to Au solutes in the TiO 2 layer [ 36 ] 
and/or the surface plasmon resonance of the Au nanoparticles in the TiO 2 layer [ 37 ].
T. Ueda et al.
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2.4  Summary 
 The surface modifi cation of Ti and its alloys using ceramic coatings and their anti-
bacterial activity were described in this chapter. Both Ag-containing ACP coating 
fi lms and Au-containing TiO 2 layers, fabricated by RF magnetron sputtering and 
two-step thermal oxidation, respectively, indicated antibacterial activity. Control 
over Ag ion elution from Ag-containing ACP coating fi lms and the improved 
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 Ti and its alloys are expected to see continued use as metallic biomaterials for 
implants. Figure  2.9 shows factors that must be considered when developing 
ceramic coatings on Ti and its alloy substrates for biomedical applications [ 5 ]. The 
interface between a coating fi lm and the human body requires designed properties 
such as hard/soft tissue and blood compatibilities, antibacterial activity, wear and 
corrosion resistance, resorbability, and suppression/enhancement of protein and cell 
attachment. These properties are affected by surface morphology, phase, composi-
tion, and orientation of the coating fi lms. High-strength and durable bonding 
between a coating fi lm and substrates, which are affected by physical and chemical 
properties of the substrates and the morphology at the interface, are also crucial. 
Therefore, the mechanical properties and thickness of coating fi lms, as well as the 
reaction between coating fi lm and substrates, must be taken into consideration.
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Chapter 3
Dealloying Toxic Ni from SUS316L Surface
Hidemi Kato, Takeshi Wada, and Sadeghilaridjani Maryam
Abstract SUS316L (18 %Cr-12 %Ni-2.5 %Mo-<0.03 %C) is one of the most pop-
ular metallic materials for biomedical uses such as implants and surgical instru-
ments owing to its lower cost, good corrosion resistance, and excellent workability 
compared with those of other types of biomedical metallic materials. Although Ni 
stabilizes the austenitic FCC structure to give the excellent workability of SUS316L, 
elution of toxic Ni ions into the human body can cause various health problems. In 
SUS316L, the elution of Ni ions is suppressed by the stable passive thin film arising 
from the Cr component. However, there remains some risk of Ni elution. In this 
paper, we remove Ni element from the surface of SUS316L using a novel dealloy-
ing technique with a metallic melt and study its effect on the corrosion resistance 
and Ni ion elution of the steel in a simulated human body fluid.
Keywords SUS316L • Biomedical material • Ni • Dealloying • Surface 
improvement
3.1  Introduction
SUS316L (18 % Cr, 12 % Ni, 2.5 % Mo, <0.03 %C) is an austenitic stainless steel 
that contains 18 wt% Cr, 12 wt% Ni, 2.5 % Mo, and less than 0.03 % C (the “L” in 
316L standing for low carbon), which tends to degrade the stability of the face- 
centered cubic (FCC) structure and segregate as carbides in grain boundaries, caus-
ing intergranular cracking. Owing to these elements, SUS316L has the advantages 
of high corrosion resistance, excellent workability, low cost, and highly reliable 
mechanical properties and has thus been widely used as a biomedical material, such 
as in surgical instruments and bone fixtures. The Ni element in SUS316L stabilizes 
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the FCC structure to produce excellent workability. However, Ni is a toxic element, 
meaning that using SUS316L potentially risks causing health problems. Therefore, 
Ni is necessary for workability but is unwanted for the biocompatibility of 
SUS316L. To solve this problem, we investigated the removal of Ni element from 
the surface of SUS316L using a novel dealloying technique, “dealloying in metallic 
melt,” as shown in Fig. 3.1. This work intends to demonstrate the dealloying of Ni 
element from the SUS316L surface and investigate its effects on the corrosion resis-
tance and Ni ion release of the SUS316L in Hank’s balanced salt solution (HBSS).
3.1.1  Dealloying in a Metallic Melt
This method is first reported in Ref. [1], and its principle was mentioned in Ref. [2] 
as follows. When two metal elements are mixed, the free energy change is
 ∆ ∆ ∆G H T Smix mix mix= − ,  (3.1)
where ∆Hmix is the heat of mixing, ∆Smix is the entropy of mixing, and T is the abso-
lute temperature. Usually, the entropy increases after mixing. Therefore, if 
∆Hmix < 0 , then ∆Gmix < 0 , and the mixing reaction can occur spontaneously from 
a thermodynamic point of view. Conversely, if ∆Hmix > 0 , the sign (positive or neg-
ative) of ∅Gmix  depends on the temperature. If the temperature is adequately con-
trolled to make the enthalpy term larger than the entropy term, then ∆Gmix > 0 , and 
the mixture of the two elements is prevented. Here, we dip an A–B binary alloy 
precursor into a metallic melt consisting of element C. If the heat of mixing between 
elements B and C is negative, i.e., ∆Hmix B C, − < 0  and if the heat of mixing between 
elements A and C is positive, i.e., ∆Hmix A C, − > 0 , then by adequately controlling the 
temperature, only element B will dissolve from the precursor into the C melt. 
Because in this case element A is rejected from the C melt, it is expected to self- 
organize into a porous structure by surface diffusion in the same manner as that of 
the ordinary dealloying method in aqueous solution [3, 4]. Figure 3.2 shows a sche-
matic of this novel dealloying method involving the selective dissolution of B atoms 
(orange) in the C atom melt (pink) and surface diffusion of the remaining A atoms 
Fig. 3.1 Strategy of the present research for improving the biocompatibility of SUS316L
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(yellowish green). Figure 3.3 summarizes this “triangle” relationship in terms of the 
heat of mixing among elements A, B, and C required for the dealloying reaction in 
a metallic melt. Because the heat of mixing is usually expressed using temperature 
and chemical composition, we must calculate a rigid value for the heat of mixing 
with these parameters to design the dealloying reaction. However, this can be com-
plicated. The heat of mixing between the transition metals and between the transi-
tion metals and metalloids can be obtained from the table in Ref. [5], the values of 
which were approximately calculated by the Miedema model, while that of other 
metals can be obtained from the table constructed by Takeuchi et al. In this study, 
we first identified the candidates for elements A, B, and C from these values and 
then confirmed the relationships A–B, B–C (mixture), and A–C (separation) using 
the related binary phase diagrams if they were available in relevant databases.
3.1.2  Reaction Design for Dealloying Ni from SUS316L
SUS316L consists of Fe, Cr, Mo, and Ni. Mg is miscible with Ni but immiscible 
with the other elements, which can be confirmed from the corresponding mixing 
enthalpies: ΔHmix= −4 kJ/mol (Ni-Mg), +18 kJ/mol (Fe-Mg), +24 kJ/mol (Cr-Mg), 
and +36 kJ/mol (Mo-Mg) [5]. Thus, as shown in Fig. 3.4, Fe, Cr, and Mo are 
Fig. 3.2 Schematic of the dealloying method using a metallic melt, in which B atoms (orange) 
dissolve into a melt composed of C atoms (pink), and the remaining A atoms (yellowish green) 
self-organizes into a porous structure by surface diffusion [3]
Fig. 3.3 Triangle 
relationship of the 
enthalpies of mixing 
among elements A, B, and 
C for dealloying in a 
metallic melt [1]
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regarded as “A” group elements in the triangle relationship in Fig. 3.3, Ni is regarded 
as a “B” group element, and Mg is regarded as a “C” group element. Therefore, if 
the temperature is adequately controlled, we can expect that only Ni will dissolve 
from the surface when SUS316L is dipped into liquid Mg, resulting in the construc-
tion of a Fe-Cr-Mo porous alloy in the Mg melt.
3.2  Experimental Procedure
The method used for sample preparation is schematically illustrated in Fig. 3.5. The 
SUS316L used in this research was a commercial product purchased from Nilaco, 
Japan, in the form of rods of 10 mm in diameter. The rods were sliced into disks of 
1 mm thickness, and these were then cold rolled to ~200 μm thickness. Mg was 
inductively melted in a chamber under inert argon gas using a graphite crucible.
The temperature of the Mg liquid bath was set to 700 or 900 °C, and the cold 
rolled SUS316L was dipped for 30 min. The resulting dealloyed sample was then 
dipped in an aqueous solution of HNO3 to etch away the surrounding Mg-Ni phase, 
followed by washing and drying. The treated samples were evaluated using scan-
ning electron microscopy-energy dispersive X-ray analysis (SEM-EDX).
Polarization tests were conducted in HBSS solution with a potentiostat/galvano-
stat (HZ5000, Hokuto Denko, Japan) within a voltage range of −800 to 500 mV vs 
the Ag/AgCl reference electrode. A pure platinum electrode was used as a counter 
electrode.
The ion release test was conducted in 1.7 g of HBSS solution at 310 K for 
10 days, after which the amount of ions released was evaluated. The HBSS was then 
replaced with the same weight of fresh solution, and the test was continued for 
another 14 days. The ion release of Fe, Cr, and Ni was analyzed by inductively 
coupled plasma optical emission spectrometry (ICP-OES), the detection limit of 
which was ~0.1 μg.
Fig. 3.4 Reaction design 
for removing Ni element 
from the surface of 
SUS316L by dealloying in 
a metallic melt. Here, the 
carbon component is 
ignored owing to its low 
concentration. Based on 
the mixing enthalpy 
between each component, 
Fe, Cr, Mo=A, Ni=B and 
Mg=C group in Fig. 3.3
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3.3  Results and Discussion
3.3.1  Dealloying Ni Treatments
The surface and cross section of the samples were observed by SEM, and analysis 
of their composition was performed by EDX. Cross sections were made by cutting 
and polishing the samples as shown in Fig. 3.6.
Figure 3.7 shows an SEM image of the surface of a sample that was dealloyed in 
the Mg melt at 900 °C, the highest temperature in the present study, for 30 min. 
Hollows and pits are clearly observable, especially in the grain boundaries. It was 
also found that the characteristic porous structure usually observed on dealloyed 
surfaces did not develop. The cross-sectional SEM images shown in Fig. 3.8a, b 
indicate that the sample became thinner, from 200 to ~175 μm, after the dealloying 
treatment at 900 °C. The composition at point A shown in Fig. 3.8b determined by 
EDX was Fe69.4Cr18.0Ni11.5Mo1.1 (at.%), which is almost the same as that of the origi-
nal SUS316L. The homogeneity of the elemental mappings shown in Fig. 3.9a–d 
indicated that there was no change in the composition of the SUS316L sample after 
it was dipped into the Mg melt at 900 °C.
Based on these results, i.e., the sample became thinner while keeping its original 
composition homogeneously, it can be concluded that all the components, Fe, Cr, 
Ni, and Mo, dissolved from the surface into the Mg melt because its temperature 
was too high, such that ΔGmix < 0 in Eq. 3.1. Thus, the temperature of the Mg melt 
should be lower than 900 °C to prevent the dissolution of the Fe, Cr, and Mo ele-
ments in the Mg melt.
Figure 3.10 shows SEM images of the surface (a) and polished cross section (b) 
and (c) of SUS316L dipped in the Mg melt at 700 °C for 30 min, followed by etch-
ing of the surrounding Mg-Ni phase in aqueous HNO3 solution. The treated surface 
appeared to be rougher than the pristine sample, and the grain boundaries, which 
were observed in Fig. 3.7, could no longer be observed. The thickness of this sample 
was not greatly changed by the dealloying treatment, as shown in Fig. 3.10b. The 
polished cross section exhibited porous reaction layers of approximately 50 μm in 
thickness (Fig. 3.10c, similar to that typically observed on traditionally dealloyed 
sample surfaces [1, 6–9]. Figure 3.11a–d shows the elemental mappings for Fe, Ni, 
Fig. 3.5 Method for SUS316L surface improvement, i.e., removing toxic Ni from the surface
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Cr, and Mo of the sample dealloyed in 700 °C for 30 min, respectively. In the Fe, Cr, 
and Mo mappings, the porous reaction layer was a little brighter than the unreacted 
part, while that of Ni was clearly darker. This means that the Fe, Cr, and Mo con-
centrations were a little higher in the reaction layer, while the Ni concentration was 
Fig. 3.6 Cutting direction 
used to make cross 
sections for SEM 
observation and EDX 
analysis
Fig. 3.7 SEM image of 
the surface of SUS316L 
sample which was dipped 
into a Mg melt at 900 °C 
(highest temperature of the 
present research) for 
30 min, then in aqueous 
HNO3 solution to etch 
away the surrounding 
Mg-Ni phase
Fig. 3.8 SEM images of 
(a), (b) polished cross 
section of SUS316L 
dealloyed in Mg melt at 
900 °C for 30 min. Red 
dotted line in (a) indicates 
the initial dimensions of 
the cross section before the 
dealloying treatment. Red 
dot marked A in (b) is the 
point at which quantitative 
EDX analysis was 
conducted
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much lower than in the untreated part. Quantitative analysis of point A in the reacted 
porous region and point B in the solid inner revealed respective compositions of 
Fe76.4Cr20.0Ni2.2Mo1.4 (at. %) and Fe68.9Cr18.1Ni11.8Mo1.2 (at.%). The Ni concentration 
at point A point decreased to 2.2 at.%, which is less than 19 % of that at B point in 
the nonreacted inside. These results indicate that in the Mg melt at 700 °C, almost 
only the Ni element was removed from the SUS316L by a dealloying reaction, leav-
ing a constricted porous structure.
3.3.2  Polarization Tests
Figure 3.12 shows the polarization curve of the SUS316L dealloyed at 700 °C for 
30 min compared with that of the original SUS316L after cold rolling. After the 
dealloying, the corrosion potential of the SUS316L decreased from −240 to 
−400 mV, indicating that the dealloying treatment increased the corrodibility of the 
sample. However, after the corrosion potential, the passive region was maintained 
up until almost the same potential as that of the original sample. Therefore, it was 
concluded that the excellent corrosion resistance of the SUS316L was not degraded 
by the dealloying treatment.
Fig. 3.9 Element mappings for Fe (a), Cr (b), Ni (c), and Mo (d) for the polished cross section of 
SUS316L dealloyed in Mg melt at 900 °C for 30 min
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3.3.3  Ion Release Tests
For ion release tests, the original and dealloyed samples were dipped in 1.7 g of 
HBSS at 37 °C for 10 days, after which the HBSS was replaced with fresh solution 
and the immersion was continued for another 14 days. Herein, HBSS without sam-
ples was used as a reference. The observed ion release of Fe, Cr, and Ni is 
Fig. 3.10 SEM image of 
surface (a), polished cross 
section of SUS316L 
dealloyed in a Mg melt at 
700 °C for 30 min (b), and 
enlarged image of the 
reacted surface part (c). 
Red dotted line in (b) 
indicates the initial 
dimensions of the cross 
section before the 
dealloying treatment
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summarized in Fig. 3.13. During the first 10 days, the Fe ion release from both the 
original and dealloyed samples was comparatively large, but then decreased over 
the next 10–24 days. Little Cr release was observed, just within the detection limit, 
because surface Cr is considered to construct a passivated Cr hydroxide thin film on 
SUS316L. Ni ion release from the dealloyed sample, which is the most important 
for us to control, was found to be slightly increased compared with that of the origi-
nal sample, especially during days 10–24. However, it then decreased after 24 days.
The main reasons for the increased Ni ion release were:
When the Ni in the SUS316L was dealloyed in the Mg melt, a Mg-Ni phase solidi-
fied on the surface. This Mg-Ni phase should have been etched away completely 
in the aqueous HNO3 solution. However, if Mg-Ni remained after this etching 
Fig. 3.11 Elemental mappings for Fe (a), Ni (b), Cr (c), and Mo (d) for the polished cross section 
of SUS316L dealloyed in Mg melt at 700 °C for 30 min, and SEM image taken near the boundary 
of the dealloyed and unreacted regions (e). Red and blue dots marked A and B in the reacted region 
and unreacted region, respectively, in (e) are the points at which quantitative EDX analysis was 
conducted
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Fig. 3.12 Polarization curves for SUS316L dealloyed in Mg melt at 700 °C for 30 min (red) and 































































Fig. 3.13 Ion release of Fe (a), Cr (b), and Ni (c) from the surface of SUS316L dealloyed at 
700 °C for 30 min compared with that of the original cold rolled SUS316L during the first 10 days 
(blue), 11–24 days (pink), and 25–52 days (green) immersion in HBSS. The HBSS was replaced 
with fresh solution after sampling at 10 and 24 days. Reference values are those measured with the 
same setup without the presence of a SUS316L sample
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treatment, Ni-ion release could have been increased in the HBSS as shown in the 
following illustration (Fig. 3.14).
Dealloying tends to increase the surface area of the steel. This would increase the 
rate and amount of Ni ion release even after decreasing the concentration of Ni 
at the surface. If this is correct, then it should be possible to decrease the Ni ion 
release by decreasing the thickness of the reaction layer to decrease the surface 
area of treated steel.
3.4  Conclusions
 1. The surface Ni concentration of SUS316L was successfully decreased from 11.8 
to 2.2 at.% by dealloying the Ni in Mg liquid at 700 °C for 30 min.
 2. Dealloyed SUS316L maintains excellent corrosion resistance in HBSS at room 
temperature.
 3. Mass of Ni ion release from the Ni-dealloyed SUS316L surface was almost com-
parable or slightly increased compared with that of untreated SUS316L.
 4. The main reasons for (3) are:
• Increased surface area caused by the dealloying treatment, although the Ni 
concentration per unit area was decreased
• Mg-Ni phase remaining on the sample surface after the etching in HNO3 
aqueous solution
Acknowledgment This research was financially supported by the interuniversity cooperative 
research program “Innovative Research for Biosis-Abiosis Intelligent Interface” from the Ministry 
of Sports, Culture, and Education of Japan.
Fig. 3.14 Schematic illustration explaining origin of increased Ni ion release during 10–24 days 
immersion of the dealloyed SUS316L sample in HBSS. After dealloying treatment (left), Mg-Ni 
liquid solidified on the surface of the sample. Some Mg-Ni phase, perhaps located deep inside of 
the pores, remained even after the etching treatment in the aqueous HNO3 solution (right). This 
phase likely dissolved slowly into the HBSS, resulting in a higher Ni ion release during this period
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 Chapter 4 
 Bio-ceramic Coating of Ca–Ti–O System 
Compound by Laser Chemical Vapor 
Deposition 
 Hirokazu  Katsui and  Takashi  Goto 
 Abstract  Bio-ceramic Ca–Ti–O system compound fi lms were prepared by laser 
chemical vapor deposition (laser CVD). Laser CVD is a high-speed technique for 
coating fi lms with versatile controllability of microstructures and crystal phases. 
Highly oriented CaTiO 3 fi lms with specifi c textures and Ca  n +1 Ti  n  O 3 n +1 fi lms with the 
Ruddlesden–Popper-type structure were prepared at high deposition rates. The for-
mation of calcium phosphate in simulated body fl uid (SBF) was promoted by 
Ca  n +1 Ti  n  O 3 n +1 fi lms. 
 Keywords  Calcium titanate •  Laser CVD •  Microstructure •  Bioactive coating • 
 High deposition rate 
4.1  Introduction 
 Ti and Ti-based alloys are used as artifi cial bones and dental implants because of 
their acceptable mechanical properties, low weight, and adequate corrosion resis-
tance in the human body. However, they suffer certain disadvantages, such as poor 
osteoinductive properties and a duration of several months for the reconstruction of 
the bone/implant interface with adequate adhesion. The osseointegration of an 
orthopedic implant involves a cascade of cellular and extracellular biological events 
that occur at the bone/implant interface [ 1 ]. The processes can be enhanced by the 
surface treatments and bio-ceramic coating on implants [ 2 ,  3 ]. The plasma-sprayed 
hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 , HAp) coating on Ti is practically used for dental 
implants [ 3 ,  4 ]. However, the low interface bonding strength and coating toughness 
can cause a fracture in the interface between HAp and Ti implants. HAp fi lms with 
low crystallinity coated on Ti implants dissolve rapidly when Ti is implanted into a 
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human body. The crystallinity and microstructure of coated fi lms is an important 
factor for establishing a good interface between the bone and implants [ 4 ,  5 ]. 
 Recently, calcium titanate (CaTiO 3 ) has gained considerable attention as a bio-
material. CaTiO 3 coatings with controlled thickness and crystallinity are effective 
for bone formation because CaTiO 3 is chemically stable at low pH and can form 
HAp in SBF [ 6 – 8 ]. CaTiO 3 has also been proposed as an intermediate layer to 
improve the adhesion between HAp and Ti-based implants [ 9 – 13 ]. To date, a vari-
ety of techniques, such as sol–gel [ 13 ], hydrothermal reactions [ 14 ], ion implanta-
tion [ 15 ], sputtering [ 8 ], and anode oxidation techniques [ 7 ], were employed for 
CaTiO 3 coating. Chemical vapor deposition (CVD) is a versatile technique to pre-
pare various ceramic fi lms and is widely used in the industry. Sato et al. reported the 
synthesis of CaTiO 3 fi lms by CVD using metal organic precursors followed by apa-
tite formation on the fi lm surface upon immersion in SBF [ 16 ]. Auxiliary energies 
such as plasmas and lasers could be employed to accelerate chemical reactions and 
prepare highly crystalline fi lms with controlled morphology and crystal phases at 
high deposition rates [ 17 – 21 ]. In this study, we demonstrate the synthesis of Ca–
Ti–O fi lms by laser CVD, and the effects of deposition parameters on crystal phases, 
morphology, and deposition rate are investigated. Laser CVD can produce 
Ca  n +1 Ti  n  O 3 n +1 fi lms which exhibited a signifi cant formability of calcium phosphate 
precipitates on the coating surface in the SBF immersion. 
4.2  Laser Chemical Vapor Deposition 
 CVD is a gas-phase deposition process, comprising several chemical reactions 
between source gases (precursors). Dense fi lms can be coated by CVD even on 
rough surfaces with high adherence and good conformal coverage. This is advanta-
geous for bio-ceramic coatings on complex-shaped dental implants and artifi cial 
bones. Hence, bio-ceramic coatings of well-crystallized Ca–P–O system com-
pounds, such as HAp, α- and β-Ca 3 P 2 O 8 , Ca 4 P 2 O 9 , and α- and β-Ca 2 P 2 O 7 , have been 
performed using CVD [ 22 – 24 ]. Generally, the deposition rate of CVD is lower than 
that of plasma spray and electron beam physical vapor deposition. In conventional 
thermal CVD, the chemical reaction at the interface between the gas and substrate 
surface is driven by thermal energy. Laser irradiation can accelerate the chemical 
reactions and enable low-temperature deposition to avoid degradation and corrosion 
of the substrate materials. Figure  4.1 shows a schematic of the laser CVD apparatus 
for the coating of Ca–Ti–O compounds. The source materials (precursors) of Ca and 
Ti were evaporated, and the source vapors were introduced into a CVD reaction 
chamber. Oxygen was separately introduced into the chamber. A substrate was 
placed on a hot stage for preheating. The substrate surface was irradiated by an 
Nd:YAG laser (wavelength 1064 nm) through a quartz window. By controlling 
deposition parameters, such as laser power, deposition temperature, total pressure, 
and precursor supply conditions, various forms of deposits can be obtained, e.g., 
amorphous, fi ne crystals, columnar crystals, dendritic crystals, whiskers, plate-like 
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crystals, and epitaxial single-crystal fi lms. In this study, aluminum nitride (AlN) 
was fi rst used as the substrate, because it is thermochemically stable at high tem-
perature, and its good workability enables us to investigate the effect of a wide 
range of CVD parameters on the Ca–Ti–O fi lm characteristics. Based on the insight 
into the correlation between the CVD parameters and the fi lm characteristics using 
the AlN substrates, bioactive Ca–Ti–O fi lms were coated on metallic Ti substrates 
under optimum laser CVD conditions.
4.3  Bio-ceramic Coating of Ca–Ti–O by Laser CVD [ 25 ,  26 ] 
 The phase diagram of a CaO–TiO 2 pseudo-binary system is shown in Fig.  4.2 [ 27 , 
 28 ]. At a Ca/Ti ratio of 1.0, the CaTiO 3 phase exists, which is the most common 
calcium titanate compound. No other phases are stable in the Ti-rich region between 
TiO 2 and CaTiO 3 , whereas Ca  n +1 Ti  n  O 3 n +1 phases exist in the Ca-rich region between 
CaTiO 3 and CaO. The crystal structures of CaTiO 3 and Ca  n +1 Ti  n  O 3 n +1 are illustrated 
in Fig.  4.3 . Further CaTiO 3 has a perovskite structure with a space group of  Pnma , 
 Fig. 4.1  Schematic of laser CVD apparatus 
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comprising the corner-sharing TiO 6 octahedra surrounded by Ca ions with a 12-fold 
coordination [ 29 ]. The Ca  n +1 Ti  n  O 3 n +1 phases have perovskite-related structures, the 
so-called Ruddlesden–Popper structure, formed by alternate stacking of perovskite 
blocks and CaO layers, as shown in Fig.  4.3 [ 30 ]. The stacking sequence in a unit 
cell corresponds to the  n value in Ca  n +1 Ti  n  O 3 n +1 . Two phases, Ca 2 Ti 3 O 7 ( n = 2) and 
Ca 3 Ti 4 O 10 ( n = 3), have been reported to exist in the TiO 2 –CaO system. Although 
CaTiO 3 fi lms fabricated by various methods and their bioactivities were investigated 
using in vivo and in vitro experiments [ 3 ,  6 ,  8 ,  10 ,  11 ,  13 ], there are few reports of 
the synthesis of Ca  n +1 Ti  n  O 3 n +1 fi lms as a biomaterial [ 31 ]. Laser CVD can be used to 
synthesize CaTiO 3 and Ca  n +1 Ti  n  O 3 n +1 by controlling deposition parameters, such as 
the Ca/Ti supply ratio of the precursors and deposition temperature depending on 
the laser power. Figure  4.4 depicts the effects of deposition temperature and Ca/Ti 
supply ratio on the phase formation of Ca–Ti–O fi lms by laser CVD. At a Ca/Ti 
supply ratio of approximately 1.0, single-phase CaTiO 3 fi lms were formed at depo-
sition temperatures below 1100 K. At deposition temperatures above 1100 K, 
CaTiO 3 fi lms contained TiO 2 , Ca–Al–O compounds (e.g., CaAl 2 O 4 and CaAl 4 O 7 ) 
and Al 2 O 3 , resulting in a reaction between the source gases and the AlN substrate at 
high temperatures. At Ca/Ti supply ratios <0.8, Ti-rich Ca–Ti–O compounds were 
formed; however, no phases were thermodynamically stable according to the phase 
diagrams [ 27 ,  28 ]. Under Ca-rich conditions (Ca/Ti supply ratio >1.0), Ca  n +1 Ti  n  O 3 n +1 
 Fig. 4.2  Phase diagram of CaO–TiO 2 system [ 27 ,  28 ] 
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fi lms were deposited at relatively low deposition temperatures (<1000 K), whereas 
fi lms prepared at deposition temperatures higher than 1000 K comprised CaO and 
CaTiO 3 . In the Ti-rich compositional region between CaTiO 3 and TiO 2 , several Ca–
Ti–O compounds were reported. Bertaut and Blum [ 32 ] and Bright et al. [ 33 ] 
reported the synthesis of CaTi 2 O 4 by electrolysis of TiO 2 and CaTiO 3 in a CaCl 2 
melt. CaTi 2 O 4 single crystals were synthesized by a fl ux method from CaTiO 3 in 
CaCl 2 and Ti metal [ 34 ]. The existence of CaTi 4 O 9 and CaTi 2 O 5 was reported in a 
wet chemical method and sol–gel method [ 35 – 38 ]. Ancora et al. published patents 
on the production of CaTi 2 O 5 and CaTi 5 O 11 [ 39 ], where the CaTi 2 O 5 crystal structure 
differed from that produced by Limar and Kisel [ 35 ,  36 ]. Since these Ti-rich phases 
were considered to be metastable and decomposed into CaTiO 3 and TiO 2 at high 
temperatures and the synthesis process was limited, the detailed crystal structures 
and compositions remain unknown. In this study, the X-ray diffraction (XRD) pat-
terns of Ti-rich Ca–Ti–O fi lms by laser CVD in this study were similar to those of 
CaTi 2 O 5 and CaTi 5 O 11 reported by Ancora; however, the phase identifi cation was 
diffi cult because the fi lms may comprise a mixture of phases and have preferred 
orientations. The Ti-rich Ca–Ti–O fi lms were transformed into TiO 2 and CaTiO 3 by 
heat treatment (post annealing) at 1273 K. Further investigation of the detailed 
chemical compositions and microstructure was required for the Ti-rich Ca–Ti–O 
compounds.
 Fig. 4.3  Crystal structures of CaTiO 3 , Ca 3 Ti 2 O 7 , and Ca 4 Ti 3 O 10 
 
4 Bio-ceramic Coating of Ca–Ti–O System Compound by Laser Chemical Vapor…
52
 Figure  4.5 illustrates the effect of the deposition temperature on the crystal ori-
entations of CaTiO 3 fi lms prepared at a total pressure of 800 Pa, where the texture 
coeffi cient ( TC ) is the degree of crystal orientation. A  TC value of 10 corresponds 
to perfect orientation, whereas a  TC value of 1 corresponds to random orientation 
[ 40 ]. At temperatures below 800 K, CaTiO 3 fi lms with (011) orientation were 
formed. With an increase in the deposition temperature, the preferred orientation 
changed from (011) to (101) at approximately 800 K. Further increases in the depo-
sition temperature resulted in the formation of CaTiO 3 fi lms having no preferred 
orientation. The preferred orientation during the growth of CaTiO 3 fi lms can be 
controlled not only by the deposition temperature but also by the total pressure in 
the chamber. The (121)-oriented CaTiO 3 fi lms were deposited in the total pressure 
range of 400–600 Pa at a deposition temperature of 825–855 K, whereas the pre-
ferred orientation was (101) at a total pressure of 800 Pa in the same deposition 
temperature range (Fig.  4.5 ). Figure  4.6 shows the typical surface and cross- 
sectional morphologies of CaTiO 3 fi lms with the preferred orientations ((011), 
(101), and (121)) and without orientation. (011)-oriented CaTiO 3 fi lms have a cone- 
like morphology with pyramidal facets, as shown in Fig.  4.6a . Square facets, which 
are several micrometers in size, were formed in (101)-oriented CaTiO 3 fi lms, as 
shown in Fig.  4.6c . (121)-oriented CaTiO 3 fi lms had a granular morphology with 
fi ne grains smaller than several micrometers in size (Fig.  4.6e ). These CaTiO 3 fi lms 
with strongly preferred orientations were grown in the columnar regime (Fig.  4.6b, 
d, f ). CaTiO 3 fi lms without preferred orientation prepared at a high deposition tem-
perature composed randomly arranged faceted grains (several micrometers in size) 
with a dense and smooth cross section, as shown in Fig.  4.6c, f .
 Figure  4.7 depicts the detailed microstructures with crystal structure models of 
the corresponding textures in the (011)- and (101)-oriented CaTiO 3 fi lms. The 
 Fig. 4.4  Phase formation 
relation between 
deposition temperature and 
Ca/Ti precursor supply 
ratio for Ca–Ti–O fi lms 
formed by laser CVD 
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 cone- like morphology of the (011)-oriented CaTiO 3 fi lm comprised pyramidal fac-
ets, which are several tens nanometers in size. Considering the preferred (011) ori-
entation and the shapes of the grains, the pyramidal texture could be associated with 
the CaTiO 3 crystal structure, and the faceted planes would be {010} and {110} as 
shown in Fig.  4.7b . The microstructure of the square facets in the (101)-oriented 
CaTiO 3 fi lm is shown in Fig.  4.8a . Figure  4.8b shows the terrace on the top surface 
 Fig. 4.5  Effect of 
deposition temperature on 
 TC (022) and  TC (101) of 
CaTiO 3 fi lms 
 Fig. 4.6  SEM images of typical CaTiO 3 fi lms deposited by laser CVD on AlN substrates. ( a ,  b ) 
(011)-oriented CaTiO 3 fi lm at 795 K and 800 Pa, ( c ,  d ) (101)-oriented CaTiO 3 fi lm at 935 K and 
800 Pa, ( e ,  f ) (121)-oriented CaTiO 3 fi lm at 855 K and 400 Pa, and ( g ,  h ) CaTiO 3 fi lm with random 
orientation at 1080 K and 800 Pa 
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 Fig. 4.7  Microstructure and oriented texture of (011)-oriented CaTiO 3 fi lm. ( a ) Surface SEM 
image at high magnifi cation and ( b ) crystallographic texture of the pyramidal facet 
 Fig. 4.8  Microstructure and oriented texture of (101)-oriented CaTiO 3 fi lm. ( a ) Surface SEM 
image at high magnifi cation, ( b ) crystallographic texture of the square facet, ( c ) cross-sectional 
TEM image of the square facet, and ( d ) relation between crystallographic texture and the forma-
tion of nanopores 
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of the square facet corresponding to the (101) plane, along which the corner-sharing 
TiO 6 octahedra are aligned. Here, the lateral planes of the square facet were {101} 
and {010}. In Fig.  4.8c , the cross-sectional transmission electron microscopy 
(TEM) image of the square facet revealed that nanopores formed along the (110) 
and (011) planes, which are the close-packed planes of Ca–O atoms. These nano-
pores may relax the stress between the bio-ceramic fi lms and metallic substrates 
[ 41 – 43 ].
 Figure  4.9 shows the surface and cross-sectional morphologies of the Ca  n +1 Ti  n  O 3 n +1 
fi lm prepared at a Ca/Al supply ratio of 1.6 and a deposition temperature of 
777 K. The surface exhibited a cone-like morphology with a grain size of approxi-
mately 5–10 μm (Fig.  4.10a ). Each cone-like grain comprised granules that were 
several tens nanometers in size. The cross section was cone-like, which is a typical 
morphology for CVD-deposited fi lms [ 44 ]. The Ca/Ti composition of this fi lm was 
 Fig. 4.9  SEM images of a Ca n Ti  n +1 O 3 n +1 fi lm at 777 K and 800 Pa. ( a ) Surface morphology, ( b ) 
enlarged image of caulifl ower-like grains, and ( c ) cross-sectional image 
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1.54 by EPMA, which was nearly the same as that of Ca 3 Ti 2 O 7 . However, it was 
diffi cult to identify the detailed phases in the Ca  n +1 Ti  n  O 3 n +1 fi lms, because the XRD 
powder pattern of Ca 3 Ti 2 O 7 was similar to that of Ca 4 Ti 3 O 10 owing to the same type 
of long-range perovskite-related structure.
 Figure  4.10 shows the temperature dependence of the deposition rate for CaTiO 3 
fi lms by laser CVD and conventional thermal CVD in an Arrhenius format. The 
deposition rates of the CaTiO 3 fi lms by laser CVD reached 230 μm h −1 in the tem-
perature range of 800–1000 K. For the case of conventional thermal CVD, CaTiO 3 
fi lms without preferred crystal orientation were grown at the deposition rates in the 
range of 10–30 μm h −1 and at deposition temperatures above 900 K. Laser CVD 
enables the preparation of CaTiO 3 with several types of oriented textures at lower 
deposition temperatures and considerably higher growth rates compared with those 
obtainable by thermal CVD. 
 Figure  4.11 depicts the surface morphologies of the CaTiO 3 and Ca  n +1 Ti  n  O 3 n +1 
fi lms coated on the AlN substrates before and after immersion in SBF (Hanks’ solu-
tion) for 3 days. Although no signifi cant change in the randomly faceted grains of 
the CaTiO 3 fi lms without preferred orientation occurred during immersion, the 
grain boundaries and the faceted edges became slightly obscured (Fig.  4.11a, b ). On 
the other hand, for the as-deposited CaTiO 3 fi lm comprising square-faceted grains 
with strong (101) orientation, the edges and corners of the facets became round and 
smooth after immersion in Hanks’ solution (Fig.  4.11c, d ). These changes in grain 
boundaries and facet edges could be caused by the dissolution of CaTiO 3 into 
Hanks’ solution, indicating the biosolubility of the CaTiO 3 coating. The surface 
cone-like morphology with pyramidal facets of (011)-oriented CaTiO 3 fi lms became 
 Fig. 4.10  Effect of 
deposition temperature on 
deposition rates of CaTiO 3 
fi lms formed by laser 
CVD. For comparison, 
plots of the deposition 
rates of CaTiO 3 fi lms 
formed by conventional 
thermal CVD are also 
included 
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 Fig. 4.11  Effect of immersion in Hanks’ solution for 3 days on the surface morphologies of 
CaTiO 3 fi lms coated on AlN substrates. ( a ,  b ) CaTiO 3 fi lm with random orientation, ( c ,  d ) CaTiO 3 
fi lm with (101)-orientation, and ( e ,  f ) CaTiO 3 fi lm with (011)-orientation. Images ( a ,  c , and  e) 
show as-deposited fi lms, whereas ( b ,  d , and  f) show fi lms after the immersion 
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smooth, as shown in Fig.  4.11f . Figure  4.11f shows that a small amount of calcium 
phosphate precipitate (several hundred nanometers in size) with a bright contrast 
appeared on the fi lm’s surface after immersion in Hanks’ solution. The biosolubility 
and calcium phosphate formation of CaTiO 3 fi lms are affected by the morphology 
and preferred orientation. Figure  4.12 depicts the change in the surface morphology 
of Ca  n +1 Ti  n  O 3 n +1 fi lms caused by immersion in the Hanks’ solution. The caulifl ower- 
like grains of the as-deposited Ca  n +1 Ti  n  O 3 n +1 fi lm became smooth, and calcium phos-
phate precipitate was formed after immersion for 1 day (Fig.  4.12b ). The entire 
surface of the fi lm was covered by calcium phosphate precipitate after 3 days, as 
shown in Fig.  4.12c . Compared with the conventional perovskite CaTiO 3 fi lms (Fig. 
 4.11 ), the Ruddlesden–Popper-type Ca  n +1 Ti  n  O 3 n +1 fi lms exhibited signifi cant changes 
in the surface morphology and high calcium phosphate formation ability after the 
short-term immersion in SBF.
 Fig. 4.12  The effect of immersion in Hanks’ solution on the surface morphologies of Ca n Ti  n +1 O 3 n +1 
fi lms coated on AlN substrates; ( a ) as-deposited, ( b ) after immersion for 1 day, and ( c ) after 
immersion for 3 days 
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 Ca  n +1 Ti  n  O 3 n +1 fi lm was coated on a CP-Ti substrate. Figure  4.13 shows the surface 
morphologies of the Ca  n +1 Ti  n  O 3 n +1 fi lm prepared at a deposition temperature of 
620 K on a CP-Ti substrate. The as-deposited Ca  n +1 Ti  n  O 3 n +1 fi lm had a caulifl ower- 
like morphology similar to that on an AlN substrate (Fig.  4.12a ). After the SBF 
immersion for a day (Fig.  4.13b ), the surface of the caulifl ower-like grains became 
smooth, and the grain boundaries were obscured. The entire fi lm surface was cov-
ered with calcium phosphate precipitate after immersion for 3 days, as shown in 
Fig.  4.13c . Therefore, laser CVD enables the bio-ceramic coating of Ca  n +1 Ti  n  O 3 n +1 
fi lm on Ti substrates, and this coating is promising for enhancing the osteoinductiv-
ity of Ti-based implants.
 Fig. 4.13  The effect of immersion in Hanks’ solution on the surface morphologies of Ca n Ti  n +1 O 3 n +1 
fi lms coated on Ti substrates; ( a ) as-deposited, ( b ) after immersion for 1 day, and ( c ) after immer-
sion for 3 days 
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4.4  Summary 
 Well-crystallized Ca–Ti–O fi lms with various crystal phases and microstructures 
were produced at high deposition rates by laser CVD. Highly (011)-, (101)-, and 
(121)-oriented CaTiO 3 fi lms were obtained, forming caulifl ower-like, granular, and 
faceted morphologies. These various preferred orientations and morphologies 
affected the solubility, regeneration of calcium phosphate, and bio-inertness of 
CaTiO 3 fi lms. For the Ca-rich compositions, Ca  n +1 Ti  n  O 3 n +1 fi lms with a Ruddlesden–
Popper-type crystal structure were formed and exhibited promising bioactivity for 
calcium phosphate regeneration. 
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 Chapter 5 
 Development of a Robot-Assisted Surgery 
System for Cranio-Maxillofacial Surgery 
 Chuanbin  Guo ,  Jiang  Deng ,  Xingguang  Duan ,  Li  Chen ,  Xiaojing  Liu , 
 Guangyan  Yu ,  Chengtao  Wang , and  Guofang  Shen 
 Abstract  Medical robots have been developed rapidly in recent years. Clinical 
application of da Vinci system showed its advantages. Currently, there is no special-
ized robot system for cranio-maxillofcial surgery. We developed a cranio- 
maxillofacial surgical robot system focusing on the reconstruction of mandibular 
defects. 
 With the funding of the Chinese National High Technology Research and 
Development Program (863 Program), we developed a computer-aided design 
(CAD) system for four typical operations: reconstruction of mandibular defects, 
orbit reconstruction, skull base tumor resection, and orthognathic surgery, a naviga-
tion system and a robot with three arms for mandibular reconstruction. In the CAD 
system, the operation pattern was designed based on surgeons’ habits and experi-
ences. The software system was easy to be used with many functions for designing 
different surgical procedures. In surgical navigation system for guiding the robot, 
the hardware of the navigation system was assembled, and the software system of 
real-time registration was realized. The robot was designed and assembled. It had 
three arms and was able to fi nish the bone graft placement precisely and automati-
cally under the navigation guidance according to the preoperative design. The whole 
system was assessed by model and animal experiment with good results. 
 Keywords  Robot •  Cranio-maxillofacial surgery •  Navigation 
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5.1  General Information of Surgical Robots 
 Surgical robots have been tried in many fi elds of surgery like in orthopedics, micro-
surgery, neurosurgery, ENT surgery, catheterization procedure, etc. The fi rst robot 
assisting orthopedic operations was made by Integrated Surgical System Company, 
called ROBODOC system, in 1992 [ 1 ,  2 ]. It was developed from industry robots 
and was able to perform operations like knee joint replacement. Since then the other 
robots assisting surgery were developed, but very few of them could be used in 
clinic. In August of 2015, a newly developed robot by a research team in Beijing 
was used to assist spine surgery in a real patient and got satisfactory result. Currently 
the commercially available surgical robot is da Vinci surgical robot which helped in 
fi nishing prostatectomy for the fi rst time in the University of Frankfurt in 2000 and 
has become the main and much welcome surgical robot in the world. So far, as we 
know, there is no specially designed surgical robot for cranio-maxillofacial (CMF) 
surgery [ 3 – 6 ]. We began to develop our system in 2010 and have made two robots: 
one for mandibular reconstruction and the other for needle insertion to diagnose and 
treat lesions in the skull base. In this chapter we introduce the fi rst robot system. 
 Our robot-assisted surgery (RAS) system for CMF surgery consisted of the fol-
lowing three parts: computer-aided design (CAD) system for CMF surgery, surgical 
robot for CMF surgery, and medical experiment for the CAD and robot. The out-
lines of RAS system for CMF surgery is showed in Fig.  5.1 .
PREOPERATIVE DESIGN





Assisted by Digital Technique
Surgery
Design Update and Model Update
Robotic–Assisted Manipulation
Operation Design
3D Printed Model Used in The Operation
 Fig. 5.1  The outlines of RAS system for CMF surgery 
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5.2  Computer-Aided Design (CAD) System for CMF 
Surgery 
 The CAD was designed for four typical and more or less diffi cult operations: 
orthognathic surgery, reconstruction of the orbital defects, resection of skull base 
tumors, and reconstruction of mandibular defects. It has the following fi ve main 
functions: volume rendering of medical images, segmentation on medical images, 
CT/MRI image fusion, craniofacial database service, and virtual surgery 
designing. 
 The software is easy to use with good interactive regulation of transfer function. 
It can produce high-quality volume rendering of medical images and get quick and 
precise segmentation of soft tissue tumors based on graph-cut algorithm. Abstracted 
tumor from CT data can be visualized three dimensionally and measured for its 
volume with 99.5 % agreement of the true volume of the tumor. GPU marching 
cubes algorithm was used to build highly precise three-dimensional reconstruction 
of bony structures of the skeleton from CT images. The CT/MRI image fusion is 
another character of the CAD; it well fuses the bony structures abstracted from CT 
with the vessels abstracted from MRI and creates a new image with more informa-
tion for more precise medical image analysis and treatment planning. It can also 
fuse other images obtained by the other image equipments, like fusion of CT data 
with 3D laser scan image data for the dentition. 
 We also built a CMF database with more than 20,000 CT data of CMF to assist 
preoperative design. Currently, one of its functions we already used in clinic is to 
search for “similar skull.” We selected 71 landmarks on the CMF bones. Based on 
the landmarks, it can retrieve “similar skull” in a few seconds. 
 With the above mentioned basic functions, the CAD performs its most important 
task: carrying virtual surgery design for different operations, mainly for orthogna-
thic surgical management, mandibular reconstruction, orbital reconstruction, and 
removal of the skull base tumors. The designing system is easy to be learned and 
used for virtual surgical planning step by step. All procedures can be stored and 
repeated, which helps young surgeons to learn how to design and do these opera-
tions. After the virtual planning is done, 3D stereolithographic model (STL model) 
can be manufactured from the virtual planning model by using rapid prototyping 
technique for model surgery. Or the virtual planning data is inputted into the naviga-
tion system to guide surgeons or robots to perform operations according to the vir-
tual preoperative plan. Thus the precise real-time registration of the CAD system 
with navigation system is the key point for realization of accurate navigation. 
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5.3  Surgical Robot for CMF Surgery 
 The development of the robot had the following main contents: conformation of 
robotic system, control system, safety control of the robotic system, navigation and 
trail program, and test of the robot. 
5.3.1  Conformation of the Robotic System 
 The robot had three arms and six degrees of freedom, its hold strength was 30–50 
N, and its working square was 200 × 200 × 200 mm. Each arm consisted of two seg-
ments and three joints. Figure  5.2 shows the mechanical structure of the robot and 
the appearance of the robot after assembling.
5.3.2  Safety Control of the Robotic System 
 Safety is the fi rst consideration for clinical application of medical robots. It was 
reported that more than 60 % of adverse events in clinical use were caused by robots’ 
malfunction. Our robot safety control involved the workfl ow from patients’ diagno-
sis, virtual surgical planning, navigation to robot assisting surgery, robotic system 
itself like essential electro-circuit for safety control, interactive process, and 
 Fig. 5.2  ( a ) The mechanical structure of the robot. ( b ) The appearance of the robot 
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recovery mechanisms when unexpected faults occur. With these measures, patient 
safety and operator safety can be guaranteed. 
5.3.3  Navigation and Trail Program 
 Navigation was realized by coordinate switch of four coordinates: 3D object space, 
image coordinate {V}; physical space, patient coordinate {P}; robotic space, robotic 
coordinate {R}; and optical space, optical coordinate {M}. The algorithms of trail 
program included cube polynomial and quintic polynomial. 
 After all these works were completed, the whole system of the robot was pack-
aged. It consists of the robot, optical tracker, and workstation. 
5.3.4  Test of the Robot 
 We assessed positioning accuracy of the robot and found its repeat positioning error 
was less than 0.10 mm and the systemic absolute positioning error <2.45 mm, which 
met the requirement of the design indicators for performance check. And the robot 
was ready for medical experiment. 
5.4  Medical Experiment for the Robotic System 
5.4.1  Evaluation of the CAD Software 
 Twenty-fi ve young oral and maxillofacial surgeons were asked to use and evaluate 
the CAD software. The satisfaction degree was 91 %. 
5.4.2  Accuracy of the Three-Dimensional Reconstruction 
of the CAD Software 
 The accuracy of three-dimensional reconstruction and the accuracy of the naviga-
tion system and the robot were all tested by model or animal study. 
 Thirty model skulls were used to test the accuracy of the three-dimensional 
reconstruction of the CAD software. Titanium screws of 0.1 mm were fi xed on the 
models. The marked models were CT scanned. Reconstruction of the models was 
performed on the CT data. The comparative study between the reconstructed mod-
els and the real models showed that the error was 0.21 mm. 
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5.4.3  Accuracy of the Navigation System 
 For navigation assessment, the fl owchart of the animal experiment includes the fol-
lowing: (1) use living goats as study animal, (2) fi x marks on the cranio- maxillofacial 
region, (3) have CT scan, (4) have virtual surgical design, (5) do operation under 
navigation, (6) have postoperative CT scan, and (7) compare pre- and postoperative 
results. All of the four typical operations were tested for navigation accuracy. 
Comparison of postoperative results with preoperative design showed that the error 
of mandibular reconstruction was 2.9 mm, error of orthognathic surgery 2.7 mm, 
error of orbital reconstruction 1.2 mm, and error of skull base surgery 1.8 mm. 
There are many factors that can affect the accuracy of navigation. These factors are 
CT scan slice thickness, resolution and radiation dosage, shadow of titanium plates, 
accuracy of three-dimensional reconstruction, titanium plate bending, movements 
of remaining bone segments, etc. Current animal study results are acceptable for 
clinical application. 
5.4.4  Animal Experiment of Robot-Assisted Operations 
 The experimental fl ow was similar to the abovementioned navigation study. After 
the animal CT data were collected, the preoperative design was planned using the 
CAD system. The robot and animal registration was performed, the surgery of mak-
ing osteotomy on the mandible was done, and the fi bular bone graft was fabricated 
under navigation according the preoperative design (Fig.  5.3 ). When the mandibular 
defect was made, the robots’ two side arms held two remaining bone segments, the 
 Fig. 5.3  Making osteotomy on the mandible under navigation 
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middle arm held the bone graft, and under navigation the middle arm carried the 
bone graft automatically to the defect (Fig.  5.4 ). After the bone graft was posi-
tioned, it was fi xed with titanium plates. Comparison of postoperative results with 
preoperative design showed that errors of left, right, and middle arms were 1.15 
mm, 2.68 mm, 2.175 mm, respectively.
 The robot animal study showed that the robot can move smoothly and do accu-
rate placement of bone graft and aid fi xation. Its three arms can coordinate well to 
aid bone graft placement for different types of mandibular defects. Its fl exibility, 
bone holding method, miniaturization, etc. need improvement for higher stability 
and accuracy. 
 Confl ict of Interest  There is no confl ict of interest. This project was funded by the Chinese 
National High Technology Research and Development Program (863 Program), China. 
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 Chapter 6 
 Facilitating the Movement of Qualifi ed Dental 
Graduates to Provide Dental Services Across 
ASEAN Member States 
 Suchit  Poolthong and  Supachai  Chuenjitwongsa 
 Abstract  The Association of Southeast Asian Nations (ASEAN) is a political and 
economic organization of ten countries located in Southeast Asia. Its one purpose is 
to promote a free trade area in services among member states. Dentistry is one sec-
tor subjected to the free movement policy in which dental practitioners can migrate 
freely across ASEAN to provide dental services. ASEAN policies and strategies to 
facilitate the free movement of dental professionals have been developed since 
2009. To ensure that dental graduates from all dental schools across ASEAN pos-
sess comparable standards of practice, harmonization of undergraduate dental edu-
cation across ASEAN was announced in 2015. Currently, ASEAN is focusing on 
developing common competencies for its dental graduates. To maximize the free 
movement, ASEAN dental education development will work toward developing 
curriculum guidelines and quality assurance for ASEAN undergraduate dental cur-
ricula as well as educational and academic development for ASEAN dental schools 
and staff. 
 Keywords  Free movement of dental professionals •  Harmonizing undergraduate 
dental education •  ASEAN dental graduates 
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6.1  Formation of ASEAN to AJCCD 
 The Association of Southeast Asian Nations (ASEAN) is a political and economic 
organization of ten countries located in Southeast Asia: Brunei Darussalam, 
Cambodia, Indonesia, Laos PDR, Malaysia, Myanmar, the Philippines, Singapore, 
Thailand, and Vietnam. Its aims include accelerating free trade area among its mem-
ber states, protection of regional peace and stability, and opportunities for member 
countries to discuss differences peacefully. In 1995, ASEAN Framework Agreement 
on Services (AFAS) was established and signed by ASEAN Economic Ministers. 
Main purposes are to enhance cooperation in services among member states, elimi-
nate substantially restrictions to trade in services, and liberalize trade in services 
with the aim to realizing a free trade area in services within ASEAN member states. 
Later on, Coordinating Committee on Services (CCS) was established on its pur-
pose to undertake service integration initiatives within six service sectors, and one 
sector was healthcare services. Healthcare Services Sectoral Working Group 
(HSSWG) was then initiated to discuss matters pertaining to facilitation and coop-
eration within three healthcare professions, and dental profession was one of them. 
Finally, ASEAN Joint Coordinating Committee on Dental Practitioners (AJCCD), a 
committee under the HSSWG, was started to facilitate cooperation on Mutual 
Recognition Arrangement (MRA) for dental practitioners. 
6.2  MRA for Free Flow of Services and Professionals 
 The MRA on dental practitioners was fi nally signed in February 2009 and planned 
for implementation in 2015. Its objectives are to facilitate mobility of dental practi-
tioners within ASEAN, enhance exchange of information and expertise on stan-
dards and qualifi cations, promote adoption of best practices for professional dental 
services, and provide opportunities for capacity building and training of dental prac-
titioners. According to the mobility of dental practitioners within ASEAN, there is 
a concern on the standard of dental services by dentists across the ASEAN. With 
this regard, harmonization of undergraduate dental education in order to create 
comparable dental curricula of all dental schools in ASEAN member states is 
necessary. 
 ASEAN MRA on dental practitioners was fi rst established in Singapore in 2008. 
It has been the issue of discussion in the AJCCD meeting ever since. In the MRA, it 
was stated that this MRA would be discussed for improvement and be revised offi -
cially every 5 years. The detail of MRA consists of ten articles [ 1 ]. A summary of 
ten MRA articles is provided in Table  6.1 .
 For the content of MRA, an introduction provides some basic understanding and 
terminologies including objectives of AFAS, vision of ASEAN, and some notes 
regarding level of recognition on education and certifi cation granted in other 
S. Poolthong and S. Chuenjitwongsa
75
ASEAN countries as well as their expectation from the MRA to facilitate free fl ow 
of dental practitioners across the region. This is to form a highly competitive 
ASEAN economic region resulting in free fl ow of goods, services and investment, 
 Table 6.1  A summary of ten MRA articles 
 Article  Summary 
 1  Outlining the four objectives of the MRA: (1) to facilitate mobility of dental 
practitioners within ASEAN, (2) to exchange information and enhance cooperation in 
respect of mutual recognition of dental practitioners, (3) to promote adoption of best 
practices on standards and qualifi cations, and (4) to provide opportunities for capacity 
building and training of dental practitioners. 
 2  Providing defi nitions of professional terminologies used in dental services and the 
names of those authorized organizations, namely, Professional Dental Regulatory 
Authority (PDRA). The PDRA is responsible for dental regulations in their own 
countries. Those PDRAs vary from Medical Board, Medical Council, Dental Council, 
and Professional Regulation Commission to Ministry of Health. Majorities are for 
Dental Council and Ministry of Health. 
 3  Explaining recognition and eligibility of foreign dental practitioners in host countries. 
The foreign dental practitioners can apply for registration in the host country in 
accordance with its domestic regulations. With these regulations, they generate 
limitations which may not strongly facilitate free fl ow of dental practitioners such as 
the nationality issue and the examination using local languages. Though English is 
used as a common language in ASEAN, local languages play important role in the 
eligibility to apply for registration in many countries especially the countries outside 
the commonwealth. 
 4  Defi ning roles of PDRA and its duties including: to evaluate qualifi cation, to impose 
other requirements where applicable, to grant recognition and register eligibility to 
practice in the host country, to monitor the compliance of foreign dental practitioners 
in order to conform with the domestic regulations, and to take action in case one fails 
to practice under domestic regulation. 
 5  An agreement from all member states indicating that they will not reduce, eliminate, 
or modify power and authority of PDRA. 
 6  Explaining about the establishment of AJCCD as a working group under 
HSSWG. The AJCCD committee comprises two representatives from each ASEAN 
country. The AJCCD’s important role is to facilitate the implementation of MRA 
through better understanding of domestic regulation. AJCCD also encourages 
information exchange among all members and will review the MRA every 5 years if 
necessary. 
 7  Discussion about the possibility of mutual exemption where each PDRA has 
responsibility to protect health, safety, environment, and welfare of the community 
within its authority. 
 8  Containing the critical issue of dispute settlement. In order to avoid confl ict, every 
attempt through communication, consultation, and cooperation is expected to 
mutually satisfy any matter that might affect the implementation of the MRA. 
 9  Stating about amendment that can be done through only mutual written agreement by 
the representatives of all member states. However, the PDRA can be done by its own 
country representative regardless of other members’ agreements. 
 10  Representing the fi nal provisions that was agreed for the deferment of the MRA, if 
desired, by any member to be informed within 6 months after MRA signing. 
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equitable economic development, reduced poverty and socioeconomic disparities, 
and enhanced political as well as economic and social stability. One part of free fl ow 
of goods, services, and investment is a free fl ow of dental professionals and dental 
services. The expected outcomes of the MRA are to strengthen professional capa-
bilities by promoting fl ow of relevant information and exchanging expertise, experi-
ences, and best practices suited to the specifi c needs of ASEAN member states. 
6.3  Impact on Dental Education 
 To achieve high standard dental services from new dental graduates across the 
ASEAN member states, all dental schools ideally need an agreed upon common 
curriculum with similar learning outcomes and competencies of the graduates. The 
common curriculum must be of a high standard that is comparable to international 
standards such as the standards for undergraduate dental curricula in Europe [ 2 ]. 
Because there is currently no such curriculum, learning outcomes, or competencies 
in the ASEAN region, developing a standard curriculum is one of the keys to suc-
cess for the free movement of dental professionals across the region and will pro-
vide new graduates with the common dental competencies required for all ASEAN 
dentists. 
 Competency is “a combination of knowledge, skills, professional attitude, per-
sonal attributes, an ability to work independently (without direct supervision), 
and context” [ 3 ]. Competency is a primary concern in competency-based dental 
curriculum [ 4 ] in which the societal needs for oral healthcare, institutional factors 
(e.g., structures of the dental school), and national factors (e.g., educational pol-
icy, politics) are taken into account [ 3 ]. In several parts of the world (e.g., USA, 
Europe), a list of competencies for new dental graduates has been already devel-
oped and implemented [ 5 ,  6 ]. However, in Southeast Asia, the common profi le 
and competencies for ASEAN dentists have not yet been established. General 
competencies for dentists in any country could be similar; for example, a dentist 
should be able to perform a simple extraction. However, the community character, 
local sociocultural context, and oral health status can infl uence how the compe-
tencies are set up [ 3 ]. Thus, competencies for ASEAN dentists might be different 
from dentists in other areas outside Southeast Asia. Such competencies for 
ASEAN dentists, in particular, need to be identifi ed and developed. New gradu-
ates from the ASEAN dental competencies would fulfi ll the purpose of facilitat-
ing the free movement of dental professionals and dentists across the Southeast 
Asia region. 
 Developing competencies for ASEAN dentists will also lead to further dental 
education development including standards for an undergraduate dental curricu-
lum, quality assurance, teacher training, and collaborative research in dental 
education. 
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6.4  Facilitating Free Movement of Dental Professionals 
Across ASEAN 
6.4.1  Current Work 
 In May 2015, the Faculty of Dentistry, Chulalongkorn University, hosted the 
ASEAN Dental Forum (ADF) where 26 of the AJCCD members from ASEAN 
member states and representatives from Thai dental schools have attended and 
signed the Bangkok Declaration of 22 May 2015. The declaration emphasizes that 
ASEAN dental schools will work together, on the basis of trust and willingness, 
toward primary goals to achieve the harmonization of dental education across the 
ASEAN region by (1) developing common competencies for the safe and indepen-
dent practice of ASEAN general dental practitioners and (2) developing an ASEAN 
undergraduate dental curriculum. Currently the harmonization of ASEAN under-
graduate dental education is one part of the AJCCD work plan 2016–2020. With an 
agreement of the AJCCD, the Faculty of Dentistry, Chulalongkorn University, is 
now the leading institution responsible for conducting an international meeting 
(ADF) to develop major competencies for ASEAN dentists. The next ADF meeting 
will be held in late August 2016. 
 In order to improve quality and gain acceptability of the common competencies 
developed by the ADF, information, opinions, and agreements from stakeholders 
within dental education are required. As a part of the ADF, representatives from 
ASEAN member states (educators and policy makers) are included in the meeting 
panel, and a wider audience (practitioners, academics, patients) will have an oppor-
tunity to get involved in a public hearing. ASEAN students – who are directly 
affected by the common competencies developed by the ADF – will be invited to 
attend a meeting in September 2016 (after the ADF meeting) to provide the “student 
voice” toward creating common dental competencies for ASEAN dentists. The stu-
dent representatives will provide in-depth information and critique based on their 
perspectives (i.e., students as consumers of dental education). The consensual 
agreements from student representatives will be combined with the consensual 
agreements from the ADF (educators and policy makers) to develop the fi rst draft of 
common competencies. When the fi rst draft is written, a public hearing will be held, 
before being passed on to the main AJCCD body for fi nal approval and implementa-
tion. Then the AJCCD member from each country will pass this message to the 
policy makers of the ASEAN member states and start to set the time line for the new 
curriculum of all dental schools across ASEAN to comply with the common com-
petencies for ASEAN dentists. As a result, there will be less concern of the quality 
of dentists when they cross the border for free movement of dental services as 
required by the MRA. 
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6.4.2  Future Work 
 Only developing common competencies for ASEAN dental graduates may not fully 
support the free movement of dental professional across ASEAN. Future work that 
AJCCD and other political bodies need to focus includes four main areas:
 1.  The guidelines for an undergraduate dental curriculum in ASEAN emphasizing 
contemporary educational strategies, assessment, and credit transfer system in 
relation to the principles of competency-based dental education 
 2.  Quality assurance for an undergraduate dental curriculum in ASEAN ensuring 
that the curriculum is developed and regularly improved in line with the ASEAN 
and international standards 
 3.  Educational development policies and strategies embedding research-based edu-
cation, enterprise education, public engagement, and modern educational meth-
ods (e.g., technology-enhanced learning, evidence-based practice) into the 
ASEAN undergraduate dental education 
 4.  Academic training and continuing professional development for ASEAN dental 
educators/staff in the area of educational practice 
6.5  Conclusion 
 Facilitating the free movement of dental professionals across ASEAN is not a 
straightforward process. This paper has summarized how the free movement of den-
tal professionals across ASEAN was initiated and how harmonization of under-
graduate dental education has been fundamental to the free movement process. The 
success of this process strongly relies on the mutual respect and collaboration 
among stakeholders especially ASEAN dental educators, students, practitioners, 
policy makers, and the whole ASEAN community. 
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 Chapter 7 
 Putting the Mouth into Health: 
The Importance of Oral Health for General 
Health 
 Christopher  C.  Peck 
 Abstract  Good oral health is important to overall health and wellbeing. From the 
most fundamental perspectives of the oral–systemic health relationship, good oral 
health ensures an individual can eat, speak and socialise without pain or embarrass-
ment. These capabilities improve an individual’s wellbeing and ability to contribute 
to society. There are more complex oral–systemic health relationships in which 
poor oral health can contribute to systemic diseases including the links between 
orofacial disease and, for example, diabetes, cardiovascular disease, pneumonia or 
rheumatoid arthritis. Furthermore, the oral environment is a complex biological 
ecosystem which provides an opportunity to understand mechanisms underlying 
pathological processes and which can be a model for other body systems. Examples 
of these oral–systemic interactions are presented to demonstrate the importance of 
the orofacial environment and the need for it to be incorporated into health more 
broadly. By putting the mouth into health through integrated education, research 
and clinical care across the health disciplines, there will be advances in health that 
will improve individual and community health. 
 Keywords  Health •  Oral–systemic health •  Pain •  Disability 
7.1  Introduvction 
 The orofacial region is unique because of its importance in social interactions, 
including communication and emotional expression, and in survival with mastica-
tion and lifesaving refl exes that protect other external sensory (e.g. retina, olfactory 
epithelium, taste receptors) and internal homeostatic (e.g. respiratory and digestive 
tracts) systems from damaging environmental changes. Consequently this region 
and good oral health are important components to overall health and wellbeing. 
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From the most fundamental perspectives of the oral–systemic health relationship, 
good oral health ensures an individual can eat, speak and socialise without pain or 
embarrassment. These capabilities improve an individual’s wellbeing and ability to 
contribute to society. There are more complex oral–systemic health relationships in 
which poor oral health can contribute to systemic diseases including the links 
between orofacial disease and, for example, diabetes, cardiovascular disease, 
 pneumonia or rheumatoid arthritis. Furthermore, the oral environment is a complex 
biological ecosystem which provides an opportunity to understand mechanisms 
underlying pathological processes, and which therefore can be a model for other 
body systems. 
 There have been signifi cant advances in oral health improvement over the past 30 
years, where there has been a change in focus from the acute management of the 
disease burden of dental caries and periodontal disease to an increased focus on 
prevention and more complex oral rehabilitation to improve function and aesthetics. 
Nevertheless, in Australia as in many parts of the world, there is still a worrying oral 
disease burden; oral cancer continues with signifi cant morbidity and mortality [ 1 ], 
30 % of adults have untreated tooth decay [ 2 ], 15 % of adults experience oral pain 
[ 3 ], 25 % adults are uncomfortable about their dental appearance [ 3 ] and oral prob-
lems account for the third highest level of acute preventable hospital admissions [ 4 ]. 
Furthermore they can affect self-esteem, social interaction, education, career 
achievement and emotional state [ 5 ] and lead to a deteriorating diet and compro-
mised nutrition [ 6 ]. 
7.2  The Oral–Systemic Nexus 
 Whilst many countries, including Japan and Australia, have universal healthcare 
systems, frequently dental care is partly or completely excluded. This leads to soci-
etal inequality with groups, such as Aboriginal Australians, who are on low income, 
with limited education or living in remote areas suffering worse oral health. In a 
similar way that many governments exclude oral health from healthcare, many indi-
viduals, when prioritising household expenditure, consider oral health as a cosmetic 
issue rather than essential to overall health. In Australia over 45 % of adults over 25 
years did not visit a dental practitioner in the past year [ 7 ]. 
 There is much research indicating links between oral health and, for example, 
cardiovascular disease, mental health and diabetes. There are interesting fi ndings 
showing that a person with fewer than ten of their own teeth is seven times more 
likely to die of coronary disease than someone with more than 25 of their own teeth 
[ 8 ] and that treating gum disease improves vascular health [ 9 ]. With Alzheimer’s 
disease, a study of more than 4000 Japanese participants, aged 65 and older, found 
those with missing teeth were much more likely to have experienced memory loss 
or have early-stage Alzheimer’s disease than those with an intact dentition [ 10 ]. The 
relationship between diabetes mellitus and periodontal disease appears bidirectional 
with diabetes increasing the risk for periodontitis and periodontal infl ammation 
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negatively affecting glycaemic control [ 11 ]. The relationship between the two dis-
eases is strong and in fact periodontal disease has been coined the sixth complica-
tion of diabetes [ 12 ]. These and many other associations between oral and systemic 
health are important and the focus of much research, particularly exploring aetio-
logical mechanisms underlying these associations. 
 As a result of the strong links between oral and systemic health, we have 
embarked on a strategic initiative to put the mouth into health, through education, 
research and clinical care. Our research endeavours are focussed on oral–systemic 
health interactions in exploring known associations, using the oral environment as a 
biomarker and as a model for disease processes or clinical care. Some examples of 
these endeavours follow. 
7.3  Oral–Systemic Health Associations 
 There are strong associations between rheumatoid arthritis and periodontal disease, 
and it is important to determine if this is because they are two common chronic dis-
eases or indeed if there is a causal link between the two diseases [ 13 ]. Interdisciplinary 
research suggests that the periodontal pathogen  Porphyromonas gingivalis exacer-
bates collagen-induced arthritis (rheumatoid arthritis). The bacteria express an 
enzyme that causes human and bacterial protein citrullination (conversion of the 
amino acid arginine into citrulline) and autoantibodies to these citrullinated proteins. 
A pathogenic autoimmune response to these citrullinated proteins ensues causing 
earlier onset, accelerated progression and enhanced severity of the arthritic disease 
[ 14 ]. These fi ndings may help with diagnosis and targeted treatments. 
 Chronic orofacial pain can be disabling affecting approximately 10 % of the 
adult population [ 15 ]. Pain is frequently not limited to the orofacial region; a local 
survey demonstrated up to 60 % of clinical patients reported pain elsewhere in their 
body (Fig.  7.1 ). Furthermore, subjects with temporomandibular disorders frequently 
had symptoms of widespread conditions including chronic fatigue syndrome and 
fi bromyalgia [ 16 ]. We have demonstrated that temporomandibular disorders can be 
associated with catastrophic beliefs and with depression and that these psychologi-
cal factors can impact jaw motor activity [ 17 ,  18 ].
 Oral health appears to be related to physical health, specifi cally cardiorespiratory 
fi tness. In a clinical study of 72 men, peak oxygen uptake during exercise testing 
was signifi cantly lower, indicating lower levels of fi tness, in those with moderate to 
severe periodontitis [ 19 ]. 
 In an interesting study comparing genetic details of calcifi ed dental plaque from 
34 early European skeletons, it was shown that the transition from hunter-gatherer 
to farming shifted the oral microbial community to a disease-associated confi gura-
tion. During the Industrial Revolution, cariogenic bacteria became dominant, and 
the modern oral microbial community is much less diverse than historic populations 
[ 20 ]. This may be contributing to contemporary chronic diseases, affecting both oral 
and systemic environments. 
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7.4  The Oral Environment: A Model for Other Body 
Systems 
 The oral environment is a complex and harsh biological setting connecting the inter-
nal body with the external environment. It consists of hard and soft tissues, biofi lm 
and sensory and motor innervation and consequently can be a good model to moni-
tor systemic health and demonstrate interactions between systems and the external 
environment. It is important for health professionals and especially dental practitio-
ners to promote the importance of oral health to health overall. 
 Fig. 7.1  An example of a pain map for an orofacial pain patient demonstrating pain extending 





 The tooth can be a biomarker to determine, for example, past chemical exposure 
during development. One topical area is iron exposure during development in the 
form of iron-fortifi ed supplements, and the possible relationship with age-related 
neurodegenerative disorders. Iron has been implicated in disorders such as 
Parkinson’s disorder and it may be the iron levels during development that are 
implicated. Iron levels in tooth enamel and dentine can be directly mapped to the 
source and timing of infant nutrition during development of the tooth, thus provid-
ing an opportunity to correlate this with neurodegenerative disorders [ 21 ]. This ret-
rospective method is attractive for exploring past chemical exposure during the 
development years. In turn, fi ndings from this will be able to help inform on devel-
opment of disorders and health policy for nutritional supplements. 
 Glial cells which make up the majority of cells in the brain were considered pre-
viously as scaffolds to support neurons. We now know that these cells’ role is much 
more, and recent work has demonstrated an important role in the dental pulp. With 
dental caries, and associated hypoxic stress, there is angiogenic remodelling of the 
pulpal microvasculature through an interaction of endothelial cells, pericytes, 
microglia and telacytes in the pulp. This response provides vascular remodelling 
whilst maintaining a blood barrier. The directional expansion of the microvascula-
ture is achieved through glial-assisted guided migration of endothelial cells [ 22 ]. 
This important function can be compared with other glial cell activities in the ner-
vous system. 
 Temporomandibular disorders are the most common chronic pain disorders in 
the orofacial region and consist of a number of problems affecting the jaw’s muscu-
loskeletal system including the temporomandibular joints or masticatory muscles. 
The classifi cation scheme for these disorders has been a model for other pain condi-
tions and disorders as it includes both physical and psychosocial dimensions [ 23 ]. 
Recently it has been revised [ 24 ] with validated diagnostic criteria and an extended 
taxonomy has also been developed [ 25 ]. This research on temporomandibular dis-
orders spanning 26 years provides a valuable record for developing diagnostic 
frameworks for other conditions throughout the body. 
7.5  Summary 
 It is imperative to put the mouth into health to improve health and wellbeing of the 
individual and of society. There are many associations between oral and systemic 
health and research is investigating causal links. Embedding research, education 
and clinical care across the health disciplines provides opportunities to better under-
stand the role of oral health in a much broader context. 
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 Chapter 8 
 Orofacial Stem Cells for Cell-Based Therapies 
of Local and Systemic Diseases 
 Munira  Xaymardan 
 Abstract  Orofacial region and dental tissues harbour a wide range of stem/pro-
genitor cells including mesenchymal stem cells and tissue-specifi c progenitors such 
as muscle satellite cells. The stem cells of the orofacial areas are readily available, 
highly proliferative and possess multi-differentiation abilities. These cells not only 
provide therapeutic and tissue engineering cell source for the defects of orofacial 
area and dental tissues but also provide additional cell source for the diseases of 
other organs. Understanding their differentiation pathways and mechanisms will be 
imperative in developing the most appropriate approaches for stem cell-based tissue 
engineering and therapeutic strategies. 
 Keywords  Orofacial •  Stem cells •  Therapy 
8.1  Overview 
8.1.1  Need for Stem/Progenitor Cell-Based Therapy 
 Stem cells are defi ned as the cells that have two important abilities: (1) self-renewal 
and (2) differentiation. They have remarkable potential to develop into many differ-
ent cell types in the body during early life and growth [ 1 ]. In adults, they serve as a 
cell source for continuous repair system, dividing essentially without limit to replen-
ish other cells as long as the person or animal is still alive, as best exampled with the 
haematopoietic system, bone marrow (BM) stem cells providing blood cells 
throughout a person’s life. Other adult organs are less regenerative in comparison; 
still, minor wears and tears are constantly repaired with stem cells by providing 
broader matrix turnover and cellular replenishment or by exerting more specialized 
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function, such as differentiating into muscle cells, neurons, or, in the dental context, 
odontoblasts. 
 However, in adult mammalians, this reparative ability seems to be limited to 
minor injuries. In catastrophic events such as myocardial infarction (MI), spinal 
cord injury (SCI) or autoimmune and degenerative diseases, the endogenous stem 
cells do not seem to have the capacity to provide suffi cient support for the parenchy-
mal tissue regeneration. The lost tissue is often replaced by fi brous scar, compro-
mising the integrity and function of the damaged organs. Therefore, developing 
approaches that can either activate the endogenous stem cells  in vivo or expand 
them  in vitro for transplantation still hold major research interest in the regenerative 
medicine. 
 Stem and progenitor cells exert their therapeutic abilities mainly through two 
mechanisms:
 1.  Functional cellular replacement of the damaged organs, for example, replace-
ment of the neurons in SCI or replacement of the cardiomyocytes after MI. This 
aspect is the most desirable property of the stem cell therapeutics but currently is 
also diffi cult to achieve with adult stem cell sources. Embryonic stem (ES) cells 
and the induced pluripotent promise the pluripotency that can be used to differ-
entiate various cell types for transplantation, however with caveats including 
uncontrolled cell proliferations and teratogenicity limiting the clinical use of 
these cells. 
 2.  Modulation of the repair processes by providing extracellular matrix remodel-
ling, paracrine trophic factors and immune modulation. More often than not, and 
in the mesenchymal stem cell (MSC) therapies in particular, the trophic effects 
seem to play a major role in the improvement of the organ function by modulat-
ing vascular supply and maintenance of tissue architectures rather than providing 
engraftment of the parenchymal cell types. The immunomodulatory effects of 
the MSCs have been exploited to treat various diseases including cardiac injuries 
and autoimmune diseases, with cells isolated and investigated from virtually all 
organs and tissues in the body. 
 Studies of the orofacial stem cells have been relatively newer events. Majority of 
the orofacial stem cell studies have been focused on the MSC cell types of the dental 
pulp, periodontal ligaments, facial BM, submucosal stromal and tongue. In the 
meantime, studies include generation of the parenchymal cell types of salivary 
glands, and recent speculation of the possible use of the tongue myogenic progeni-
tors for cardiac repair also hold intriguing perspectives for future exploration of the 
stem cells in the orofacial region. 
 Orofacial region provides advantages over other cell sources:
 1.  Easy accessibility: Cells can be obtained from extracted third molars (pulp and 
periodontal cell sources), exfoliated deciduous teeth, oral mucosa biopsies and 




 2.  Higher potency: For example, MSCs isolated from the dental sources may pos-
sess high potencies compared to BM source as discussed below. 
 3.  Complexity: Multi-lineage derivation of the orofacial tissues that contain all 
three germ layers of embryonic origins (endoderm, ectoderm and mesoderm, as 
discussed below) that may provide expanded versatility for stem cell therapies. 
 In this chapter, we discuss the developmental cell sources of the orofacial areas 
focusing on the discussion of the MSCs derived from orofacial region and their util-
ity in the local and systemic diseases, as well as the potential promise of the orofa-
cial muscle progenitor usage for cardiac regenerations. 
8.1.2  Cell Sources During Orofacial Development 
 During vertebrate development, including humans, the oral and facial region devel-
ops very early in the embryos following formation of the cardiac tube and folding 
of the neural tube, approximately at the end of week 3 of prenatal life. The earliest 
orofacial progenitors originate posteriorly to the heart fi eld and contain vascular 
(aortic arch) and muscular progenitors, which are joined by the neural crest mesen-
chymal (also known as ectomesenchyme) progenitor migration as the neural tube 
closes [ 2 ]. Expansion of these two populations facilitates the formation of the fi rst 
and second pharyngeal arches that provide initial myogenic progenitors for orofa-
cial musculatures, including masticatory, facial expressions and tongue [ 3 ,  4 ], and 
the multi-fated neural crest progenitors for formation of facial cartilage, fl at bones, 
teeth and tooth support tissues such as periodontal ligaments [ 5 ]. Recent studies 
indicate that, albeit to a limited extent, adult tissues may retain some of these stem/
progenitor cells at various stages of the development, become dormant and, when 
activated, are able to achieve minor repairs of the tissues during injury. Indeed, stud-
ies have shown the MSCs isolated from the orofacial area are neural crest in origin 
[ 6 ] and may have different differentiation potential compared to the MSCs isolated 
from other tissues such as the BM and heart which are thought to have been derived 
from the mesodermal origin [ 7 ]. 
 At the later stages of the embryonic development, the mesodermal muscle pro-
genitors (paraxial/occipital) and mesenchymal stromal cells aid the expansion of the 
muscle cell pools and the connective tissue (including bone) maturations. However, 
these cell sources provoke less interest from orofacial stem cell research point of 
view as the clonogenic stem cells isolated from this region seem to be more neural 
crest in origin [ 8 ]. 
 The pharyngeal arches that give rise to orofacial tissues are internally lined by 
the endodermal epithelium and externally covered by the ectodermal epithelium; 
both form the oral mucosa lining as well as give rise to salivary glands [ 9 ]. Isolation 
of the myoepithelial progenitors from the salivary glands has shown to generate 
organoids in vitro and is able to engraft in the irradiated mice to form functional 
salivary glands [ 10 ]. 
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8.2  Mesenchymal Stem Cell-Derived Oral Tissues 
8.2.1  Markers and Sources of Orofacial MSCs 
 Majority of the orofacial stem cell research involves isolation of the so-called MSC 
population from various tissues. MSCs are fi rst isolated by Friedenstain from BM 
and generally described as a group of plastic adherent cells that assume a spindle- 
shaped morphology and form so-called colony-forming unit fi broblasts (CFU-F), 
which can differentiate into connective tissue cells (adipocytes, osteocytes and 
chrondrocytes) in vitro [ 11 ]. In the orofacial region, the MSCs are isolated from 
adult human dental pulp, pulp of the exfoliated deciduous teeth, periodontal liga-
ments, apical follicles, mandibular BM and oral mucosal connective tissues that can 
be transplanted to various organs. 
 Similar to the MSCs derived from other tissues, orofacial MSCs do not display 
any tissue-specifi c markers  in vivo . Some of the markers of  in vitro derivatives of 
dental pulp stem cells (DPSCs) and periodontal ligament stem cells (PDLCs) 
include stromal markers such as CD90, CD44, CD13, CD19 and CD79 and pericyte 
markers such as CD146. In mouse, the MSCs are marked within a broader stromal 
population of the stem cell antigen 1 (Sca-1)-positive cohorts. In humans, Stro-1 
and CD34 were described as MSC makers that can be used to isolate the  in vitro 
 CFU-F forming cells, albeit all these markers are expressed by other cell types and 
highly unspecifi c. Recently, platelet-derived growth factor receptor alpha (PDGFRa) 
has been described as a possible  in vivo  marker for the enrichment of MSC CFU-F 
forming ability  in vitro and engraftment  in vivo [ 12 ,  13 ]. Studies have shown that 
the PDGFRa expresses broadly in the neural crest cells, [ 14 ] and in the dental 
organs, clonogenic MSCs can be isolated from the dental pulp tissue using this 
marker [ 8 ]. However, no comprehensive enrichment studies have been conducted 
using PDGFRa . Similar to other MSCs, these cells generally lack haematopoietic 
cell markers such as CD45 and CD31 [ 1 ,  15 ]. 
 Orofacial MSCs cells originate from the embryonic neural crest, generally 
described as possessing higher differentiation potencies than the MSCs isolated 
from other sites [ 16 ]. For example, MSCs isolated from the mandibular bone can 
engraft and regenerate tibial defect but the reverse is not possible. Dental pulp 
MSCs express embryonic markers that are not expressed in the MSCs isolated from 
other tissues as detailed below. This is partially due to a cordial form of Hox gene 
expression in these cells compared to the mesoderm-derived MSCs [ 17 ]. 
 The presence of adult MSC populations within orofacial tissue, and their ability 
to adopt tissue-specifi c phenotypes, given the appropriate differentiation conditions, 
has led many investigators to suggest that the primary role of MSCs is to serve as 
cell replacement during the natural course of tissue turnover and homeostasis [ 18 ]. 
In addition, MSCs may serve important therapeutic roles because they appear to 
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escape immune recognition and exert anti-infl ammatory and immunomodulatory 
effects via the suppression of T, B, natural killer and antigen-presenting cells, both 
 in vitro and  in vivo . The immunomodulatory properties of these cells, and the ability 
to isolate and expand them  in vitro  without loss of their phenotypic or multi-lineage 
potential, have generated great interest in using MSCs as a therapeutic modality for 
immune-mediated diseases and tissue repair [ 19 – 21 ]. 
8.2.2  Mesenchymal Stem Cells of Dental Pulp Stem Cells 
(DPSCs) 
 Dental pulp tissue is derived from the embryonic dental papilla, which originates 
from neural crest mesenchymal cells during the morphogenesis of the fi rst pharyn-
geal arches. DPSCs are presumably inherent descendants of this lineage that occupy 
a perivascular niche of the dental pulp and possess MSC-like properties [ 15 ]. Dental 
pulp tissue is isolated from coronal pulp of the routinely extracted human teeth or 
exfoliated deciduous teeth, therefore a non-invasive process. DPSCs have shown to 
generate bone when they are implanted in mice [ 22 ]; deciduous teeth MSCs were 
found to be able to induce bone formation, generate dentin and survive in mouse 
brain along with expression of neural markers that appear to be different from previ-
ously identifi ed stem cells such as from BM [ 23 ]. 
 In culture, DPSCs have been shown to express ES cell markers not currently 
identifi ed in other adult MSCs; these markers include Oct-4, Nanog, SSEA-3, 
SSEA-4, TRA-1-60 and TRA-1-81 [ 24 ], and their presence may signify higher 
potency and enhanced stem cell activity for DSPCs compared to other adult tissue- 
derived stem cells. They can differentiate into dental structures, as well as smooth 
and skeletal muscles, neurons, cartilage and bone under defi ned  in vitro  culture 
conditions [ 15 ,  25 ], engraft to muscular dystrophic skeletal muscle and improve 
post-myocardial infarction cardiac function in animal models although without evi-
dence of engraftment [ 26 ,  27 ]. 
 Notably, recent reports further speculated that the DPSCs might have originated 
from a neuroectodermal lineage. Indeed, the dental pulp stem cells express neural 
markers, and they can differentiate into functionally active neurons [ 28 – 30 ] and, 
when stimulated, express neurogenic substance such as glutamate. Transplantation 
of human DPSCs into rat SCI model has shown marked recovery of hind limb loco-
motor functions via improved preservation of neuronal fi laments and myelin sheaths 
by inhibition of apoptosis, promotion of regeneration of transected axons through 
paracrine mechanisms and replacement of lost cells by differentiating into mature 
oligodendrocytes [ 31 ]. 
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8.2.3  MSCs of the Periodontal Ligament, Apical Papilla 
and Follicles 
 Periodontal tissue contains both hard and soft tissues. Periodontal tissue ligaments 
are and gingival tissues are derived neural crest mesenchyme reside in the dental 
follicles during tooth development. Similar to the dental pulp and BM MSCs, the 
periodontal ligament stem cells (PDLSCs) are also thought to be perivascular. 
Clonally selected Stro-1 and CD146 as markers have been isolated from extracted 
human third molars and shown to differentiate into collagen-producing fi brogenic 
and calcifi ed cementogenic cells  in vivo to repair attachment lost in the periodon-
tium in immunosuppressed rats, showing the capacity of these cells to form colla-
gen fi bres, similar to Sharpey’s fi bres, connected to the cementum-like tissue 
suggesting the potential to regenerate PDL attachment [ 32 ]. 
 Other studies, however, failed to reproduce the osteogenic potential of the 
PDLSCs. These variations in fi ndings may support the notion that PDLSCs are 
heterogeneous MSC population that may contain subpopulations that have propen-
sities for either collagen-producing fi brogenic subclones or cement/osteogenic cell 
types. PDLSC do not form dentin-pulp complexes and instead possess osteoblastic 
and cementoblastic lineages in order to regenerate periodontal tissue and maintain 
PDL integrity [ 33 ]. Currently, PDLSCs are not currently reported for use in non- 
dental diseases; it is not clear whether this is due to a higher  susceptibility of 
PDLSCs to periodontal disease states and age related changes. 
 CFU-F forming cells isolated from the dental apical follicle (DFS) and stem cells 
of apical papilla (SCAP) of the developing tooth display similar MSC characteris-
tics in vitro, however with perhaps superior differentiation capacity of early/pro-
genitor cells compared to other MSCs from PDL and BM. These cells rapidly attach 
to the culture dishes, proliferate at a higher rate than other MSCs and express puta-
tive stem cell markers such as Notch-1 and nestin, as well as ES cell markers Oct-3/
Oct-4, Sox-2 and Nanog reported in SCAP [ 21 ,  33 ]. DFS and SCAP are shown to 
differentiate into dentine-like structures in  in vitro , functional hepatocyte-like cells 
and neuronal tissue structures (Table  8.1 ).
8.3  Muscle Stem Cells 
8.3.1  Potential of Orofacial Muscle Stem Cells in Cardiac 
Repair 
 Another intriguing potential source of stem cells may come from the progenitors of 
the orofacial muscle. The muscles of orofacial area including tongue, facial expres-
sion and mastication are classifi ed as skeletal myocytes. These muscles are vital for 
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mammalian survival dictated by their roles in the infant suckling and adult nutri-
tional intake. As well, recent studies have shown that these muscles possess devel-
opmental kinship to the cardiac muscle cells that are marked by similar gene 
expressions such as cardiac-specifi c transcription factors  Isl1  and  Nkx2-5 . The simi-
larities between these two groups also extend to the fatigue resistance of orofacial 
muscles [ 36 ], presumably due to similar glycolytic metabolic properties of the heart 
and presence of connexin molecules that are similar to cardiac confi gurations [ 37 ]. 
Unlike the cardiac muscles, the orofacial muscles have a remarkable ability to repair 
after injury, providing continuous myofi bril remodelling throughout life, suggesting 
an active and proliferative myogenic properties of the satellite cells in these mus-
cles. These attributes suggest that the orofacial muscle progenitors may emerge as 
an interesting and attractive source for regeneration of myocardium which only 
heals with non-contractile fi brosis after insults of MI. Thus far, limb muscle pro-
genitors which have been isolated to transplant into myocardium failed to couple 
with the endogenous cardiomyocytes resulting in arrhythmia [ 38 ]. This may be pre-
sumably due to the developmental origin and characteristics of the skeletal muscles 
of the trunk and limbs being distinct from those of the cardiac and facial muscle. 
Other cell types such as MSCs from the BM and endogenous cardiac source have 
produced less than optimal results in cardiac stem cell treatments [ 7 ,  39 ], with for-
mer resulting in short-term benefi ts due to trophic effect rather than new cardiomyo-
cyte generation [ 40 ] and the latter having limited therapeutic value as it is confi ned 
to neonates [ 41 ]. 
 Table 8.1  Orofacial MSC sources and their applications 
 Location  Differentiation potential 
 Applications for systemic 
diseases 
 Dental pulp stem cells 
(DPSCs) 
 Dentine  Cementum, PLD regeneration 
[ 32 ,  33 ] 
 Human exfoliated deciduous 
tooth (SHED) 
 Osteocytes  Bone generation [ 22 ] 
 Periodontal ligament stem 
cells (PDLS) 
 Cementum  Myocardial infarction [ 27 ] 
 Stem cells of apical papilla 
(SCAP) 
 Sharpey’s fi bres  Muscular dystrophy [ 26 ] 
 Cardiomyocytes  Limbal stem cell defi ciency 
[ 34 ] 
 Muscle cells  Hind limb ischemia [ 35 ] 
 Neurons  Rat spinal cord injury [ 31 ] 
 Hepatocytes 
 Corneal epithelium 
 Neurotrophic factor 
secretion 
8 Orofacial Stem Cells for Cell-Based Therapies of Local and Systemic Diseases
96
8.3.2  Developmental Similarities of Cardiac and Orofacial 
Myogenic Progenitors 
 Recent lineage tracing and clonal analysis have shown that the orofacial and the 
heart myocytes originate from the multipotent pharyngeal mesoderm cells which 
ingress through the streak at the same stage [ 42 ,  43 ] and share a distinct lineage 
kinship in development. Two myogenic linkages have been identifi ed [ 4 ]: (1) First, 
pharyngeal arch lineage gives rise to masticatory muscle and also contributes to 
myocardial cells in the right ventricle. (2) Second, pharyngeal arch lineage gives 
rise to muscles of facial expression and contributes myocardial cells to the arterial 
pole of the heart. 
 A key gene in early pharyngeal mesoderm genetic programme encodes the LIM 
homeodomain transcription factor  Islet1 ( Isl1 ) which has been shown to identify the 
multipotent cardiac progenitor cells in the early embryo and the differentiating ES 
cells that can give rise to myocardial, endothelial and smooth muscle descendants. 
This gene is also expressed in pharyngeal myogenic progenitor cells and downregu-
lated on differentiation to either cardiac or skeletal muscle fates [ 41 ]. Tzahor  et al . 
have shown that pharyngeal myogenic muscle progenitors apparently have exactly 
the same subset of craniofacial muscles originating from  Isl1 -expressing progenitor 
cells [ 42 ]. Others have found that treatment of brachiometric satellite cells activates 
cardiac gene expression including  Isl1 and  Tbx20 . This fi nding suggests that satel-
lite cells retain the environmental signals of their embryogenic progenitors, high-
lighting the potential use of these myoblasts for cardiac repair. Interestingly, while 
no equivalent population to satellite cells is found in cardiac muscle, a small number 
of residual ISl1-positive cells have been identifi ed and proposed to be resident pro-
genitor cells that may contribute to cardiac growth and repair in the foetal and early 
postnatal heart [ 44 ]. 
 Additionally in our laboratory, initial fi ndings of genetic lineage tracking and 
protein expression experiments using  Nkx2-5 , a cardinal cardiomyocyte marker, 
have shown remarkable similarity of the tongue and masticatory muscle throughout 
the embryonic development and in adults; as well, the adult tongue has a signifi cant 
pool of satellite that is marked by the cardiac transcription gene (data not shown), 
supporting the notion that the activation and cardiogenic differentiation are possible 
using these cells. 
8.3.3  An Interesting Example of Using Tongue Stem Cell 
for Cardiac Repair 
 Shibuya et al., in 2010, characterized for the fi rst time cardiomyocyte-like proper-
ties of cultured tongue muscle-derived stem cells. They showed that Sca-1-positive 
cells isolated from tongue muscles appear to differentiate into cardiomyocytes that 
electrically cooperate with adjacent cardiomyocytes. They presented the 
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cardiomyocyte phenotype with beating and Nkx2-5 expression. Interestingly, these 
cells preserve their expression of connexin43 and appear to form gap junctions, as 
indicated by the transfer of dye and synchronization of calcium transients among 
adjacent cells. Collectively, these fi ndings strongly suggest tongue progenitors may 
be ideal for cell therapy in heart disease [ 37 ]. Although their in vitro studies prove 
promising and their  in vivo fi ndings are limited, this may also be due to the markers 
that are used to isolate the progenitors which may not be targeted to the myogenic 
progenitors. 
 Myogenesis including cardiogenesis is complexly orchestrated. Understanding 
the developmental governance and the regulatory factors that determine the cell fate 
of the orofacial myocytes may shed light into both the function of the orofacial 
musculature and the cardiac repair mechanisms. 
8.4  Closing Remark 
 The interest in organ regeneration using stem cells has increased in the last decade. 
In this context, orofacial stem cells are promising candidates, as they are readily 
available and highly proliferative and possess multi-differentiation abilities. These 
cells not only provide therapeutic and tissue engineering cell source for orofacial 
area and dental regeneration but also provide additional source for systemic cells. 
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 Chapter 9 
 Biomaterials in Caries Prevention 
and Treatment 
 Lei  Cheng ,  Yaling  Jiang ,  Yao  Hu ,  Jiyao  Li ,  Hockin  H. K.  Xu ,  Libang  He , 
 Biao  Ren , and  Xuedong  Zhou 
 Abstract  Dental caries is one of the most widespread diseases in humans and has 
become a heavy economic burden. Tremendous progress aiming at improving the 
clinical performance of dental composite has been made in the past decades but 
secondary caries still remains a main problematic issue in composite restoration 
failure. Recently, some novel biomaterials have been developed in caries prevention 
and treatment and showed broad prospects of application. Nanoparticles of amor-
phous calcium phosphate (NACP) and CaF 2 were synthesized and could release 
calcium/phosphate and fl uoride ions, contributing to remineralize tooth lesions and 
neutralize acids. Biomineralization agents, PAMAM, could mimic the natural min-
eralization process of dental hard tissues. Quaternary ammonium methacrylates 
(QAMs) were identifi ed to be effective against dental biofi lms. These biomaterials 
are promising for incorporation into dental composite in preventive and restorative 
dentistry, thus improving the effi cacy and success rate in caries prevention and 
treatment. 
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 Dental caries is a dietary carbohydrate-modifi ed bacterial infectious disease caused 
by biofi lm acids and is one of the most prevalent chronic diseases of people world-
wide [ 1 – 4 ]. It’s the main cause of oral pain and tooth loss, affecting the oral health 
of human beings seriously and also creating a heavy fi nancial burden; meanwhile, it 
has been associated with some systematic diseases as well [ 5 ,  6 ]. Basically, dental 
caries is a multifactorial disease, but demineralization of susceptible dental hard 
tissues resulting from acidic by-products from bacterial fermentation of dietary car-
bohydrates is considered to be the fundamental mechanism. Once biofi lm acids 
have caused tooth decay, the most effective treatment currently is to remove the 
carious tissues and fi ll the tooth cavity with a restorative material [ 7 ,  8 ]. 
 Resin-based dental composites are increasingly used for tooth cavity restoration 
due to their excellent esthetics and improved performance [ 9 – 12 ]. Signifi cant prog-
ress has been made to equip the esthetic composite restorations with less removal of 
tooth structures, enhanced load-bearing properties, and improved clinical perfor-
mance [ 13 – 16 ]. However, as composites tend to accumulate more biofi lms/plaques 
in vivo than other restorative materials, plaque adjacent to the restoration margins 
could lead to secondary caries [ 17 ,  18 ]. Indeed, previous studies demonstrated that 
secondary caries and bulk fracture are considered to be the most important factors 
leading to dental composite restoration failure, among which secondary caries are a 
main reason for replacing the existing restoration materials [ 19 ,  20 ]. As a result, half 
of all dental restorations fail within 10 years, and nearly 60 % of the average den-
tist’s practice time is expended on replacing them [ 21 ,  22 ]. Replacement dentistry 
costs $5 billion annually in the USA alone [ 23 ]. Therefore, there is a great need to 
explore novel anticaries materials to combat secondary caries by incorporating bio-
active agents possessing remineralization and antibacterial properties into the resin 
composites and bonding systems. 
9.1  Synthesis of Novel Mineralization Materials 
in Preventive Dentistry 
 In the normal status, there is a physiological equilibrium between the remineraliza-
tion and demineralization of dental hard tissues in the oral cavity [ 24 – 26 ]. The equi-
librium will break toward demineralization when the organic acids produced by 
bacteria increase to a certain extent [ 7 ]. In consideration of this, it would be benefi -
cial to employ mineralization materials in caries prevention. To date, two main strat-
egies have been carried out to remineralize demineralized dental hard tissues. One 
is the ion-based strategy, and the other is the use of biomineralization agents. 
 Composites containing calcium phosphate (CaP) composites were previously 
synthesized [ 27 ,  28 ]; these composites could release supersaturating levels of cal-
cium (Ca) and phosphate (PO 4 ) ions and achieve remineralization of tooth lesions 
in vitro. More recently, nanoparticles of amorphous calcium phosphate (NACP) of 
about 100 nm in size were fi rstly synthesized via a spray-drying technique [ 29 ]. 
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Owing to the small size and high surface area effects, the “smart” NACP nanopar-
ticles exhibit excellent characteristics, dramatically increasing the calcium and 
phosphate ions released at a cariogenic low pH while possessing mechanical prop-
erties nearly twofold of abovementioned CaP composite. In addition, NACP 
nanoparticles could neutralize a lactic acid solution of pH 4 by increasing the pH 
rapidly to nearly 6, which could avoid caries formation [ 30 ,  31 ]. Besides NACP, 
nanocomposites containing CaF 2 nanoparticles were also developed [ 32 ]. Studies 
have shown that these novel nanocomposites can release calcium and fl uoride ions 
in a long-term stable manner. Both calcium and fl uoride ions can inhibit demineral-
ization and promote remineralization of dental hard tissues, and fl uoride also has 
some antibacterial activity by interfering the formation and metabolism of dental 
plaque biofi lm [ 33 – 35 ]. 
 Although employed widely in the remineralization of carious dentin, such an 
ion-based strategy cannot be effective in locations where the crystallites are totally 
destroyed [ 36 ]. Another promising class of mineralization materials is the biomin-
eralization agents. Inspired from the function of non-collagenous proteins (NCPs) 
in the biomineralization process of natural teeth, using biomimetic templates to 
remineralize the demineralized dentin is of great interest in recent years as NCPs, 
the natural nucleation templates, lose their abilities to induce in situ remineraliza-
tion in the mature dentin [ 37 ,  38 ]. Poly(amino amine) (PAMAM)-type dendrimer is 
widely studied in dental biomineralization. It is a class of monodispersed polymeric 
nanomaterials with plenty of branches radiating from one central core and highly 
ordered architecture. It has been referred as “artifi cial protein” due to its biomimetic 
properties and well-defi ned/easily tailored structure, such as its functional group, 
generation, and spatial structure. Previous studies [ 39 ,  40 ] have clearly demon-
strated that PAMAM and its derivatives could induce biomineralization of the 
demineralized dentin. Combined PAMAM with antibacterial agents also obtained 
double effects of mineralization, and antibacterial and needlelike crystals can pre-
cipitate both on the dentin surface and in the dentinal tubules, suggesting that 
PAMAM is a promising biomineralization material for dental use. 
9.2  Quaternary Ammonium Methacrylates (QAMs) 
 Quaternary ammonium salts (QAMs),widely used in water treatment, food industry, 
textiles, and surface coating because of their low toxicity and broad spectrum of 
antimicrobial activity, are some ionic compounds which can be regarded as derived 
from ammonium compounds by replacing the hydrogen atoms with alkyl groups of 
different chain lengths [ 41 ]. They were fi rst introduced to dental material industry 
in the 1970s as mouth rinses [ 42 ,  43 ]. Since then numerous researchers have devoted 
to exploring novel QAMs to meet the “immobilized bactericide” [ 44 ,  45 ] concept in 
dental materials. To date, a great many kinds of QAMs, such as 12- methacryloylox
ydodecylpyridinium bromide (MDPB) [ 44 ,  46 ,  47 ], methacryloxylethylcetylammo-
nium chloride (DMAE-CB) [ 48 ], quaternary ammonium dimethacrylate (QADM) 
9 Biomaterials in Caries Prevention and Treatment
104
[ 49 ,  50 ], and quaternary ammonium polyethylenimine (QPEI) [ 51 ], have already 
been synthesized and incorporated into dental materials including glass ionomer 
cement (GIC) [ 52 ], etching-bonding systems [ 53 ,  54 ], and resin composites [ 55 ], 
attempting to achieve antibacterial effect. Recent researches have given us evi-
dences that they make promising dental materials with properties which are suitable 
for treatments of dental caries and with much potential for preventing secondary 
caries. 
9.2.1  Killing Bacteria and Inhibiting Biofi lms 
 Many of the QAMs have been proven to be effi cient in killing bacteria or inhibiting 
biofi lms, including methacryloxylethylcetylammonium chloride (DMAE-CB), qua-
ternary ammonium dimethacrylate (QADM), quaternary ammonium polyethyleni-
mine, and quaternary ammonium dimethacrylate. An in vitro [ 49 ] study which 
intended to develop novel antibacterial dentin primers containing both quaternary 
ammonium dimethacrylate (QADM) and nanoparticles of silver (NAg) proved that 
uncured primer could kill the planktonic bacteria in caries cavity, as well as inhibit 
dental biofi lms. 
 Recently, it has been revealed that glass ionomer cements (GIC) containing dif-
ferent concentrations of a novel material – dimethylaminododecyl methacrylate 
(DMADDM) – which also belongs to the QAM family, have antibacterial effects to 
different extents as well [ 56 ]. The results of this study indicated that with DMADDM, 
both the live bacteria and the EPS decreased in the biofi lms of  S. mutans . And the 
group with the higher concentration had more signifi cant effect. Consistent with the 
reduced live bacteria and EPS production, the glucosyltransferase-encoding genes, 
 gtfB ,  gtfC , and  gtfD , of  S. mutans were also signifi cantly downregulated after add-
ing DMADDM. Another research [ 57 ] found that with DMADDM added to dental 
adhesives, the ratio of  S. mutans steadily dropped in the multispecies biofi lms of 
 Streptococcus mutans ,  Streptococcus gordonii , and  Streptococcus sanguinis . 
9.2.2  Mechanical Properties 
 The mechanical properties are critical indexes for the evaluation antimicrobial mod-
ifi ed dental materials, such as dental adhesives and resin composites. QAMs have 
been proved that they did not change the adhesion and strength of the dental materi-
als For example, the SEM examination of dentin-adhesive interfaces of a QADM 
modifi ed dental adhesive revealed numerous resin tags “T” with no difference with 
the control [ 49 ]. Only at high mass fraction, QADM decreased the strength of the 
tetracalcium phosphate (TTCP) composite. Nevertheless, QADM can guarantee 
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both the antibacterial and the mechanical properties of the material at suitable 
 concentrations  [ 58 ]. 
9.2.3  Durability 
 Resin aging is another reason for secondary caries or failure of restorations. 
Accordingly, tests for durability are needed if QAMs are making a difference in this 
aspect of composites. 
 A recent study [ 50 ] compared the fl exural strength and elastic modulus of a novel 
nanocomposite containing nanoparticles of amorphous calcium phosphate (NACP) 
and quaternary ammonium dimethacrylate (QADM) with two different commercial 
composites in water immersion. Like the other two composites, the new nanocom-
posite displayed a moderate decrease during the fi rst month of aging, with little 
decrease during 1–6 months. After a 180-day immersion, the strength and modulus 
of NACP-QADM nanocomposite were similar to those of commercial control com-
posites. Also, NACP-QADM nanocomposite maintained its antibacterial properties 
during immersion. These statistics indicated that composites with QAMs maintain 
the same level of durability as common commercial composites. 
9.2.4  Biological Safety 
 Researchers recently have provided us with the human gingival fi broblast cytotoxic-
ity data of a certain kind of QAMs [ 59 ]. In this study, the control had fi broblast 
culture in fi broblast medium (FM) without resin eluents, and its cell viability was 
set at 100 %. For groups with resins, the fi broblasts were cultured in FM containing 
resin eluents. The fi broblast viability for all the bonding agent groups was nearly 
100 %. There was generally little difference between 12- methacryloyloxydodecylp
yridinium bromide (MDPB) and NAg groups and the non-antibacterial adhesive 
control or between bonding agent groups and the FM control without resin eluents 
( p > 0.1). Another measurement [ 52 ] of the DMADDM release showed that 
DMADDM concentrations decreased continuously and after 12 h values were found 
near to the zero level for both 1.1 wt.% and 2.2 wt.% DMADDM containing speci-
mens in water. And in saliva, only one set presenting ten specimens of 2.2 wt.% 
DMADDM revealed release of the substance near the detection level. 
 With 12-methacryloyloxydodecylpyridinium bromide (MDPB) displaying no 
more fi broblast cytotoxicity than the routine medium and DMADDM’s low release 
rate and time, we may draw the conclusion that QAMs are biologically safe with 
humans. But more researches are needed to further explain it. 
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9.2.5  Inhibiting MMPs 
 Proteolytic degradation of hybrid layer by host-derived matrix metalloproteinases 
(MMPs) leading to reduction of resin-dentin bond strength is believed to be among 
the major reasons for the failure of resin restorations [ 60 ,  61 ]. Fortunately, it has 
been found that the resin-dentin bonding systems containing DMADDM inhibited 
MMPs effi caciously. 
 Assay of the loss mass of demineralized dentin beams revealed that dentin incu-
bated in DMADDM lost signifi cantly less mass than the control group at 7 or 
30 days. While with both DMADDM and chlorhexidine digluconate (CHX), dentin 
mass dropped even sharply. And spectrophotometrical measurement of hydroxypro-
line (HYP), used to determine the dissolution of collagen peptides, refl ected that the 
combination of DMADDM and CHX dramatically lowered hydroxyproline disso-
lution weight [ 62 ]. 
9.2.6  Mechanism 
 The antibacterial mechanism of quaternary ammonium methacrylates (QAMs) is 
now widely thought to be “contact killing.” That is, the positively charged (N + ) sites 
of the QAMs molecules would attract the negatively charged bacterial cells, and 
once contact is made, the electric balance of the cell membrane could be disturbed 
and the bacterium could explode under its own osmotic pressure. Previous studies 
[ 56 ,  63 ,  64 ] have confi rmed that the surface charge density of the tested materials 
increased with the increase of the mass fraction of DMADDM, and higher mass 
fraction showed stronger antibacterial effects. A recent study [ 65 ] on the antibacte-
rial effects of quaternary ammonium chain length revealed the increasing antibacte-
rial potency with increasing CL from 3 to 16 while CL 18 may be a cutoff point. It 
was supposed that long-chained quaternary ammonium compounds could have 
additional antimicrobial activity by insertion into the bacterial membrane, resulting 
in physical disruption [ 66 ]. The evaluation of three-dimensional (3D) biofi lms on 
antibacterial bonding agents containing QAMs showed that not only the bacteria 
contacting the resin surface but also through the bacteria in the 3D biofi lm away 
from the resin surface were killed [ 67 ]. It was suggested that a stress condition in 
the bacteria could trigger a built-in suicide program in the biofi lm, which was also 
termed the programmed cell death. However, the exact mechanism of QAMs still 
remained unclear and needed further research in the future. 
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9.2.7  Resistant/Persister Bacteria 
 Although the strong killing effects of QAMs are clinically benefi cial, their frequent 
use may also have the possibility of leading to the development of bacterial drug 
resistance and tolerance as with other antibiotics, which are associated with the 
failure of antibacterial treatment and the relapse of many chronic infections. No 
reports have reported or investigated the possibility that oral bacteria can acquire 
resistance to QAMs so far. However, a new study recently has found that 
 Streptococcus mutans could form a small portion of persisters which can survive 
lethal doses of DMADDM treatment. Persisters are nongrowing dormant cells that 
are produced in a clonal population of genetically identical cells and are generally 
believed to be responsible for drug tolerance [ 68 ,  69 ]. In contrast to the drug- 
resistant bacteria, persisters are not mutants but phenotypic variants of the wild-type 
population. The isolated persisters in the abovementioned study have the typical 
characteristic of multiple drug tolerance, and the experimental drugs of different 
mechanisms are proven to have little effects on the persisters. This fi nding will par-
tially challenge the clinical use of QAMs, and further studies are needed to eluci-
date possible mechanisms behind this in order to tackle the problem. 
9.2.8  Models 
 Different models were used to study the biomaterials in caries preventions and treat-
ment. Most of the investigations applied in vitro models. Besides, an individual 
removable acrylic upper jaw splint in situ has already been built to test some proper-
ties of QAMs including antibacterial effect and biological safety [ 52 ]. Transparent 
custom-made acrylic splints (Thermoforming foils®, Erkodent, Pfalzgrafenweiler, 
Germany) were fabricated from alginate impressions as carrier of the GIC speci-
mens. Six samples were fi xed in the left and right buccal position in the molar and 
premolar regions with silicon impression material (President Light Body®, Colténe, 
Altstätten, Switzerland) onto the splints for intraoral exposure. Animal models are 
under construction and more fi gures are coming out soon. 
 References 
  1.  Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007;369(9555):51–9. 
  2.  Takahashi N, Nyvad B. Caries ecology revisited: microbial dynamics and the caries process. 
Caries Res. 2008;42(6):409–18. 
  3.  Takahashi N, Nyvad B. The role of bacteria in the caries process. JDR. 2011;90(3):294–303. 
  4.  Paes Leme AF, Koo H, Bellato CM, et al. The role of sucrose in cariogenic dental biofi lm 
formation – new insight. J Dent Res. 2006;85(10):878–87. 
  5.  Hu DY, Hong X, Li X. Oral health in China-trends and challenges. Int J Oral Sci. 
2011;3(1):7–12. 
9 Biomaterials in Caries Prevention and Treatment
108
  6.  Fejerskov O, Kidd EAM. Dental caries: the disease and its clinical management. Commun 
Dent Oral Epidemiol. 2003;8(3):80–6. 
  7.  Fejerskov O. Changing paradigms in concepts on dental caries: consequences for oral health 
care. Caries Res. 2004;38(3):182–91. 
  8.  Banava S, Yazdi MS, Heshmat H. Restorative: bio-treatment of caries. Br Dent 
J. 2014;216(6):267–7 
  9.  Ferracane JL. Resin composite – state of the art. Dent Mater Off Publ Acad Dent Mater. 
2011;27(1):29–38. 
 10.  Chen MH. Update of dental nanocomposites. J Dent Res. 2010;89(6):549–60. 
 11.  Ilie N, Hickel R. Investigations on mechanical behaviour of dental composites. Clin Oral 
Investig. 2009;13(4):427–38. 
 12.  Pereira-Cenci T, Cenci M, Fedorowicz Z, et al. Antibacterial agents in composite restorations 
for the prevention of dental caries. Cochrane Database Syst Rev. 2009;12(3):1559–9 
 13.  Ruddell DE, Maloney MM, Thompson JY. Effect of novel fi ller particles on the mechanical 
and wear properties of dental composites. Dent Mater Off Publ Acad Dent Mater. 
2002;18(1):72–80. 
 14.  Pashley DH, Tay FR, Imazato S. How to increase the durability of resin-dentin bonds. 
Compend Contin Educ Dent. 2011;32(7):60–4. 66. 
 15.  Satterthwaite JD, Maisuria A, Vogel K, et al. Effect of resin-composite fi ller particle size and 
shape on shrinkage-stress. Dent Mater Off Publ Acad Dent Mater. 2012;28(6):609–14. 
 16.  Tyas MJ, Anusavice KJ, Frencken JE, et al. Minimal intervention dentistry—a review. Int Dent 
J. 2000;50(1):1–12. 
 17.  Svanberg M, Mjör IA, Ørstavik D. Mutans streptococci in plaque from margins of amalgam, 
composite, and glass-ionomer restorations. J Dent Res. 1990;69(3):861–4. 
 18.  Beyth N, Domb AJ, Weiss EI. An in vitro quantitative antibacterial analysis of amalgam and 
composite resins. J Dent. 2007;35(3):201–6. 
 19.  Sakaguchi RL. Review of the current status and challenges for dental posterior restorative 
composites: clinical, chemistry, and physical behavior considerations. Dent Mater. 
2005;21:3–6. 
 20.  Sarrett DC. Clinical challenges and the relevance of materials testing for posterior composite 
restorations. Dent Mater. 2005;21(1):9–20. 
 21.  Deligeorgi V, Mjör IA, Wilson NH. An overview of reasons for the placement and replacement 
of restorations. Prim Dent Care J Fac Gen Dent Pract. 2001;8(1):5–11. 
 22.  Frost PM. An audit on the placement and replacement of restorations in a general dental prac-
tice. Prim Dent Care J Fac Gen Dent Pract. 2002;9(9):31–6. 
 23.  Jokstad A, Bayne S, Blunck U, et al. Quality of dental restorations FDI Commission Project 
2–95. Int Dent J. 2001;51(3):117–58. 
 24.  Featherstone J. Dental caries: a dynamic disease process. Aust Dent J. 2008;53(3):286–91. 
 25.  Moreno EC, Zahradnik RT. Demineralization and remineralization of dental enamel. J Dent 
Res. 1979;58(Spec Issue B):896–903. 
 26.  Featherstone JD. The caries balance: the basis for caries management by risk assessment. Oral 
Health Prev Dent. 2004;2 suppl 1:259–64. 
 27.  Skrtic D, Antonucci JM, Eanes ED, et al. Physiological evaluation of bioactive polymeric 
composites based on hybrid amorphous calcium phosphates. J Biomed Mater Res. 
2000;53(4):381–91. 
 28.  Langhorst SE, O’Donnell JNR, Skrtic D. In vitro remineralization of enamel by polymeric 
amorphous calcium phosphate composite: quantitative microradiographic study. Dent Mater. 
2009;25(7):884–91. 
 29.  Xu HHK, Moreau JL, Sun L, et al. Nanocomposite containing amorphous calcium phosphate 
nanoparticles for caries inhibition. Dent Mater. 2011;27(8):762–9. 
 30.  Moreau JL, Sun L, Chow LC, et al. Mechanical and acid neutralizing properties and bacteria 
inhibition of amorphous calcium phosphate dental nanocomposite. J Biomed Mater Res B 
Appl Biomater. 2011;98B(98):80–8. 
L. Cheng et al.
109
 31.  Weir MD, Chow LC, Xu HH. Remineralization of demineralized enamel via calcium phos-
phate nanocomposite. J Dent Res. 2012;91(10):979–84. 
 32.  Xu HHK, Moreau JL, Sun L, et al. Strength and fl uoride release characteristics of a calcium 
fl uoride based dental nanocomposite. Biomaterials. 2008;29(32):4261–7. 
 33.  Singh ML, Papas AS. Long-term clinical observation of dental caries in salivary hypofunction 
patients using a supersaturated calcium-phosphate remmeralizing rinse. J Clin Dent. 
2009;20(3):87–92. 
 34.  Kulshrestha S, Khan S, Hasan S, et al. Calcium fl uoride nanoparticles induced suppression of 
Streptococcus mutans, biofi lm: an in vitro and in vivo approach. Appl Microbiol Biotechnol. 
2015;100(4):1–14. 
 35.  Xu HH, Mdsun W. Strong nanocomposites with Ca, PO(4), and F release for caries inhibition. 
J Dent Res. 2010;89(1):19–28. 
 36.  Frencken JE, Peters MC, Manton DJ, et al. Minimal intervention dentistry for managing dental 
caries – a review. Int Dent J. 2012;62(5):223–43. 
 37.  Chen L, Liang K, Li J, et al. Regeneration of biomimetic hydroxyapatite on etched human 
enamel by anionic PAMAM template in vitro. Arch Oral Biol. 2013;58(8):975–80. 
 38.  Tay FR, Pashley DH. Guided tissue remineralisation of partially demineralised human dentine. 
Biomaterials. 2008;29(8):1127–37. 
 39.  Liang K, Yuan H, Li J, et al. Remineralization of demineralized dentin induced by amine- 
terminated PAMAM dendrimer. Macromol Mater Eng. 2014;300(1):107–17. 
 40.  Wu D, Yang J, Li J, et al. Hydroxyapatite-anchored dendrimer for in situ remineralization of 
human tooth enamel. Biomaterials. 2013;34(21):5036–47. 
 41.  Kourai H, Yabuhara T, Shirai A, et al. Syntheses and antimicrobial activities of a series of new 
bis-quaternary ammonium compounds. Eur J Med Chem. 2006;41:437–44. 
 42.  Rosa M, Sturzenberger OP. Clinical reduction of gingivitis through the use of a mouthwash 
containing two quaternary ammonium compounds. Periodontology. 1976;47:535–7. 
 43.  Bonesvoll P, Gjermo PA. Comparison between chlorhexidine and some quaternary ammonium 
compounds with regard to retention, salivary concentration and plaque-inhibiting effect in the 
human mouth after mouth rinses. Arch Oral Biol. 1978;23:289–94. 
 44.  Imazato S, Ebi N, Takahashi Y, Kaneko T, Ebisu S, Russell RR. Antibacterial activity of 
bactericide- immobilized fi ller for resin-based restoratives. Biomaterials. 2003;24:3605–9. 
 45.  Imazato S, Imai T, Russell RR, Torii M, Ebisu S. Antibacterial activity of cured dental resin 
incorporating the antibacterial monomer MDPB and an adhesion-promoting monomer. 
Biomed Mater Res. 1998;39:511–5. 
 46.  Imazato S, Kuramoto A, Takahashi Y, Ebisu S, Peters MC. In vitro antibacterial effects of the 
dentin primer of Clearfi l Protect Bond. Dent Mater. 2006;22:527–32. 
 47.  Imazato S, Ohmori K, Russell RR, McCabe JF, Momoi Y, Maeda N. Determination of bacte-
ricidal activity of antibacterial monomer MDPB by a viability staining method. Dent Mater 
J. 2008;27:145–8. 
 48.  Li F, Chai ZG, Sun MN, et al. Anti-biofi lm effect of dental adhesive with cationic Monomer. 
J Dent Res. 2009;88(4):372–6. 
 49.  Cheng L, Zhang K, Melo MAS, et al. Anti-biofi lm dentin primer with quaternary ammonium 
and silver nanoparticles. J Dent Res. 2012;91(6):598–604. 
 50.  Cheng L, Weir MD, Zhang K, et al. Antibacterial nanocomposite with calcium phosphate and 
quaternary ammonium. J Dent Res. 2012;91(5):460–6. 
 51.  Beyth N, Yudovin-Farber I, Bahir R, et al. Antibacterial activity of dental composites contain-
ing quaternary ammonium polyethylenimine nanoparticles against Streptococcus mutans. 
Biomaterials. 2006;27(21):3995–4002. 
 52.  Feng J, Cheng L, et al. In situ antibiofi lm effect of glass-ionomer cement containing dimethyl-
aminododecyl methacrylate. Dent Mater. 2015;31(8):992–1002. 
 53.  Zhang K, Cheng L, Wu EJ, et al. Effect of water-ageing on dentine bond strength and anti- 
biofi lm activity of bonding agent containing new monomer dimethylaminododecyl methacry-
late. J Dent. 2013;41(6):504–13. 
9 Biomaterials in Caries Prevention and Treatment
110
 54.  Cheng L, Weir MD, Zhang K, et al. Dental primer and adhesive containing a new quaternary 
ammonium monomer and nano-silver with anti-biofi lm properties. J Dent. 
2013;41(4):345–55. 
 55.  Zhou C, Weir MD, Zhang K, Cheng L, et al. Synthesis of novel antibacterial quaternary ammo-
nium monomer for incorporation into calcium phosphate nanocomposite to inhibit caries. Dent 
Mater. 2013;29(8):859–70. 
 56.  Wang S, Cheng L, et al. Int J Oral Sci. 2015, accepted. 
 57.  Zhang K, Wang S, Cheng L, et al. Effect of antibacterial dental adhesive on multispecies bio-
fi lms formation. J Dent Res. 2015;94(4):622–9. 
 58.  Cheng L, Weir MD, et al. Tetracalcium phosphate composite containing quaternary ammo-
nium dimethacrylate with antibacterial properties. J Biomed Mater Res B Appl Biomater. 
2012;100(3):726–34. 
 59.  Zhang K, Li F, Imazato S, Cheng L, et al. Dual antibacterial agents of nano-silver and 12- met
hacryloyloxydodecylpyridinium bromide in dental adhesive to inhibit caries. J Biomed Mater 
Res B Appl Biomater. 2013;101(6):929–38. 
 60.  Osorio R, Yamauti M, Osorio E, et al. Effect of dentin etching and chlorhexidine application 
on metalloproteinase-mediated collagen degradation. Eur J Oral Sci. 2011;119:79–85. 
 61.  Tjaderhane L, Nascimento FD, Breschi L, et al. Optimizing dentin bond durability: control of 
collagen degradation by matrix metalloproteinases and cysteine cathepsins. Dent Mater. 
2013;29:116–35. 
 62.  Zhou W, Cheng L et al. unpublished. 
 63.  Wang SP, Zhang KK, Cheng L, et al. Antibacterial effect of dental adhesive containing dimeth-
ylaminododecyl methacrylate on the development of streptococcus mutans biofi lm. Int J Mol 
Sci. 2014;15(7):12791–806. 
 64.  Imazato S, Ma S, Chen JH, et al. Therapeutic polymers for dental adhesives: loading resins 
with bio-active components. Dent Mater Off Publ Acad Dent Mater. 2014;30(1):97–104. 
 65.  Li F, Weir MD, Xu HHK. Effects of quaternary ammonium chain length on antibacterial bond-
ing agents. J Dent Res. 2013;92(10):932–8. 
 66.  Simoncic B, Tomsic B. Structures of novel antimicrobial agents for textiles – a review. Text 
Res J. 2010;80(14):1721–37. 
 67.  Zhou H, Weir MD, Xu HHK, et al. Evaluation of three-dimensional biofi lms on antibacterial 
bonding agents containing novel quaternary ammonium methacrylates. Int J Oral Sci. 
2014;6(2):77–86. 
 68.  Fauvart M, Groote VND, Michiels J. Role of persister cells in chronic infections: clinical rel-
evance and perspectives on anti-persister therapies. J Med Microbiol. 2011;60(6):699–709. 
 69.  Jermy A. Bacterial physiology: no rest for the persisters. Nat Rev Microbiol. 
2013;11(3):148–9. 
 Open Access  This chapter is distributed under the terms of the Creative Commons Attribution 4.0 
International License ( http://creativecommons.org/licenses/by/4.0/ ), which permits use, duplica-
tion, adaptation, distribution and reproduction in any medium or format, as long as you give appro-
priate credit to the original author(s) and the source, provide a link to the Creative Commons 
license and indicate if changes were made. 
 The images or other third party material in this chapter are included in the work’s Creative 
Commons license, unless indicated otherwise in the credit line; if such material is not included in 
the work’s Creative Commons license and the respective action is not permitted by statutory regu-
lation, users will need to obtain permission from the license holder to duplicate, adapt or reproduce 
the material.
 
L. Cheng et al.
 
 Part III 
 Symposium III: Regenerative Oral Science 
113© The Author(s) 2017 
K. Sasaki et al. (eds.), Interface Oral Health Science 2016, 
DOI 10.1007/978-981-10-1560-1_10
 Chapter 10 
 Effi cacy of Calcium Phosphate-Based 
Scaffold Materials on Mineralized and 
Non- mineralized Tissue Regeneration 
 Osamu  Suzuki ,  Takahisa  Anada , and  Yukari  Shiwaku 
 Abstract  Calcium phosphate materials have been advocated as useful implantable 
scaffolds for bone tissue engineering. We have reported that synthetic octacalcium 
phosphate (OCP) is capable of enhancing differentiation of hard tissue-forming 
cells including osteoblastic cells, osteoclast precursor cells, and odontoblastic cells. 
The differentiation of mesenchymal stem cells is promoted to form new bone in the 
presence of OCP with atelo-collagen in vivo condition. The stimulatory capacity of 
OCP to conduct new bone increases with the copresence of amorphous calcium 
phosphate (ACP). Physical and chemical analyses of the materials suggested that 
the bioactivity of such hydroxyapatite (HA) precursor phases is induced as a result 
of the progressive change of chemical property of these materials during the hydro-
lysis into HA under physiological environment. The composite materials composed 
of OCP and natural polymers are capable of repairing not only mineralized tissues 
but also non-mineralized tissue. The form of OCP-based materials and the tissue 
responses to the materials will be summarized. 
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10.1  Introduction 
 Calcium phosphate ceramics, such as sintered hydroxyapatite (HA, Ca 10 (PO 4 ) 6 (OH) 2 ) 
and β-tricalcium phosphate (β-TCP, β-Ca 3 (PO 4 ) 2 ), have widely been used as fi lling 
materials for various bone defects due to the superior osteoconductivity which is 
capable of bonding to bone tissue without intervention of connective tissues [ 1 ]. HA 
and β-TCP have been used as implantable scaffold materials with mesenchymal 
stem cells (MSCs) for bone regeneration [ 2 ]. These calcium phosphate materials 
provide suitable site where osteoblastic cells can attach, proliferate, and differenti-
ate [ 2 ]. The physicochemical property of calcium phosphate materials affects 
the cellular responses to some extent [ 3 ,  4 ]. Octacalcium phosphate (OCP, 
Ca 8 H 2 (PO 4 ) 6 ·5H 2 O) is a non-sintered calcium phosphate material which was fi rst 
proven to directly bond to bone tissue by onlaying it on mouse calvaria [ 5 ]. OCP has 
been regarded as a precursor phase in HA formation from supersaturated calcium 
and phosphate solutions with respect to HA and is therefore suggested to be a pre-
cursor to bone apatite crystals [ 6 ,  7 ] as well as amorphous calcium phosphate (ACP, 
Ca 3 (PO 4 ) 2 ·nH 2 O) [ 8 ]. OCP shows diversity regarding the stoichiometry [ 9 ] and the 
microstructure [ 10 ] depending on the preparation condition [ 11 ], which controls its 
bioactivity in vitro and in vivo [ 11 ]. This article summarizes the bioactivity of OCP 
and the composite materials with natural polymers as scaffold materials we have 
reported previously. 
10.2  Mineralized and Non-mineralized Tissue Responses 
 OCP displays a unique osteoconductive property which tends to biodegrade and be 
followed by new bone formation if implanted in various bone defects, including the 
defects in intramembranous bone and long bones in various animal models [ 11 ,  12 ]. 
The effi cacy of OCP has recently been reported by implanting its composite with 
collagen in human maxilla after cystectomy [ 13 ]. The stimulatory capacity of OCP 
could be induced by the environmental changes around the crystals, including cal-
cium ion concentration change, due to the progressive hydrolysis from OCP to HA 
under physiological conditions [ 5 ,  14 ,  15 ]. The hydrolysis of OCP to HA is enhanced 
if ACP coexists with OCP, and the bone regenerative capacity of OCP is augmented 
by mechanically mixing OCP with ACP in rat critical-sized calvaria defect [ 16 ]. A 
composite of OCP with gelatin matrix, prepared through a wet synthesis, showed a 
greater biodegradable property coupled with a greater bone regenerative property if 
the material was implanted in rat critical-sized calvaria defect [ 17 ,  18 ]. The in vivo 
studies indicated that OCP/gelatin composite repairs not only rabbit tibia defect 
model [ 19 ] but also reforms infraspinatus tendon insertion using rabbit rotator cuff 
tear model [ 20 ]. 
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10.3  Matrix Materials for Calcium Phosphate 
 Various calcium phosphate composites with natural polymers have been developed 
for bone and other tissue engineering (Table  10.1 ). Collagen (Col) is the major com-
ponent of extracellular matrix proteins in bone, and its reconstituted Col has been 
utilized as matrix materials for calcium phosphates. HA/Col composites have been 
prepared by different processes, such as direct physical mixing [ 21 ,  22 ], chemical 
deposition of HA [ 23 ], or biomimetic mineralization [ 24 ]. Biodegradable calcium 
 Table 10.1  Calcium phosphate composites with various natural polymers designed for bone 
tissue engineering 
 Natural polymers 
 Calcium 
phosphates  Composites  Notes (references) 
 Collagen  HA  Sponge  Chemical deposition [ 23 ] 
 Nano HA  Sponge  Physical mixture [ 22 ] 
 Nanofi ber  Physical mixture [ 21 ] 
 Fiber  Biomimetic mineralization [ 24 ] 
 OCP  Sponge  Chemical deposition [ 26 ] 
 β-TCP  Sponge  Physical mixture [ 25 ] 
 Gelatin  HA  Particles  Chemical deposition [ 29 ] 
 Sponge  Chemical deposition [ 30 ] 
 Porogen leaching [ 31 ] 
 Film  Physical mixture [ 28 ] 
 OCP  Sponge  Chemical deposition [ 17 ] 
 Chemical deposition and physical 
mixture [ 18 ] 
 β-TCP  Sponge  Physical mixture [ 49 ] 
 Chitosan  HA  Sponge  Biomimetic mineralization [ 36 ] 
 Nano HA  Sponge  Physical mixture [ 35 ] 
 Chemical deposition [ 33 ] 
 β-TCP  Sponge  Physical mixture [ 37 ] 
 Silk fi broin  HA  Sponge  Physical mixture [ 34 ] 
 Film  Biomimetic mineralization [ 50 ] 
 Ca-defi cient HA  Particles  Chemical deposition [ 32 ] 
 Alginate  HA  Sponge  Physical mixture [ 40 ] 
 Biomimetic mineralization [ 39 ] 
 Beads  Chemical deposition [ 41 ] 
 OCP  Sponge  Chemical deposition [ 42 ] 
 Physical mixture [ 43 ] 
 Beads  Physical mixture [ 45 ] 
 β-TCP  Beads  Physical mixture [ 38 ] 
 Hyaluronic acid  HA  Hydrogel  Physical mixture [ 46 ] 
 OCP  Hydrogel  Physical mixture [ 48 ] 
 β-TCP  Hydrogel  Physical mixture [ 47 ] 
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phosphates/Col composites, such as OCP/Col and β-TCP/Col, have also been 
obtained using coprecipitation methods [ 25 ,  26 ] and by physical mixing [ 27 ]. 
Gelatin (Gel) is a denatured form of collagen and has the advantage of higher bio-
degradability. HA/Gel composites have been obtained in various forms, not only in 
porous form but also in fi lm and particle forms [ 28 – 31 ]. OCP/Gel composites have 
been prepared by physical mixing and coprecipitation [ 17 ,  18 ]. Other natural poly-
mers, such as chitosan and silk fi broin, have also been combined with calcium phos-
phates [ 32 – 37 ].
 Alginate (Alg) is a natural polysaccharide obtained from brown algae and applied 
for wound healing and drug delivery due to its biocompatibility. HA/Alg and β-TCP/
Alg have been prepared as porous scaffolds or beads [ 38 – 41 ]. Our group has devel-
oped OCP/Alg porous scaffolds [ 42 ,  43 ]. Although it is known that Alg is not able 
to interact with mammalian cells [ 44 ], OCP/Alg was capable of enhancing osteo-
blastic cell attachment and bone formation depending on the pore size and the 
porosity of the composites [ 42 ]. OCP/Alg beads including osteoblastic cells have a 
potential to activate and deliver osteoblastic cells from the beads to the local sites of 
bone defects [ 45 ]. Hyaluronic acid (HyA) is a major component of the extracellular 
matrix in the connective tissue. HyA hydrogel can be used as injectable materials 
fi lling bone defects directly and has been reported to promote bone regeneration 
[ 46 ,  47 ]. OCP/HyA is a bone substitute material which was proven to show the 
injectable and bioactive properties [ 48 ]. 
10.4  Cell Responses to Calcium Phosphate Materials 
 We have reported that OCP induces osteoblastic differentiation of mouse stromal 
cells [ 15 ,  51 ]. When mouse ST2 cells were cultured on the OCP or HA coatings, 
expression of osteogenic markers, such as type I collagen, alkaline phosphatase, and 
osterix, was enhanced on the OCP coating plates in an OCP dose-dependent manner 
[ 51 ]. We also reported that OCP enhanced alkaline phosphatase (ALP) activity of 
mouse mesenchymal stem cell line D1 cells in a three-dimensional cell culture sys-
tem compared to HA and β-TCP [ 52 ]. When rat dental pulp cells were cultured on 
the OCP or HA coatings, OCP promoted their odontoblastic differentiation more 
than HA, as confi rmed by ALP activity, mineralization, and enhancement of dentine 
sialophosphoprotein expression [ 53 ]. Furthermore, OCP is capable of inducing 
osteoclast formation from bone marrow cells in vitro in the presence of osteoblasts 
without vitamin D 3 [ 54 ]. 
 OCP can gradually convert into the crystal structure of apatite in the physiologi-
cal conditions [ 11 ]. The conversion induces the release of phosphate ions to the 
periphery of the crystals and the uptake of calcium ion into the crystals [ 14 ]. We 
demonstrated that these changes in ion concentration have effects on osteoblastic 
differentiation through the phosphorylation of p38 MAP kinase [ 55 ], migration of 
macrophage-like cells [ 56 ], and osteoclastic differentiation by the increase of the 
expression of RANKL in osteoblasts [ 54 ]. 
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10.5  Conclusion 
 We have designed OCP-based materials and reported their tissue regenerative prop-
erties not only in the calcifi ed tissues but also in the noncalcifi ed tissue. The physi-
cochemical properties of OCP induced in the conversion process from OCP to HA 
could be involved in promoting osteoblastic and osteoclastic differentiation and 
bone formation and reformation of infraspinatus tendon insertion. The composite 
materials of OCP with natural polymers, described in this article, could be used as 
scaffold materials for mineralized tissue regeneration and potentially for non- 
mineralized tissue regeneration. 
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 Chapter 11 
 Gene Delivery and Expression Systems 
in Induced Pluripotent Stem Cells 
 Maolin  Zhang ,  Kunimichi  Niibe ,  Takeru  Kondo ,  Yuya  Kamano , 
 Makio  Saeki , and  Hiroshi  Egusa 
 Abstract  Induced pluripotent stem (iPS) cells, which can be generated from 
somatic cells by genetic manipulation, are invaluable experimental and therapeutic 
tools for development of tissue regeneration technologies. Many studies have dem-
onstrated that gene delivery to pluripotent stem cells is useful for basic studies in 
developmental biology and for driving differentiation toward a specifi c cell lineage 
for regenerative applications. Several gene delivery systems using viral and nonviral 
vectors have been used for stem cell research. These gene delivery systems are 
designed to accommodate specifi c research purposes; thus, each of them possesses 
its own advantages and disadvantages according to the experimental design. In 
addition, the type of constitutive promoter in the expression vector greatly affects 
the transcriptional activity of transgenes in pluripotent stem cells. Therefore, it is 
necessary to consider the characteristics of the vectors and their promoters when 
selecting a gene delivery system to transfer the target gene into iPS cells. In this 
mini-review, characteristics of commonly used viral (adenoviral, adeno-associated 
viral, retroviral, and lentiviral) vectors and a nonviral  piggyBac transposon DNA 
vector with constitutive promoters are outlined to support the selection of an appro-
priate gene delivery and expression system for iPS cell research. 
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11.1  Introduction 
 Stem cells, which are characterized as immature, self-renewal, and undifferentiated 
cells that can give rise to many different cell lineages, are expected to open new 
needed therapeutic avenues [ 1 ]. Induced pluripotent stem (iPS) cells are cells repro-
grammed from somatic cells via genetic modifi cation to obtain embryonic stem 
(ES) cell characteristics [ 2 ,  3 ]. Although multipotent adult stem cells such as mes-
enchymal stem cells (MSCs) have been well investigated for clinical application 
[ 4 ], basic research on pluripotent stem cells, such as ES cells and iPS cells, may lead 
to further understanding of in vitro tissue/organ development, which in turn could 
be applied to next-generation therapeutic approaches for whole-tissue/organ 
regeneration. 
 Gene delivery to pluripotent stem cells provides a powerful experimental system 
to investigate the early stages of tissue/organ development. In addition, genetic 
modifi cation of patient-specifi c iPS cells, particularly disease-model iPS cells, 
could facilitate the study of pathological mechanisms and provide new therapeutic 
approaches in personalized medicine [ 5 ]. To obtain effi cient and stable transgene 
expression, various gene delivery methods ranging from viral vectors to plasmid- 
based transient gene expression have been applied to pluripotent stem cells [ 6 ]. In 
these methods, many types of constitutive promoters have been utilized in the 
expression vectors, such as the cytomegalovirus (CMV), human elongation factor 
1α (EF1α), CMV enhancer/ β -actin promoter with  β -actin intron (CA), Rous sar-
coma virus (RSV) [ 7 ], human β-actin (ACTB), phosphoglycerate kinase (PGK) [ 8 ], 
and simian virus 40 early (SV40) [ 9 ] promoters. The transcriptional activity of 
transgenes considerably varies among these promoters depending on the cell type 
[ 10 ]. Notably, the CMV promoter, which is one of the most popular choices for gene 
delivery vectors because of its strong activity in most cell lines, shows considerably 
weak transgene activation in stem cells [ 7 ,  8 ,  11 – 14 ]; therefore, it is important to 
select an optimal promoter to obtain the expected transgene expression in iPS cell 
experiments. 
 Beyond the constitutive promoter systems described above, regulated control of 
gene expression has great signifi cance for stem cell research because of the ability 
to avoid undesirable effects of constitutive transgene expression after cellular dif-
ferentiation [ 15 ]. Several studies have employed tetracycline (tet)-regulated sys-
tems to control transgene expression in both ES cells and iPS cells, thereby enabling 
the transgene function to be explored in a spatiotemporal manner [ 16 – 18 ]. Each 
gene delivery and expression system has particular advantages and disadvantages 
depending on the desired outcome of the experimental design. Here, we briefl y 
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review representative gene delivery and expression systems from the perspective of 
their application to iPS cell research. 
11.2  Viral-Based Gene Delivery Systems 
 Gene delivery systems are classifi ed into two major classes: virus-based vectors and 
nonviral vectors (Table  11.1 ). Viruses are suitable for effi cient gene delivery experi-
ments because of their ability to penetrate into the cell nucleus and replicate [ 19 ]. 
Viral vectors have been widely used to deliver foreign genes into the cell nucleus 
because of their high transduction effi ciency and capacity for long-term transgene 
expression [ 20 ]. Ideally, the vector should be nontoxic, minimally immunogenic, 
and capable of highly effi cient penetration and delivery to numerous cell types [ 21 ]. 
The principal viral vectors currently in use include adenovirus, adeno-associated 
virus (AAV), retrovirus, and lentivirus [ 22 ].
11.2.1  Adenovirus Vectors 
 Adenovirus, a 70–100-nm, non-enveloped, double-stranded DNA virus [ 23 ], 
belongs to the family  Adenoviridae and is well known to cause respiratory tract 
infections. Adenoviruses enter mammalian cells via attachment to the  Coxsackievirus 
and adenovirus receptor (CAR) [ 24 ]. Adenoviruses rarely integrate with the host 
genome because their genome is maintained episomally in the cell nucleus. Because 
of their ability to transduce many cell types, including both dividing and nondivid-
ing cells, without genomic integration, adenoviral vectors have been considered as 
 Table 11.1  Comparison of commonly used viral vectors and  piggyBac transposon system 













 DNA  DNA  RNA  RNA  DNA 
 Packaging 
capacity [ 32 ] 
 4–5 kb  5 kb  9–12 kb  8 kb  9–14 kb 
 Genome 
integration 
 No  No  Yes  Yes  Yes 
(removable: 
cut and paste) 
 Gene 
expression 
 Transient  Transient/stable  Stable  Transient/stable  Stable 
 Applicable 
cell types 
 Broad  Broad  Dividing 
cells only 
 Broad  Broad 
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promising delivery systems for gene transduction experiments. However, the tran-
sient nature of their transgene expression limits their utility in in vitro research 
designs, and the toxicity and associated immune responses may hamper their clini-
cal application. 
 Adenovirus vectors can easily introduce exogenous genes into mouse ES cells 
[ 7 ] and iPS cells [ 13 ], and they are also used as effective gene delivery tools for 
human ES cells and iPS cells [ 25 ]. The transient expression mediated by adenovirus 
vectors is actually an advantage for stem cell research, in that undesirable effects of 
constitutive transgene expression after cell differentiation can be avoided. Indeed, 
adenovirally mediated transient expression of  Runx2 or  PPARγ was shown to effi -
ciently guide mouse iPS cells to differentiate into osteoblasts or adipocytes, respec-
tively [ 13 ]. 
 It should be noted that selection of an appropriate constitutive promoter, such as 
EF1α and CA promoters, is important for effective adenoviral transgene expression 
in pluripotent stem cells [ 26 ]. When used in adenovirus vectors, the CMV and RSV 
promoters show weak activity in mouse pluripotent stem cells [ 7 ,  13 ] because they 
are silenced by DNA methylation [ 27 ,  28 ]; therefore these promoters may not be the 
best choice for adenoviral transduction experiments in iPS cell research. 
11.2.2  AAV Vectors 
 AAV is a nonpathogenic, nonautonomous single-stranded DNA parvovirus that 
requires a helper virus such as adenovirus or herpes virus for replication. AAV has 
many serotypes, and among them, AAV2 is well studied and widely used as a gene 
delivery vector. Without the helper virus, the AAV genome remains episomal in 
target cells [ 29 ,  30 ]. Genome integration is observed at a low frequency and at a 
specifi c site on chromosome 19 [ 31 ]. AAV vectors derived from AAV lack viral 
coding sequences and rarely cause toxic and immune reactions, and they are thus 
considered as a promising gene delivery system for clinical use. However, the lim-
ited packaging capacity of AAV (approximately ~5 kb) is a major limitation of this 
vector system [ 32 ]. 
 One interesting property of AAV is that the inverted terminal repeats (ITRs) of 
the AAV genome permit AAV vectors to effi ciently introduce gene-targeting con-
structs into homologous chromosomal loci in a cellular genome [ 33 ]. This unique 
property permits gene editing, and effi cient gene targeting by AAV vectors has been 
achieved in human ES cells and iPS cells [ 34 – 36 ]. Damdindorj et al. [ 37 ] reported 
that when used in an AAV vector, the CMV promoter provided stable and robust 
gene expression in cancer cell lines; however, this promoter does not seem to be 
preferable for noncancerous cell lines and for the purpose of AAV-based gene tar-
geting. Further studies are needed to identify the most suitable constitutive pro-
moter for the application of AAV vectors to precise genetic manipulation of iPS 
cells, which could have great scientifi c and therapeutic potential. 
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11.2.3  Retrovirus Vectors 
 Retroviral vectors are among the most commonly used gene delivery systems for 
target gene transduction. They possess several advantages compared with other 
viral vectors, such as high-level transgene expression activity in long-term culture 
of most dividing somatic cells and their large DNA capacity (9–12 kb) [ 32 ]. 
Retroviral vectors reverse-transcribe their single-stranded RNA genome into DNA 
that is then integrated into target cell genome. According to their genome organiza-
tion, retroviruses are broadly divided into two categories: simple onco-retroviruses, 
such as Moloney murine leukemia virus (MLV), and complex retroviruses including 
lentiviruses, such as human immunodefi ciency virus [ 23 ]. Onco-retrovirus-based 
vectors are not capable of gene transfer to nondividing cells because they rely on 
cell division for transduction. 
 Importantly, transgene expression by MLV-based vectors is restricted in undif-
ferentiated pluripotent stem cells by de novo DNA methylation [ 38 ,  39 ] and other 
mechanisms, such as TRIM28-mediated silencing of the promoter element within 
the MLV long-terminal repeat (LTR) [ 40 ,  41 ]. A retroviral mutant vector, the murine 
ES-cell virus (MESV), was developed to facilitate target gene expression in ES cells 
through its ability to escape immediate silencing and initiate proviral expression 
[ 38 ,  42 ]; however, the MESV vector is still prone to inactivation during long periods 
of culture [ 38 ]. The self-silencing property of retroviral vectors is advantageous 
during reprogramming for iPS cell generation because it is necessary for the forced 
expression of exogenous reprogramming factors to cease once the cell reaches the 
ES-cell-like state. Indeed, Yamanaka and colleagues fi rst generated iPS cells from 
mouse and human fi broblasts using MLA-based vectors [ 2 ,  3 ]. 
 However, the self-silencing property of retroviral transduction in pluripotent 
stem cells would be disadvantageous for molecular studies that require sustained 
expression of exogenous gene products. In addition, retrovirus vectors have the 
potential to induce insertional mutagenesis in iPS cells through their random inte-
gration into the host genome [ 43 ]. These aspects should be carefully considered 
when designing iPS cell experiments using retroviral vector systems. 
11.2.4  Lentivirus Vectors 
 In contrast to onco-retroviruses, lentiviruses are transported to the nucleus of the 
target cells by active transport but do not require cell division for transduction, 
which allows them to transduce quiescent and nondividing cells [ 44 ]. Lentivirus 
vectors have an ~8-kb packaging capacity that limits the introduction of many 
genomic DNA sequences, but most cDNA sequences can be accommodated. Given 
their advantages, lentiviral vectors have become the predominant vectors for gene 
transduction in many types of cells and in transgenic animals [ 45 ]. 
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 Similar to other retroviral vectors, lentiviral vectors possess the ability to inte-
grate into the host genome and stably express the delivered target gene. Although 
insertional mutagenesis by lentiviral vectors is still their major disadvantage, it 
occurs less frequently for lentiviruses than for onco-retroviruses [ 46 ,  47 ]. To reduce 
the risk of insertional mutagenesis, non-integrating lentiviral (NIL) vectors, which 
carry either mutant integrase or mutations in the integrase binding sits, have been 
developed [ 48 – 50 ]. In this vector system, the lentiviral genome remains episomal in 
the nucleus, with sustained transgene expression that does not require genome inte-
gration [ 48 ,  49 ]; therefore, it is expected to provide a safe and promising gene deliv-
ery system for laboratory and clinical use [ 51 ]. 
 One important characteristic of lentivirus vectors is their resistance to silencing 
during propagation and differentiation of ES cells [ 52 ]; as a result, they have become 
widely used for gene transduction in ES cells [ 53 – 56 ]. Hong et al. [ 12 ] demon-
strated that when used in a lentiviral vector, the EF1α promoter drove robust trans-
gene expression in mouse ES cells from undifferentiated status to fully differentiated 
status during neuronal differentiation, whereas the CMV promoter activated trans-
gene expression only in late stages of differentiation. Norrman et al. [ 8 ] reported 
that the use of ACTB, EF1α, and PGK promoters in lentiviral vectors permitted 
stable transgene expression in human ES cells, whereas the CMV promoter was less 
effective and expression was rapidly downregulated within 7 days. 
11.3  Transposon-Based Gene Delivery Systems 
 As a nonviral gene delivery method, electroporation has been widely used for exog-
enous gene expression in ES cells [ 57 ]; however, a major drawback of this method 
is low transfection effi ciency. Transposon DNA vectors have been recently used for 
nonviral gene delivery [ 58 ]. The  piggyBac transposon, a transposon DNA vector 
identifi ed from the cabbage looper moth  Trichoplusia ni [ 59 ], has been reported as 
a highly effi cient tool to insert exogenous genes into mammalian cells [ 60 – 62 ]. The 
 piggyBac transposon system is constituted by two basic elements: a 2,472-bp trans-
poson with 13-bp inverted terminal repeats (ITRs) and a 594 amino acid transposase 
[ 59 ,  63 ]. 
 The  piggyBac transposon mediates gene transfer through a cut-and-paste mecha-
nism (Fig.  11.1 ) [ 58 ], where it is inserted into the genomic DNA at TTAA tetranu-
cleotide sites and then integrates with the chromosomal DNA through the activity of 
the transposase [ 63 ]. This system can effi ciently deliver DNA fragments sized 9 kb, 
even up to 14 kb, without signifi cant decreases in transposition effi ciency [ 60 ]. 
Another advantage is that the  piggyBac transposon can be excised from the original 
insertion site without leaving any remnant sequence [ 64 ]; thus,  piggyBac -mediated 
genetic insertions are reversible. Given its capacity for effi cient and reversible gene 
transfer, the  piggyBac transposon system is a promising vector for gene delivery.
 The  piggyBac transposon system can be used to generate transgene-free iPS cells 
[ 65 – 68 ], which may thus have increased therapeutic utility. Additionally, the 
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 piggyBac transposon system has been used for effi cient gene delivery to human ES 
cells, where the insertion can be removed from the ES genome without leaving any 
insertional mutation as described above [ 69 ,  70 ]. This system has also been used for 
gene delivery to human iPS cells [ 71 – 73 ]. In dental research, a  piggyBac transposon- 
based gene expression system has been applied to human deciduous tooth dental 
pulp cell-derived iPS cells to express EGFP and tdTomato transgenes [ 74 ]. 
11.4  tet-Controlled Transcriptional Regulation System 
 Control of transgene expression is important for preventing potential adverse effects 
of the continued overexpression of the transgene. tet-regulated gene expression sys-
tems are among the most widely used gene regulation systems [ 75 ] and consist of 
two variants: the tet-off and the tet-on systems (Fig.  11.2 ) [ 76 ,  77 ]. In the tet-off 
system, when doxycycline, an analog of tet, is absent, the tet transactivators (tTAs) 
bind to their target element, a tet-operator sequence (tet response element, TRE) 
that is upstream of a promoter, to drive transgene expression. Conversely, in the 
presence of doxycycline, the tTAs cannot bind to the TRE; therefore, transgene 
expression is hindered. The tet-on system was derived from the tet-off system by 
inducing random mutations in the tTAs [ 77 ]. These mutant reverse transactivators 
(rtTAs) bind to the TRE in the presence of doxycycline to drive transgene expres-
sion, and transgene expression does not occur without doxycycline.
 Fig. 11.1  Mechanism of  piggyBac transposition. ( a ) In the transfected cell, transposase is 
expressed from the  piggyBac transposase expression vector, and it then recognizes and binds to the 
specifi c inverted terminal repeats (ITRs) of the transgene vector plasmid and cuts the DNA 
sequence of the transgene from the original sites. Then, the transgene DNA sequence integrates 
into the genomic DNA of the target cell. ( b ) For excision, re-expression of transposase by transfec-
tion of the  piggyBac transposase expression vector leads to cutting of the transgene at the ITRs in 
the genomic DNA, which results in removal of the inserted transgene from the genomic DNA 
 
11 Gene Delivery and Expression Systems in Induced Pluripotent Stem Cells
128
 Controlled regulation of transgene expression has great signifi cance for investi-
gating molecular mechanisms of pluripotency and cellular differentiation in stem 
cells [ 16 ], and tet-controlled transcriptional activation systems have thus been 
applied to pluripotent stem cells [ 17 ,  18 ,  78 ]. Dox-inducible lentiviral and  piggyBac 
vectors have also been used to direct reprogramming of somatic cells to iPS cells 
[ 66 ,  79 ]. This system also permits the regulation of transgene expression in iPS cells 
to drive their differentiation toward specifi c cell lineages such as myocytes 
[ 71 – 73 ]. 
11.5  Conclusions 
 Because each gene delivery system possesses its own characteristics, researchers 
should consider the suitability of the system, rather than technical convenience, for 
a particular iPS cell experiment. The choice of promoter is also important, espe-
cially for experiments in iPS cells. Although little systematic information is avail-
able regarding the activity of constitutive promoters in undifferentiated iPS cells, 
the EF1α and CA promoters, but not the CMV promoter, are expected to be suitable 
for high levels of stable transgene expression. The  piggyBac transposon-based gene 
delivery system provides several benefi ts over classic viral and nonviral gene deliv-
ery systems. In addition, it can be combined with tet-controlled transcriptional regu-
lation to achieve spatiotemporal control of transgene expression during iPS cell 
differentiation, which may provide a great impact on iPS cell research. 
 Fig. 11.2  Tetracycline (tet)-controlled transcriptional regulation systems. ( a ) tet-off system: in the 
presence of doxycycline (Dox), tet transactivators (tTAs) cannot bind to the tet-operator (tetO) 
sequence to induce target gene (transgene) expression. In the absence of Dox, tTAs bind to the tetO 
sequence to drive target gene expression. ( b ) tet-on system: reverse tet transactivators (rtTAs) bind 
to the tetO in the presence of Dox to induce transgene expression. In contrast, in the absence of 
Dox, rtTAs cannot bind to the tetO; thus, transgene expression does not occur 
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 Chapter 12 
 Emerging Regenerative Approaches 
for Periodontal Regeneration: The Future 
Perspective of Cytokine Therapy and Stem 
Cell Therapy 
 Shinya  Murakami 
 Abstract  Cytokine therapy using basic fi broblast growth factor (FGF-2) has 
attracted attention as a next-generation periodontal tissue regenerative therapy. 
Clinical trial studies to date have shown that local application of 0.3 % FGF-2 
induces statistically signifi cant new alveolar bone formation. In vitro analyses using 
cultured periodontal ligament cells showed that FGF-2 maintains stem cells in an 
undifferentiated state and promotes the proliferation of these stem cells during the 
initial stages of wound healing. This increases the cell density of periodontal tissue 
stem cells at the site of healing, promotes angiogenesis, and produces specifi c extra-
cellular matrix molecules, thereby preparing a local environment suitable for the 
regeneration of periodontal tissue. Additionally, based on an analysis in beagles, 
when adipose tissue-derived multi-lineage progenitor cells (ADMPCs) isolated 
from adipose tissue were transplanted together with fi brin gel to areas of periodon-
tal tissue loss, signifi cant regeneration of periodontal tissue was observed at the 
transplantation site. These results strongly suggest that adipose tissue, which is 
abundant in the human body and can be easily and safely collected, is a promising 
source of stem cells to promote the regeneration of periodontal tissue. 
 Keywords  Periodontal regeneration •  FGF-2 •  ADSC 
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12.1  Introduction 
 Periodontal disease occurs when a bacterial biofi lm (dental plaque) adheres to the 
boundary between the teeth and gingiva, causing chronic infl ammation and progres-
sively destroying the periodontal tissue that supports the teeth. Therefore, periodon-
tal treatment involves scaling and root planing, which mechanically removes the 
causative bacteria biofi lm together with the necrotic cementum from the surface of 
the tooth root. Appropriate application of this therapy eliminates periodontal tissue 
infl ammation and stops the process of destruction of the same tissue. However, 
removing the cause of the disease does not regenerate the lost periodontal tissue to 
its original state. Given the high prevalence of periodontal disease both in Japan and 
worldwide and the need to maintain or enhance “QOL supported by the teeth and 
the mouth” in middle-aged and elderly people, developing highly predictable peri-
odontal tissue regenerative therapy that can be performed as a follow-on after treat-
ment to remove the cause is urgently needed. 
12.2  Periodontal Ligament as a Storage Site for Periodontal 
Tissue Stem Cells 
 Induction of tissue regeneration requires the presence of stem cells. Studies of 
regenerative medicine for periodontal tissue have shown that tissue stem cells that 
make the regeneration of periodontal tissue possible are present in the tissue sur-
rounding the tooth root, known as the periodontal ligament, even in adults. The 
periodontal ligament is a ligament tissue located between the cementum and alveo-
lar bone, with a thickness of 100–200 μm. Type I collagen fi ber bundles form the 
main body of the periodontal ligament; the principal cellular components of this 
tissue include the periodontal ligament fi broblasts as well as characteristic cell 
groups such as osteoblasts and osteoclasts on the surface of alveolar bone and 
cementoblasts found on the cementum surface. Interestingly, the results of various 
molecular biological analyses of periodontal ligament tissue show that many of the 
cells in the periodontal ligament show consistently high expression of molecules 
such as RUNX-2 and alkaline phosphatase which are closely associated with cyto-
differentiation into hard tissue-forming cells. These results suggest that the peri-
odontal ligament is involved in remodeling hard tissues such as alveolar bone and 
cementum depending on environmental changes. Furthermore, undifferentiated 
mesenchymal stem cells, which can differentiate into a variety of cell types other 
than osteoblasts and cementoblasts, are present in the human periodontal ligament 
[ 1 ,  2 ]. 
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12.3  Concept and Current Status of Periodontal Tissue 
Regenerative Therapy 
 Although mesenchymal stem cells that can differentiate into osteoblasts and 
cementoblasts are present in the adult periodontal ligament, periodontal tissue does 
not successfully regenerate when conventional periodontal treatment is performed 
to remove the cause of periodontal disease. Thus, in addition to conventional treat-
ment, it is necessary to develop a method for inducing the periodontal tissue stem 
cells present in the periodontal ligament. 
 The specifi c biological processes required for the regeneration of periodontal tis-
sue can be summarized into the following three processes: (1) selective and preferen-
tial induction of periodontal ligament-derived cells on the tooth root surface facing the 
areas of periodontal tissue loss, (2) proliferation and migration of undifferentiated 
mesenchymal stem cells (periodontal tissue stem cells) contained within the periodon-
tal ligament-derived cells while retaining their differentiation potential and then 
achieving site-specifi c differentiation as hard tissue-forming cells (osteoblasts and 
cementoblasts) and periodontal ligament fi broblasts, and (3) collagen fi ber bundles 
produced by periodontal ligament fi broblasts becoming embedded into bone tissue 
and cementum newly formed by osteoblasts and cementoblasts, resulting in regenera-
tion of the fi brous connections between the teeth and alveolar bone (Fig.  12.1 ).








 Fig. 12.1  Cellular and molecular basis of periodontal tissue regeneration. Periodontal tissue stem 
cells, including undifferentiated mesenchymal stem cells, are present in the periodontal ligament, 
and regeneration of periodontal tissue can be achieved by activating these cells to proliferate, 
migrate, and site specifi cally differentiate at the site of periodontal tissue loss 
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 Periodontal tissue regenerative therapies with clinical applications have been 
developed previously, including the “guided tissue regeneration method” and 
“enamel matrix protein method.” These treatment methods have a long history of 
use in dental practice and have shown some degree of success. However, there are a 
number of issues remaining related to indicated conditions and predictability, and 
improvements to these methods are required. Therefore, the action mechanism 
should be determined and next-generation periodontal tissue regenerative therapy 
with stable predictability should be established. 
12.4  Possibility of Cytokine Therapy 
 Human recombinant cytokines are currently used as therapeutic agents in a variety 
of diseases. In the fi eld of periodontal tissue regenerative medicine, there have been 
many attempts to induce regeneration of periodontal tissue through the migration of 
periodontal tissue stem cells to the site of periodontal tissue loss and proliferation of 
these cells in the same area or differentiation to osteoblasts and cementoblasts, 
which are activated through local application of specifi c cytokines. 
 In the USA, a combination of platelet-derived growth factor (PDGF) and 
β-tricalcium phosphate (β-TCP) (β-TCP + 0.3 mg/mL PDGF) has been approved by 
the US Food and Drug Administration (FDA) to induce regeneration of periodontal 
tissue, which is marketed as GEM21S®. Cytokines are also applied in dentistry 
using a combination of bone morphogenic protein-2 (BMP-2) and bovine type I 
collagen, which has also been approved by the US FDA as a medical device used in 
alveolar ridge augmentation procedures and sinus elevation surgery. Thus, human 
recombinant cytokines are beginning to be applied in the fi eld of dentistry. 
12.5  Inducing Periodontal Tissue Regeneration with Basic 
Fibroblast Growth Factor (FGF-2) 
 Fibroblast growth factors (FGFs) are a group of proteins that promote fi broblast 
proliferation and were discovered in the brain and pituitary gland tissue. This family 
of proteins comprises FGF-1 to FGF-23. Among these, FGF-2 induces the prolif-
eration of a wide variety of cells, including fi broblasts, vascular endothelial cells, 
neuroectodermal system cells, osteoblasts, chondrocytes, vascular smooth muscle 
cells, and epithelial cells. FGF-2 has attracted attention in the fi eld of regenerative 
medicine because: (1) FGF-2 has potent angiogenesis-promoting action and (2) 
FGF-2 promotes the cellular proliferation of undifferentiated mesenchymal cells 
while retaining their pluripotency. An example of the clinical application of FGF-2 
is as a therapeutic agent for intractable skin ulcers, such as decubital ulcers, and this 
therapy has been approved for manufacture in Japan. 
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 In our laboratory, we verifi ed the effi cacy and safety and determined whether 
FGF-2 promotes the regeneration of periodontal tissue in animal studies [ 3 ,  4 ]. We 
experimentally prepared class II furcation involvement at the furcation sites of man-
dibular molars in beagles and nonhuman primate and fi lled the bone defect, on the 
experimental side, with 0.1–0.4 % FGF-2 with a gelatinous carrier and measured the 
histological morphology at 6 and 8 weeks after FGF-2 administration. The results 
showed that regeneration of periodontal tissue was associated with a statistically 
signifi cant increase in new bone volume, new trabecular bone volume, and new 
cementum volume and was induced by local administration of FGF-2 (Fig.  12.2 ). 
At the same site, we observed the reappearance of Sharpey’s fi bers and rebuilding 
of fi brous attachments [ 3 ]. Extension of the peripheral nerves and Ruffi ni nerve 
endings was detected in the regenerated periodontal ligament. This strongly sug-
gests that local administration of FGF-2 not only constructs periodontal tissue but 
also regenerates the function of sensory receptors in the tissue.
 Furthermore, abnormal healing fi ndings such as downgrowth of the gingival epi-
thelium, ankylosis, and root resorption were not detected in cases on the side admin-
istered FGF-2. 
 We conducted an early phase II (PIIa) clinical trial (double-blind study with 
dose-response concurrent control, including placebo) with 13 participating facilities 
throughout Japan to investigate whether FGF-2 could induce the regeneration of 
periodontal tissue as well as the safety of FGF-2 (2002–2004). In this study, we 
investigated the effi cacy and safety of FGF-2 as a drug to induce the regeneration of 
periodontal tissue using a placebo (3 % hydroxypropylcellulose, which was used as 
the carrier) and the investigational drug containing 0.03 %, 0.1 %, and 0.3 % FGF-2. 
The results revealed a statistically signifi cant induction of new alveolar bone forma-
tion based on standardized x-ray images after local administration of 0.3 % FGF-2 
to human 2- or 3-wall intrabony defects in the alveolar bone [ 5 ]. Next, we imple-
mented a late phase II (PIIb) clinical trial (dose-response study) with 24 participat-
ing facilities throughout Japan to investigate the effi cacy and safety of FGF-2 using 
placebo and the investigational drug containing 0.2 %, 0.3 %, and 0.4 % FGF-2 
(2005–2007). The results showed that all investigational drugs containing FGF-2 
induced statistically signifi cant new alveolar bone formation, and 0.3 % FGF-2 was 
the clinically recommended dose [ 6 ] (Fig.  12.2a ). Based on these results, we then 
implemented a phase III (PIII) clinical study (randomized double-blind parallel- 
group comparison study) with 23 participating facilities throughout Japan to inves-
tigate the effi cacy and safety of FGF-2 using placebo and the investigational drug 
containing 0.3 % FGF-2 (2008–2010). The results confi rmed that the investigational 
drug containing 0.3 % FGF-2 signifi cantly increased alveolar bone ( p < 0.001) (Fig. 
 12.2b ) [ 7 ]. Additionally, no cases throughout the entire clinical study period were 
problematic in terms of safety. 
 We conducted detailed investigations into the effect of FGF-2 on cultured human 
periodontal ligament-derived cells to elucidate the mechanism of FGF-2-induced 
periodontal tissue regeneration; we predict the action mechanism to be as follows 
(Fig.  12.3 ). First, during the initial stages of wound healing, FGF-2 promotes the 
proliferation of stem cells while retaining their undifferentiated state and increases 
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the cell density of periodontal tissue stem cells at the wound site. Furthermore, 
FGF-2 promotes angiogenesis and the production of specifi c extracellular matrix 
molecules, creating a suitable local environment for the regeneration of periodontal 
tissue. After the effect of the locally administered FGF-2 is removed from the 
administration site through degradation or other actions, the periodontal tissue stem 
cells, which had increased in number, begin to differentiate into hard tissue-forming 
cells in the optimal environment created by FGF-2 administration. This promotes 
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 Fig. 12.2  Rate of increase in the height of alveolar bone 9 months after FGF-2 administration 
(clinical trial results on effi cacy). ( a ) Late phase II clinical study: The subjects were divided into 
four groups (placebo group and 0.2 %, 0.3 %, and 0.4 % FGF-2 treatment groups); each investiga-
tional drug was administered under double-blinded conditions. The fi gure shows the digitized 
results of a standardized dental x-ray taken 9 months after administration of the investigational 
drug and shows the percentage of the depth of the intrabony defect prior to treatment that had been 
fi lled with new bone (Adapted from literature [ 6 ]). ( b ) Phase III clinical study: The subjects were 
divided into two groups (placebo group and 0.3 % FGF-2 treatment group); each investigational 
drug was administered under double-blinded conditions. The fi gure shows the digitized results of 
a standardized dental x-ray taken 9 months after administration of the investigational drug and 
shows the percentage of the depth of the intrabony defect compared to before treatment that had 




the regeneration of periodontal tissue, both in number and time period, including the 
formation of new alveolar bone and cementum [ 8 ].
12.6  Future Outlook of Cytokine Therapy Using FGF-2 
 The concept of “scaffold” has not been introduced for FGF-2 preparations, and 
clinical studies are currently underway. This is because the aim of both clinical stud-
ies was to fi rst clarify the effi cacy and safety of FGF-2 alone as a drug. However, in 
the next stage, we will examine tissue engineering-type methods for the FGF-2 
carrier. 
 To date, in animal experiments using a severe periodontal tissue loss model (one 
wall intrabony defect model), we have found that following administration of 0.3 % 
FGF-2 with β-TCP, there is no recession of the gingiva postoperatively and that 
signifi cant periodontal tissue regeneration is induced at the same loss site [ 9 ]. If a 
new carrier for FGF-2 preparation is developed that can retain the space (space- 
making) at which the regeneration of periodontal tissue is expected, and with the 
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 Fig. 12.3  Mechanism of induction of periodontal tissue regeneration with FGF-2. FGF-2 strongly 
promotes the migration and proliferation of immature human periodontal ligament (PDL) cells 
while retaining the cells’ differentiation potential and increases the number of periodontal tissue 
stem cells at the site of periodontal tissue loss. Furthermore, FGF-2 promotes the production of 
angiogenesis and various extracellular matrices at the administration site, creating a suitable local 
environment for “periodontal tissue regeneration” 
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appropriate formativeness and osteoconductive properties required by operators, the 
application of FGF-2 preparations is expected to be further broadened. Additionally, 
the results of animal experiments suggest that if the 0.3 % FGF-2 preparation is used 
concurrently during dental implant surgery, the healing time to achieve osseointe-
gration will be shortened and robust integration will be achieved; further verifi ca-
tion of these concepts is required in the future [ 10 ]. 
12.7  Possibility of Periodontal Tissue Regenerative Therapy 
with Stem Cell Transplantation 
 The periodontal tissue regenerative therapy described above promotes the regenera-
tion of periodontal tissue by inducing the functions of stem cells present in all peri-
odontal ligaments. However, the number of stem cells in periodontal ligament 
decreases with age [ 11 ]. Therefore, in elderly people and in cases of severe peri-
odontal disease, we do not expect an adequate amount of regeneration simply by 
activating the stem cells present in the periodontal ligament. In these cases, it may 
be necessary to promote periodontal tissue regeneration by transplanting mesenchy-
mal stem cells collected from other tissue in the same patient to the site of periodon-
tal tissue loss. 
 The use of induced pluripotent stem cells is expected in the future, but it will still 
be some time before this technology can be clinically applied in the fi eld of den-
tistry. However, it has been clarifi ed that undifferentiated mesenchymal stem cells 
are present in a variety of tissues in our bodies, even after reaching adulthood. 
Studies are currently being conducted to regenerate periodontal tissue by transplant-
ing stem cells collected from these tissues into the site of periodontal tissue loss 
together with suitable scaffolding materials. 
 Examples of bone marrow cells used to regenerate periodontal tissue are as fol-
lows. There is a report showing that mixing bone marrow cells collected from the 
ilium or other such sites with platelet-rich plasma and transplanting the mixture into 
the site of periodontal tissue loss is effective for inducing periodontal tissue regen-
eration [ 12 ], whereas another report found that after stimulating and proliferating 
collected bone marrow cells with FGF-2 in the laboratory, subsequent mixing the 
cells with collagen gel as scaffolding material promotes periodontal tissue regenera-
tion [ 13 ]. In these cases, undifferentiated mesenchymal cells and osteoblast pro-
genitor cells in the bone marrow were used as stem cell sources during periodontal 
tissue regeneration. 
 Another study investigated the promotion of periodontal tissue regeneration by 
collecting tissue slices from the maxilla periosteum, culturing the cells collected 
from the same tissue slice (periosteum-derived cells: expected to be cells with high 
osteogenic potential) in a sheet format, and transplanting the cultured cells together 
with platelet-rich plasma and hydroxyapatite into the site of periodontal tissue loss; 
this process stimulated new alveolar bone formation and promoted regeneration 
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[ 14 ]. Furthermore, another study investigated culturing periodontal ligament cells 
in a sheet format, transplanting the cells onto the surface of a tooth root that had 
been exposed at the site of periodontal tissue loss, and transplanting β-TCP at the 
site of bone loss for total regeneration of periodontal tissue [ 15 ]. 
 In our laboratory, we focused on adipose tissue, which we consider to be less of 
a burden on the patient during collection and a safer tissue. We investigated the use 
of undifferentiated mesenchymal stem cells present in another tissue as a source of 
stem cells (Fig.  12.4 ). We previously reported that adipose tissue-derived multi- 
lineage progenitor cells (ADMPCs) collected using our method differentiate into 
osteoblasts, myocardial cells, liver cells, and insulin-producing cells, as ADMPCs 
are pluripotent [ 16 – 19 ]. We also confi rmed in in vitro that ADMPC isolated from 
human adipose tissue can differentiate into osteoblasts and periodontal ligament 
cells. Next, we investigated the effect of inducing periodontal tissue regeneration by 
ADMPC transplantation in a beagle periodontal disease model. We created artifi cial 
periodontal tissue loss (class II furcation involvement) at the furcation site of the 
fourth premolars in beagles and transplanted ADMPC isolated from adipose tissue 
collected from the abdominal area together with fi brin gel into the same site of the 
defect. The results confi rmed signifi cant regeneration of periodontal tissue at the 
transplantation site [ 20 ]. Interestingly, ADMPC had a remarkable trophic effect; 
insulin-like growth factor binding protein 6, which was secreted from ADMPC in 
large quantities, promoted the differentiation of periodontal tissue stem cells [ 21 ]. 
These results strongly suggest that adipose tissue, which is abundant in the body and 
Adipose





Periodontal regeneration by transplantation of ADMPC
Lipoaspiration
ADMPC
 Fig. 12.4  Periodontal regeneration by transplantation of ADMPC. Approximately 30 mL of 
abdominal adipose tissue was suction sampled from the patient with periodontal disease, and 
ADMPCs were collected from the same tissue in the Cell Processing Center. These cells were then 
cultured until a suffi cient volume of ADMPCs was acquired, which was then mixed with fi brin gel. 
Regeneration of periodontal tissue was induced by transplanting the same admixture into the site 
of the intrabony defect during periodontal surgery in the same patient 
 
12 Emerging Regenerative Approaches for Periodontal Regeneration: The Future…
144
can be easily and safely collected, can be used as a source of stem cells to promote 
the regeneration of periodontal tissue.
12.8  Conclusion 
 Periodontal tissue is a complex tissue comprised of alveolar bone, cementum, peri-
odontal ligament, and gingiva, and the end target is to regenerate each type of tissue 
at will depending on the extent of periodontal tissue destruction. In the future, after 
ensuring the safety of this therapy, optimal scaffolding material can be customized 
for periodontal tissue regeneration to support stem cell migration and proliferation, 
as well as differentiation into osteoblasts and cementoblasts. The application of 
cytokine therapy using FGF-2 and periodontal tissue regenerative therapy through 
stem cell transplantation of ADMPC will not be restricted to the fi eld of dentistry, 
but can also be expanded to other medical fi elds. Additionally, in the near future, we 
hope to establish patient-specifi c periodontal tissue regenerative therapy by com-
bining optimal conditions with cytokines, stem cells, and scaffolding materials. 
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 Chapter 13 
 Molecular Mechanisms Regulating Tooth 
Number 
 Maiko  Kawasaki ,  Katsushige  Kawasaki ,  James  Blackburn , 
and  Atsushi  Ohazama 
 Abstract  Tooth number, shape, and position are consistent in mammals and are 
subject to strict genetic control. Multiple signaling pathways including Shh, Tgf, 
Bmp, Wnt, Fgf, Notch, and NF-kB are known to play critical roles in regulating 
tooth development. Recent studies show that these signaling pathways interact with 
each other through positive and negative feedback loops to regulate tooth number, 
shape, and spatial pattern. Teeth develop via a dynamic and complex reciprocal 
interaction between dental epithelium and cranial neural crest-derived mesenchyme. 
These interactions contain a series of inductive and permissive processes that lead 
to the determination, differentiation, and organization of odontogenic cells, which 
are controlled by these signaling pathways. It is believed that dozens of different 
molecules together form complex molecular networks that regulate tooth develop-
ment. Studies of human congenital disease and transgenic mice suggest that distur-
bance of the molecular network results in abnormal tooth formation. Since molecular 
mechanisms involved in tooth development should be reproduced in tooth regenera-
tion, knowledge of tooth development from both human and mouse studies is cru-
cial for exploring tooth regenerative therapies. In this paper, we present an overview 
of the current literature covering the molecular mechanisms of tooth development, 
especially those regulating tooth number. 
 Keywords  Tooth development •  Tooth number •  Missing teeth •  Supernumerary 
teeth 
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13.1  Introduction 
 Tooth position, number, size, and shape are consistent in mammals and are deter-
mined genetically [ 6 ,  10 ,  13 ,  41 ,  80 ]. Teeth develop via sequential, reciprocal inter-
actions between the oral epithelium and neural crest-derived mesenchyme. The fi rst 
morphological sign of tooth development is an epithelial thickening (dental plac-
ode). The thickened tooth epithelium progressively takes the form of bud, cap, and 
bell confi gurations as differentiation and morphogenesis proceed. In addition to 
thickening of the epithelium, mesenchymal cells condense – a process that has been 
shown to be critical for organogenesis [ 44 ]. Subsequently, epithelial cells and mes-
enchymal cells (dental papilla) differentiate into enamel-producing ameloblasts and 
dentin-secreting odontoblasts, respectively. Since substantial research efforts over 
the last decade – using both human studies and transgenic mouse studies – have 
elucidated many aspects of the molecular mechanisms in tooth development, our 
understanding of the control of tooth shape diversity and location in the jaws has 
advanced considerably. 
 These research efforts have also elucidated that multiple signaling pathways 
including Shh, Tgf, Bmp, Wnt, Fgf, Notch, and NF-kB are known to play critical 
roles in regulating tooth development. The fi ne-tuning of these signaling pathways 
has been shown to be crucial in governing odontogenic precision. Recent studies 
show that crosstalk between these signaling pathways build complex molecular net-
works that regulate tooth development [ 6 ,  10 ,  13 ,  26 ,  28 ,  41 ,  80 ]. 
 Regenerative medicine is one of the revolutionary future therapies in dentistry. 
Since regeneration of organs starts from initiation, knowledge of the molecular 
mechanisms involved at this stage is crucial for developing tooth regenerative thera-
pies. Missing and extra teeth have been shown to be caused by disturbance of the 
developmental mechanisms during the initiation stage. Studying these numerical 
anomalies in both humans and mice therefore provides invaluable information to 
understanding the molecular mechanisms of tooth initiation and therefore tooth 
regeneration. In this paper, we present an overview covering the molecular mecha-
nisms of tooth development, especially those determining tooth number. 
13.2  Skin Appendage 
 The skin serves several functions, including thermoregulation, protection from the 
external environment, maintaining internal tissue fl uid from evaporation, sensation, 
defense against infection, and supporting scaffold for hair. To fulfi ll these multiple 
functions, skin develops many structures as epidermal appendages such as nails, 
sweat glands, hair, sebaceous glands, tooth, and mammary glands. Although diverse 
in their structural phenotypes, these organs including teeth and hair share common 
morphological features in the early stages of development – i.e., epithelial compo-
nents originate as thickenings that subsequently form buds around which the 
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underlying mesenchymal cells condense. Interactions between the epithelial and 
mesenchymal tissues play central roles in regulating the morphogenesis of the skin 
appendages. When cultured alone, neither the epithelial nor mesenchymal compo-
nents of these structures can differentiate into specifi c cells. It is also known that 
epithelial-mesenchymal interactions are sequential and reciprocal occurring in both 
directions between the epithelial and mesenchymal tissues. 
 Mice are the most highly studied mammals for investigating the mechanisms of 
tooth development. Initiation begins before the organ anlagen are morphologically 
visible. The fi rst odontogenic signals derive from the tooth epithelium. Bmps-, 
Fgfs-, Wnts-, NF-kB-, and Shh-related genes are expressed in the presumptive tooth 
epithelium before the thickening process. Unlike humans, rodent incisors grow con-
tinuously throughout life and the stem cell niche is known to be located at the apical 
end of the incisor tooth. In the laboratory, hair can be initiated from murine dental 
stem cells, suggesting that tooth epithelium also retains the ability to form hair [ 84 ]. 
13.3  Missing Teeth 
13.3.1  Missing Teeth in Humans 
 Congenital dental anomalies can occur either as non-syndromic familial cases or as 
part of a syndrome. Missing teeth are one of the most common human developmen-
tal anomalies. It has been shown that more than 20 % of humans lose at least one of 
the third molar teeth [ 36 ,  45 ,  53 ]. 1.6–9.6 % of the population suffers from hypodon-
tia, with loss of one or two teeth (except the third molar). Oligodontia, with loss of 
more than six teeth (except the third molar), ranges from 0.0 % to 1.1 %, depending 
on the population studied. Loss of all teeth is referred to as anodontia. Missing teeth 
are more common in the permanent dentition than those in the primary dentition. 
However, it is believed that hypodontia in the primary dentition is correlated to 
hypodontia in the permanent dentition [ 36 ,  45 ]. Additionally, a higher prevalence 
ratio of hypodontia has been identifi ed in women, with a 3:2 ratio [ 9 ]. 
13.3.1.1  Non-syndromic (Isolated) Familial Missing Teeth 
 Non-syndromic familial hypodontia has been reported to probably be inherited 
either as an autosomal dominant, autosomal recessive, or X-linked trait [ 1 ,  2 ,  15 ,  22 , 
 65 ,  79 ]. 
 It has been shown that mutation in  MSX1 is associated with hypodontia that pre-
dominantly affects second premolars and third molars which all have normal pri-
mary dentition [ 31 ,  45 ]. Mutation in  PAX9 results in hypodontia in the form of lost 
molars. Maxillary and/or mandibular second molars and central incisor are often 
affected in some individuals [ 37 ,  46 ]. The frequency of tooth loss is found to be 
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higher for second premolars and maxillary fi rst premolars in association with  MSX1 
mutation compared to  PAX9 mutation [ 53 ]. Each tooth type thus shows their differ-
ent response to these gene mutations. Defects identifi ed in  MSX1 and  PAX9 include 
gene deletion, as well as nonsense, frameshift, and missense mutation. In addition, 
it has been indicated that a nonsense mutation in  AXIN2 (a molecule essential for 
canonical Wnt signaling) leads to oligodontia [ 40 ]. Here, patients display an absence 
of at least eight permanent teeth, while primary dentition remains intact. 
 Mutation in  EDA has been shown to be linked to non-syndromic hypodontia, 
although mutation in  EDA can also lead to syndromic dental anomalies [ 83 ]. 
Mutation of  WNT10A is found in patients with isolated hypodontia, even though 
mutation of the gene is also linked to odonto-onycho-dermal dysplasia [ 77 ]. 
Additionally,  GREM2 mutations have been found to exist within families with 
absent teeth [ 30 ]. 
13.3.1.2  Syndromic Missing Teeth 
 There are about eighty syndromes showing hypodontia (Table  13.1 ; [ 36 ]).
 Table 13.1  Abnormal tooth numbers in human 
 Loss of tooth 
 Syndrome  Mutation 
 Hypohidrotic/anhidrotic ectodermal dysplasia  EDA, EDAR, and EDARADD 
 Odonto-onycho-dermal dysplasia  WNT10A 
 Ectrodactyly ectodermal dysplasia cleft lip/
palate syndrome 
 P63 
 Ellis-van Creveld syndrome  EVC 
 Incontinentia pigmenti  IKKγ 
 Van der Woude syndrome  IRF6 
 Rieger syndrome  PITX2, FOXC1 
 Oral facial digital syndrome type I  OFD1 
 Enamel renal gingival syndrome  FAM20 
 Extra tooth 
 Cleidocranial dysplasia  RUNX2 
 SOX2 anophthalmia syndrome  SOX2 
 Gardner syndrome  APC 
 Opitz G/BBB syndrome  MID1 
 Tricho-rhino phalangic syndrome  TRPS1 
 Ehlers-Danlos syndrome type III  Tenascin-XB, COL3A1 
 Robinow syndrome  ROR2 
 Nance-Horan syndrome  NHS 
 Fabry syndrome  a-galactosidase A 
 Rothmund-Thomson syndrome  RECQL4 
 Hallermann-Streiff syndrome  GJA1 
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 Ectodermal dysplasia consists of variable defects in the morphogenesis of ecto-
dermal derivatives such as teeth, skin, hair, sweat glands, and nails, although more 
than 150 clinically distinct ectodermal dysplasias have been identifi ed. Ectodermal 
dysplasia syndromes can be inherited in an autosomal dominant, autosomal reces-
sive, or X-linked form. Disruption of the  EDA ,  EDAR , and  EDARADD loci has been 
causally identifi ed for the onset of hypohidrotic/anhidrotic ectodermal dysplasia 
[ 56 ]. Odonto-onycho-dermal dysplasia is an autosomal recessive ectodermal syn-
drome, which is caused by mutation in  WNT10A . It is characterized by hyperkera-
tosis, smooth tongue, dry hair, nail dysplasia, and hyperhidrosis of palms and soles. 
The dysplasia also presents with severe hypodontia [ 36 ]. Ectrodactyly ectodermal 
dysplasia cleft lip/palate syndrome is an autosomal dominant disorder characterized 
by ectrodactyly, ectodermal dysplasia, and cleft lip/palate. Patients with this syn-
drome also exhibit oligodontia/anodontia. Heterozygous mutation in  P63 has addi-
tionally been shown to be responsible for ectrodactyly ectodermal dysplasia cleft 
lip/palate syndrome [ 73 ]. Incontinentia pigmenti is an X-linked dominant disorder, 
which is characterized by abnormal skin pigmentation and hair loss. It is caused by 
mutation of  IKKγ ( NEMO ) [ 56 ]. Incontinentia pigmenti is recognized as a form of 
ectodermal dysplasia by many societies, since ectodermal structures (hair, skin, 
nails, and teeth) as well as the eyes and nervous system are affected. Hypodontia is 
a common feature of the disorder [ 73 ]. 
 Ellis-van Creveld syndrome is characterized by polydactyly, chondrodyspla-
sia, nail dysplasia, and cardiac defects and is caused by mutation of  EVC . Missing 
teeth are frequently observed in Ellis-van Creveld syndrome patients [ 5 ]. Van der 
Woude syndrome is characterized by cleft lip and/or cleft palate, paramedian lip 
pits and sinuses, and conical elevations of the lower lip. It is caused by mutation 
in the  IRF6 gene. Hypodontia is a common feature of the syndrome [ 55 ,  72 ]. 
Rieger syndrome is an autosomal dominant disorder, which consists of malfor-
mations in the anterior chamber of the eye and umbilical anomalies. Rieger syn-
drome patients also show hypodontia or anodontia. Mutations in  PITX2 and 
 FOXC1 have additionally been shown to be responsible for Rieger syndrome. 
Oral facial digital syndrome type I is an X-linked disorder which is caused by 
mutation of  OFD1 . The syndrome is characterized by malformation of the face, 
oral cavity, digits, central nervous system, and kidneys. Missing teeth are often 
observed in oral facial digital syndrome type I patients [ 23 ]. Enamel renal gingi-
val syndrome is caused by the mutation of  FAM20 , and patients display impaired 
calcium metabolism and hypodontia [ 29 ]. 
 It is generally accepted that hypodontia is often accompanied by clefts of the lip 
and palate. Hypodontia has been shown to be observed in 80 % of patients with 
clefts [ 36 ,  74 ]. The prevalence ratio of hypodontia is also correlated to the severity 
of the cleft [ 69 ]. 
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13.3.1.3  Sporadic Missing Teeth 
 It is believed that sporadic hypodontia is caused by environmental factors such as 
trauma to the jaws, surgical procedures on the jaws, traumatic extraction of the pri-
mary teeth, chemotherapy, and radiation therapy [ 52 ,  71 ]. In common with environ-
mental factors, mutation of  PAX9 has been shown to be associated with sporadic 
hypoplasia [ 62 ]. 
13.3.2  Missing Teeth in Mice 
 Mice are the most highly studied mammals for investigating the molecular mecha-
nisms of tooth development, since the most common application of gene targeting 
is to produce knockout mice. Mice however only have incisor and molar teeth and 
as such their use is limited as a model for human tooth development. 
 The fi rst odontogenic signal is derived from the epithelium. Prior to this, there is 
no prespecifi cation of the cells into different populations within the mandibular 
arch. All ectomesenchyme cells in the arch are therefore equally responsive toward 
any signals, including those which instigate hair and limb development. After 
receiving appropriate signaling, the underlying mesenchyme becomes independent 
of the epithelial cues. From the bud stage, the direction of cellular communication 
is reversed and signals pass from the condensing mesenchyme to the epithelium. 
 Many genes have been shown to play a critical role in regulating tooth number 
(Table  13.2 ). In common with humans, mice with mutations in  Msx1 and  Pax9 
mutation exhibit missing teeth, driven by an arrest of tooth development at the bud 
stage [ 64 ,  70 ]. Mutation of other molecules such as  Fgfr2 ,  Lef1 , and  Runx2 also 
shows an arrest of tooth development at the bud stage [ 16 ,  18 ,  78 ]. Transition to cap 
stage from bud stage is thus a critical point in tooth development. In common with 
humans,  p63 and  Pitx2 mutant mice show missing teeth, but this is caused by an 
arrest of tooth development at stages preceding the bud stage [ 39 ,  42 ,  43 ]. Together, 
these data suggest that  p63 and  Pitx2 are essential for developmental signaling 
before the requirement of  Msx1 ,  Pax9 ,  Fgfr2 ,  Lef1 , and  Runx2 . However  Msx1/2 
mutants also show an arrest of tooth development at stages preceding the bud stage, 
suggesting that  Msx1 has a role in tooth initiation for which  Msx2 can compensate 
for gene loss in the mutant mouse [ 7 ].
 It is believed that Shh, Tgf, Bmp, Wnt, and Fgf signaling are known to play criti-
cal roles in tooth initiation.  Gli2/3 (transcription factors mediated by Shh) mutants 
show an arrest of tooth development at stages prior to bud formation [ 24 ]. Mice with 
epithelial conditional deletion of  Bmpr1a lead to an arrest of tooth development at 
the bud stage [ 4 ]. Additionally,  Fgf3/10 mutants show an arrest of tooth develop-
ment preceding the bud stage, whereas mutation of  Fgfr2 results in an arrest of tooth 
development at the bud stage [ 16 ,  82 ]. Downregulation of Wnt signaling by overex-
pression of  Dkk1 (an antagonist of Wnt signaling) shows an arrest of tooth develop-
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ment at stages prior to bud formation, whereas  Lef1 (a Wnt-related molecule) 
mutation results in an arrest of tooth development at the bud stage [ 3 ,  78 ]. In com-
mon with  Msx1 and  Msx2 , it is likely that there is redundancy between molecules 
within the same signaling pathway during tooth initiation events. 
 The term “epigenetics” refers to the covalent modifi cation of DNA, protein, or 
RNA, resulting in changes to the function and/or regulation of these molecules 
without altering the genomic sequence. MicroRNAs (miRNAs) represent one of 
these epigenetic factors. These noncoding small single-stranded RNAs are 19–25 
nucleotides in length and negatively regulate gene expression by binding target 
sequences in mRNA molecules. Absence of miRNAs in neural crest-derived cells, 
driven by deletion of  Dicer (an essential molecule for microRNA processing), have 
been shown to lead to an absence of tooth development – although exact phenotypes 
vary between animals from lack of tooth development to almost normal tooth devel-
opment [ 61 ]. This suggests that epigenetic factors also play a critical role in the 
regulation of tooth formation, but the exact mechanism is as yet unclear. 
 Table 13.2  Abnormal tooth numbers in mice 
 Loss of tooth  Extra tooth 
 Tooth type  Mutation/Tg  Tooth type  Mutation/Tg 
 All tooth  Msx1  All tooth  Apc 
 Pax9  Sp6 
 Runx2 
 p63  Incisor  Lrp4 
 Pitx2  Wise 
 Msx1/Msx2  K5-Ikkβ 
 Lef1  Lhx6/Lhx7 
 Gli2/Gli3 
 K14-Dkk1  Diastema  Ift88 
 Bmpr1a  Lrp4 
 Fgf3/Fgf10  Wise 
 Fgfr2  Sprouty2 
 Dicer  Sprouty4 
 R-Spondin2 
 Incisor  Activinβa  Eda 
 K14-Eda 
 Molar  Eda  K5-Edar 
 K14-Noggin 
 Bmp4  Molar  Osr2 
 IkBα 
 Dlx1/Dlx2 
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13.4  Supernumerary Teeth 
 Teeth are found in most vertebrates and have played a central role in their evolution. 
Change in tooth number is a signifi cant evolutionary adaptation to accommodate 
novel feeding strategies. Reduction in tooth number is a well-known evolutionary 
trend of the dentition within eutherians. The total number of teeth per dentition has 
generally decreased, whereas tooth morphological complexity has increased during 
tooth evolution. Findings in tooth evolution are therefore a key feature to under-
standing the molecular mechanisms in regulating tooth number. 
13.4.1  Supernumerary Teeth in Humans 
 The prevalence ratio of supernumerary teeth ranges from 0.2 % to 0.8 % in the 
deciduous dentition and from 0.3 % to 5.3 % in the permanent dentition [ 80 ]. The 
incidence of supernumerary teeth in men is higher than those in women (1.8:1–
4.5:1, female/male) [ 53 ,  80 ]. 
13.4.1.1  Syndromic Extra Teeth in Humans 
 Multiple supernumerary teeth are usually a syndromic symptom, and the prevalence 
for non-syndromic multiple supernumerary teeth have been reported to be less than 
1 % (Table  13.1 ; [ 68 ]). 
 Cleidocranial dysplasia (dysostosis) is characterized by general bone dysplasia, 
short stature, delayed closure of the cranial sutures, and hypoplastic or aplastic clav-
icles. Cleidocranial dysplasia is known to be associated with supernumerary denti-
tion. Mutations in  RUNX2 are responsible for the dysplasia [ 36 ,  80 ].  SOX2 
anophthalmia syndrome is caused by mutations in the  SOX2 gene and is character-
ized by anophthalmia or microphthalmia, with various extraocular symptoms such 
as hypogonadotropic hypogonadism, brain anomaly, and esophageal abnormalities. 
Again, patients show supernumerary tooth formation [ 54 ]. Gardner syndrome is a 
rare autosomal dominant disorder which is caused by mutations in  APC . The syn-
drome consists of gastrointestinal polyps, multiple osteomas, and skin and soft tis-
sue tumors including a characteristic retinal lesion. Variant tooth anomalies 
including supernumerary teeth are observed in these patients. In addition, Opitz G/
BBB syndrome, tricho-rhino phalangic syndrome, Ehlers-Danlos syndrome type 
III, Robinow syndrome, Nance-Horan syndrome, Fabry syndrome, Rothmund- 
Thomson syndrome, and Hallermann-Streiff syndrome are all known to be syn-
dromes where supernumerary teeth occur [ 13 ,  73 ,  80 ]. 
 As with hypodontia, syndromic extra tooth formation is often accompanied by 
cleft lip/palate. In this instance, splitting of the tooth germs due to cleft lip and/or 
palate is the cause of the formation of supernumerary teeth [ 38 ,  80 ]. 
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13.4.1.2  Missing and Extra Teeth in Humans 
 The concomitant occurrence of hypodontia and supernumerary teeth is observed in 
Down syndrome, oral facial digital syndrome type I, Ellis-van Creveld syndrome, 
and Ehlers-Danlos syndrome [ 76 ]. These suggest that single gene mutation can lead 
to these opposite tooth phenotypes in same patients. 
13.4.2  Supernumerary Teeth in Mice 
 It is widely accepted that modern eutherian mammals evolved from a common 
ancestor that had three incisors, one canine, four premolars, and three molars. Mice 
possess only one incisor and three molars in each jaw quadrant, separated by a 
toothless region called the “diastema.” It is believed that mice lost the remaining 
teeth during evolution. Genetically modifi ed mice therefore provide some limited 
information on the determinant of non-murine tooth types. However, it has been 
shown that mice have retained the genetic potential for the development of teeth lost 
during evolution, such as the premolars. 
 In wild-type mice, tooth germ-like structures are observed in the diastema at 
early stages of development, which disappear during later stages [ 63 ]. Both muta-
tion and overexpression of  Eda are known to lead to extra tooth formation in the 
diastema, suggesting that the precise signaling regulated by  Eda is essential for 
controlling odontogenesis in the diastema [ 48 ,  63 ]. Extra tooth formation in the 
diastema is also observed in mice with mutation of  Gas1 (an inhibitor of Shh), 
 R-spondin2 (activators of Wnt signaling),  Ift88 (molecules present in the primary 
cilia where Shh signaling is activated),  Wise (a secreted BMP antagonist and Wnt 
modulator),  Lrp4 (a negative Wnt co-receptor),  Sprouty2 (a negative feedback regu-
lator of Fgf), and  Sprouty4 (a negative feedback regulator of Fgf) [ 32 ,  33 ,  35 ,  59 , 
 60 ]. Evolutionary tooth loss in the diastema is likely to be associated with changes 
in these signaling pathways. These also suggest that odontogenic activity in the 
diastema is mainly controlled by inhibitors of signaling pathways. 
 Mammals have single-rowed dentitions, whereas many other vertebrates have 
dentition which consists of multiple rows. It is believed that mammals lost this addi-
tional dentition during evolution.  Osr2 is expressed in the molar tooth germ area 
with a lingual-to-buccal gradient and restricts expression of  Bmp4 – which is also 
mediated by  Msx1 . Mice with mutations in  Osr2 develop supernumerary teeth lin-
gual to the endogenous molars due to expansion of  Bmp4 expression [ 85 ]. The inter-
action between  Osr2 ,  Bmp4 , and  Msx1 thus plays a critical role in regulating molar 
tooth initiation in the buccolingual axis [ 41 ]. 
 In common with the diastema and molar region, extra incisor tooth formation is 
also observed in mice with mutations in  Wise ,  Lrp4 ,  Lhx6/7 and  Sprouty2/4 , and 
overexpressing  Ikkβ [ 8 ,  11 ,  17 ,  32 ,  59 ]. Single extra incisor in a jaw quadrant is thus 
formed by changes in the Wnt, Bmp, Fgf, and NF-kB pathways. 
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 Constitutive stabilization of β-catenin in the epithelium results in numerous 
supernumerary tooth formation in the mouse [ 25 ].  Apc is known to play a critical 
role in regulating the Wnt signaling pathway and conditional deletion of  Apc in the 
epithelium also results in multiple supernumerary tooth formation [ 81 ]. Mice with 
overexpression of  Lef1 (a Wnt-related molecule) have been associated with ectopic 
tooth formation [ 86 ]. Numerous extra teeth are also observed in  Epiprophin ( Sp6 )-
defi cient mice, which show upregulation of Wnt signaling [ 49 ]. Taken together, 
numerous extra tooth formation is thus directly related to over-activation of Wnt 
signaling. Wnt inhibitors, Dkks, are known to be expressed in wild-type developing 
tooth germs, suggesting that Wnt signaling activity is regulated by the balance 
between ligands and inhibitors [ 21 ]. 
13.5  Odontogenic Activity Between Tooth Germs 
 Each tooth type is known to show different developmental timing in humans. In 
mice, the second and third molars start to develop after the fi rst molar reach the bell 
stage. It has been shown that the fi rst molar tooth germs inhibit development of the 
second molar at an early stage [ 34 ]. The development of the second molar tooth 
initiates only when inhibitory factors from the fi rst molar are suffi ciently reduced. 
Odontogenic activity is thus regulated by the interaction between tooth germs. Bmp 
signaling is likely to be involved in this interaction. Indeed, mice with mesenchymal 
conditional deletion of  Bmp4 and mice overexpressing  Noggin (Bmp antagonist) 
present with an absence of second and/or third molars [ 27 ,  67 ]. Mice with mutation 
of  Eda and with reduction of NF-kB also exhibit loss of the second and/or third 
molars, suggesting that Eda-NF-kB cascade is also involved in the interaction 
between tooth germs [ 57 ,  66 ]. 
13.6  Tooth Initiation and Tooth Type 
 It has been shown that more than 20 % of humans lose at least one of the third 
molars [ 36 ,  45 ,  53 ]. Apart from the third molars, lower second premolars and/or 
upper lateral incisors are most commonly affected, followed by the upper second 
premolars [ 53 ]. Most of the common supernumerary teeth (46.9–92.8 % of supernu-
merary teeth) are observed between the upper central incisors – the so-called 
mesiodens [ 20 ,  68 ,  87 ]. Supernumerary teeth are also observed in the premolar 
region (10 % of the total supernumerary cases) and almost 75 % of those are in the 
mandible [ 80 ]. Supernumerary teeth are also found in the molar region as a disto-
molar (fourth molar). Furthermore, mice with targeted null mutations of both  Dlx1 
and  Dlx2 homeobox genes have a tooth patterning phenotype where development of 
maxillary molar teeth is inhibited but development of all other teeth is normal. 
 ActivinβA mutants show the opposite tooth phenotype, where maxillary molar teeth 
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are present and other teeth are absent [ 19 ]. Odontogenic activities are thus differ-
ently regulated between regions of the maxillary and mandibular jaw. 
 It has been established that instructive signals are involved in the determination 
of tooth type. Homeobox genes have been found to regulate patterning in the devel-
opment of many tissues including the maxillae and mandibles. In the developing 
jaws, several homeobox genes show highly restricted expression patterns in the 
ectomesenchyme along the proximodistal axis. For example,  Barx1 are expressed in 
mesenchymal cells of the presumptive molar region, whereas  Msx1 and  Msx2 are 
expressed in mesenchymal cells where the incisors develop. Spatially restricted 
gene expression is also observed in the epithelium.  Bmp4 is expressed in the pre-
sumptive incisor region, while  Fgf8 expression is restricted to the presumptive 
molar region. In the epithelium, these molecules have been shown to be responsible 
for regulating mesenchymal homeobox gene expression. Mis-expression of  Barx1 
in the murine presumptive incisor mesenchyme results in a transformation of tooth 
shape, with molars developing from incisor primordia. Transposition of teeth (i.e., 
adjacent teeth switching positions) is an extremely rare dental anomalies in humans 
[ 12 ,  75 ]. However, examples of molar-like teeth in the maxillary central incisor 
region and premolar-like teeth in the maxillary lateral incisor region have previ-
ously been reported [ 28 ]. It is believed that the maxillary canine is most frequently 
involved in the transposition event [ 51 ]. Tooth identity is believed to be determined 
by complicated mechanisms, such as spatially restricted homeobox gene expres-
sion, and the gradient and overlap of signaling molecules [ 13 ,  14 ,  47 ]. Although the 
etiology of transposed teeth remains unclear, it is possible that changes in the bal-
ance of the determinant molecules results in the switching of tooth types. 
13.7  The Midline and Tooth Development 
 Holoprosencephaly is a relatively common defect of the forebrain and midface in 
humans and is caused by impaired midline cleavage of the embryonic forebrain. It 
is believed that the holoprosencephaly spectrum is associated with the appearance 
of a solitary median maxillary central incisor. Single maxillary central incisors are 
also a feature of single median maxillary central incisor syndrome, which is caused 
by a failure in growth at the midline [ 10 ,  50 ]. Craniofacial development is thus 
linked to tooth development. 
13.8  Conclusion 
 Tooth number, shape, and position are consistent in mammals and are subject to 
strict genetic control. Here, we highlight an overview covering the molecular mech-
anisms of tooth development, especially those regulating tooth number. Dozens of 
different molecules together form complex molecular networks creating positive 
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and negative feedback loops, and a series of inductive and permissive processes that 
regulate tooth number. Multiple signaling pathways such as Shh, Tgf, Bmp, Wnt, 
Fgf, Notch, and NF-kB – and crosstalk between them – are known to play critical 
roles in regulating tooth development. Activity of signaling pathways is also regu-
lated by the balance of ligands, activators, inhibitors, and receptors. Teeth develop 
via a dynamic and complex reciprocal interaction between dental epithelium and 
cranial neural crest-derived mesenchyme. It has been shown that transcription fac-
tors are involved in epithelial-mesenchymal interactions through the signaling loops 
between tissue layers by responding to inductive signals and regulating the expres-
sion of other signaling molecules. It has been shown that all these factors function 
as distinct role between tooth type, timing, location, and gender in mammals. 
 Studies of human congenital disease and transgenic mice suggest that distur-
bance of the molecular network results in abnormal tooth formation. Since molecu-
lar mechanisms involved in tooth development should be reproduced in tooth 
regeneration, knowledge of tooth development from both human and mouse studies 
provides crucial information for the advancement of tooth regenerative therapy. 
Among the molecular mechanisms involved in tooth development, those regulating 
tooth number are the most critical for tooth regeneration, as replacement dentition 
should start from tooth initiation. Rodent incisors grow continuously throughout 
life by utilizing a stem cell niche located at the apical end of the incisor tooth. As 
such, this structure is also able to provide crucial information pertinent to the study 
of tooth regeneration. 
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 Chapter 14 
 Open-Source Technologies and Workfl ows 
in Digital Dentistry 
 Rong-Fu  Kuo ,  Kwang-Ming  Fang , and  Fong-Chin  Su 
 Abstract  The Medical Device Innovation Center (MDIC) at the National Cheng 
Kung University has developed a complete and professional digital dentistry design 
workfl ow with cutting-edge equipment and software. MDIC certifi ed with ISO13485 
can provide total solutions in digital dentistry. An “Intelligent Manufacturing 
Systems Center” (IMSC) has been established using dental open technologies 
toward providing digital dentistry training and restoration design services. This 
digital dental laboratory is able to control the entire digital process from digital 
impressions to the CAD/CAM creation of the restoration and model milling. An 
intraoral scanner is used to make digital impressions for 3D geometric models from 
the chair side or from traditional impressions. In the design phase, three different 
commercial software packages are considered for the design portion. After import-
ing the digital impression STL data fi le, one or more of these packages are used to 
design the restoration. The design is then sent to a fi ve-axis milling machine for 
production. The CNC machines are chosen for machining or milling of the prosthet-
ics from various materials including wax, PMMA, zirconia, chromium cobalt, resin 
nano-ceramics, glass ceramics, lithium disilicate, silicate ceramics, and titanium. 
As a cloud base solution, these design packages allow a connection to a remote 
manufacturing site. Our R&D team built a web-based cloud solution that can be 
deployed to each pertinent location. All data from the design package is stored on a 
private cloud which is then automatically synced to the remote public cloud. Work 
orders from various sources are then processed by any remote technician. Through 
the above settings, we may produce several common digital dentistry products 
including crowns and bridges, veneers, inlays and onlays, temporary crowns, and 
virtual diagnostic wax-ups. This digital dentistry laboratory is also equipped to han-
dle advanced clinical cases such as implant planning, digital smile design analysis 
and customized surgical guides, custom abutments, implant bridges and bar designs, 
and orthodontics. Digital animation is applied for patient education and communi-
cation. For academics and training, a comprehensive digital technology training 
program has been developed to help dentists and dental technicians. 
 R.-F.  Kuo •  K.-M.  Fang •  F.-C.  Su (*) 
 Medical Device Innovation Center and Department of Biomedical Engineering ,  National 
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 Cloud base solution 
14.1  Cloud Base Solution for Intelligent Dental Clinic 
and Manufacturing System 
 Industrial technologies are growing rapidly in recent years. Dental industry is 
toward a digital revolution as shown in Fig.  14.1 which causes traditional dental 
industry to face a serious impact and revolution [ 1 ,  2 ]. Dental clinics also transform 
gradually toward an intelligent environment illustrated in Fig.  14.2 . In order to face 
this challenge, MDIC presents an innovative dental full-chain model focusing on 
digital design phase as a core concept plus the utilization of open-source technolo-
gies. This model based on an ecosystem platform provides a variety of services 
corresponding to the demand of dental clinics and dental labs. These needs may 
cover a variety of customizable dental products and services which are closely con-
nected to dental design and manufacturing processes.
 Integrating design and manufacturing for digital dentistry as a complete chain to 
provide custom service is the core in the model. In order to achieve high compe-
tence, MDIC established a mobile interface APP platform based on cloud comput-
ing and mobile ecommerce. Cloud computing provides a lot of advantages including 
high fl exibility, low cost, mass storage, and parallel computing capacities to the 
 Fig. 14.1  Dental digital workfl ow 
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proposed architecture [ 3 ,  4 ]. Further, mobile services provide customers with ubiq-
uitous services and shorter response time to quickly respond to customers’ demand. 
Moreover, a lot of customer messages can be aware and collected by the sensors of 
mobile devices to continuously improve service quality [ 5 ]. 
 The platform provides further features including fl exible communications on 
geometry and color shading, the customizable dental order, and global data analy-
sis. Moreover, the platform offers a variety of connecting services for various mobile 
devices such as smartphones and tablet PCs to connect to the system and communi-
cate with global partners. 
14.2  Integration of Digital Information 
 In the dental clinic, there are quite a lot of data produced on a regular base including 
information of extraoral impression, intraoral impression, CBCT dental medical 
image, occlusion and TMJ analysis, and tooth shade matching. The development of 
tooth shading device is discussed in the following. 
 Fig. 14.2  Intelligent dental clinic 
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14.3  A Shade Guide Development Based on Open-Source 
Technology 
 Dental color matching is a challenging aspect of prosthetic dentistry. A dental shade 
guide is an essential tool used in dental labs and dental clinics to determine the color 
of natural teeth [ 6 – 13 ]. Color measurement apparatus consisted of a spectrometer 
and fi ber bundles fi xed on an optical table as shown in Fig.  14.3 with probe bundles 
with round bundle light source and single-fi ber spectrometer legs with SMA con-
nector. The bifurcated fi ber cables with a source leg to carry light from a light- 
emitting diode (LED) to a tooth surface and a spectrometer leg to carry light refl ected 
by the tooth to a spectrometer. The probe tip is in contact with the tooth surface and 
the height of the tip raised from tooth surface to 0.5 mm and 1 mm, respectively.
14.4  3D Printing Applications in Digital Dentistry 
 3D printing, also referred to as “additive manufacturing,” has become one of the 
most well-known technologies since the twentieth century. Comparing to the con-
ventional manufacturing, 3D printing has several remarkable advantages, such as 
overcoming the limitation of machining to make complex structures, high resolu-
tion, being simple for manipulation, and being easy for customization. Moreover, 
some 3D printers are small and economic enough for public to afford. Ideas and 
products can be made without sending into the workshop, which reduces the criteria 
of designing and fabrications at present; medical applications for 3D printings can 
be briefl y catalogued into several uses, such as a means of manufacturing prototypes 
rapidly, or models for clinic, teaching, and surgical guides, or implants and prosthet-
ics, or bioprinting [ 14 ,  15 ]. 
 Fig. 14.3  Experiment setup using Y-shaped bifurcated fi ber cables with a source leg to carry light 
from a light-emitting diode ( LED ) to a tooth surface and a spectrometer leg to carry light refl ected 
by the tooth to a spectrometer 
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 IMSC has established a 3D printing production line to assist industries and clin-
ics in dental areas. Among different methods of 3D printing, “projection-based ste-
reolithography apparatus” (PSLA) has additional advantages of economic and 
relatively smooth fi nished textures. In Fig.  14.4 which shows that two tooth models 
(colored in red) were manufactured for a dental technology company. In contrast to 
conventional manufacturing of making tooth models, the advantages of using PSLA 
manufacturing are higher resolution provided by digital fi les and less relaxation 
occurring in the PSLA material. The manufacturing procedure of PSLA requires .stl 
fi les to regenerate geometries, and these .stl fi les are often obtained by either intra-
oral or extraoral scanners [ 16 ]. Despite the improvement of resolution of scanners 
from macros to micros, one of the major reasons that this technique has not yet been 
largely used in practice is due to its loose accuracy and inconsistency, especially 
when it is applied to those assemblies requiring high precision. The accuracy of a 
fi nished component is infl uenced by many effects, from a preparation process [ 17 ], 
operating conditions [ 18 ,  19 ], a post-process [ 20 ], and other manufacturing pro-
cesses with specifi c chemical reaction [ 21 ]. A standard operation procedure is 
defi ned to overcome these issues making loose accuracy and inconsistency to allow 
a printed model fi tted with a manufactured zirconium denture, as shown in Fig.  14.5 
below. It is believed that once accuracy and precision are repeatable, 3D printing 
cannot only be used in making models for teaching or guiding but also explores 
more applications, for instance, making orthodontic braces and quality control in 
the production line of tooth manufacturing.
14.5  Conclusions 
 Change toward digital era is an irreversible global trend. Due to business competi-
tion, most medical facilities are designed as a close system. With the gradual open-
ing up of the technology and broad network connection, medical processes will 
become simplifi ed and effi cient. Thus, both dental lab and dental clinics work 
 Fig. 14.4  RP model 
products from FDP and 
milling machine 
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increasingly in a smart way. Based on the development and validation of new tech-
nologies, MDIC continuously develops an international digital ecosystem platform 
that allows patients’ clinical satisfaction even higher than before. 
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 Chapter 15 
 Detection of Early Caries by Laser-Induced 
Breakdown Spectroscopy 
 Yuji  Matsuura 
 Abstract  To improve sensitivity of dental caries detection by laser-induced break-
down spectroscopy (LIBS) analysis, it is proposed to utilize emission peaks in the 
ultraviolet. We newly focused on zinc whose emission peaks appear in ultraviolet 
because zinc exists at high concentration in the outer layer of enamel. It was shown 
that by using ratios between heights of an emission peak of Zn and that of Ca, the 
detection sensitivity and stability are largely improved. It is also shown that early 
caries are differentiated from healthy part by properly setting a threshold in the 
detected ratios. The proposed caries detection system can be applied to dental laser 
systems such as ones based on Er:YAG lasers. When ablating early caries part by 
laser light, the system notices the dentist that the ablation of caries part has been 
fi nished. We also show the intensity of emission peaks of zinc decreased with abla-
tion with Er:YAG laser light. 
 Keywords  Laser-induced breakdown spectroscopy •  Dental caries detection • 
 Ultraviolet spectroscopy •  Hollow optical fi ber 
15.1  Introduction 
 Visual observation and contact methods using a dental probe have been applied for 
diagnosis of dental caries although they sometimes cause misdiagnosis and pain. To 
improve diagnosis accuracy without pain, many non-contact methods based on radi-
ation of electromagnetic wave have been developed [ 1 – 5 ]. In contrast to these meth-
ods that are usually performed as comparison between decayed and healthy parts, 
caries detection methods based on laser-induced breakdown spectroscopy (LIBS) 
enable absolute and quantitative analysis of elements contained in teeth. It is a 
method for elemental analysis which is based on spectral analysis of plasma 
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 Graduate School of Biomedical Engineering ,  Tohoku University , 
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emission generated by irradiation of high-powered laser pulses [ 6 ]. LIBS is differ-
ent from other element analysis methods such as inductively coupled, argon plasma- 
atomic emission spectroscopy (ICP-AES) [ 7 ], and LIBS needs no pretreatment of 
samples and, thus, it is capable of real-time analysis of very small amount. Recently, 
many groups applied LIBS methods to biomedical applications because they can be 
in vivo, less invasive diagnosis methods for a variety of soft and hard tissues [ 8 – 10 ]. 
For dental applications, many groups have proposed LIBS methods for caries detec-
tion by analyzing element contents in teeth [ 11 ,  12 ], and some groups have shown 
results of in vivo studies [ 13 ]. Enamels that are the outermost layer of the tooth are 
biochemical composite whose components are 96 % of inorganic materials includ-
ing minerals, hydroxyapatites (Ca 10 (PO 4 ) 6 (OH) 2 ), and a small amount of metals, 3 % 
of water, and 1 % of organics such as protein and fat. In decayed parts of tooth, the 
amounts of the above contents vary in accordance with degree of caries progress, 
and therefore, by analyzing these elements, one can detect caries and execute accu-
rate diagnosis of decaying stages. These methods usually detect relatively strong 
emission lines of elements such as Ca and P in hydroxyapatite and C, Mg, Cu, and 
Sr in visible wavelengths. However, the sensitivity and the accuracy were not suf-
fi cient for detection of early caries. 
 We have built an optical-fi ber-based LIBS system for in vivo and real-time anal-
ysis of teeth enamels during laser dental treatment using a dental Er:YAG laser 
system. These two systems are combined by using a hollow optical fi ber that trans-
mits both of Q-switched Nd:YAG laser for LIBS and infrared Er:YAG laser for 
tooth ablation. In this paper, we expand the spectral region under analysis to ultra-
violet light to improve the sensitivity of caries detection and show that, by analyzing 
emission peaks of zinc (Zn) in ultraviolet, early caries are detected in high 
accuracy. 
15.2  Experimental Setup 
 Figure  15.1 shows the schematic of experimental setup. A Q-switched Nd:YAG 
laser with an operating wavelength of 1,064 nm, a pulse width of 7–8 ns, and a rep-
etition rate of 10 pps was used as the light source for plasma generation. The laser 
light was coupled to a hollow optical fi ber with an inner diameter of 700 μm by a 
convex lens with a focal length of 250 mm. By using a hollow optical fi ber for deliv-
ery of laser light to the sample surface, a system is capable of both of diagnosis 
based on LIBS and caries removal because the hollow optical fi bers deliver high- 
powered infrared laser light for tooth ablation as well [ 14 ,  15 ]. Plasma emission 
induced by laser radiation was detected by a step-index, pure-silica-glass optical 
fi ber with a core diameter of 400 μm and numerical aperture of 0.22. Detected emis-
sion was delivered to a fi ber-coupled spectrometer (Ocean Optics HR2000+, slit 
width 10 μm, 1,800 lines/mm) to measure the power spectra of emitted light from 
200 to 340 nm wavelength with a resolution of 0.14 nm. Experiments were per-
formed at atmospheric pressure, and argon gas was injected onto the sample via the 
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bore of hollow optical fi ber to enhance emitted plasma intensities of low concentra-
tion elements [ 16 ].
 As measurement samples, extracted human teeth in different levels of decay 
were prepared. The samples were divided into three stages: early stages of decay 
called “E1” and “E2” where the decays and cavities are stayed only in the tooth 
enamel, advanced stages called “D1” and “D2” where the cavities reach into the 
dentin, and healthy teeth without a decay or a cavity. More than ten samples in each 
stages including both of incisors and molars were prepared, and the samples were 
washed with brushes and pure water before being tested. 
15.3  Results and Discussion 
 It is known that, usually, healthy teeth contain Ca and P that are main components 
of hydroxyapatite in high concentration. As tooth decay progresses, other inorganic 
elements such as Mg and Cu precipitate when crystals of hydroxyapatite are demin-
eralized. Therefore, one can detect development of dental caries as increases of 
densities of minor inorganic materials in LIBS spectra. However, in our preliminary 
tests, we found that the differences in the intensities of these elements showing 
strong emission peaks in visible and near infrared wavelengths are too small 
between caries and healthy parts to detect early caries. Therefore, in this study, we 
focus on ultraviolet region where characteristic emission peaks of various minor 
components appear. 
 A measured LIBS spectrum of a healthy tooth in a wavelength region of 200–
340 nm is shown in Fig.  15.2 . This is an averaged spectrum of emissions by 50 laser 
shots, and the integration time of each emissions were 100 ms. Radiated pulse energy 
was 21–22 mJ. In the LIBS spectrum in Fig.  15.2 , we found that, in addition to com-
ponents in hydroxyapatite, minor inorganic components such as Mg were detected.
 Figure  15.3 shows LIBS spectra of a healthy tooth and a decayed tooth. In the 
measurement of caries, radiated pulse energy was set to 15–16 mJ. We confi rmed 
from the fi gure that, for the caries tooth, the densities of C were higher and that of 
Ca was lower than the healthy tooth. Based on this result, we fi rstly tried to set an 
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and Ca that show relatively high peak intensities and large differences between car-
ies and healthy teeth. We prepared fi ve samples from each of healthy teeth, early 
caries (E1 and E2), and dentin caries (D1 and D2). We performed 30 measurements 
for each samples and calculated intensity ratios of C at 247.7 nm and Ca at 317.9 nm 
for quantitative evaluation that was not affected by fl uctuation of the emission inten-
sities [ 17 ,  18 ]. Figure  15.4 shows a scatter diagram of the measured results. From 
this result, we found that dentin caries were differentiated from the other levels. 
However, averaged values of the healthy teeth and the early caries were 0.0050 and 
0.0059, respectively, and the difference was too small to distinguish.
 Based on the above result, we repeatedly performed similar experiments while 
changing the combination of focusing elements to choose the optimum target ele-
ments for detection of early caries. In the spectra shown in Fig.  15.5 , we found that the 
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peak height of Zn increases in caries teeth as well. It is known that, compared with 
other inorganic materials, zinc exists at high concentration in the outer layer of enamel 
[ 19 ,  20 ]. Although various inorganic elements precipitate when hydroxyapatite is 
demineralized, change in the concentration due to tooth decay is seen more obviously 
in zinc because early caries stays only at the very surface of the enamel layer. 
Therefore, we assume that zinc was strongly detected in early stage of dental decay.
 Figure  15.6 shows a scatter diagram of measured intensity ratios between Zn at 
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0.0044 for the healthy teeth and 0.013 for the early caries. By setting a boundary at 
around 0.008, one can clearly distinguish between healthy teeth and early caries. 
Accuracies of diagnosis based on this result were as high as 98.2 % for the healthy 
teeth, 85.2 % for the early caries, and 96.6 % for the dentin caries. In additional 
experiments using more than fi ve samples, the healthy parts and early caries are 
repeatedly tested. As a result, we confi rmed that diagnosis accuracy for early caries 
was higher than 80 %.
 Next, we evaluated feasibility of real-time analysis of the proposed method dur-
ing laser treatment using an Er:YAG dental laser system. We utilized a dental laser 
system (J. MORITA, Erwin Adverl) and laser pulses with a wavelength of 2.94 μm 
and pulse energy of 100 mJ were radiated onto early caries by using a hollow optical 
fi ber. Simultaneously, the LIBS analysis proposed above was performed. The results 
are shown in Fig.  15.7 as the measured intensity ratio Zn/Ca as a function of number 
of radiated pulses of the Er:YAG laser. For all of fi ve samples that we tested, 
decreases in the intensity ratio were observed, and thus we confi rmed that the pro-
posed system is feasible for informing a practitioner fi nish of removal of caries 
parts.
15.4  Conclusion 
 We proposed a LIBS system for in vivo analysis of teeth enamels. The system uti-
lizes a hollow optical fi ber that transmits both of Q-switched Nd:YAG laser light for 
LIBS and infrared Er:YAG laser light for tooth ablation, and thus the system enables 
real-time analysis of teeth during laser dental treatment. By expanding the spectral 
region under analysis to ultraviolet light and focusing on emission peaks of Zn in 
the UV region, we largely improved the sensitivity of caries detection. We showed 
that, by using ratios of peak intensities of Zn and Ca, early caries were distinguished 
from healthy teeth with accuracies higher than 80 %. Then we applied this LIBS 
analysis to caries teeth while ablating the caries part with Er:YAG laser light and 
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 Fig. 15.7  Measured 
intensity ratio Zn/Ca as a 
function of number of 





have shown that the intensity ratio Zn/Ca decreases with radiation of Er:YAG laser 
pulses. Therefore, the proposed system is feasible for informing a practitioner fi nish 
of removal of caries. 
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 Chapter 16 
 Acoustic Diagnosis Device for Dentistry 
 Kouki  Hatori ,  Yoshifumi  Saijo ,  Yoshihiro  Hagiwara ,  Yukihiro  Naganuma , 
 Kazuko  Igari ,  Masahiro  Iikubo ,  Kazuto  Kobayashi , and  Keiichi  Sasaki 
 Abstract  There are a lot of diseases which show the abnormal elastic property. 
Although many medical doctors and dentists have noticed the change of tissue elas-
ticity due to the disease, the diagnostic device to examine the tissue elastic property 
objectively has not well developed. 
 At Tohoku University, acoustic microscopy (AM) for medicine and biology has 
been developed and applied for more than 20 years. Application of AM has three 
major features and objectives. First, specifi c staining is not required for character-
ization or observation. Second, it provides the elastic property and information of 
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the subject, because acoustic properties have close correlation with the mechanical 
property of the subject. Third, it makes the observation easy and rapid. The purpose 
of this study is to observe carious dentin and periodontal ligament (PDL) using 
AM. Moreover, I would like to propose the prototype of the portable caries 
detector. 
 AM clearly visualizes the color distribution of the acoustic properties of the 
subject. 
 The acoustic examination device may be a powerful apparatus not only to visual-
ize the morphological appearance but also to diagnose the disease. 
 Keywords  Acoustic imaging •  Human teeth •  Dentin caries •  Periodontal ligament 
•  Diagnosis 
16.1  Introduction 
 We have been developing a scanning acoustic microscope (SAM) system at Tohoku 
University since 1985. SAM has been applied to observe the acoustic properties of 
various cells, organs, and disease state: vein endothelial cells, gastric cancer, normal 
kidney and renal cancer, infarcted myocardium, atherosclerosis of aorta and carotid 
arterial plaques, etc. In biomedical study, the application of SAM is useful for the 
intraoperative pathological examination, the observation of low-frequency ultra-
sonic images, and the assessment of biomechanical properties at a microscopic level 
[ 1 – 11 ]. The application of SAM in biomedical study has two major features and 
objectives. First, the specifi c staining is unnecessary for observation. Second, SAM 
provides the acoustic properties and information such as the acoustic intensity, the 
sound speed propagating in the sample, and the acoustic attenuation. Therefore, 
SAM enables to acquire the elastic property of the subject and the quantitative val-
ues of the acoustic properties, because the acoustic properties have close correlation 
with the mechanical property of the subject. After 2004, the third advantage to use 
SAM was added, which is that SAM makes the observation easy and rapid. One 
scanning takes 2 min approximately using new concept SAM, because new concept 
SAM system was developed using a single-pulsed wave instead of continuous waves 
used in the conventional SAM system in 2004 [ 12 ,  13 ]. Sano et al. reported that the 
decalcifi cation during tissue preparation did not alter the sound speed propagating in 
fi brocartilage or bone [ 14 ]. Hagiwara et al. reported that the sound speed propagat-
ing in the posterior synovial membrane after knee joint contracture increased signifi -
cantly using decalcifi ed specimen [ 13 ]. These reports indicate that the decalcifi ed 
specimen is also appropriate to observe the acoustic properties using SAM. 
 Periodontal ligament (PDL) is the dense fi brous connective tissue which binds 
the root cementum to the alveolar bony socket. This tissue is especially cellular and 
vascular tissue and plays pivotal role to develop and maintain periodontal mem-
brane. PDL supports and dissipates the occlusal force and regulates the tooth erup-
tion. Thus, PDL performs these important oral functions [ 15 ,  16 ]. Since many 
studies of the mechanical properties of PDL have been reported using animal model 
K. Hatori et al.
183
[ 17 ], it was pointed out that mechanical properties of PDL showed the values (0.9–
1.6 N/mm 2 ) in the extrusion testing in rat mandibular fi rst molar [ 18 ,  19 ]. These 
reports were the dynamic tests for the measurement of the mechanical properties of 
PDL, but little is known about the static test for the measurement of the mechanical 
properties of PDL in vivo. In this paper, the fi rst purpose is to observe the rat PDL 
using SAM. 
 Acoustic impedance, which is given as a product of sound speed and density, has 
a close correlation with the elastic modulus, when the value of density of the embed-
ding material was constant. Based on the above background, HONDA ELECTRONICS 
Co., Ltd. (Toyohashi, Japan) and Tohoku University Graduate School of Biomedical 
Engineering have developed the acoustic impedance microscope (AIM) which 
enables to image the two-dimensional distribution of the acoustic intensity and 
impedance of the sample [ 20 ]. AIM has been applied to observe cerebellum tissue 
[ 21 ] and cultured glial and glioma cells [ 22 ]; these studies reported that AIM also 
provided the acoustic intensity and impedance image at a microscopic level. 
 Dental caries is a common and chronic disease in oral cavity and results from the 
production of acid by caries-inducing bacterial fermentation on the tooth surface. 
The acid by caries-inducing bacterial metabolism causes the decalcifi cation of the 
hard tissues of the teeth such as enamel and dentin [ 23 ]. Finally the decalcifi ed 
lesion becomes soft and is recognized as dental caries. Dental caries cause the 
change of hardness of the teeth [ 24 ,  25 ]. The change of acoustic properties of dentin 
caries has not been observed using AIM yet. In this paper, the second purpose is to 
observe the human dentin caries using AIM and to observe the microstructure of the 
human dentin caries using the scanning electron microscope (SEM). 
 Based on these the technology of producing such acoustic imaging devices, 
HONDA ELECTRONICS Co., Ltd. and Tohoku University Graduate School of 
Biomedical Engineering fabricated a prototype of portable acoustic stiffness 
checker. In this paper, the last purpose is to introduce about this acoustic stiffness 
checker. 
16.2  Materials and Methods 
16.2.1  Observation of Rat Periodontal Ligament Using 
Scanning Acoustic Microscopy 
16.2.1.1  Scanning Acoustic Microscope (SAM) 












ρ δ δ   
 ( 16.1 ) 
 
where  C is the sound speed propagating in the object,  E is the Young’s modulus of 
the object,  ρ is the Poisson’s ratio, and  δ is the density of the object. Thus, it is 
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implied that the change of the sound speed propagating in the tissue is the change of 
the tissue elastic property [ 26 ]. The Young’s modulus ( E ) is in proportion to the 
square of the sound speed; in the other words, the change of the sound speed pro-
vides with the information of the change of material hardness. The observation of 
the sound speed propagating in the thin sliced sample enables us to understand the 
proper hardness of the thin sliced sample [ 14 ]. 
 Our SAM is mainly composed of fi ve units: (1) ultrasonic transducer with acous-
tic lens, (2) pulse generator, (3) digital oscilloscope with system control PC 
(Windows), (4) stage control microcomputer, and (5) display monitor (Figs.  16.1 
and  16.2 ). The emission of the electric pulse was within 400 ps from excitation, and 
the pulse voltage was 40 V. A single-pulsed ultrasonic impulse with a pulse width 
of 5 ns was generated and received by the same ultrasonic transducer above the sec-
tion. The aperture diameter of the ultrasonic transducer was 1.2 mm, and the focal 
length was 1.5 mm (Fig.  16.3 ). The central frequency was 80 MHz, the nominal 
bandwidth was 50–105 MHz (−6 dB), and the pulse repetition rate was 10 kHz. 
Taking the focal distance and the sectional area of the transducer into consideration, 
the diameter of the focal spot was estimated as 20 μm at 80 MHz. Physiologic saline 
was used as the coupling medium between the transducer and the section. An ultra-
sonic wave with a wide frequency component was generated by applying the volt-
age pulse of 40 V and was irradiated to the section on the glass slide. The refl ections 
from the section surface and those from interface between the section and the glass 
slide were detected by the transducer and were introduced into the digital oscillo-
scope (TDS 5052, Tektronix Inc., Portland, USA). The band limit was 300 MHz, 
and the sampling rate was 2.5 GS/s. In order to reduce random noise, four times of 
pulse responses at the same point were averaged in the digital oscilloscope prior to 
being introduced into the computer.
 The transducer was mounted on an X-Y stage driven by the stage control micro-
computer which was operated by the system control PC via an RS232C. The X- and 
Y-scan were operated by a linear servo motors by the incoming signal from stage 
control circuit. 
 Fig. 16.1  System of scanning acoustic microscopy. This system can display a two-dimensional 
distribution of sound speed and acoustic impedance 
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 The distance from the transducer to the glass surface was 1.5 mm. Refl ected 
ultrasonic wave included three types of waveforms, which were from the surface of 
the section ( S  front  ), from the interface between the section and the glass ( S  rear  ), 
and the surface from the glass ( S  ref  ) (Fig.  16.4 ). The ultrasonic phases of these 
waveforms were standardized and recognized as a refl ection wave from the glass in 
system control PC. Finally, two-dimensional distributions of the acoustic intensity, 
the sound speed, the acoustic attenuation, and the thickness of the sample of the 
2.4 × 2.4 mm sample area were visualized with 300 × 300 pixels and calculated by 

































 Fig. 16.3  Schematic 
illustration of SAM 
transducer. The aperture 
diameter of the ultrasonic 
transducer was 1.2 mm, 
and the focal length was 
1.5 mm. The central 
frequency was 80 MHz 
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16.2.1.2  Tissue Preparation 
 The protocol for this experiment was approved by the Animal Research Committee 
of Tohoku University (approval number: 22–24). 
 A total of 28 male Wistar rats at 3-, 5-, 7- and 10-week-old postnatally were used 
in this study. Twenty-eight rats were prepared for SAM analysis (3-, 5-, 7- and 
10-week-old;  n = 7/each age). 
 The rats were generally anesthetized with intraperitoneal injection of pentobarbi-
tal sodium (30 mg/kg body weight) (Somnopentyl®; Kyoritsu Seiyaku, Tokyo, 
Japan) and fi xed with 4 % paraformaldehyde (PFA) in 0.1 M phosphate buffered 
saline (PBS) (pH7.4) by perfusion through the aorta. The mandibles were resected 
and immersed in the same fi xative overnight at 4 °C. The fi xed specimens were 
decalcifi ed in 10 % ethylenediaminetetraacetic acid (EDTA) in 0.01 M PBS (pH7.4) 
for 6 weeks at 4 °C. After dehydration through a graded series of ethanol solution, the 
specimens were embedded in paraffi n and fi nally cut into 5-μm sagittal (mesiodistal) 
sections from the buccal to the lingual side of the mandible. Standardized serial sec-
tions were made in the medial periodontal space region of the lower fi rst molar. 
16.2.1.3  Image Analysis 
 Normal light microscope (DM3000, LEICA, Wetzlar, Germany) was used to take 
the microscopic images corresponding to the stored SAM images. A region of 















 Fig. 16.4  Schematic illustration of scanning image of sound speed microscope. A single-pulsed 
ultrasonic impulse was generated and received by the same transducer.  S  front  is the refl ection from 
the surface of the section,  S  rear  is the refl ection from the interface between the section and the 
glass, and  S  ref  is the refl ection the surface from the glass 
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radicular region (MRR) of PDL in each section (Fig.  16.5 ). SAM images with a 
gradation color scale were acquired to visualize the clear distribution of the sound 
speed. In order to calculate the sound speed propagating in PDL, the color SAM 
images were processed for the gray scale images by the same SAM system. Finally, 
in the observed region, the sound speed propagating in PDL, excluding cementum, 
dentin, and alveolar bone, was calculated using commercially available image anal-
ysis software (PhotoShop 7.0, Adobe Systems Inc., San Jose, CA, USA).
16.2.1.4  Statistics 
 Data in each PDL region were analyzed using one-way factorial analysis of variance 
(ANOVA) with Tukey’s post hoc multiple comparisons. Differences between IRR 
and MRR at each rat age were analyzed using paired  t -test. All data were expressed 
as the mean ± SD. A value of  p < 0.05 was accepted as statistically signifi cant. 
16.2.2  Observation of Human Carious Dentin Using Acoustic 
Impedance Microscopy 
16.2.2.1  Acoustic Impedance Microscope (AIM) 
 Acoustic impedance mode was applied for visualization and observation of sample 
surface. The acoustic impedance of a material is defi ned as a product of the density 
and the sound speed. The acoustic impedance of physiological saline is used to 
verify the calibration curve in the following equation in its simplest form [ 22 ]:
 Z c= ρ    ( 16.2 )  
 Fig. 16.5  Histological 
appearance of PDL of the 
fi rst molar of rat mandible. 
Interradicular region ( IRR ) 
area is encircled by the 
 black solid rectangle . 
Mesial radicular region 
( MRR ) is encircled by the 
 black dotted rectangle . 5× 
original magnifi cation. Bar 
= 500 μm 
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where  Z is acoustic impedance,  ρ is density, and  c is sound speed. 
 The acoustic approach should provide the information of the elastic bulk modu-
lus because the relationship among the sound speed, the density, and the elastic bulk 





ρ   
 ( 16.3 ) 
 
where  C is sound speed,  K is elastic bulk modulus, and  ρ is density [ 27 ]. 
 Taken together these equations, the elastic bulk modulus is described in the fol-
lowing equation:
 K Z=
2 / ρ    ( 16.4 )  
where  K is elastic bulk modulus,  Z is acoustic impedance, and  ρ is density. Therefore, 
if the density of embedding material is constant, the change of acoustic impedance 
will indicate the change of tissue elasticity. This equation indicates that the elastic 
bulk modulus is in proportion to the square of the acoustic impedance. In other 
words, the change of the acoustic impedance indicates the change of the elastic 
property. 
 The acoustic impedance microscope (AIM) (AMS-50SI, HONDA 
ELECTRONICS CO., LTD, Toyohashi, Japan) in the present study was shown in 
Figs.  16.1 and  16.6 .
 An electric impulse was generated by a high-speed switching semiconductor. 
The start of the pulse was within 400 ps, the pulse width was 2 ns, and the pulse 
voltage was 40 V. The frequency of the impulse covered up to 380 MHz. The elec-
tric pulse was used to excite a transducer that had a central frequency of 300 MHz 
and a sapphire rod as an acoustic lens. The ultrasound spectrum of the refl ected 
ultrasound was broad enough to cover 220–380 MHz (−6 dB). The refl ections from 
the sample were received by the transducer and were introduced into a Windows- 
based PC (Pentium D, 3.0 GHz, 2 GB RAM, 250 GB HDD) via digital oscilloscope 
(Tektronix TDS7154B, Beaverton, USA). The frequency range was 1 GHz, and the 
sampling rate was 20 GS/S. Four pulse echo sequences were averaged for each scan 
point in order to increase the signal-to-noise ratio. 
 The transducer was mounted on an X-Y stage with a microcomputer board that 
was driven by the PC through RS232C. The both X-scan and Y-scan were driven by 
linear servo motors. Finally, two-dimensional distribution of the acoustic imped-
ance was visualized and the image area was 2.4 × 2.4 mm. The total scanning takes 
121 s [ 20 ]. 
16.2.2.2  Tissue Preparation 
 The protocols for the experiments were approved by the Ethical Committee of 
Tohoku University (approval number: 26–28). 
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 Human molar teeth with dental caries ( n = 10) were used in this study. The teeth 
were extracted under the diagnosis of severe periodontitis, and the extracted teeth 
were immediately fi xed with 0.1 % glutaraldehyde and kept into the same fi xative 
for 24 h. The teeth samples were embedded in the self-curing resin (UNIFAST III 
CLEAR, GC, Tokyo, Japan). The embedded samples were cut sagittally by saw 
microtome (SP1600, LEICA, Wetzlar, Germany) perpendicular to the caries sur-
face, and the sliced sections (sagittal sections) were polished and smoothened with 
waterproof abrasive papers (#1000 and #2000) (Fig.  16.7 ). The thickness of  polished 
section was 400–600 μm. The prepared sections were assessed by AIM and the 
scanning electron microscope (SEM), respectively.
16.2.2.3  Scanning Electron Microscopy (SEM) 
 After the acoustic microscopic observation, the scanning electron microscopic 
investigation for the carious dentin lesion and the sound dentin area was carried out 
in order to observe the microstructural surface of both the carious lesion and the 
sound dentin area. The polished samples for SEM observation were initially air- 
dried and mounted on aluminum stubs. The sample was sputtered with a 
20-μm-thickness of carbon fi lm layer (JFC-1100, JEOL Ltd., Tokyo, Japan) and 
then analyzed with SEM (JSM-6060, JEOL Ltd., Tokyo, Japan). The accelerating 















 Fig. 16.6  Schematic illustration of scanning image of the acoustic impedance microscope.  S  tgt  is 
the refl ection from the sample;  S  ref  is the refl ection from the investment material. In this case, 
substrate is water 
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16.2.2.4  Statistics 
 Differences between the dentin caries and the sound dentin were analyzed using 
paired  t -test. All data were expressed as the mean ± SD. A value of  p < 0.05 was 
accepted as statistically signifi cant. 
16.2.3  Portable Acoustic Stiffness Checker (PASC) 
 A prototype of portable acoustic stiffness checker was shown in Fig.  16.8 . Our 
PACS is mainly composed of three units: (1) acoustic probe, (2) pulsar receiver, and 
(3) tablet PC (Windows) (Fig.  16.9 ).
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where  S  0  is the transmitted signal,  S  target  and  S  ref  are refl ections from the target and 
reference, respectively, and  Z  target  ,  Z  ref  , and  Z  sub  are the acoustic impedances of the 
target, reference, and substrate, respectively [ 20 ]. 
 Fig. 16.7  Sliced human 
molar teeth with dental 
caries. Dentin caries is 
encircled by the  red dotted 
rectangle , and sound 
dentin is encircled by the 
 black dotted rectangle 
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 Finally, we can acquire the acoustic impedance of the targeted object on the tab-
let PC, based on the acoustic impedance of the reference. 
16.3  Results 
16.3.1  SAM Observation of PDL 
 Figure  16.10 is the result of the PC screen of SAM showing rat PDL. This result 
provided four visual information such as the sound speed intensity, the sound speed, 
the attenuation, and the sample thickness (Fig.  16.10a–d ). SAM clearly visualized 
two-dimensional color distribution of the sound speed of both IRR and MRR (Fig. 
 16.11a, b ). SAM also clearly visualized two-dimensional color distribution of the 
dentin and the alveolar bone. The gradation color table indicated the sound speed 
propagating in the sample. In the gradation color table, the lowest sound speed was 
1,500 m/s, and the highest sound speed was 1,800 m/s (Fig.  16.11c ).
 IRR and MRR were composed of very low sound speed areas (blue) in 3-week- 
old postnatal group (Fig.  16.12a, e ). In 5-week-old postnatal group, IRR and MRR 
were composed of low to middle sound speed areas (blue to green) (Fig.  16.12b, f ). 
 Fig. 16.8  A prototype of 
ultrasound stiffness 
checker. Figure is the 
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In a 7-week-old postnatal group, IRR and MRR were composed of middle sound 
speed areas (yellow to green) (Fig.  16.12c, g ). In 10 weeks postnatal group, IRR and 
MRR were composed of middle to high sound speed areas (green) (Fig.  16.12d, h ). 
The low sound speed area decreased, and middle sound speed areas gradually 
increased in both IRR and MRR depending on the rat growth.
16.3.2  Sound Speed Analysis 
 The mean value of sound speed propagating in each region was calculated. The 
sound speed of IRR and MRR is shown in Table  16.1 . In IRR, there was no statisti-
cal difference between 3-week group and the 5-week group (3w 1,529 m/s ± 15.2 
m/s vs. 5w 1,541 m/s ± 14.1 m/s;  p = 0.605), between 5-week group and 7-week 
group (5w 1,541 m/s ± 14.1 m/s vs. 7w 1,563 m/s ± 18.2 m/s;  p = 0.169), between 
5-week group and 10-week group (5w 1,541 m/s ± 14.1 m/s vs. 10w 1,564 m/s ± 21.4 
m/s;  p = 0.054), and between 7-week group and 10-week group (7w 1,563 m/s ± 18.2 
m/s vs. 10w 1,564 m/s ± 21.4 m/s;  p = 0.999). However, the sound speed of IRR was 
signifi cantly increased depending on the development (3w 1,529 m/s ± 15.2 m/s vs. 
7w 1,563 m/s ± 18.2 m/s;  p = 0.012 and 3w 1,529 m/s ± 15.2 m/s vs. 10w 1,564 
m/s ± 21.4 m/s;  p = 0.002). In MRR, there was no statistical difference between 
3-week group and 5-week group (3w 1,536 m/s ± 16.1 m/s vs. 5w 1,556 m/s ± 18.4 
m/s;  p = 0.125), between 3-week group and 7-week group (3w 1,536 m/s ± 16.1 m/s 
vs. 7w 1,560 m/s ± 15.7 m/s;  p = 0.063), between 5-week group and 7-week group 
 Fig. 16.9  Block diagram of ultrasound stiffness checker 
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(5w 1,556 m/s ± 18.4 m/s vs. 7w 1,560 m/s ± 15.7 m/s;  p = 0.974), between 5-week 
group and 10-week group (5w 1,556 m/s ± 18.4 m/s vs. 10w 1,566 m/s ± 16.9 m/s; 
 p = 0.583), and between 7-week group and 10-week group (7w 1,560 m/s ± 15.7 m/s 
vs. 10w 1,566 m/s ± 16.9 m/s;  p = 0.881). However, the sound speed of MRR was 
 Fig. 16.10  PC screen of SAM image of PDL. Two-dimensional color distribution with the resolu-
tion of the 2.4 × 2.4 mm sample area is visualized with 300 × 300 pixels. ( a ) sound speed intensity 
image, ( b ) sound speed image, ( c ) attenuation image, and ( d ) sample thickness image 
 Fig. 16.11  SAM image of IRR. IRR is encircled by the  solid rectangle ( a ). SAM image of 
MRR. MRR is encircled by the  dotted rectangle ( b ). The color graduation table of the sound speed 
( c ) 
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signifi cantly increased depending on the development (3w 1,536 m/s ± 16.1 m/s vs. 
10w 1,566 m/s ± 16.9 m/s;  p = 0.003).
 There was signifi cant difference between IRR and MRR in 5-week group (IRR 
1,541 m/s ± 14.1 m/s vs. MRR 1,556 m/s ± 18.4 m/s;  p = 0.003). 
16.3.2.1  AIM Observation of Dentin Caries 
 Figure  16.13 is the result of the PC screen of AIM showing dentin caries. This result 
provided two visual information, the acoustic intensity (Fig.  16.13a ) and the acous-
tic impedance (Fig.  16.13b ). In the acoustic impedance image, AIM clearly visual-
ized two-dimensional color distribution of the acoustic impedance of the sound 
 Fig. 16.12  SAM images of IRR ( a – d ) and MRR ( e – h ). 3-week-old ( a ,  e ). 5-week-old ( b ,  f ). 
7-week-old ( c ,  g ). 10-week-old ( d ,  h ) 
 Table 16.1  Mean sound 
speed propagating in IRR and 
MRR, respectively, and 
standard deviations between 
IRR and MRR. Statistic 
evaluation was performed by 
one-way ANOVA and 
Tukey’s method, or by paired 
 t -test 
 IRR(m/s)  sMRR(m/s) 
 3w  1,529 ± 15.2 a,b  1,536 ± 16.1 c 
 5w  1,541 ± 14.1 d  1,556 ± 18.4 d 
 7w  1,563 ± 18.2 a  1,560 ± 15.7 
 10w  1,564 ± 21.4 b  1,566 ± 16.9 c 
 a,b P < 0.01 by one-way ANOVA and 
Tukey’s method 
 c P < 0.05 by one-way ANOVA and 
Tukey’s method 
 d P < 0.05 by paired  t -test 
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dentin as well as the dentin caries. The gradation color of the dentin caries 
(Fig. 16.14a ) differed from that of the sound dentin (Fig.  16.14b ). The dentin caries 
was composed of low acoustic impedance areas (blue to light blue). However, the 
sound dentin was composed of higher acoustic impedance areas (green to yellow) 
than the carious dentin lesion. The comparison of the acoustic impedance of both 
sound dentin and dentin caries is shown in Fig.  16.15 . The acoustic impedance of 
the dentin caries was signifi cantly lower than that of the sound dentin (sound dentin 
vs. dentin caries; 6.75 ± 0.14 kg/m 2 s vs. 2.47 ± 0.41 kg/m 2 s;  p = 2.29 × 10 −12 ).
16.3.2.2  SEM Observation of Dentin Caries 
 SEM images are shown in Fig.  16.16 . The sound dentin areas showed smooth sur-
face, and the transverse sections of dentinal tubules were aligned regularly (Fig. 
 16.16a ). However, surface erosion and destruction were detected on the dentin car-
ies. The dentinal tubules were aligned irregularly, and the cross sections of dentinal 
tubules showed wider and narrower on the dentin caries than those on the sound 
dentin (Fig.  16.16b ).
 Fig. 16.13  PC screen of AIM image of dentin caries. Two-dimensional color distribution with the 
resolution of the 2.4 × 2.4 mm sample area is visualized with 300 × 300 pixels. Acoustic intensity 
image ( a ), acoustic impedance ( b ) image 
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 Fig. 16.14  Acoustic impedance image of the carious dentin lesion. Sound dentin area consists 
of higher acoustic impedance area ( green to  yellow ) ( a ). Dentin caries consists of low acoustic 


























** p<0.01  
 Fig. 16.15  Bar graph of the acoustic impedance between sound dentin area and carious dentin 
lesion.  Blue bar is the mean acoustic impedance of sound dentin.  Red bar is the mean acoustic 
impedance of dentin caries 
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16.3.3  Ultrasound Stiffness Checker 
 Figure  16.17 shows the actual measurement of human sound tooth. Since the probe 
surface is fl at, it is diffi cult to measure the dental carious cavity. Many improve-
ments are necessary to apply the diagnosis for dental caries.
16.4  Discussion 
16.4.1  SAM Observation of PDL 
 In the present study, our SAM clearly visualized the gradation color images and 
distribution of rat PDL. SAM images were equal to histological appearances 
obtained by light microscopy. These results are the fi rst time that SAM is applied to 
investigate the elastic property of PDL. 
 Previous studies reported that the elastic property of PDL was decreased along 
with development [ 28 – 31 ]. In  in vivo studies, the elastic property of PDL were 
investigated by the displacement of the rat molar under the mechanical loads [ 28 , 
 31 ] and the measurement of the load by pushing the rat incisor out of alveolar socket 
[ 29 ,  30 ]. However, these methods measured not only the elastic property of PDL but 
also the elastic property of alveolar bone. Meanwhile, in  in vitro studies, numerical 
analyses using fi nite element model (FEM) study did not precisely refl ect the elastic 
property of PDL [ 32 ,  33 ], because the occlusal conditions are not fully considered. 
 In the present study, the sound speed propagating in PDL was signifi cantly 
increased in a course of development. These results indicate that the elasticity of 
PDL is decreased along with rat development; in other words PDL becomes harder 
during development. Previous studies reported that collagens such as type I, III, and 
 Fig. 16.16  SEM images of sound dentin ( a ) and dentin caries ( b ). 500 × original magnifi cation. 
Bar = 100 μm 
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XII collagen were implicated in the regulation of the development and/or matura-
tion of PDL [ 34 – 36 ]. And other previous studies reported that non-collagens such 
as fi broblast growth factor (FGF), alkaline phosphatase, and connective tissue 
growth factor (CCN/CTGF) were implicated in the regulation of the development 
and/or maturation of PDL [ 36 – 38 ]. Therefore, the present study indicates that the 
extracellular matrix molecules may play a pivotal role to regulate the elasticity of 
PDL. 
 Previous studies reported that occlusal force infl uence to mature PDL [ 35 ,  39 ]. 
In a study, the occlusal forces induced to promote the collagens synthesis [ 35 ]. In 
another study, the occlusal forces induced to express insulin-like growth factor-1. 
These collagens and growth factor had infl uence on the development and/or matura-
tion of PDL [ 39 ]. In the present study, MRR elasticity was lower than IRR elasticity 
in 5-week-old. We speculate that in order to resist the lateral loading of occlusal 
force MRR became harder to bind fi rmly between the tooth root and the alveolar 
bony socket. 
 The present study indicates that the decreased elasticity of PDL is induced by the 
morphological development such as the production of collagen(s) and/or 
proteoglycan(s) and the functional development such as the occlusal construction 
and/or the development of the masticatory muscles. 
 SAM is a powerful tool for evaluating the elasticity and its distribution in the 
targeted tissues  in situ . This study suggests that the increased elasticity of PDL is 
one of the developmental processes of the periodontal tissues. 
 Fig. 16.17  Actual examination of human teeth. Ultrasound stiffness checker shows the ultrasound 
impedance of the tooth in the  yellow circle 
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16.4.2  AIM Observation of Dentin Caries 
 To date, AIM has been mainly applied for the observation of soft tissues such as 
synovial membrane [ 13 ] and coronary artery [ 20 ]. In the present study, AIM was 
able to clearly visualize the color distribution of the acoustic impedance of both the 
sound and carious dentin. Moreover, AIM enabled to evaluate the elastic property 
calculating the acoustic impedance of the sample. Taken together these results, we 
propose that AIM may be useful to diagnose the dental caries visually and 
numerically. 
 Previous study reported that the Vickers hardness of the carious dentin lesion 
was signifi cantly lower than that of the sound dentin areas [ 40 ]. In the present study, 
the acoustic impedance of the carious dentin lesion was signifi cant lower than in the 
sound dentin area. The Vickers hardness test is a destructive examination; therefore, 
there are limitations to apply the measurement of the Vickers hardness to diagnose 
human caries. The ultrasonic testing is a nondestructive examination, so the calcula-
tion of the acoustic impedance of the dentin caries may be a noninvasive and safe 
method to diagnose human caries. 
 SEM observation revealed that caries induced microstructural deterioration of 
dentin. This result suggested that acid produced by oral bacterial metabolism decal-
cifi ed the Ca element included in dentin. 
 To understand the elastic property due to the pathological change is important 
information to diagnose the disease in medicine and dentistry. It has been well 
known that caries make dentin soft. But, unfortunately, it has not established to 
evaluate precisely the elasticity of the carious dentin. In the present study, AIM 
enabled to visualize the dentin caries clearly and evaluate it numerically. Based on 
the principle of AIM, we are going to complete a novel portable acoustic caries 
detector. 
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 Chapter 17 
 Activation of TLR3 Enhance Stemness 
and Immunomodulatory Properties 
of Periodontal Ligament Stem Cells (PDLSCs) 
 Nuttha  Klincumhom ,  Daneeya  Chaikeawkaew ,  Supanniga  Adulheem , 
and  Prasit  Pavasant 
 Abstract  Periodontal ligament stem cells (PDLSCs) have been served as a cell 
reservoir for tissue regeneration during adulthood. For clinical applications, the 
challenging steps are to maintain the stem cell properties and to improve the regen-
eration capacity of PDLSCs during culture. Toll-like receptor 3 (TLR3) signaling 
has been shown to enhance therapeutic potential in several cell types including mes-
enchymal stem cells (MSCs) by inducing the secretion of multifunctional trophic 
factors. However, the role of TLR3 in PDLSCs is still unknown. The aim of this 
study was to investigate the responses of PDLSCs after TLR3 engagement using 
TLR3 agonist, poly(I:C). The result indicated that stimulation of TLR3 signifi cantly 
enhanced pluripotent stem cell gene expression (e.g., REX-1 and SOX2) as well as 
immunomodulatory molecules (e.g., IFNγ and IDO). Interestingly, inhibition of 
NF-kB signaling decreased the TLR3-activated IFNγ but increased the TLR3- 
activated IDO expression, suggesting the multiple pathways in the inductive mecha-
nism. Our fi nding supports the concept that activated TLR3 could encourage the 
stem cell and immunosuppressive properties of PDLSCs. Since immunosuppressive 
properties of stem cells could support tissue healing and regeneration, activation of 
TLR3 in PDL cells may trigger the effective PDL tissue regeneration. 
 Keywords  TLR3 •  Immunosuppressive property •  PDLSCs •  Stem cell markers 
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17.1  Introduction 
 Toll-like receptor 3 (TLR3) is a member of TLR family, the group of pattern recog-
nition receptors (PRRs) that recognizes double-stranded RNA (dsRNA) produced 
by positive-strand RNA viruses and DNA viruses, resulting in pathogen clearance 
and recruitment of adaptive immune response [ 1 ]. TLR3-dsRNA interaction gener-
ally induces the expression and secretion of IFNγ and other proinfl ammatory cyto-
kines through the Toll-interleukin-1 receptor domain-containing adaptor molecule-1 
(TICAM-1, also known as TRIF) [ 2 ]. Recent study revealed that stimulation of 
TLR3 signaling by poly(I:C), the specifi c TLR3 agonist, enhanced immunosuppres-
sive ability of human umbilical cord-derived mesenchymal stem cells (UC-MSCs) 
through microRNA-143 inhibition [ 3 ]. Nonetheless, the therapeutic advantages of 
TLR3 activation are not only limited to its immunoregulatory response but also to 
its regenerative capacity by secretion of multifunctional trophic factors [ 4 ]. In bone 
marrow-derived MSCs (BM-MSCs), treatment with poly(I:C) potentially aug-
mented the therapeutic capability for hamster heart failure through induction of 
relevant trophic factors such as interleukin-6 (IL-6), STO-1, hepatic growth factor 
(HGF), and vascular endothelial growth factor (VEGF) [ 5 ]. 
 There is evidence suggesting that TLR3 may function as sensor to perceive the 
signal from damaged tissues upon injury. Literatures indicate that dsRNA released 
from damaged and necrotic cells can activate TLR3, resulting in an acceleration of 
the reepithelialization for wound closure. Moreover, dsRNA-induced TLR3 activa-
tion could promote the release of several cytokines including IL-6, IL-11, LIF, 
IL-10, SDF-1, VEGF, and HGF [ 6 ,  7 ]. However, the release of these cytokines is 
dependent on the type of cells and the concentration of ligand. 
 Periodontal ligament stem cells (PDLSCs) are the MSC-like cell population 
resided in periodontal ligament tissue, the connective tissue connected tooth root to 
the surrounding alveolar bone. Thus, PDLSCs have the potential to regenerate mul-
tiple cells comprising periodontal structures such as cementum, bone, and ligament 
and may pave the way for periodontal regenerative treatment via cell-based trans-
plantation [ 8 – 10 ]. Apart from regenerative properties, the potential of PDLSCs for 
therapeutic application regarding to their immune privilege and immunosuppressive 
capability has been reported recently [ 11 ]. The immunomodulatory effect of 
DAMP-activated TLR3 has been indicated in periodontopathic gingival cells by 
stimulating TLR2-mediated infl ammatory response to infected pathogen [ 12 ]. 
 It has been proposed that for tissue regeneration, three interrelated events must 
be occurred. First, our body must sense the loss of tissue integrity, followed by the 
signals to induce the migration of precursor cells to reconstitute missing structures. 
Finally, these migrating cells must be signaled for an appropriate differentiation or 
functions [ 13 ]. However, upon infection or injury of PDLSCs, the signal that trig-
gers PDLSC function for tissue regeneration has not been dignifi ed yet. In this 
study, to imitate TLR3-dsRNA recognition, poly(I:C) was used for stimulating 
TLR3 in PDLSCs. The responses of PDLSCs after poly(I:C) treatment were inves-
tigated regarding to their stemness and immunosuppressive properties. 
N. Klincumhom et al.
207
17.2  Materials and Methods 
17.2.1  PDLSC Culture 
 Human PDLSCs were collected from healthy third molars as previously described 
[ 14 ]. The protocol was approved by the Ethical Committee, Faculty of Dentistry, 
Chulalongkorn University. PDLSCs were expanded in growth medium containing 
Dulbecco’s Modifi ed Eagle’s Medium supplemented with 10 % fetal bovine serum, 2 
mM L-Glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 5 μg/ml ampho-
tericin B. All cell culture reagents were purchased from Gibco BRL (Carls- bad, CA). 
Human PDLSCs were characterized for MSC properties as our previous report [ 15 ]. 
 For osteogenic differentiation, PDLSCs were cultured in osteogenic medium 
which was normal growth medium supplemented with 50 μg/ml ascorbic acid, 100 
nM dexamethasone, and 10 mM β-glycerophosphate. 
17.2.2  Poly(I:C) Treatment 
 For TLR3 activation, PDLSCs were seeded at a density of 1.2 × 10 5 cells/well in 
12-well plate in growth medium for 24 h and then treated with poly(I:C) at concen-
tration of 5, 10 and 25 μg/ml for 24 h (InvivoGen, San Diego, CA) in fresh growth 
medium. PDLSCs cultured in medium without poly(I:C) were used as control. 
17.2.3  Mineralization Assay 
 Detection of calcium deposition was evaluated on day 14 after cultured in osteo-
genic medium using the Alizarin red S staining assay. Briefl y, cells were washed 
with phosphate-buffered saline (PBS) prior to being fi xed with cold methanol for 
10 min and stained with 1 % Alizarin red S staining solution (Sigma-Aldrich, St. 
Louis, MO). 
17.2.4  Gene Expression Analysis 
 Total amount of RNA was extracted using Trizol reagent and 1 μg of RNA was con-
verted into complementary DNA (cDNA) using a reverse transcriptase enzyme kit 
(Promega, Madison, WI). Conventional PCR was performed using Taq polymerase 
(Biotechrabbit Gmbh, Hennigsdorf, Germany) in a DNA thermal cycler (Biometra 
GmH, Göttingen, Germany). The products were electrophoresed on a 2 % agarose 
gel and visualized using ethidium bromide (EtBr; Bio-Rad, Hercules, CA). 
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 qPCR was performed using SYBR GREEN FastStart Essential DNA Green 
Master which was detected by the LightCycler 96 (Roche Diagnostic GmbH, 
Mannheim, Germany). GAPDH was used as a reference gene for all experimental 
quantifi cation. The primer sequences for qPCR can be reviewed in Table  17.1 .
17.2.5  Flow Cytometry 
 PDLSCs (2 × 10 6 cells/sample) were dissociated and resuspended in 200 μl of FAC buf-
fer and stained with MSC surface marker comprised of FITC-conjugated anti- human 
CD90 (Abcam, Cambridge, MA), PE-conjugated anti-human CD105 (BD Biosciences 
 Table 17.1  Primer sequences for mRNA expression analysis (conventional PCR, qPCR) 
 Gene  Sequence 5–3′ 
 Product 
size (bp)  Sequence ID 
 GAPDH  F  5′-TGAAGGTCGGAGTCAACGGAT-3′  396  NM_002046.5 
 R  5′-TCACACCCATGACGAACATGG-3′ 
 OC  F  5′-CTTTGTGTCCAAGCAGGAGG-3′  165  NM_199173.4 
 R  5′-CTGAAAGCCGATGTGGTCAG-3′ 
 NANOG  F  5′- CAGCCCCGATTCTTCCACCAGTC-3′  389  NM_024865.3 
 R  5′- CGGAAGATTCCCAGTCGGGTTCA-3′ 
 OCT4  F  5′-GCAACCTGAGAATTTGTTCCT-3′  173  NM_002701.5 
 R  5′-AGACCCAGCAGCCTCAAAATC-3′ 
 REX1  F  5′-CAGATCCTAAACAGCTCGCAGAA-3′  305  NM_174900.4 
 R  5′-GCGTACGCAAATTAAAGTCCAGA-3′ 
 SOX2  F  5′-ACCAGCTCGCAGACCTACAT-3′  319  NM_003106.3 
 R  5′-ATGTGTGAGAGGGGCAGTGT-3′ 
 TLR3  F  5′-AAATTGGGCAAGAACTCACAGG-3′  319  NM_003265.2 
 R  5′-GTGTTTCCAGAGCCGTGCTAA-3′ 
 qOCT4  F  5′-TCGAGAACCGAGTGAGAGG-3′  124  NM_002701.5 
 R  5′-GAACCACACTCGGACCACA-3′ 
 qNANOG  F  5′-ATGCCTCACACGGAGACTGT-3′  102  NM_024865.3 
 R  5′-AAGTGGGTTGTTTGCCTTTG-3′ 
 qREX1  F  5′-TGGGAAAGCGTTCGTTGAGA-3′  89  NM_174900.4 
 R  5′-CACCCTTCAAAAGTGCACCG-3′ 
 CD73  F  5′-ACACTTGGCCAGTAAAATAGGG-3′  122  NM_002526.3 
 R  5′-ATTGCAAAGTGGTTCAAAGTCA-3′ 
 CD90  F  5′-GAAGACCCCAGTCCAGATCCA-3′  172  NM_006288.3 
 R  5′-TGCTGGTATTCTCATGGCGG-3′ 
 CD105  F  5′-CATCACCTTTGGTGCCTTCC-3′  195  NM_001114753.2 
 R  5′-CTATGCCATGCTGCTGGTGGA-3′ 
 IFNƴ  F  5′-CTAGGCAGCCAACCTAAGCA-3′  179  NM_000619.2 
 R  5′-CAGGGTCACCTGACACATTC-3′ 
 IDO  F  5′-CATCTGCAAATCGTGACTAAG-3′  187  NM_002164.5 
 R  5′-GTTGGGTTACATTAACCTTCCTT-3′ 
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Pharmingen, San Diego, CA), and purifi ed anti-human CD73 (Abcam). For CD73 
detection, after incubating in primary antibody, cells were stained with biotinylated 
anti-mouse IgG2A followed by APC streptavidin. Stained cells will be analyzed on a 
FACSCalibur ™ using the CellQuest ™ software (BD Bioscience, San Jose, CA). 
17.2.6  Statistical Analyses 
 Data were reported as Mean ± S.D. Statistical analyses of signifi cance were evalu-
ated using a two-tailed Student’s  t -test or analysis of variance where values of 
 P < 0.05 were considered signifi cant. The analysis was performed by the statistical 
software (SPSS, Chicago, IL). A minimum of three replicates were analyzed for 
each experiment. 
17.3  Results and Discussion 
 In periodontitis, the unhealthy cells of sulcular epithelium as well as gingival tissue 
were damaged either from the effect of proinfl ammatory cytokines or from mechan-
ical stimulation such as chewing or brushing [ 16 ]. As in skin wound healing that 
was reported previously, the damaged or dying cells could release dsRNA, resulting 
in the activation of TLR3 and subsequently initiating tissue regeneration [ 17 ]. In 
this case, damaged cells in periodontitis may activate TLR3 in PDLSCs leading to 
the healing and regeneration of periodontal tissue. 
17.4  TLR3 Activation Promote Stemness of PDLSCs 
 Human PDLSCs isolated from PDL tissue expressed the MSC markers including 
CD73, CD90 and CD105, as well as pluripotent markers such as REX-1, OCT4, 
NANOG, and SOX2. They also exhibited osteogenic characteristic as presented in 
upregulation of osteocalcin (OC) mRNA level and calcium deposition after osteo-
genic induction (Fig.  17.1 ). These results support that our isolated PDL cells pos-
sess stem cell characteristics, referred as PDLSCs.
 Next, we examined the expressions of TLR2-4 in PDL tissue and PDLSCs. PDL 
tissue and dental pulp and gingival tissues from healthy patients were obtained with 
informed consent and subjected to RT-PCR analysis for the detection of TLR2-4 
expressions. The results indicated that the expression levels of TLR2-4 were 
detected differently depended on cell types. Our study found that PDL tissue 
expressed the highest level of TLR3 compared to cells from dental pulp and gingiva. 
Moreover, gingival tissue showed the highest level of TLR2. No difference in 
expression of TLR4 was observed among tissue types (Fig.  17.2a ).
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 As shown in Fig.  17.2 , PDLSC itself promptly expressed TLR3. Poly(I:C) was 
used as specifi c TLR3 ligand to stimulate TLR3 function in PDLSCs. Cells were 
treated with poly(I:C) at concentration of 5, 10, and 25 μg/ml for 24 h. Our result 
showed the signifi cant increased in mRNA levels of MSC-specifi c surface markers, 
CD73 and CD105, and the self-renewal markers REX-1 and SOX2 as compared to 
untreated control. No signifi cant difference among poly(I:C)-treated groups was 
presented (Fig.  17.3a, b ). Our result which corresponds with recent study indicated 
that activation of TLR3 by poly(I:C) promoted the cancer stem cell phenotype by 
upregulating the pluripotent genes including SOX2 in breast cancer [ 18 ]. Moreover, 
the increased mRNA level of hair progenitor-specifi c marker has been observed 
upon TLR3 activation in keratinocyte which contributed to hair follicle regeneration 
[ 17 ]. Attractively, TLR3 activation was required for induction of pluripotency in 
fi broblast by modifi cation of epigenetic mechanism [ 19 ].
 We imply that TLR3 may serve as a trigger receptor for damaged/infected response 
by enhancing the stemness of PDLSCs. Further determining of the signaling that 
involved in TLR3-acivated stem cell properties in PDLSCs would be needed to pro-
vide the better understanding of underlying mechanism of regeneration upon infection 
or injury. Besides, there are studies showing that the proliferation and differentiation 
capacities of PDLSCs had been weakened during in vitro culture expansion or in aged 
donors-derived, resulting in loss of proliferative and regenerative capacity [ 20 ,  21 ]. 
Here, we suggest that enhancement of PDLSC stemness by poly(I:C) treatment could 
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 Fig. 17.1  Human PDL cells possessed the MSC characteristics. Human PDL cells were estab-
lished from periodontal tissue obtained from extracted third molars. Cells from passage 3 were 
analyzed for the expression of mesenchymal stem cell markers. The results from FACS analysis 
showed that more than 90 % of cells expressed CD73, CD90, and CD105 ( a ). HPDL cells also 
expressed pluripotent markers such as Rex-1, Oct4, nanog, and Sox2 as judged by RT-PCR ( b ). For 
osteogenic differentiation ability, cells were cultured in osteogenic medium for 14 days. The 
increased expression of osteocalcin ( OC ) was detected. Moreover, in vitro calcifi cation was 
observed as judged by alizarin red S staining ( c ). The fi gure was the representative results from 
three established PDL cell lines 
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17.5  TLR3 Activation Enhance Immunosuppressive 
Properties of PDLSCs 
 The MSC-like phenotypes of PDLSCs are not only the expression of stem cell 
markers, but also the immunosuppressive activity that can suppress immune 
responses after allogeneic transplantation [ 11 ]. The immune response interference 
of PDLSCs is generally processed through a cell-cell contact and secretion of 
immunomodulatory factors resulting in inhibition of T and B cell proliferation. 
Additionally, recent study indicated the immunosuppressive activity of PDLSCs is 
resisted even after osteogenic differentiation [ 22 ]. 
 The role of TLR3 regarding the immunomodulation properties has been examined 
extensively in MSCs derived from several origins such as BM-MSCs [ 5 ], AD-MSCs 
[ 23 ], and UC-MSCs [ 3 ]; however, no comprehensive study in dental stem cells has 
been studied. In present study, after exposing to 25 μg/ml of poly(I:C) for 24 h, the 
upregulation of immunomodulatory mRNA levels, IFNγ, and IDO in PDLSCs was 
detected by qPCR (Fig.  17.4a ). IFNγ is known as an upstream regulator of immuno-
modulatory molecules in MSCs. These cytokines promote an IDO production, result-
ing in restoring immunosuppressive ability of dental pulp stem cells (DPSCs) derived 
from irreversible pulpitis [ 24 ]. IDO is a catalytic enzyme of tryptophan, a crucial 
 Fig. 17.2  Expression of TLR3 in periodontal tissue and PDL cells. Periodontal ( PDL ), dental pulp 
(pulp), and gingiva tissues were obtained from healthy patient and subject for RT-PCR analysis. 
The results ( a ) showed that all three tissues expressed TLR2, TLR3, and TLR4 with different 
levels. The highest expression of TLR3 was found in PDL tissue while gingiva expressed the high-
est level of TLR2. ( b ) showed the expression of TLR3 from three PDL cell lines ( a – c ). GAPDH 
was used as the internal control 
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 Fig. 17.3  Poly(I:C) enhanced the expression of stem cell markers in human PDL cells. Human 
PDL cells were treated with poly(I:C) at concentration of 5, 10 and 25 μg/ml for 24 h. Real-time 
RT-PCR analysis showed that poly(I:C) enhanced the expression of MSC markers; CD73, CD105 
( a ), and pluripotent markers; Rex-1, Sox2 ( b ). * indicated the signifi cant difference ( p < 0.05). The 
results were shown as mean ± S.D. from three experiments 
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amino acid for T cell growth. Upregulation of IDO thus leads to the inhibition of T cell 
proliferation [ 25 ,  26 ]. In AD-MSCs, IDO is secreted in conditioned supernatant by 
IFNγ and potentially inhibited PBMC proliferation. Previous study indicated immu-
nosuppressive mechanism of TLR3 in UC-MSCs through inhibiting microRNA-143 
that results in IDO production [ 23 ]. We therefore denote that activation of TLR3 pro-
motes immunosuppressive properties of PDLSCs via stimulating IFNγ and IDO. It 
has been shown that upon injury or infl ammation of tissue, the immunosuppressive 
cytokines released from MSCs indicated to play a role in tissue homeostasis by inhib-
iting infl ammatory response as well as stimulating the proliferation and differentiation 
of stem/progenitor cells [ 27 ]. By this cell protective mechanism, we prospect that 
activation of PDLSCs to secrete these immunosuppressive cytokines could augment 
the therapeutic potential of MSCs for tissue regeneration.
17.6  TLR3 Activation Induces IFNγ Production in PDLSCs 
Via NF-kB Pathway 
 Normally, released dsRNA after viral infection is recognized by TLR3, and then 
activate NF-kB signaling, through TIR domain-containing adaptor TRIF [ 28 ,  29 ]. 
To examine whether activation of TLR3 in PDLSCs regulates production of IFNγ 
and its downstream IDO via NF-kB signaling, the NF-kB inhibitor was added into 
 Fig. 17.4  TLR3 activation induced immunosuppressive property of human PDL cells. Human 
PDL cells were treated with 25 μg/ml poly(I:C) for 24 h. RT-PCR analysis revealed that poly(I:C) 
signifi cantly induced the expression of IFNγ and IDO ( a ). Addition of NF-kB inhibitor inhibited 
the poly(I:C)-induced IFNγ but could not inhibit the induction of IDO ( b ). Moreover, poly(I:C)-
induced stem cell markers were also NF-kB independent ( c ,  d ). * indicated the signifi cant differ-
ence ( p < 0.05). The results were shown as mean ± S.D. from three experiments 
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normal medium with and without poly(I:C) treatment. The mRNA expression of 
immunomodulatory molecules IFNγ and IDO was determined using qPCR. The 
result showed that, without poly(I:C) treatment, NF-kB inhibitor did not affect the 
endogenous IFNγ and IDO in PDLSCs. Interestingly, pretreatment of NF-kB inhib-
itor could attenuate the induction of IFNγ while further increasing IDO expression 
when compared to those in poly(I:C) treatment alone (Fig.  17.4b ). Typically, IDO is 
induced by IFNγ in dendritic cells and macrophages. However, the regulation of 
IDO expression via IFNγ-independent pathways has been reported previously in 
astrocyte [ 30 ]. The result revealed that TLR3 activates IFNγ production in PDLSCs 
via NF-kB signaling, while TLR3-activated IDO expression may be possessed by 
other NF-kB-independent pathways. 
 Additionally, TLR3-activated NF-kB nuclear translocation has been reported to 
play an important role in epigenetic mechanisms during reprogramming of fi bro-
blast into induced pluripotent stem cells (iPSCs) via retrovirus encoding reprogram-
ming factors [ 19 ]. Therefore, it is possible that TLR3-induced stemness of PDLSCs 
was regulated via NF-kB signaling. To test this idea, the mRNA expression of plu-
ripotent stem cell markers (e.g., REX-1 and SOX2) and MSC markers (e.g., CD73 
and CD105) of TLR3-activated PDLSCs was determined after pretreatment with 
NF-kB inhibitor using qPCR. We found that addition of NF-kB inhibitor had no 
effect on the induction of those stem cell markers in either with poly(I:C) activation 
or NF-kB inhibitor alone in PDLSCs (Fig.  17.4c, d ), though more studies are 
required for better understanding on how TLR3 signaling regulates stemness in 
PDLSCs. 
17.7  Conclusion 
 In summary, our study discovered that TLR3 engagement by its specifi c ligand 
poly(I:C) could stimulate the stem cell properties of PDLSCs including self-renewal 
and immunomodulation. In periodontitis, it is possible that PDLSCs might generate 
new cells and prevent the immune cell-initiated infl ammation for repairing the dam-
aged structure through these mechanisms. Hence, TLR3 agonist may be a novel 
approach to enhance stem cell properties of PDLSCs for tissue regeneration, espe-
cially allogeneic cell-based therapy. 
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 Chapter 18 
 Infl uence of Exogenous IL-12 on Human 
Periodontal Ligament Cells 
 Benjar  Issaranggun Na Ayuthaya and  Prasit  Pavasant 
 Abstract  Periodontal disease is the most prevalent oral disease. The pathogenesis 
of this disease is mostly due to the robust host immune response, leading to the 
destruction of tooth-supporting tissue. Several cytokines have been shown to play 
roles in pathogenesis of periodontal disease; however, infl ammatory cytokines can 
also activate the immunomodulatory properties of mesenchymal stem cells (MSCs), 
the mechanism to protect and maintain cell survival under infl ammatory environ-
ment. Therefore, infl ammation can exert both negative and positive effects for regu-
lating tissue homeostasis. Interleukin 12 (IL-12) is one of the potent destructive 
stimulators in pathogenesis of many infl ammatory diseases. In periodontitis, the 
increased level of IL-12 in serum and gingival crevicular fl uid was found associated 
with the severity of the periodontal disease. However, the exact role of IL-12 in 
periodontitis is still unclear. The aim of this study was to investigate the responses 
of human periodontal ligament (PDL) cells to exogenous IL-12, especially on the 
immunomodulatory effects of IL-12. The results demonstrated the presence of 
IL-12 and IL-12 receptor (IL-12R) in periodontal tissues, and the expression was 
enhanced in tissues from periodontitis patients. Exogenous IL-12 stimulated the 
expression of some infl ammatory cytokines as well as the immunomodulatory mol-
ecules, such as interferon gamma (IFNγ), human leukocyte antigen (HLA), and 
indoleamine-pyrrole-2,3-dioxygenase (IDO) enzyme. In conclusion, the data sug-
gested the infl uence of increased IL-12, during periodontal infl ammation, on con-
trolling tissue’s homeostasis by upregulating the infl ammatory cytokines and 
modulating the function of immune cells through the expression of immunosup-
pressive molecules. 
 Keywords  Interleukin 12 •  Immunomodulation •  Periodontal ligament cell • 
 Interferon gamma (IFNγ) •  Indoleamine-pyrrole-2,3-dioxygenase (IDO) •  Human 
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18.1  Introduction 
 Periodontitis or periodontal disease is one of the most prevalent chronic infl amma-
tory diseases involved in periodontium destruction. The plaque microorganism is 
the cause of the periodontal disease formation; however, the presence of pathogen 
alone is not suffi cient to trigger the onset of periodontitis. Indeed, the recognition of 
this pathogen by host immune cells is an essential process in the pathogenesis of 
periodontal disease [ 1 ]. 
 One of the critical recognition components of the host immune response to the 
pathogenic microorganisms and their products is a family of toll-like receptors 
(TLRs). The most common TLRs implicated as potent receptors for pathogen- 
associated periodontitis are TLR-2 and TLR-4 [ 2 ,  3 ]. TLR activation stimulates an 
intracellular signaling cascade that leads to the activation of transcription factors, 
such as nuclear factor-kB (NF-kB) and activator protein-1 (AP-1) [ 4 ]. Subsequently, 
the production of pro-infl ammatory cytokines that play roles in the induction of 
osteoclastogenesis leading to bone resorption occurs. Attempts to reduce infl amma-
tion could decrease the progression and severity of bone resorption, indicating the 
importance of infl ammatory process in pathogenesis of periodontal disease [ 5 ]. 
 The activation of host immune response required antigen-presenting cells (APCs) 
such as dendritic cells (DCs) to recognize the pathogens and stimulate the adaptive 
immune response [ 6 – 8 ]. During periodontal infl ammation, the increased number of 
DCs was found related to the severity of infl ammation [ 8 ]. It has been shown that, 
at the initiation stage of periodontal infl ammation, most of DCs resided in gingival 
epithelium. However, at the later stage, they moved into the periodontal tissue and 
activated the differentiation of adaptive immune cells [ 8 ,  9 ]. 
 Interleukin 12 (IL-12) is a potent cytokine that plays an important role in immune 
response by driving the differentiation of naïve T cells to T helper 1 (Th1) cells and 
mediating long-term protection against the pathogen [ 10 ,  11 ]. IL-12 is mainly pro-
duced by DCs as a result of the induction by antigenic signals, particularly lipopoly-
saccharide (LPS), and activated T cell signals [ 12 ]. Moreover, IL-12 production is 
further regulated by other cytokines such as interleukin 1beta (IL-1β), a potent 
osteolytic cytokine [ 13 ,  14 ]. These fi ndings are concordant with the reports from 
many studies that the level of IL-12 was upregulated and associated with severity of 
infl ammatory diseases [ 15 – 17 ]. 
 IL-12 has been implicated as a potent destructive stimulator in the pathogenesis 
of several infl ammatory diseases that lead to bone destruction [ 1 ,  18 ,  19 ]. The accu-
mulation of infl ammatory cytokines infl uences bone remodeling by alternating 
osteoblast and osteoclast activities. In an in vivo study, the injection of exogenous 
IL-12 resulted in the aggressive joint infl ammation [ 20 ]. These evidences impli-
cated the destructive role of IL-12 as a trigger of the infl ammatory-induced bone 
destruction. 
 Although infl ammation usually promotes tissue destruction, some infl ammatory 
cytokines can activate immunomodulatory properties of MSCs, a negative mecha-
nism that modulate host immune response. Immunomodulation is an important 
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property of MSCs to promote cell survival under infl ammatory environment, since 
MSCs are susceptible to be destroyed by activated T cells and NK cells [ 21 ]. The 
immunomodulatory property of MSCs occurred via the upregulation of immuno-
suppressive molecules such as human leukocyte antigen (HLA) molecules [ 22 ,  23 ] 
and indoleamine-pyrrole 2,3-dioxygenase (IDO) enzyme [ 23 – 25 ]. HLA molecules 
attenuate immune cells’ activity by signaling via their specifi c inhibitory receptors 
[ 26 ], while IDO enzyme inhibits immune response by degrading tryptophan, an 
essential amino acid required for T cell growth, resulted in a decrease of T cell pro-
liferation [ 24 ]. Therefore, the function of IL-12 may involve in the moderation of 
host immune response and control survival and function of periodontal ligament 
cells. 
 In this study, the presences of IL-12 and IL-12R were detected in all dental tis-
sues. The responses of hPDL cells to IL-12, regarding the expression of immuno-
modulatory molecules, were investigated. The function of IL-12 in hPDL cells will 
provide more information toward the understanding of pathogenesis of periodontal 
disease. 
18.2  Materials and Methods 
18.2.1  Cell Culture 
 All experimental protocols were approved by the Ethics Committee of the Faculty 
of Dentistry, Chulalongkorn University. Non-carious third molars extracted for 
orthodontic reason were collected for periodontal ligament (PDL) cell isolation as 
previously described [ 27 ]. Cells were cultured in standard medium (Dulbecco’s 
modifi ed Eagle’s medium (DMEM) containing 10 % fetal bovine serum with 
L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 mg/ml), and ampho-
tericin B (5 mg/ml)) and incubated at 37 °C in a humidifi ed atmosphere of 5 % CO 2 
in air. After the cells reached confl uency, they were subcultured at a 1:3 ratio. Cells 
from the third to fi fth passages were used in the experiments. Cell established from 
at least three different donors were used in each study. 
18.2.2  Application of IL-12, IFNγ, IL-1β, and TNFα 
 Human PDL cells were seeded in 12-well plates (2×10 5 cells/well) for 24 h and then 
treated with recombinant human IL-12 (p70) (0–10 ng/ml) (Peprotech, Rocky Hill, 
NJ), recombinant human interferon gamma (IFNγ) (1 ng/ml) (ImmunoTools, 
Friesoythe, Germany), recombinant human IL-1β (1 ng/ml) (R&D System, 
Minneapolis, USA), or human recombinant TNFα (1 ng/ml) (Millipore, Darmstadt, 
Germany) for 1 day. In some experiments, 50 μM of lisofylline (STAT4 inhibitor) 
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(Cayman chemical, Ann Arbor, MI, USA) or 10 μM of NF-kB inhibitor (Millipore) 
was added into the culture medium 30 min prior to the IL-12 treatment. 
18.2.3  Reverse Transcription-Polymerase Chain Reaction 
(RT-PCR) 
 Trizol reagent (Molecular Research Center, Cincinnati, OH) was used for total cel-
lular RNA extraction. Total amount of RNA was quantifi ed using a NanoDrop 2000 
Spectrophotometer (Thermo Scientifi c, Wilmington, DE). One microgram of total 
RNA per sample was converted to complementary DNA by reverse transcriptase 
(Promega, Madison, WI). Subsequently, polymerase chain reactions (PCR) were 
performed with specifi c primers for IL-12Rβ 2, IL-1β, TNFα, and GAPDH. 
The sequences of used primers were GAPDH (NM002046.3), forward 5ʹ 
(TGAAGGTCGGAGTCAACGGAT-3ʹ), reverse 5ʹ 
(TCACACCCATGACGAACATGG-3ʹ); IL-12Rβ 2 (NC018912.2), forward 5ʹ 
(CAGCACATCTCCCTTTCTGTTTTC-3ʹ), reverse 5ʹ 
(ACTTTAAGGCTTGAAGCCTCACC-3ʹ); IL-1β (NM000576.2), forward 5ʹ 
(GGAGCAACAAGTGGTGTTCT-3ʹ), reverse 5ʹ 
(AAAGTCCAGGCTATAGCCGT-3ʹ); and TNFα (NM000594.2), forward 5ʹ 
(AAGCCTGTAGCCCATGTTGT-3ʹ), reverse 5ʹ 
(CAGATAGATGGGCTCATACC-3ʹ). Conventional PCR was performed using Taq 
polymerase (Taq DNA Polymerase, Invitrogen, Brazil) in a DNA thermal cycler 
(BiometraGmH, Göttingen, Germany). The products were electrophoresed on a 2 % 
agarose gel and visualized using ethidium bromide (EtBr; Bio-Rad, Hercules, CA) 
fl uorostaining. 
18.2.4  Real-Time Polymerase Chain Reaction 
(Real-Time PCR) 
 Real-time PCR was performed in a MJ Mini ™ Thermal Cycler (Bio-Rad) using the 
LightCycler 480 SYBR Green I Master kit (Roche diagnostic) according to the 
manufacturer’s specifi cations. Gene expression levels were normalized to the 
GAPDH expression. Then relative gene expression was calculated by CFX 
Manager ™ software (Bio-Rad). The results were shown as fold-change values rela-
tive to the control group. The sequence of primers used in the experiment was shown 
in Table  18.1 .
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18.2.5  Statistical Analyses 
 Data were reported as mean ± standard deviation (SD). Statistical signifi cance was 
assessed by the Kruskal-Wallis test. The differences at  p < 0.05 were considered as 
a statistical signifi cant difference. 
18.3  Results and Discussions 
18.3.1  Expressions of IL-12 and IL-12 Receptor in Periodontal 
Tissue Increased During Periodontal Infl ammation 
 The results in Fig.  18.1a showed the expression of IL-12 and IL-12 receptor 
(IL-12R) in dental tissues. Total RNA was extracted from healthy gingiva (Gin), 
periodontal ligament (PDL), and dental pulp (Pulp) and subjected to RT-PCR analy-
sis. The expression of IL-12 and its receptor were found in all three dental tissues. 
In PDL cells, the expression of IL-12R, but not IL-12, could be detected (data not 
shown, manuscript in preparation).
 The expression of IL-12 in dental tissue might be associated with DCs, the major 
cell types that are responsible for IL-12 production [ 28 ]. It has been shown that, 
during gingivitis, DCs were resided in gingival tissues. These cells penetrated into 
the periodontal tissue when the disease progresses into periodontitis [ 6 – 9 ]. This 
data suggested the distribution of DCs within all of the dental soft tissues. In addi-
tion, the expression of IL-12Rβ 2 detected in all three dental tissues suggested the 
presence of IL-12 responsive cells in the healthy dental tissues. 
 The expression of both IL-12 and IL-12Rβ 2 was signifi cantly increased in peri-
odontal tissue isolated from infl ammatory lesion (Fig.  18.1b ). The upregulation of 
IL-12 suggested the increased number of IL-12 producing cells, possibly DCs, dur-
ing periodontal infl ammation. These data were in agreement with the report show-
ing the increased number of DCs in the tissue from healthy to gingivitis and to 
 Table 18.1  Primer sequence for real-time PCR 
 Primer 
 Forward/
reverse  Sequence (5ʹ–3ʹ)  Sequence ID 
 qGAPDH  F  CACTGCCAACGTGTCAGTGGTG  NM 002046.4 
 R  GTAGCCCAGGATGCCCTTGAG 
 IDO  F  CAT CTG CAA ATC GTG ACT AAG  NG_028155.1 
 R  GTT GGG TTA CAT TAA CCT TCC TT 
 HLA-G  F  GCT GTG ATC ACT GGA GCT GT  NM_002127.5 
 R  ACT CTT GCC TCT CAG TCC CA 
 HLA-A  F  AAG AGG AGA CAC GGA ACA CC  NM_001242758.1 
 R  TCG CAG CCA ATC ATC CAC TG 
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periodontitis [ 8 ]. In case of IL-12R, it is possible that the upregulation of IL-12Rβ 2 
represents the autocrine regulation of IL-12 for promoting the cellular response dur-
ing periodontal infl ammation. 
 Figure  18.1c, d showed a signifi cant increase of IL-12Rβ 2 expression after IL-12 
treatment in hPDL cells, supporting the concept of autocrine feedback loop. This 
loop has been demonstrated previously in the in vivo study reported by Thibodeaux 
et al. [ 29 ], showing the increased expression of both IL-12Rβ 1 and β 2 following the 
systemic administration of recombinant IL-12. 
 The production of IFNγ following IL-12 activation has been demonstrated to be 
a potent cytokine that regulated the expression of IL-12R [ 30 ]. Thus, the presence 
of IFNγ found in infl amed periodontal tissue (Fig.  18.1b ) might enhance the expres-
sion of IL-12R during periodontal infl ammation. 
 Fig. 18.1  The expression of IL-12 and IL-12R in dental tissues. Dental tissues, including gingiva 
(Gin), periodontal ligament (PDL), and dental pulp (Pulp), were obtained from patient with 
informed consent. Total RNA was extracted and subjected to RT-PCR analysis. The results showed 
all three types of tissue expressed in both IL-12 and IL-12R expression ( a ). The expression level 
of both IL-12 and IL-12R was higher in the infl ammatory PDL tissue than the healthy tissue ( b ). 
IL-12 could also induce IL-12R expression in hPDL cells ( c ). The relative expression of IL-12R 
after induced with 1 ng/ml of IL-12 was shown as a graph in ( d ). The pictures were the representa-
tive of triplicated experiments and * indicated the statistical signifi cance ( p < 0.05) 
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18.3.2  IL-12-Mediated IFNγ Expression in hPDL Cells 
via STAT4 and NF-kB Signaling Pathways 
 Next, we monitored the expression levels of IFNγ, a classical target of IL-12 signal-
ing [ 28 ,  31 ,  32 ] after IL-12 treatment in hPDL cells. Figure  18.2a showed that IL-12 
signifi cantly increased IFNγ expression within 24 h. However, other destructive 
cytokines, including IL-1β and TNFα, could also induce the expression of IFNγ and 
IL-12R (Fig.  18.2b ). It is possible that the inductive effect of IL-12 might occur via 
other IL-12-induced cytokines. Nevertheless, both IL-1β and TNFα could promote 
the response of PDL cells to IL-12 via the increased expression of IL-12Rβ 2 .
 Normally, IL-12 signaling is generated via STAT4 [ 33 ]. In addition, STAT4- 
defi cient mice had an identical phenotype to IL-12-defi cient mice [ 34 ] supporting 
the role of STAT4 in IL-12 signaling pathway. However, in DCs, NF-kB has been 
proposed as a major signaling molecule mediated in IL-12 activation [ 35 ]. Thus, the 
role of STAT4 and NF-kB in IL-12-induced IFNγ in hPDL cells by means of inhibi-
tors was examined. The results in Fig.  18.2c showed that both STAT4 and NF-kB 
inhibitors signifi cantly reduced the IL-12-induced IFNγ expression, suggesting the 
involvement of both STAT4 and NF-kB in IL-12-induced IFNγ in hPDL cells. 
 Fig. 18.2  IL-12-induced IFNγ expression in HPDL cells. Human PDL cells were treated with 
0.5–10 ng/ml of IL-12 for 24 h. RT-PCR analysis showed the upregulation of IFNγ in a dose- 
dependent manner ( a ). The graph below showed the relative expression of IFNγ when cells were 
treated with 1 ng/ml of IL-12. * indicated the signifi cant difference when compared to the control 
( p < 0.05).  b showed the inductive effect of 1 ng/ml of IL-12, IL-1β, and TNFα on the expressions 
of IFNγ and IL-12R. The inductive effect of IL-12 on IFNγ was inhibited by NF-kB and STAT4 
inhibitors as determined by RT-PCR ( c ) 
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18.3.3  IL-12-Modulated Periodontal Infl ammatory Response 
and Immunomodulatory Property of hPDL Cells 
 To investigate the modulatory effect of IL-12 on periodontal infl ammatory response, 
the expression levels of IL-1β and TNFα in hPDL cells following IL-12 treatment 
were monitored. After 24 h incubation, a signifi cant increase in IL-1β and TNFα 
mRNA expressions was detected, as shown in Fig.  18.3a, b . IL-12-induced TNFα 
expression was also reported in mouse BV-2 microglial cells [ 36 ]. Moreover, the 
study by Kim et al. [ 37 ] demonstrated the upregulation of IL-1β following IL-12 
administration in joint tissue. These evidences support the possible role of IL-12 on 
the enhancement of infl ammatory response during periodontal disease.
 Indeed, infl ammatory cytokines also function as a key inducer to activate the 
immunomodulatory properties of mesenchymal stem cells (MSCs) [ 22 ]. In physio-
logical condition, immunomodulatory property of MSCs is kept inactive and will be 
activated by infl ammatory environment [ 22 ]. It is possible that during infl ammation, 
the presence of pro-infl ammatory cytokines could also serve as a potent activator to 
induce the immunomodulatory property of MSCs [ 38 ,  39 ]. 
 The immunomodulatory properties of MSCs are the ability to express immuno-
suppressive molecules, such as human leukocyte antigen (HLA) [ 22 ,  23 ] and 
 Fig. 18.3  IL-12 induced the expression of IL-1β and TNFα in HPDL cells. Human PDL cells 
were treated with 0.5–10 ng/ml of IL-12. The upregulation of IL-1β ( a ) and TNFα ( b ) was detected 
dose dependently. Graphs on the right showed the relative expression of IL-1β and TNFα after 
being treated with 1 ng/ml of IL-12 as compared to the control. * indicated the statistic difference 
( p < 0.05) 
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indoleamine-pyrrole-2,3dioxygenase (IDO) enzyme [ 23 – 25 ]. HLA genes are the 
gene encoding the major histocompatibility complex (MHC) in human. HLA func-
tions by binding to their inhibitory receptors expressed on various types of immune 
cells and subsequently attenuating the immunological activation and inhibits the 
infl ammatory response [ 40 ,  41 ]. IDO is a catalytic enzyme that catalyzes and 
degrades tryptophan, a crucial amino acid for T cell growth, leading to the inhibi-
tion of T cell proliferation [ 24 ,  42 ]. HPDL cells have been shown to be able to 
secrete IDO enzyme upon activation [ 43 ,  44 ]. Therefore, the upregulation of HLA- 
G, HLA-A, and IDO in this study may participate in the survival of PDLSCs as well 
as the reduction of immune responses. 
 The results in Fig.  18.4a–c indicated that 1 ng/ml of exogenous IFNγ, IL-1β, and 
TNFα could induce IDO, HLA-G, and HLA-A as judged by real-time RT-PCR. Taken 
together with the results that IL-12 could induce IFNγ, IL-1β, and TNFα, these data 
strongly suggested the important role of IL-12 in modulating host immune response 
during periodontal infl ammation.
 Fig. 18.4  Upregulation of IDO, HLA-G, and HLA-A by IFNγ, IL-1β, and TNFα. Human PDL 
cells were treated with 1 ng/ml of IFNγ, IL-1β, and TNFα for 24 h. Real-time PCR analysis indi-
cated that all three molecules could signifi cantly induce the expression of IDO, HLA-G, and HLA- 
A. * indicated the statistical difference ( p < 0.05) 
 
18 Infl uence of Exogenous IL-12 on Human Periodontal Ligament Cells
226
18.4  Conclusion 
 Our data indicated the ability of hPDL cells to respond to IL-12. The IL-12-induced 
IL-12R expression might be an autocrine mechanism of IL-12 to promote its cellu-
lar response in hPDL cells. IL-12 also stimulated the expression of IL-1β and TNFα, 
indicated the pro-infl ammatory activity of IL-12 in periodontal infl ammation. 
Moreover, the increase in infl ammatory cytokine production induced by IL-12 was 
demonstrated as the factors to activate the immunomodulatory property of hPDL 
cells, a mechanism to protect the cells from infl ammatory environment. Thus, the 
increased level of IL-12 in periodontal infl ammation may play roles in regulating 
periodontal tissue destruction and survival of PDL stem cells. 
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 Chapter 19 
 Development and Performance of Low-Cost 
Beta-Type Ti-Based Alloys for Biomedical 
Applications Using Mn Additions 
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 Abstract  The microstructures, mechanical properties, and biocompatibility of var-
ious low-cost  β -type Ti-Mn alloys fabricated by both cold crucible levitation melt-
ing (CCLM) and metal injection molding (MIM) were investigated after solution 
treatment. Mn was chosen as a potential low-cost alloying element for Ti. Among 
the alloys fabricated by both methods, Ti-9Mn shows the best combination of ten-
sile strength and elongation, and their performances are mostly comparable to or 
superior to those of Ti-6Al-4V (Ti-64) ELI. However, alloys fabricated by MIM 
show a higher O and C content, along with precipitated Ti carbides and pores, which 
all cause the ductility of the alloys fabricated by MIM to be lower than that of the 
alloys fabricated by CCLM. Furthermore, the cell viability and metallic ion release 
ratios of the alloys fabricated by CCLM are comparable to those of commercially 
pure Ti, making this alloy promising for biomedical applications. The Young’s modulus 
of the alloys is also lower than that of Ti-64 ELI (which is of approximately 110 
GPa), which can possibly reduce the stress shielding effect in implanted patients. 
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19.1  Introduction 
 Among the most widely used metallic biomaterials, titanium (Ti) and its alloys are 
the most suitable because of their high specifi c strength, good corrosion resistance, 
and biocompatibility [ 1 – 3 ]. However, the most widely used Ti-based alloys in bio-
medical applications were not designed for this kind of application and can show 
issues. Commercially pure Ti (CP-Ti) has insuffi cient mechanical properties for 
some biomedical applications, whereas Ti-6Al-4V (Ti-64) ELI has the necessary 
mechanical properties, but contains Al and V, which can be released as ions from the 
alloy and are associated to health issues in the human body [ 2 ,  4 – 8 ]. Therefore, 
recent efforts have been made in recent years to produce new and more biocompat-
ible  β -type Ti alloys, designed specifi cally for biomedical applications [ 3 ].  β -type Ti 
alloys can achieve the highest specifi c strength when compared with  α - or ( α + β )-
type Ti alloys [ 9 ]. Furthermore,  β stabilizing alloying elements can contribute to 
reduce the Young’s modulus of the alloys [ 10 ,  11 ]. The lower Young’s modulus is 
useful because metallic biomaterials usually have a Young’s modulus much higher 
than that of the human bone, which can end up causing the stress shielding effect 
[ 12 ]. However, many of the newly developed alloys contain scarce and high-cost 
elements such as Nb and Ta, which may be diffi cult to obtain in the future because 
of the limited amounts of their natural deposits [ 13 ,  14 ]. 
 Considering the abovementioned factors (i.e., biocompatibility, balance of 
mechanical properties, availability, and cost), Mn was selected as the primary alloy-
ing element for Ti-Mn system alloys due to its  β stabilizing effect, lower cytotoxic-
ity, higher availability, and lower cost when compared to other popular alloying 
elements [ 15 ,  16 ]. Some of the binary Ti-Mn alloys fabricated using a cold crucible 
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levitation melting (CCLM) showed a performance comparable or superior to that of 
the Ti-64 ELI for biomedical applications [ 15 ]. Furthermore, Ti-Mn alloys contain-
ing up to 13 mass% Mn showed cytotoxicity levels comparable to that of CP-Ti, but 
the alloy containing 18 mass% Mn showed cytotoxicity [ 15 ]. Thereafter, further 
cost reduction was considered by fabricating Ti-Mn alloys using a metal injection 
molding (MIM), a powder metallurgy near-net shape fabrication method [ 16 ]. The 
alloys fabricated by MIM showed some mechanical properties comparable to those 
of the alloys fabricated by CCLM, but because of both high porosity and high 
amount of interstitial impurities – inherent to the fabrication method – there was a 
drastic decrease in ductility compared to the alloys fabricated using CCLM [ 16 ]. 
Therefore, it is necessary to improve the ductility of the alloys. 
19.2  Experimental Procedures 
19.2.1  Ingots Preparation 
 For the fi rst part of this study, ingots of Ti-(6, 9, 13, and 18 mass%)Mn were fabri-
cated by CCLM. The ingots were initially subjected to a homogenization treatment 
for 21.6 ks at 1,273 K followed by ice water quenching and then to hot forging and 
hot rolling, both at 1,173 K. Finally, in order to retain the  β phase in the alloys, the 
plates were subjected to solution treatment for 3.6 ks at 1,173 K in vacuum, fol-
lowed by ice water quenching. Hereafter, the alloys fabricated by CCLM will be 
identifi ed by the subscript “LM,” as in Ti-Mn LM . 
 For the second part of this study, ingots of Ti-(8, 9, 12, 13, 15, and 17 mass%)Mn 
were fabricated by MIM. Sintering was conducted in vacuum at 1,373 K for 28.8 ks. 
Finally, in order to retain the  β phase in the alloys, the plates were subjected to solu-
tion treatment for 3.6 ks at 1,173 K in vacuum, followed by ice water quenching. 
Further details on the specimen preparation methods are described elsewhere [ 16 ]. 
Hereafter, the alloys fabricated by MIM will be identifi ed by the subscript “MIM,” 
as in Ti-Mn MIM . 
19.2.2  Microstructure Characterization 
 For all parts of this study, the material characterization was performed by chemical 
composition analysis, optical microscopy (OM), X-ray diffractometry (XRD), and 
transmission electron microscopy (TEM). Furthermore, electron probe microanaly-
sis (EPMA) was carried out on the alloys fabricated by MIM. The experimental 
conditions and other details are described elsewhere [ 15 ,  16 ]. 
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19.2.3  Mechanical Properties Evaluation 
 For all parts of this study, the mechanical property investigation was conducted by 
means of Vickers hardness tests, Young’s modulus measurements, and tensile tests. 
Furthermore, compressive tests were carried out on the alloys fabricated by 
MIM. The experimental conditions and other details are described elsewhere [ 15 ,  16 ]. 
19.2.4  Biocompatibility Evaluation 
 The biocompatibility of the alloys fabricated by CCLM was evaluated by means of 
immersion tests in simulated body fl uids (SBF), followed by X-ray photoelectron 
spectroscopy (XPS) of the surface of SBF-immersed samples, and also cytotoxicity 
tests using MC3T3-E1 cells. The experimental conditions and other details are 
described elsewhere [ 15 ]. 
19.3  Results and Discussion 
19.3.1  Ti-Mn Binary Alloys Fabricated by CCLM 
 Table  19.1 shows the chemical compositions of Ti-(6-18)Mn LM . The lower amount 
of Mn content in comparison to the nominal value is caused by the evaporation of 
Mn during melting processes [ 17 ]. Mn loss of up to 25 % was expected [ 17 ]. 
However, the observed difference (2–10 %) is considerably smaller in the Ti-Mn LM , 
thanks to the shorter melting time required by this method.
 Figures  19.1 and  19.2 show the optical micrographs and XRD profi les of the 
Ti-(6-18)Mn LM , respectively. As shown in Fig.  19.2 , only diffraction peaks attrib-
uted to  β planes are detected in the XRD profi les of Ti-(9-18)Mn LM . However, dif-
fraction peaks that can be attributed to  ω and  α or  α ′ phases are also detected in the 
XRD profi le of Ti-6Mn LM . A concentration of approximately 6.3 mass% Mn is 
required to fully retain the  β phase upon quenching [ 4 ]. However, the Mn content of 
Ti-6Mn LM used for this study is 5.60 mass%. Furthermore, the presence of the ather-
mal  ω phase has been confi rmed by the TEM observations. Figure  19.3a–d shows 
 Table 19.1  Chemical compositions of Ti-Mn alloys fabricated by CCLM (mass%) 
 Alloy 
 Element 
 Nominal Mn  Ti  Mn  O  C  N 
 Ti-6Mn LM  bal.  5.60  0.0736  0.0036  0.0045  6.0 
 Ti-9Mn LM  bal.  9.47  0.0727  0.0031  0.0036  10.0 
 Ti-13Mn LM  bal.  12.65  0.0747  0.0024  0.0043  14.0 
 Ti-18Mn LM  bal.  17.65  0.0591  0.0073  0.0021  18.0 
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the selected area electron diffraction (SAED) patterns, where the spots or streaks 
attributed to the athermal  ω phase decrease in intensity with increasing Mn content. 
The bright particles in the corresponding dark fi eld (DF) images (Fig.  19.3e–h ) 
represent the athermal  ω phase particles. Ti-6Mn LM contains the largest amount of 
particles, as it decreases with increasing Mn content. The decrease in the volume 





 Fig. 19.1  Typical optical micrographs of ( a ) Ti-6Mn LM , ( b ) Ti-9Mn LM , ( c ) Ti-13Mn LM , and ( d ) 
Ti-18Mn LM 
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Mn LM , is attributed to increasing  β phase stability obtained by increasing the Mn 
content. Because of the higher  β phase stability of the Ti-13Mn LM and Ti-18Mn LM , 
the  ω phase cannot be observed in the DF images of these alloys (Fig.  19.3g, h ).
 Figures  19.4 and  19.5 show the Vickers hardness and Young’s modulus of the 
Ti-(6–18)Mn LM alloys, respectively. The hardness of Ti-9Mn LM and Ti-13Mn LM is 
comparable to that of Ti-64 ELI reported in the literature (approximately 325 HV) 









Ti-6MnLM Ti-9MnLM Ti-13MnLM Ti-18MnLM
Ti-6MnLM Ti-9MnLM Ti-13MnLM Ti-18MnLM
a
e f g h
b c d
 Fig. 19.3  Typical SAED patterns viewed from [110]  β  , and corresponding DF images of diffraction 
spots or streaks of  ω phase of ( a ) and ( e ) Ti-6Mn LM , ( b ) and ( f ) Ti-9Mn LM , ( c ) and ( g ) Ti-13Mn LM , 
and ( d ) and ( h ) Ti-18Mn LM 
 Fig. 19.4  Vickers hardness of Ti-Mn LM alloys compared to that of Ti-64 ELI alloy ( dashed line ) 
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of Young’s modulus in comparison to that reported for Ti-64 ELI (110 GPa), indi-
cated by the dashed line in Fig.  19.5 [ 5 ]. The main factors that affect both the 
Vickers hardness and Young’s modulus measurements of Ti-(6–18)Mn LM are the 
solid solution hardening effects of Mn and the presence and amount of the athermal 
 ω phase in the alloys. The increase in Mn leads to an increase in both the Vickers 
hardness and Young’s modulus of the alloys by solid solution hardening and its 
effect on the lattice, respectively [ 15 ,  16 ,  18 ]. On the other hand, the decrease in the 
volume fraction of the athermal  ω phase with increasing Mn leads to a decrease in 
both Vickers hardness and Young’s modulus [ 4 ,  19 ].
 Figure  19.6 shows the tensile properties of Ti-(9–18)Mn LM along with that of 
Ti-64 ELI obtained from literature [ 5 ]. The tensile properties of Ti-6Mn were not 
obtained because the specimens suffered premature fracture due to the high amount 
of athermal  ω phase. Ti-9Mn LM and Ti-13Mn LM show ultimate tensile strength 
(UTS,  σ  B  ), 0.2 % proof stress ( σ  0.2  ), and elongation comparable to those reported for 
Ti-64 ELI ( σ  B  : 965 MPa,  σ  0.2  : 869 MPa, elongation: 15 %) [ 5 ]. However, the results 
shown by Ti-9Mn LM ( σ  B  : 1,048 MPa,  σ  0.2  : 1,023 MPa, and elongation: 19 %) make 
the use of this alloy in biomedical applications more promising than either 
Ti-13Mn LM or Ti-64 ELI.
 Figure  19.7 shows the ratio of the amount of released Mn ions to the sum of 
released Ti and Mn ions to a 1 % lactic acid solution, as a function of Mn content in 
the Ti-Mn alloys released from the alloys. The ratio of released Mn ions increases 
in an almost linear relationship with the Mn content observed in the alloys. 
Concerning the toxic effect of Mn ions released in the human body, adult patients 
that displayed symptoms related to Mn intoxication were parenterally administered 
 Fig. 19.5  Young’s moduli of Ti-Mn LM alloys compared to that of Ti-64 ELI ( dashed line ) 
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a daily dosage of at least 0.1 mg of Mn and usually more [ 20 ,  21 ]. The Ti-Mn LM 
alloys immersed in a 1 % lactic acid solution, which is a solution recommended for 
accelerated immersion tests [ 22 ], showed a maximum amount of released Mn ions 
of approximately 0.9 μg/cm 2 (Ti-18Mn) over a period of 7 days. Because the amount 
released is orders of magnitude lower than the amount administered during paren-
teral nutrition, it is believed that the amount of released Mn ions will not reach the 









































Mn content in Ti-Mn alloys (mass%)
 Fig. 19.7  Ratio of amount 
of released Mn ions to the 
sum of released Ti and Mn 
ions as a function of Mn 
content in the Ti-Mn LM 
alloys 
 Fig. 19.6  Tensile properties of Ti-Mn LM alloys along with that of Ti-64 ELI ( rightmost column ) 
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implant with considerable surface area. Furthermore, XPS analysis [ 15 ] revealed 
that the immersion tests using 1 % lactic acid caused the passive oxide layer of the 
alloys to become thinner, but the oxide layer regenerated.
 Figure  19.8 shows the results obtained for the cytotoxicity test. After counting 
the living cells following a 72 h incubation period, signifi cant differences are 
observed between Ti-18Mn LM , CP-Mn, and the other materials. The cytotoxicity of 
Ti-(6–13)Mn LM is comparable to that of CP-Ti. The cell proliferations of Ti-18Mn LM 
and CP-Mn are lower than those of the other alloys. The incubation time of the 72 h 
test leads to a higher amount of released Mn ions from the alloy. It is supposed that 
the amount of released Mn ions from Ti-18Mn LM can inhibit cell proliferation [ 15 ].
19.3.2  Ti-Mn Binary Alloys Fabricated by MIM 
 Table  19.2 shows the chemical compositions of Ti-(8–17)Mn MIM fabricated by 
MIM. The O content of Ti-(8–17)Mn MIM increases with increasing Mn content, from 
approximately 0.23–0.32 mass%. Most of the O present in the alloys originates 
 Fig. 19.8  MC3T3-E1 cell viability ratios for the CP-Ti, Ti-Mn LM alloys, and CP-Mn after 72 h of 
incubation 
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from the Ti and Mn powders, which contain 0.16 and 0.77 mass% O, respectively. 
The C content of the alloys is of approximately 0.06 mass%. This is likely due to C 
pickup during the debinding process [ 23 ]. Furthermore, Mn evaporation is also 
observed to occur during fabrication by MIM, as the Mn content of the alloys is 
lower than the nominal content [ 16 ].
 Figures  19.9 and  19.10 show the optical micrographs and XRD profi les of the 
Ti-(8–17)Mn MIM , respectively. Small closed pores, large interconnected pores, and 
elongated precipitates can be observed in each alloy. Both the pores (ellipses) and 
precipitates (arrows) are mostly located at the grain boundaries. Only the diffraction 
peaks of the attributed to  β planes are observable in the XRD profi les of Ti-(8–17)
Mn MIM . Again, the presence of the athermal  ω phase has been confi rmed by the 
TEM observations. Figure  19.11 shows the SAED patterns and DF images of the 
diffraction spots or streaks of the  ω phase of Ti-(8–17)Mn MIM . Clear diffraction 





 Fig. 19.9  Typical optical micrographs of ( a ) Ti-8Mn MIM , ( b ) Ti-9Mn MIM , ( c ) Ti-12Mn MIM , ( d ) 
Ti-13Mn MIM , ( e ) Ti-15Mn MIM , and ( f ) Ti-17Mn MIM .  Ellipses indicate some of the pores and  arrows 
indicate some of the precipitates 
 Table 19.2  Chemical compositions of Ti-Mn alloys MIM fabricated by MIM (mass%) 
 Alloy 
 Element 
 Nominal Mn  Ti  Mn  O  C  N 
 Ti-8Mn MIM  bal.  7.56  0.233  0.0606  0.0064  8.0 
 Ti-9Mn MIM  bal.  9.29  0.244  0.0654  0.0081  10.0 
 Ti-12Mn MIM  bal.  11.5  0.252  0.0604  0.0096  12.0 
 Ti-13Mn MIM  bal.  13.3  0.270  0.0512  0.0081  14.0 
 Ti-15Mn MIM  bal.  15.4  0.275  0.0655  0.0123  16.0 
 Ti-17Mn MIM  bal.  17.1  0.316  0.0512  0.0075  18.0 
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Ti-8Mn MIM (Fig.  19.11a ). The DF image of the  ω spots (Fig.  19.11g ) evidences a 
high-volume fraction of the athermal  ω phase of Ti-8Mn MIM . The intensity of the 
spots attributed to the athermal  ω phase and the apparent volume fraction of the 
athermal  ω particles gradually decrease with increasing Mn content. It is observed 
that Ti-18Mn LM still shows very diffuse streaks associated to the athermal  ω phase, 




























 Fig. 19.10  XRD profi les of Ti-Mn MIM alloys 
Ti-8MnMIM Ti-12MnMIM Ti-13MnMIM Ti-15MnMIM Ti-17MnMIMTi-9MnMIM





β β β β β βω ω ω ω
a c eb d f
g h i j k l
 Fig. 19.11  Typical SAED patterns viewed from [110]  β  , and corresponding DF images of the dif-
fraction spots or streaks of  ω phase of ( a ) and ( g ) Ti-8Mn MIM , ( b ) and ( h ) Ti-9Mn MIM , ( c ) and ( i ) 
Ti-12Mn MIM , ( d ) and ( j ) Ti-13Mn MIM , ( e ) and ( k ) Ti-15Mn MIM , and ( f ) and ( l ) Ti-17Mn MIM 
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higher O content of the MIM alloys. O has been reported to inhibit the formation of 
 ω phase in Ti alloys [ 24 ]. Figure  19.12 shows the results of the EPMA analysis of 
the precipitates. The precipitates are low in Mn and high in C. The precipitates are 
thus identifi ed as Ti carbides.
 The volume fraction and average diameter of both pores and carbides in the 
alloys have been estimated from the optical micrographs using an image analysis 
software [ 16 ]. There is no signifi cant variation of either the volume fraction and 
average diameter of both pores and precipitates among Ti-(8–17)Mn MIM . However, 
the shapes of the pores in Ti-(8–17)Mn MIM are irregular, although there are no sig-
nifi cant differences among the pore morphologies of the alloys. The irregular pore 
shape is most likely due to the fact that the Mn powder has a more irregular shape 
compared to the Ti powder [ 16 ]. The high C levels facilitate the formation of carbides. 
The morphology of the carbides does not particularly vary among Ti-(8–17)Mn MIM . 
 Figures  19.13 and  19.14 show the Vickers hardness and Young’s modulus of the 
Ti-(8–17)Mn MIM alloys, respectively. The hardness does not signifi cantly vary 
among the alloys, and they are comparable to that of Ti-64 ELI, indicated by the 
dashed line in Fig.  19.13 [ 5 ]. The Young’s moduli of the alloys are all lower than 
that for annealed Ti-64 ELI, indicated by the dashed line in Fig.  19.14 [ 5 ]. Besides 
the parameters already discussed for the alloys fabricated by CCLM, such as the 
amount of athermal  ω phase and the effects of increasing Mn, which can affect both 
hardness and Young’s modulus measurements, other parameters must be considered 
for the alloys fabricated by MIM [ 15 ,  16 ]. The presence of the pores, which cause 
localized stress concentration, tends to decrease the hardness of the alloys [ 23 ,  25 ]. 
Conversely, the presence of carbides, which can cause precipitation strengthening, 
tends to increase the hardness [ 23 ,  25 ]. However, because there is little variation of 
the volume fraction and average diameter of both pores and carbides, these param-
eters do not cause signifi cant variation of the measured hardness and Young’s mod-
ulus among the alloys. Furthermore, higher O contents increase the solid solution 
hardening effect, which in turn increases the hardness [ 25 – 27 ]. These opposing 





 Fig. 19.12  SEM image and EPMA elemental mapping images of Ti, Mn, O, and C in a precipitate 
in a Ti-17Mn MIM alloy specimen 
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 Fig. 19.13  Comparison of Vickers hardness of Ti-Mn MIM alloys with that of Ti-64 ELI ( dashed 
line ) 




19 Development and Performance of Low-Cost Beta-Type Ti-Based Alloys…
242
 Fig. 19.15  Comparison of tensile properties of Ti-Mn MIM alloys. The properties of Ti-64 ELI are 
also shown 
 Figure  19.15 shows the tensile properties of Ti-(8–17)Mn MIM along with those of 
Ti-64 ELI [ 5 ]. Both  σ  B  and  σ  0.2  values for Ti-(8–12)Mn MIM are higher than the cor-
responding values for Ti-64 ELI [ 5 ]. However, the elongation of the Ti-Mn MIM 
alloys is lower than that of annealed Ti-64 ELI. It is noted that the elongation of 
Ti-Mn MIM , which contains higher O content, pores, and carbides, is lower than that 
of Ti-Mn LM , which do not contain pores and carbides and have lower O content. 
Thus, the lower elongation of Ti-Mn MIM can be attributed to the combined effects of 
a higher O content primarily, along with the presence of pores and carbides, which 
are inherent to the MIM process [ 23 ,  28 ,  29 ].
 Figure  19.16 shows the compressive properties of Ti-(8–17)Mn MIM . The com-
pressive 0.2 % proof stress ( σ  c0.2  ) and compressive strain ( ε  c  ) values for Ti-(8–17)
Mn MIM are higher than those for Ti-64 [ 4 ], also shown in Fig.  19.16 . The two main 
parameters that affect the compressive properties of an alloy are the Mn content 
(which causes solid solution strengthening) and the amount of the  ω phase (which 
causes precipitation strengthening). The higher volume fraction of athermal  ω phase 
in Ti-8Mn MIM and Ti-9Mn MIM causes their  σ  c0.2  values to be higher than those of 
Ti-(12–17)Mn MIM . As the volume fraction of the athermal  ω phase decreases in 
Ti-(12–15)Mn MIM , the solid solution strengthening effect of the Mn balances the 
effect of the decreasing  ω phase. The increase in compressive strain with increasing 
Mn content is also due to the decrease in the volume fraction of the athermal  ω 
phase with increasing Mn content.
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19.4  Conclusions 
 Mn was selected as a low-cost  β -stabilizer alloying element to fabricate Ti alloys of 
various compositions. The alloys were fabricated by both CCLM and 
MIM. Microstructural observations, mechanical performance tests, and biocompat-
ibility tests were used to evaluate the mechanical properties and biocompatibility of 
the fabricated Ti-Mn alloys. Regarding the use of Mn as an alloying element with Ti 
and the competitive applicability of Ti-Mn alloys, it was possible to conclude that:
 1.  The alloys are primarily composed of equiaxed  β grains. Some of the alloys with 
lower Mn content also contain the athermal  ω phase. The  β phase stability 
increases, thus decreasing the volume fraction of the athermal  ω phase, with 
increasing Mn content. The alloys fabricated by MIM contain high amounts of O 
and C, which are due to the powders and organic binder used, respectively. 
Because of the high C content, there is the precipitation of Ti carbide in the 
alloys fabricated by MIM. Furthermore, the alloys fabricated by MIM also con-
tain pores. 
 2.  The hardness, Young’s modulus, and tensile strength of Ti-(9–13)Mn LM are com-
parable or superior to those of Ti-64 ELI. The hardness, Young’s modulus, ten-
sile strength, and compressive properties of Ti-(8–13)Mn MIM are comparable or 
superior to those of Ti-64 ELI. However, the ductility of the alloys fabricated by 
MIM is adversely affected by the high oxygen content and the presence of car-
bides and pores. 
 Fig. 19.16  Compressive properties of Ti-Mn MIM alloys and annealed Ti-64 
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 3.  Among both alloys fabricated by CCLM and those fabricated by MIM, Ti-9Mn 
shows the best balance between tensile strength and ductility. In particular, the 
Ti-9Mn LM shows the largest elongation among all the Ti-Mn alloys. Conversely, 
Ti-9Mn MIM shows the lowest compressive properties among these alloys. 
 4.  Every Ti-Mn LM alloy shows ion release rates consistent with their chemical com-
position when immersed in SBF. Ti-(6–13)Mn LM shows good cell viability ratios, 
which are comparable to those of CP-Ti. However, higher Mn concentrations 
should be avoided because of risks of Mn intoxication. 
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 Chapter 20 
 Effect of Titanium Surface Modifi cations 
of Dental Implants on Rapid Osseointegration 
 Ting  Ma ,  Xiyuan  Ge ,  Yu  Zhang , and  Ye  Lin 
 Abstract  The initial cellular response to the dental implant is essential for the sub-
sequent tissue regeneration around the foreign implant surface. There are many 
cells and proteins involved in the integration process which leads to the fi nal osseo-
integration between implants and peri-implant bone tissue. With regard to materials 
used in dental implants, titanium is a prevalent biomaterial applied in orthopedic or 
dental implants due to its premium mechanical and biological properties and osteo-
conductivity. The roughness and chemical composition of the titanium surface 
affect the process and rate of the osseointegration of dental implants. Different stud-
ies on the effect of roughness and wettability of titanium surface on the process of 
early events in the osseointegration are reviewed in this article. In addition, in order 
to accelerate this wound-healing process, varied surface topography and chemical 
composition have been produced depending on different types of surface modifi ca-
tions. The desirable dental implant surface design caters for the development of 
implantology for immediate loading and the improvement of long-term stability. An 
appropriate understanding of the interaction between cells and implant surfaces is 
essential for the future design of new surface which could enhance the speed and 
stability of osseointegration of dental implants. 
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20.1  Introduction 
 In the 1960s, Per Ingvar Brånemark and his colleagues accidentally discovered that 
titanium implants and peri-implant bone tissues could be fi rmly bonded and there 
was no fi brous tissue between the interface according to intravital microscopy 
observation of bone defects around the microcirculation in the experiment, and they 
named this phenomenon “osseointegration.” After continuous revision, in 1985, 
professor Brånemark redefi ned “osseointegration” as a direct interface between liv-
ing bones and the implant surface, and this functional connection can be loaded 
[ 1 ,  2 ]. Due to its premium mechanical properties, chemical stability and biocompat-
ibility, titanium and its alloys have been widely used in dental and orthopedic 
implants [ 3 ]. When titanium and its alloys are exposed in the air within a very short 
time, a dense oxide layer will be formed on its surface. This oxide layer does not 
only boost good biocompatibility but also makes this metallic material biologically 
inert, and the implant surface treatment is usually referred to the modifi cation on 
this oxide layer [ 4 ]. In recent years, with technological development of implantol-
ogy, techniques that shortened treatment time and lower failure risk are urgently 
demanded. In this regard, the osseointegration is affected by the surface character-
istics of the titanium implant, such as roughness, wettability, the chemical composi-
tion, and so on [ 5 ,  6 ]. Therefore, the osseointegration biological process, the 
interaction between cells and implant surface, and some commonly used dental 
implant surface modifi cation methods are reviewed in this article. 
20.2  Cellular Events at the Bone-Implant Interface 
 During the biological process of osseointegration, a great number of different types 
of cells involved in this process exert an important role. Bone-implant integration is 
similar to the wound-healing process, which can be divided into four distinct phases: 
hemostasis phase, infl ammatory phase, proliferative phase, and remodeling phase. 
Once the implant was placed into the prepared site, hemostasis began. Subsequently, 
growth factors and matrix proteins were activated and released from the injured tis-
sue during the drilling process. Within a few seconds to hours, there was a water 
layer on the implant surface and extracellular matrix proteins were adsorbed onto 
the surface. Among these proteins, some of them such as vitronectin and fi bronectin 
have interactions with the following host infl ammatory response. Moreover, aggre-
gated fi brinogen matrix facilitates more platelet adhesion and aggregation, and then 
the release of vasoactive substances and chemokines from the platelets symbolizes 
the beginning of infl ammatory response [ 7 – 10 ] (Fig.  20.1 ).
 The initial stage of the infl ammatory phase is activated by the innate immune 
system. Once adhering to the surface of the implant, neutrophils secrete pro- 
infl ammatory cytokines, collagenase, and other enzymes to remove the foreign bac-
teria. If the bacteria have not been cleared or a large number of bacteria still exist, 
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the duration of cellular innate immune response will be extended, which would 
damage the surrounding normal tissue. Therefore, prolonged cellular innate immune 
response would also impede the wound healing. To sum up, immune and infl amma-
tory responses play an important role during the wound-healing process of foreign 
implants [ 9 ]. In addition, another cell that is adsorbed onto the implant surface is the 
macrophage. Macrophages play an important role in phagocytosis of necrotic tis-
sue, secretion of fi broblast growth factor, and angiogenic growth factors [ 11 ]. As 
osteoblast precursor cells adhered fi rmly, with the expression of osteocalcin and 
alkaline phosphatase, the cells gradually differentiate into mature osteoblasts, fol-
lowed by continuously woven bone formation. In the process of bone remodeling, 
the gradual replacement of woven bone with lamellar bone depends on the interac-
tions between osteoblasts and osteoclasts [ 12 ]. However, the differences between 
the natural wound-healing process and dental implant osseointegration lie in the 
topography, roughness, surface energy, chemical properties, and other elements of 
the implant surface that play an important role during this process [ 13 ,  14 ]. 
20.3  Topography and Roughness of Implant Surface 
 A great number of previous studies suggest that compared to the smooth surface, 
proper micron roughness serves to enhance osteoblast differentiation and increase 
bone-implant contact rate in vivo, even in the absence of osteogenic growth factors 
[ 15 – 18 ]. However, with the increase of surface roughness, the implant surface was 
also enlarged, which might aggravate bacterial colonization [ 19 ]. As a result, the 
balance between the required biological reaction and elimination of plaque accumu-
lation around the implant needs to be considered [ 20 ]. In addition, roughness of 
micron surface topography to a certain extent could activate specifi c cell membrane 
receptors such as integrins, which serves as a communicator in the interactions 
between the extracellular matrix and the cytoskeleton [ 21 ,  22 ]. Previous studies 
indicate that surface roughness of natural bones is about 32 nm, and pore size of 
epithelial basement membrane is about 70–100 nm. Nanoscale roughened material 
 Fig. 20.1  Schematic showing fi brin clot formation on the implant surface and macrophages and 
MSCs play important roles in this process 
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might affect a variety of cells, such as epithelial cells, osteoblasts, fi broblasts, and 
so on [ 23 ]. Some studies show that the nanoscale surface materials are potent in 
altering the adhesion between the surface and the protein or cells. Moreover, 
Webster et al. found that nanosurface materials effectively improved the adhesion of 
vitronectin compared with the microscale surfaces. In addition, the surface of nano-
materials promotes osteoblast adhesion and proliferation [ 24 ,  25 ]. Also, Ellingsen 
et al. found that implants with nanosurface accelerate the bone formation around the 
implants [ 26 ]. 
20.4  The Surface Wettability 
 Wettability is another important feature of the material surface. This basic physical 
parameter can be quantifi ed by the value of the surface contact angle (CA), which is 
fi rst proposed by Thomas Young in 1805 [ 27 ]. Generally, a surface with a contact 
angle of less than 90° is considered as a hydrophilic one and if the contact angle is 
equal to 0°, it is considered as a super-hydrophilic surface. On the contrary, the 
hydrophobic surface is defi ned as the one with the value of CA more than 90°. 
 The roughness would also infl uence the wettability of material surfaces. Previous 
studies have shown that the surface contact angle of the pure titanium was about 
70–90° regardless of surface roughness. However, after a serial surface roughening 
process including acid etching and sandblasting, the CA of the surface could reach 
up to 150°. Moreover, it is reported that the CA of the surface rarely exceeds 120° 
if the material is only treated by chemical methods rather than roughening. 
Therefore, the hydrophobic surfaces with the CA ranging from 125 to 180° often 
call for a combination of different treatments [ 28 – 30 ]. Surfaces with different wet-
tability produce diverse biological effects of osseointegration, and the impact can be 
divided into the following four aspects: protein and biological macromolecular 
adhesion to the material surface, biological behavior of different cells on the sur-
face, the formation of the bacteria biofi lm, and in vivo study of osseointegration. 
 There are different views on the adhesion of protein on the surfaces with differ-
ent wettability. Previous studies have shown that the fi bronectin adhesion is much 
more facilitated on a hydrophilic surface than on the hydrophobic surface, and the 
fi bronectin adhering to the hydrophilic surface can maintain a better biological 
activity which could promote osteoblast adhesion and differentiation [ 7 ,  31 ]. 
However, Tugulu et al. [ 32 ] found that the super-hydrophilic surface treated by 
diluted alkaline solution would reduce the adhesion of the fi brinogen and thereby 
reduce the infl ammation around the implant, which enhances the potential of the 
promotion of implant osseointegration in vivo [ 33 ]. Besides, the adhesion of other 
proteins which play important roles in osteogenic differentiation such as vitronectin 
and type I collagen is also affected by surfaces with diverse characteristics [ 34 ]. 
 More recently, some results demonstrate that the expression of genes related to 
the osteogenic differentiation of mesenchymal stem cells on the super-hydrophilic 
surface is higher than the level of the expression of the cells on the hydrophobic 
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surface, indicating that the super-hydrophilic surface is more conducive to the 
osteogenic differentiation of mesenchymal stem cells than the hydrophobic surface 
[ 17 ,  35 ]. It was also implied that super-hydrophilic surface can serve better to pro-
mote osteoblast maturation and mineralization [ 15 ,  36 ]. In 2005, Buser et al. [ 37 ] 
found that the super-hydrophilic surface modifi ed SLA (modSLA) promoted the 
bone-implant contact rate in the early period (2 and 4 weeks) in vivo, while there 
was no difference between the experimental group and the control group 8 weeks 
later after the implantation. In 2007, Schwarz et al. [ 38 ] indicated that the formation 
of collagen fi bers was observed on the super-hydrophilic surface modSLA of the 
implant in the fi rst 4 days after the implantation. Two weeks later, bones formed 
around the super-hydrophilic surfaces became much denser than those formed on 
the control surfaces. Another experiment conducted on healthy adult volunteers 
showed that the implants with super-hydrophilic surface can promote bone integra-
tion after 2–4 weeks [ 39 ]. In addition, the adhesion and proliferation of the soft 
tissues around the implant such as epithelial cells and fi broblasts were simultane-
ously affected by the wettability of the surface. Similar results showed that super- 
hydrophilic surface was helpful to form the rapid and compact soft tissue seal 
around the implant [ 31 ,  40 ]. In summary, a large number of studies deliver a conclu-
sion that the hydrophilic surface, especially the super-hydrophilic surface, exhibits 
preferable advantages in terms of promoting osseointegration in the early stage. 
20.5  The Common Methods of Surface Modifi cations 
 Since the surface morphology and characteristics of the implant play important 
roles in the osseointegration process, researches on the surface of the implant are 
particularly indispensable. The surfaces with relatively similar features can be 
obtained even through several completely different processes, whereas the same 
process can fabricate two different types of surfaces only by changing their param-
eters [ 41 ]. Based on the topology and the average roughness value (Sa) of the mate-
rial surface, Albrektsson and Wennerberg et al. [ 42 ] classifi ed implant surfaces into 
four categories: smooth surface (Sa: 0–0.04 μm), slightly rough surface (Sa: 0.5–1 
μm), medium rough surface (Sa: 1–2 μm), and rough surface (Sa: > 2 μm). Among 
them, the medium rough surface exhibited satisfactory clinical results in compari-
son with smooth surface and rough surface. In another way by some other research-
ers, the implant surfaces can be classifi ed into three categories based on the surface 
roughness: large roughness surface (Sa greater than 10 μm), micro-sized roughness 
surface (Sa: 1–10 μm), and nano-sized roughness surface [ 16 ]. Among them, the 
rough surface demonstrated satisfactory performance in the protein adhesion, the 
formation of extracellular matrix, the promotion of osteogenic differentiation and 
osseointegration in vivo, etc. Therefore, the roughening treatment is still prevalent 
in modifying the implant surface. 
 The following is the common practical roughening methods, such as plasma 
spraying, sand blasting, chemical etching, anodic oxidation, electrochemical 
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 micro- arc oxidation treatment method, and so on [ 41 ]. By virtue of plasma spraying 
technique, the osteoinductive hydroxyapatite (HA) particles with good biocompat-
ibility and mechanical strength could adhere to the surface and roughen the surface 
at the same time. Moreover, it has been confi rmed that osseointegration can be 
enhanced by this HA-coated surfaces [ 43 ]. 
 Sandblasted and acid-etched (SLA) is a common roughening method employed 
in titanium dental implant surfaces, which forms the complex surface with consider-
ate roughness and micro-roughness. The method mentioned above has been com-
mercialized. Moreover, this approach has a “gold standard” in the industry: fi rstly, 
the surface of the implant is sandblasted by using aluminum oxide particles (250–
500 μm), and then the specimen is etched by HCl/H 2 SO 4 solution of specifi c con-
centration. The average surface roughness (Ra) of the treated material is 1.5 μm 
[ 44 ]. In 1990, Wilke et al. [ 45 ] fi rst reported the in vivo application of SLA surface 
implants and found that the treatment could effectively improve the mechanical 
stability of the implant. Buser et al. [ 46 ] observed that the SLA surface treatment 
effectively increased the bone contact rate of the implant from small pigs in vivo 
compared to the titanium plasma spray method (titanium plasma spray, TPS). A 
body of evidence presented in published data indicates that pits with the diameter of 
1–2 μm can be observed being distributed regularly on the SLA surface and that the 
processing method may raise the short-term bone contact rate of the implant after 
the implantation. In addition, a large number of studies have shown that the SLA 
surfaces of in vitro experiments, animal experiments, and clinical practices have 
achieved good results [ 44 ,  47 ]. Besides, nanoscaled treatments on the implant sur-
face not only affect the topography of the implant surface but also change the chem-
ical properties of the material surface. There are several common nanotechnologies 
for surface processing, including physical compression method, self-assembled 
monolayers, chemical treatment method (acid, alkali, and hydrogen peroxide), 
nanoparticle deposition method, the anodic oxidation method, etc. [ 23 ]. 
 There are several surface treatment methods which could enhance the wettability 
of the surface of the material. For example, Baier et al. [ 48 ] found that the use of 
radio-frequency glow discharge (RFGD) technology could effectively clean and 
disinfect the surface of inorganic materials, thus increasing the surface energy of the 
materials and strengthening the adhesion of the cells. It was reported that the super- 
hydrophilic surface could be formed after an atmospheric plasma treatment on tita-
nium foil. In this way, the contact angle could approach 0°, which greatly facilitates 
osteoblasts to spread on the treated surface [ 49 ]. But at the same time, some 
researchers believe that the chemical or plasma treatment yields satisfactory hydro-
philicity that could not last for long in air [ 50 ]. 
 However, by roughening and chemical treatment of the implant surface, the 
osteoconductivity could thus be enhanced. With the development of biochemical 
techniques, some specifi c short peptide fragments, proteins or growth factors, and 
other biologically active substance could be fi xed onto the surface of the material so 
as to promote surface osteoinductivity. Currently used biologically active molecules 
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currently fall into the following categories: cell adhesion molecules, such as those 
containing arginine-glycine-aspartic acid (RGD) peptide which could promote cell 
adhesion and extracellular matrix attachment; bone morphogenetic proteins (BMP) 
such as the application of BMP-2 and BMP-7, which have strong ability to promote 
bone formation; and growth factors, such as insulin-like growth factors (IGFs), 
transforming growth factor-β (TGF-β), vascular endothelial growth factor (VEGF), 
fi broblast growth factor (FGF), and so on [ 51 ,  52 ]. 
20.6  Polydopamine Surface Modifi cation 
 Marine mussels adhered to the surface of the metal, rock, and so many different 
materials even under humid conditions that rely on the main component of mussel 
adhesive protein (MAPs). The protein contains lysine and L-3,4- 
dihydroxyphenylalanine (L-3,4-dihydroxyphenylalanine, L-DOPA). Inspired by 
the adhesion of mussels, a versatile poly dopamine (PDA) has been developed 
which could adhere to a wide range of organic and inorganic materials, such as met-
als, glasses, ceramics, and other synthetic polymers. In 2007, Lee et al. [ 53 ] found 
that by soaking the material in an alkaline (pH = 8.5) dopamine solution, a layer of 
PDA membrane could be formed on the material surface, which also provided a 
platform for secondary material modifi cation. The two-step method of covalent 
modifi cation of the fi xed type I collagen on the titanium surface by means of PDA 
coating promotes MC3T3-E1 cell adhesion and early osteogenic differentiation 
[ 54 ]. Lee et al. [ 55 ] used 15 short peptides derived from BMP-7 amino acid which 
is called bone formation peptide1 (BFP1) to modify the polylactic acid-glycolic 
acid (PLGA) copolymer surface through PDA coating. The modifi ed materials were 
implanted to reconstruct the skull defects in mice. Eight weeks later, the modifi ed 
materials exhibited enhanced new bone formation around the bone defects. In 
another animal experiment, human adipose-derived stem cells (hADSCs) cultured 
on the PDA and BMP-2-modifi ed PLGA scaffold were implanted in mice skull 
defects, and the modifi ed materials were also found to effectively enhance new bone 
formation [ 56 ]. It is reported that PDA coating is a biocompatible coating which can 
be reduced by PDA-modifi ed PLLA of infl ammation and immune responses [ 57 ]. 
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Chapter 21
Development of Powder Jet Deposition 
Technique and New Treatment for  
Discolored Teeth
Kuniyuki Izumita, Ryo Akatsuka, Akihiko Tomie, Chieko Kuji, 
Tsunemoto Kuriyagawa, and Keiichi Sasaki
Abstract The powder jet deposition (PJD) process is for creation of a hydroxyapa-
tite (HA) layer on human teeth. To develop the PJD device, the layer-forming prop-
erties have improved. Created HA layers with a new handpiece-type PJD device 
demonstrate excellent material properties in vitro. Titanium dioxide (TiO2) is known 
to cause whitening because of the selective reflection of the light. Therefore, we 
assessed the possibility of using the creation of TiO2-HA layers with the new PJD 
device as a new treatment for discolored teeth. In this study, the microstructural and 
mechanical properties of TiO2-HA layers were evaluated under the same conditions 
of the previous study. These properties were evaluated before and after 500 cycles 
of thermal cycling (5–55 °C). Furthermore, the CIE L*a*b* color system was used 
for color measurement and ⊿E* values for color differences were calculated. The 
maximum thickness of the TiO2-HA layers was about 60 μm. There were no signifi-
cant differences in thickness, hardness, or bonding strength before and after thermal 
cycling. The layers showed an increased L* parameter and a decreased b* parameter, 
and the color difference ⊿E* was approximately 6.7 units. Creation of TiO2-HA 
layers by PJD might be a valuable new treatment for discolored teeth.
Keywords Powder jet deposition • Hydroxyapatite • Titanium dioxide • Discolored 
teeth • Thermal cycle
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21.1  Introduction
The biomaterials used for dental restorative treatments have quite different chemi-
cal compositions and mechanical properties from tooth substances which are enamel 
and dentin. Even if the adhesion technique is properly applied, these differences in 
properties between restorative materials and tooth substance can give rise to differ-
ent mechanical, thermal, or chemical stresses in the oral cavity and can lead to clini-
cal problems such as drop-off of the restorative material from the tooth or secondary 
caries [1]. In our previous studies, we presented the possibility of applying a layer 
of HA as a new restorative material with chemical, compositional, and mechanical 
properties corresponding to the tooth substance [2, 3]. A newly developed advanced 
technology called powder jet deposition (PJD) was used to create the HA layers. 
The PJD technique was originated in abrasive jet machining (AJM), which is one of 
the precise processing methods for hard-brittle materials through an average parti-
cle size of approximately 10–20 μm, and it is also a well-established or developed 
noncontact mechanical removal process. When smaller particles of ceramic or 
metal, approximately 1–3 μm in diameter, were blasted onto ceramic substrate by 
the AJM process, the particles were deposited on the substrate. This is called the 
PJD technique. The PJD technique is performed at room temperature and at atmo-
spheric pressure, which enables it to be used with HA particles for the creation of 
HA layers on human teeth [1].
White and well-aligned teeth are the most important aspect of a smile; discolored 
teeth can influence self-esteem and professional relationships [4, 5]. Tooth discolor-
ation is classified as an intrinsic or extrinsic depending on its cause [4–7]. 
Discoloration caused by extrinsic factors, including chromogens derived from cof-
fee, cigarettes, or dental plaque, is generally removed by professional tooth polish-
ing [4–8]. Treatment of teeth with intrinsic discoloration, which may be drug related 
(tetracycline) or caused by pulp tissue remnants after endodontic therapy [9], is 
done by bleaching with radical agents or tooth restoration with dental materials 
such as composite resin. Several studies [10, 11] have reported side effects of tooth 
bleaching agents, such as tooth hypersensitivity, irritation of dental pulp, and 
decreased hardness of enamel. These observations suggest the need for a new treat-
ment for discolored teeth including the creation of an interface layer with material 
similar to the tooth and no adverse tooth substance and pulpal response.
In daily life, TiO2 is a common additive in many foods, pigments, and other con-
sumer products used. TiO2-based ingredients are mostly used as a coloring agent 
[12]. According to a study carried out to determine the influence of TiO2 particles in 
a concentration of 0.10–0.25 %, the particles induced a whiter tooth color and simu-
lated the opalescence of human enamel [13]. We therefore proposed the possibility 
of applying creation of TiO2-HA layers on the human tooth surface by noble PJD 
process as a new treatment for discolored teeth.
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21.2  The Initial Development of PJD Process  
and Evaluation of HA Layers
The first previous study aimed to create HA layers by PJD with manipulating the 
blasting nozzle above human enamel and to evaluate the microstructural properties 
of HA layers in vitro. The caries-free human molars extracted for orthodontic treat-
ment with the informed consent of the patients were used. For each specimen, the 
crown of the molar was severed using a diamond blade cutter and fixed onto an 
aluminum scanning electron microscope (SEM) stage using an epoxy resin-based 
adhesive agent. A flat enamel surface perpendicular to the enamel rods was pre-
pared by polishing each specimen with a silicon carbide grinding wheel, using dia-
mond pastes, to obtain an identical surface. The specimens were treated by PJD, 
using HA particles synthesized by Sangi Co., Ltd. (Tokyo, Japan). A dental PJD 
device developed by Kuriyagawa and Sendai Nikon Co., Ltd. (Miyagi, Japan) was 
used to create the HA layers on the enamel substrate of specimens. The PJD device 
with a blasting nozzle was about 3 cm long, 4 cm wide, and 4 cm tall. In this system, 
when the high- speed solenoid value is opened, the difference in cross-sectional area 
across the particle feed tube generates negative pressure at the particle charging port 
located in the middle of the particle feed tube. The negative pressure causes parti-
cles to be taken up into the tube. The high-speed solenoid value is controlled by a 
personal computer and can be opened and closed at a frequency of approximately 
100 Hz. The particles are carried to the mixing chamber, where they are mixed with 
a continuous flow of accelerating gas and then blasted from the nozzle. The details 
of experimental conditions are shown in Table 21.1. The specimens were fixed on a 
stage, with their enamel surface perpendicular to the nozzle. The layers were pol-
ished using diamond polishing paste (Dia Polisher Paste; GC, Tokyo, Japan) and a 
felt wheel for 30 s with intermittent pressure of 5,000 g [2]. To evaluate the micro-
structure, the cross section of the HA layers was observed by SEM (JSM-6500F, 
JEOL, Tokyo, Japan). Three-dimensional profiles were obtained and surface thick-
ness evaluated using a three-dimensional noncontact measurement system (NH-3; 
Table 21.1 The experimental conditions





study The present study
Substrate Enamel Enamel Enamel
Particles HA HA TiO2-HA
Size of particles [μm] 4.7 3.0 ± 1.0 3.0 ± 1.0
Accelerating gas pressure [MPa] 0.5 0.5 0.5
Feed gas pressure [MPa] – 0.5 0.5
Blasting angle [°] 90 90 90
Blasting time[s] – 30 30
Gap between nozzle and substrate [mm] 1 1 1
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Mitaka Kohki, Tokyo, Japan). The HA particles were densely packed, and there 
were no obvious gaps between the HA layers and the enamel substrate. The maxi-
mum and average thickness was approximately 40 μm and 30 μm, respectively.
21.3  New Handpiece-Type PJD Device and Evaluation 
of Thermal Stress in HA Layers
The aims of the second previous study were to use the PJD device, newly developed 
for use with dental handpieces, to create the HA layer, and to evaluate the micro-
structural and mechanical properties of the HA layer, in particular the effects of 
thermal stress. To apply the HA layers, a newly developed PJD device, of similar 
size to normal dental handpieces, was used (Fig. 21.1). The HA particles were 
mixed in the camber of the PJD device with a continuous flow of accelerating gas 
(air), and then blasted form the nozzle onto the enamel substrate at room tempera-
ture (25 °C) and atmospheric pressure (1 atm). Detailed experimental conditions of 
this study are shown in Table 21.1. For thermal-cycling procedure, a computer- 
controlled two-temperature thermal-cycler (Thermal-cycling K-179; Tokyo-Giken, 
Tokyo, Japan) was used. Two water baths were maintained at 5 °C and 55 °C. Each 
cycle consisted of 20 s immersion in each water bath and a travel time of 10 s. The 
water baths were constantly stirred with stirrers, and the variation in the temperature 
of each water bath was within 1 °C of the set temperature [2, 14]. The specimens 
were first immersed in distilled water at 37 °C for 1 day. After the immersion, the 
specimens underwent 500 thermal cycles [2]. To evaluate their microstructure, the 
cross section of the HA layers was observed by SEM. The three-dimensional pro-
files, including surface thickness, of the layers were evaluated using a three- 
dimensional noncontact measurement system. To evaluate the mechanical properties 
of the layers, micro-Vickers hardness was measured using a dynamic microhardness 
tester (FM-ARS 9000; Future-Tech, Kawasaki, Japan). A load of 100 gf was applied 
for 5 s using a pyramid-shaped die; the depth of the impression was used to 
Fig. 21.1 New handpiece-type PJD device
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calculate the hardness of the specimens [2, 15]. Furthermore, the bonding strength 
of the HA layers to the enamel substrates was evaluated using a micro-tensile test 
(Romulus; Quad Group, Spokane, WA, USA) [2, 16]. An epoxy pre-coated alumina 
stud was placed perpendicularly onto the surface of the specimen. The area of the 
surface coated with the epoxy glue was approximately 2.7 mm in diameter. After 
curing at 150 °C for 1 h, the specimen was set into the testing machine and gripped. 
The study was pulled until destruction of the specimen, and the bonding strength 
was determined as the maximum load recorded [2]. The microstructural properties 
(SEM images, three-dimensional profiles, and surface thickness) and the mechani-
cal properties (micro-Vickers hardness and bonding strength) were evaluated before 
and after the abovementioned thermal-cycling process. The HA particles in the 
deposited layer were densely packed, and the surface of the HA layer was unchanged 
after thermal cycling. The maximum and average thickness were approximately 
60 μm and 50 μm, respectively. There were also no significant differences in the 
hardness and the bonding strength of HA layer before and after thermal cycling.
21.4  New Handpiece-Type PJD Device and Evaluation 
of Thermal Stress in TiO2-HA Layers
These previous studies have led to an understanding of the excellent properties of 
HA layers created by PJD process. However, the microstructural and mechanical 
properties of TiO2-HA layers have not yet been clarified. The objectives of the pres-
ent study are to evaluate the microstructural and mechanical properties of TiO2-HA 
layers before and after thermal-cycling tests under the same conditions of the sec-
ond precious study. To apply the TiO2-HA layers, a newly developed PJD device 
was used. The specimens were treated by with PJD, using HA-TiO2 particles syn-
thesized by Sangi Co., Ltd. (Tokyo, Japan), in which TiO2 was added as a color 
regulator [17]. The microstructural properties of TiO2-HA layers were evaluated 
from SEM and the three-dimensional profiles: surface thickness. The mechanical 
properties were evaluated from micro-Vickers hardness and bonding strength. 
These properties were evaluated before and after the abovementioned 500 cycles of 
thermal cycling. TiO2-HA particles were also densely packed; the maximum and 
average thickness were approximately 60 μm and 50 μm, respectively. There were 
no significant differences in thickness, hardness, or bonding strength before and 
after thermal cycling.
21.5  Color Differences of TiO2-HA Layers
In the previous study, the degree to which TiO2-HA layers influence tooth whitening 
has not been well documented. The objectives of the present study were also to 
evaluate the color differences of TiO2-HA layers. The color was measured using the 
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CIE L*a*b* color measurement system on the spectrophotometer (CMS-35FS/C; 
Murakami Color Research Laboratory, Tokyo, Japan) [17]. The CIE L*a*b* system 
is composed of three coordinates: L* (lightness, from 0 = black to 100 = white), a* 
(from –a = green to +a = red), and b (from –b = blue to + b = yellow). The area of 
irradiation and color measurement were φ6 mm and φ3 mm, respectively, and the 
illuminating and viewing configuration used was CIE diffuse/8° geometry [16, 18]. 
Each specimen was chromatically measured three times under different condi-
tions – (1) before and (2) after creation of the TiO2-HA layer – and the average 
values were calculated. The total color differences between the abovementioned 
three conditions were calculated according to the following equation:
 
∆ ∆ ∆ ∆E L a b* * * *= ( ) + ( ) + ( )2 2 2
 
Color differences between conditions (1) and (2) were calculated as ⊿E which 
evaluates the degree of whitening.
The L*, a*, and b* color parameters and color differences of the three measured 
conditions are listed in Table 21.3. The L* color parameter significantly increased 
between conditions (1) and (2). The a* color parameter did not significantly change 
between any of the conditions. In contrast, the b* color parameter significantly 
decreased between conditions (1) and (2) (p > 0.05, Steel-Dwass multiple compari-
son test). From these data, the calculated total color difference was ⊿E (Table 21.4).
21.6  Discussions
In our previous and present study, SEM images clearly showed that the HA and 
TiO2-HA particles were densely packed in the layers and there were no visible 
pores or cracks between layer and enamel substrate. Cross-sectional SEMs 
reported in a previous study on the microstructure of a plasma-sprayed 50-μm-thick 
HA coating on titanium alloy revealed the presence of cracks in the titanium alloy 
and along the HA coating-substrate interface [19]. Such cracks may be directly 
related to the coating bonding strength [20] and may affect the long-term stability 
of HA coatings [21, 22]. Although the substrate was different, it could be consid-
ered that HA layers with good material properties are more effectively created 
using the PJD process than the abovementioned plasma spray-coating technique. 
From the three-dimensional viewing of HA and TiO2-HA layers created with new 
handpiece-type PJD device, the maximum and the average layer thickness were 
approximately 60 μm and 50 μm, respectively. Using of a new developed PJD 
device enabled us to create HA and TiO2-HA layers on the enamel substrate that 
was thicker than the previously reported layers created by the initial development 
PJD device. The PJD process was improved in two ways. First, smaller particles 
were used than in the previous studies. Second, experimental conditions, such as 
the accelerating pressure and the feed pressure, could be adjusted for the new PJD 
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device for using in dental handpieces. As a result, it was considered that the 
kinetic energy of particles was effectively imparted to give good adhesion proper-
ties of the particles. In case of using new PJD device, the thickness of TiO2-HA 
layers was almost equal to that of HA layers. Therefore, it was expected that the 
TiO2-HA layers would show almost the same good microstructural properties and 
high stability as those of the previous HA layers.
The hardness of the TiO2-HA layers was in the range of approximately 350–
390 Hv. These results are almost the same as those obtained for the HA layers cre-
ated on enamel under the same PJD experimental conditions in the second previous 
study [2]. On the other hand, the bonding strength of the TiO2-HA layers was 
approximately 15 MPa. The micro-tensile bonding strength test used in present 
study has advantages including more economical use of teeth, better control of 
regional differences, and better stress distribution at the true interface [23]. The 
bonding strength of the HA layers created in the second previous study [2] was 
almost the same as that of the TiO2-HA layers in the present study. Furthermore, 
several studies [24–26] have reported bonding strengths of composite resin to 
enamel substrate of 5.9–22.2 MPa; these values are similar to the 15 MPa bonding 
strength measured for the present TiO2-HA layers. Therefore, it was confirmed that 
the present PJD process could create the HA and TiO2-HA layers with good mate-
rial properties on enamel substrates. In addition, our results suggested that addition 
of TiO2 particles would not influence the creation of layers by the PJD process and 
the material properties of HA layers, since the TiO2-HA layers showed almost the 
same excellent material properties as the HA layers.
Thermal-cycling procedures simulate the frequent changes in intraoral tempera-
ture induced by eating, drinking, and breathing [27–29]. Thermal stresses are related 
to mechanical stresses, as differential thermal changes can induce crack propagation 
through bonded interfaces, and the changing gap dimensions are associated with 
gap volume changes which pump pathogenic oral fluids in and out of the gaps [30]. 
According to a review of literature, the sequence of temperatures 35 °C, 15 °C, 
35 °C, and then 45 °C, with a corresponding dwell sequence of 28 s, 2 s, 28 s, and 
2 s, is suggested to be sufficiently clinically relevant [30]. However, the present 
study adopted thermal cycling between 5 and 55 °C for 500 cycles based on the 
International Organization for Standardization (ISO) specifications to examine the 
durability of dental materials [16] in order to evaluate under the same conditions as 
for HA layers in the second previous study [2]. The HA and TiO2-HA layers main-
tained their three-dimensional morphology even after thermal cycling, as deter-
mined from three-dimensional views and SEM images. Table 21.2 showed that 
there were no significant differences in micro-Vickers hardness and bonding 
strength before and after the thermal-cycling procedure.
The color difference results of the TiO2-HA layers are shown in Tables 21.3 and 
21.4. Between conditions (1) and (2), the L* color parameter significantly increased, 
the b* color parameter significantly decreased, and the a* parameter was not changed. 
These results indicate that the created TiO2-HA layers brightened the color of the 
specimens; their color became slightly bluer. According to the study of evaluation 
of whitening effects in vitro, whitening occurs mainly by increasing the L* param-
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eter (higher L*), reducing the yellowness (lower b*), and, to a lesser extent, reducing 
the redness (lower a*) [5, 31]. In addition, subjective responses to whiteness 
improvement are significantly correlated with changes in the b* parameter, and the 
yellow-blue shift is of primary perceptual importance in tooth-whitening proce-
dures [4]. The reason for the observed color change might be related to selective 
absorption and reflection of incident light by the TiO2 particles [21]. From the data 
of L*, a*, and b* color parameters, the calculated total color difference ⊿E, which 
evaluates the degree of whitening, was approximately 6.7 units. Several reports 
have been published about the threshold levels of total color difference that can be 
visually perceived [22, 32]. According to a study on intraoral determination of 
acceptability and perceptibility tolerances for shade mismatch, the color difference 
in the test denture which 50 % of dentists could perceive was 2.6 units, while the 
value at which 50 % of dentists would remake due to color mismatch was 5.5 units 
[32]. This indicates that although the present TiO2-HA layers significantly whitened 
the enamel substrates beyond the perceptible threshold level, their color was mis-
matched with the optical properties of natural teeth.
In conclusion, the new handpiece-type PJD device could create a thick HA and 
TiO2-HA layer on human enamel substrate, and these layers created demonstrated 
and maintained excellent microstructural and mechanical properties comparable to 
those of HA layers in our first previous study even after thermal cycling, which 
simulated the oral environment. Furthermore, it was confirmed that TiO2-HA layers 
could whiten the tooth surface and showed high color stability. However, we found 
Table 21.2 Mean values (and standard deviation) of the micro-Vickers hardness and the bonding 
strength (n = 10)









Before thermal cycling – 391.6(9.80) 371.3(20.7)
After thermal cycling – 401.3(9.74) 365.6(27.5)
Bonding strength Before thermal cycling – 15.6(5.6) 15.7(1.5)
After thermal cycling – 14.8(5.9) 15.5(3.8)
Table 21.3 Mean values (and standard deviation) of CIE L*, a*, b* color parameters for the 
TiO2-HA layers (n = 5)
L* a* b*
(1) Before creation of layers 71.2(1.2) −2.3(0.3) −1.4(0.2)
(2) After creation of layers 78.1a(1.1) −2.3(0.3) −3.9a(0.4)
aThe mean difference is significant at the 0.05 level
Table 21.4 Mean values (and standard deviation) for color difference ⊿E* of the TiO2-HA layers 
(n = 5)
⊿E 6.7(1.1)
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that the whiteness of the layers mismatched the natural tooth color to too great an 
extent, suggesting that adjustment of the HA-TiO2 particles’ TiO2 content may be 
necessary to match the natural tooth color. Stated further, if the creation of layers 
can be adjusted to match the color which patients desires, this raises the possibility 
that creation TiO2-HA layers by the PJD process may be used clinically as a new 
treatment for tooth discoloration. Our future research will assess whether layers 
demonstrating excellent material properties can be created using particles prepared 
by adjusting the TiO2 concentration.
21.7  Conclusion
It was concluded that the new handpiece-type PJD process could create thick HA 
and TiO2-HA layers on enamel substrates, and these layers demonstrated excellent 
microstructural and mechanical properties comparable to those of HA layers cre-
ated by the initial developmental PJD device, even after thermal-cycling procedure. 
Furthermore, TiO2-HA layers could whiten the tooth color and showed high color 
stability. Creation of TiO2-HA layers by the PJD process might be a valuable new 
treatment for discolored teeth.
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 Chapter 22 
 Osteogenetic Effect of Low-Magnitude 
High- Frequency Loading and Parathyroid 
Hormone on Implant Interface in Osteoporosis 
 Aya  Shibamoto ,  Toru  Ogawa ,  Masayoshi  Yokoyama ,  Joke  Duyck , 
 Katleen  Vandamme ,  Ignace  Naert , and  Keiichi  Sasaki 
 Abstract  Osteoporosis could potentially complicate oral implant treatment 
because of disease-specifi c characteristics such as the abnormal bone condition, 
poor healing ability caused by bisphosphonates (BPs), and bisphosphonate-related 
osteonecrosis of the jaw (BRONJ). These problems must be resolved to ensure that 
oral implant treatment is successful in osteoporotic patients. 
 As a novel therapeutic option for increasing the success rate of oral implantation 
in patients with osteoporosis, we focused on parathyroid hormone (PTH) and low- 
magnitude high-frequency (LMHF) loading. Compared to BPs, which inhibit osteo-
clastic bone resorption and suppress bone turnover, PTH stimulates osteoblastic 
bone formation and promotes bone turnover. Intermittent PTH administration is a 
new class of anabolic therapy for the treatment of severe osteoporosis. LMHF load-
ing, which elicits a positive effect on skeleton, has been proposed as a nonpharma-
cological and adjunctive intervention in the treatment of osteoporosis. Previous 
investigation reported that both intermittent PTH administration and LMHF loading 
have an independent osteogenic effect on peri-implant bone healing and implant 
osseointegration. In addition, our recent study reveals their combined therapy acts 
locally and synergistically on peri-implant bone healing process, strengthening 
osseointegration. 
 Therefore, this can be a new therapeutic option for oral implant treatment in 
osteoporotic patients without any problems. 
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 Osseointegration 
22.1  Background 
 Oral implants are a well-accepted and predictable treatment option for the rehabilita-
tion of partially and completely edentulous patients. The osseointegrated implants’ suc-
cess depends on the mechanical support of the host bone in achieving primary stability 
and the biological process of bone adaptation and regeneration in achieving secondary 
stability [ 1 ]. Nevertheless, the extended life expectancy in today’s society has expanded 
the indications for oral implantation in elderly patients with systemic diseases. 
 Osteoporosis is a metabolic bone disorder characterized by low bone mass and 
microarchitectural deterioration of the bone, leading to enhanced bone fragility and 
a consequent increase in fracture risk [ 2 ]. Regardless of the disease characteristics, 
osteoporosis is not considered an absolute contraindication for oral implant treat-
ment [ 3 ,  4 ]. However, some studies have reported implant failure because of a lack 
of primary stability and diffi culty in achieving osseointegration in patients with 
osteoporosis [ 5 ,  6 ]. In addition, bisphosphonates (BPs), which are antiresorptive 
agents and are widely used as the fi rst-choice therapy for osteoporosis, could be a 
risk factor for implant failure. Kasai et al. [ 7 ] compared the success rate of oral 
implants placed in female patients taking oral BPs with a control group not taking 
BPs. The BP group had an 86 % success rate, while the control group had a 95 % 
success rate. BPs also are known to induce BP-related osteonecrosis of the jaw 
(BRONJ), a serious side effect in patients undergoing invasive oral surgery [ 8 ]. There 
are no universally accepted prevention or treatment protocols for BRONJ [ 9 ,  10 ]. 
 Therefore, to treat osteoporotic patients with oral implants successfully, it is nec-
essary to overcome problems associated with the characteristics of osteoporosis, 
BPs, and BRONJ. As a novel therapeutic option for increasing the success rate of 
oral implantation in patients with osteoporosis, we focused on teriparatide [hPTH(1-
 34)] and low-magnitude high-frequency (LMHF) loading. The aim of this review 
was to evaluate the single and combined effects of LMHF loading and PTH treat-
ment on peri-implant bone healing and implant osseointegration in osteoporosis. 
22.2  Teriparatide [hPTH(1-34)] 
22.2.1  PTH as a Therapy for Osteoporosis 
 Teriparatide [hPTH(1-34)] is an analog of human parathyroid hormone (PTH) con-
taining the amino acid sequence 1–34. It is a new class of anabolic agents acting on 
the skeleton and should be considered as an alternative to existing antiresorptive 
agents for the treatment of severe osteoporosis and intractable fractures [ 11 ]. Indeed, 
intermittent systemic administration of hPTH(1-34) reduces the risk of fractures 
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[ 12 ,  13 ] by improving bone microarchitecture and enhancing overall bone mass [ 14 , 
 15 ]. Black et al. [ 16 ] reported that hPTH(1-34) exceeded BPs in increasing bone 
mineral density. In contrast with BPs, which inhibit osteoclastic bone resorption and 
decrease the bone remodeling rate, PTH stimulates osteoblastic bone formation 
through an increase in the bone remodeling rate [ 17 ]. However, the clinical prob-
lems of PTH are as follows: PTH is signifi cantly more expensive than antiresorptive 
agents [ 11 ], PTH is administered by subcutaneous injection [ 11 ], and the duration 
of administration is limited to <2 years based on the induction of osteosarcoma in a 
rat model of carcinogenicity [ 18 ,  19 ]. 
22.2.2  Effect of Intermittent PTH Administration 
on Peri- implant Bone 
 Recent studies have also reported that intermittent hPTH(1-34) administration pro-
motes peri-implant bone healing in animal and clinical models [ 20 – 22 ]. Our present 
study also confi rmed that intermittent hPTH(1-34) administration has a potent 
osteogenic capability in stimulating implant osseointegration in ovariectomized 
(OVX) rats as described in Sect.  30.4 . Although there are clinical problems associ-
ated with PTH, replacement of BPs with PTH is expected to improve bone density 
and quality in surgical sites, promote peri-implant bone formation, and prevent the 
development of BRONJ. 
22.3  Low-Magnitude High-Frequency (LMHF) Loading 
22.3.1  Effect of LMHF Loading on Skeletal Tissue 
 LMHF loading, which is generally defi ned as an LM of <1  g (1  g = 9.98 m/s 2 ) and 
HF of 20–90 Hz, elicits a positive effect on the skeleton (Fig.  22.1 ) [ 23 ,  24 ]. 
Numerous studies have evidenced that LMHF loading, applied by means of whole- 
body vibration (WBV), stimulates bone formation and fracture healing [ 25 – 28 ]. 
WBV loading has already been used clinically as a nonpharmacological interven-
tion in the treatment of osteoporosis [ 29 – 34 ].
22.3.2  Effect of LMHF Loading on Peri-implant Bone 
 Regarding titanium implant osseointegration, which has similarities with bone frac-
ture healing, the coauthors’ previous studies showed that LMHF loading has an 
osteogenetic effect on peri-implant bone [ 35 – 37 ]. In particular, Ogawa et al. [ 35 , 
 38 ] confi rmed that the specifi c parameters of a loading regimen, such as the 
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duration, session distribution, frequency, and amplitude of loading, play an impor-
tant role in the impact of LMHF loading on the bone (Fig.  22.2 ). Additionally, the 
application of LMHF loading reportedly enhances bone-implant osseointegration in 
OVX rats [ 39 – 41 ], which was observed in our present study as described in Sect. 
 30.4 .
 Fig. 22.1  Osteogenetic 
effect of LMHF loading. 
Montages of 
photomicrographs of the 
proximal sheep femur used 
for static 
histomorphometric 
evaluation after 1 year of 
exposure (20 min per day) 
to a 0.3  g , 30-Hz 
mechanical stimulus. There 
was 32 % more trabecular 
bone in the proximal femur 
of experimental animals 
( a ) compared with 
age-matched controls ( b ) 
( P < 0.04) [ 23 ] 
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22.4  Effect of LMHF Loading and Intermittent PTH 
on Peri-implant Bone 
 Both LMHF loading and intermittent hPTH(1-34) administration have an indepen-
dent osteogenic effect on peri-implant bone healing and implant osseointegration. 
However, there are no reports on the impact of their combined therapy on peri- 
implant bone. It seems likely that combined therapy would act synergistically on the 
bone healing process and strengthen bone-implant osseointegration. Additionally, 
the potential synergistic effect may shorten the healing period, thereby relieving the 
clinical problems associated with PTH. 
 Our recent study compared the osteogenic impact of LMHF loading and inter-
mittent hPTH(1-34) administration on peri-implant bone healing and implant osseo-
integration in an osteoporosis model and evaluated their combined effect on these 
processes. Thirteen-week-old ovariectomized rats ( n = 88) were divided into three 
groups: each group of rats received PTH (40 μg/kg, 5 days/week), alendronate 
(15 μg/kg, 2 days/week), and saline (volume-matched vehicle control), respectively. 
After 3 weeks, a titanium implant was inserted in both tibiae. Again, each group was 
subdivided into two groups: with or without LMHF loading via whole-body 
 vibration (WBV, 50 Hz at 0.5  g , 15 min/day, 5 days/week). The rats were sacrifi ced 
1 or 4 weeks after implant installation. Peri-implant bone healing and implant 
osseointegration were assessed using removal torque tests (RT value) and micro-CT 
analyses (relative gray (RG) value, water = 0 and implant = 100). The data were 
analyzed by three-factor ANOVA (loading, drug, healing period) followed with a 
Tukey-HSD test ( α = 0.05). RT value was signifi cantly infl uenced by all three factors 
 Fig. 22.2  Effect of LMHF 
loading on peri-implant 
bone healing and implant 
osseointegration. 
Representative images of 
the test (loaded) and 
control (unloaded) group 
from the 1-week healing 
period ( a ) and the 4-week 
healing period ( b ).  Scale 
bars : 1 mm. After 4 weeks 
of healing, the bone 
neoformation and cortical 
bone width were much 
greater in the test group 
than in the control [ 35 ] 
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( P < 0.01). In particular for PTH-WBV group, these values were highest in all 
groups after 4 weeks of healing. In the cortical bone, RG value was signifi cantly 
infl uenced by the loading ( P < 0.01). In the trabecular bone, on the other hand, RG 
value was signifi cantly infl uenced by the drug ( P < 0.01). The RG values of the 
PTH-treated groups were signifi cantly higher than those of other drug-treated 
groups ( P < 0.01). The results reveal that LMHF loading and PTH act locally and 
synergistically on bone healing process, thereby strengthening implant osseointe-
gration. Interestingly, a previous study reported that the combination of ALN and 
LMHF loading did not lead to a synergistic reaction infl uencing the bone healing 
response [ 41 ]. Similar to the present study, no obvious positive effect was found in 
the ALN and ALN+WBV groups. This might be because ALN inhibits osteoclastic 
bone activity, which is required in the process of bone adaptation and therefore of 
implant osseointegration. The results also indicate that PTH combined with LMHF 
loading has a bone- stimulating effect superior to that of ALN and LMHF loading. 
22.5  Conclusion 
 There were four main fi ndings in this review. In osteoporosis model:
•  LMHF loading has an osteogenetic effect on the peri-implant bone. 
•  Intermittent hPTH(1-34) administration has a potent osteogenic capability in 
stimulating implant osseointegration. 
•  Two treatment modalities act locally on the bone healing process. The cortical 
bone was infl uenced by LMHF loading. The trabecular bone was infl uenced by 
PTH. 
•  The combined application of LMHF loading and PTH synergistically stimulates 
implant osseointegration. Additionally, PTH combined with LMHF loading has 
a bone-stimulating effect superior to that of ALN and LMHF loading. 
 Therefore, this can be a new therapeutic option for oral implant treatment in 
osteoporotic patients without problems such as failure of osseointegration, delayed 
healing, or BRONJ. 
 Confl icts of Interest  The authors report no confl icts of interest. 
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